UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
(Mark One)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the fiscal year ended December 31, 2019
Or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the transition period from to
Commission file number 1-12139
 | ||
SEALED AIR CORPORATION (Exact name of registrant as specified in its charter) | ||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) | ||
(Address of principal executive offices) | (Zip Code) | ||
Registrant’s telephone number, including area code: (980 )-221-3235
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered |
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ☐ No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
☒ | Accelerated filer | ☐ | Emerging growth company | |||||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of the last business day of the registrant’s most recently completed second fiscal quarter, June 30, 2019, the aggregate market value of the registrant’s common stock held by non-affiliates of the registrant was approximately $6,580,640,559 , based on the closing sale price as reported on the New York Stock Exchange.
There were 154,670,740 shares of the registrant’s common stock, par value $0.10 per share, issued and outstanding as of February 21, 2020.
DOCUMENTS INCORPORATED BY REFERENCE:
Portions of the registrant’s definitive proxy statement for its 2020 Annual Meeting of Stockholders, to be held on May 21, 2020, are incorporated by reference into Part III of this Form 10-K.
SEALED AIR CORPORATION AND SUBSIDIARIES
Table of Contents
PART I | |||
Item 1. | |||
Item 1A. | |||
Item 1B. | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
PART II | |||
Item 5. | |||
Item 6. | |||
Item 7. | |||
Item 7A. | |||
Item 8. | |||
Item 9. | |||
Item 9A. | |||
Item 9B. | |||
PART III | |||
Item 10. | |||
Item 11. | |||
Item 12. | |||
Item 13. | |||
Item 14. | |||
PART IV | |||
Item 15. | |||
Item 16. | |||
| 1 |
Cautionary Notice Regarding Forward-Looking Statements
This report contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 concerning our business, consolidated financial condition and results of operations. The Securities and Exchange Commission (“SEC”) encourages companies to disclose forward-looking statements so that investors can better understand a company’s future prospects and make informed investment decisions. Forward-looking statements are subject to risks and uncertainties, many of which are outside our control, which could cause actual results to differ materially from these statements. Therefore, you should not rely on any of these forward-looking statements. Forward-looking statements can be identified by such words as “anticipate,” “believe,” “plan,” “assume,” “could,” “should,” “estimate,” “expect,” “intend,” “potential,” “seek,” “predict,” “may,” “will” and similar references to future periods. All statements other than statements of historical facts included in this report regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding expected future operating results, expectations regarding the results of restructuring and other programs, anticipated levels of capital expenditures and expectations of the effect on our financial condition of claims, litigation, environmental costs, contingent liabilities and governmental and regulatory investigations and proceedings.
Please refer to Part I, Item 1A, “Risk Factors” for important factors that we believe could cause actual results to differ materially from those in our forward-looking statements. Any forward-looking statements made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
The following are important factors that we believe could cause actual results to differ materially from those in our forward-looking statements: global economic and political conditions, currency translation and devaluation effects, changes in raw material pricing and availability, competitive conditions, the success of new product offerings, consumer preferences, the effects of animal and food-related health issues, the effects of epidemics or pandemics, including the Coronavirus Disease 2019 (COVID-19), changes in energy costs, environmental matters, the success of our restructuring activities, the success of our financial growth, profitability, cash generation and manufacturing strategies and our cost reduction and productivity efforts, changes in our credit ratings, the tax benefit associated with the Settlement agreement (as defined below), regulatory actions and legal matters, and the other information referenced in Part I, Item 1A, “Risk Factors.” Any forward-looking statements made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
| 2 |
PART I
Item 1. | Business |
The Company
We are in business to protect, to solve critical packaging challenges, and to leave our world better than we found it.
Sealed Air Corporation ("Sealed Air" or the "Company", also referred to as "we", "us", or "our") was incorporated in Delaware in 1960. We conduct substantially all of our business through two wholly-owned subsidiaries, Cryovac, LLC (formerly, Cryovac, Inc.) and Sealed Air Corporation (US). Please refer to Part II, Item 8, “Financial Statements and Supplementary Data” for financial information about the Company and its subsidiaries, which is incorporated herein by reference. Also, when we cross reference to a “Note,” we are referring to our “Notes to Consolidated Financial Statements,” unless the context indicates otherwise.
We apply knowledge and expertise to develop fulfillment and packaging solutions that minimize food waste, maximize food safety, and protect goods shipped around the world. We apply our expertise in material science to develop sustainable solutions that addresses recyclability, reusability and recycled and/or renewable content.
In 2019, we generated net sales of $4.8 billion, net earnings from continuing operations of $294 million, and Adjusted EBITDA of $965 million, all of which were higher than prior year results. Refer to Part II, Item 7 “Management’s Discussion and Analysis of Financial Conditions and Results of Operations” for reconciliation of net earnings from continuing operations based on Generally Accepted Accounting Principles in the United States of America (“U.S. GAAP”) to total company Adjusted EBITDA presented on a basis which does not conform to U.S. GAAP, which we refer to as “non-U.S. GAAP.”
Competitive Strengths
We strive to deliver the best products at the right price and make them sustainable. In the markets we serve, we leverage our iconic brands, leading market positions, differentiated technologies, global scale/market access, and well-established customer relationships. Our portfolio of leading packaging solutions includes Cryovac® brand food packaging, Sealed Air® brand protective packaging and Bubble Wrap® brand packaging which collectively enable a safer, more efficient food supply chain and protect valuable goods shipped around the world. We execute our strategy through the following competitive strengths.
Leading Market Positions. We are a global provider of packaging solutions for the food, e-Commerce, electronics and industrial markets. For food industries we provide integrated packaging materials, equipment, automation and service solutions that extend shelf life, enhance brands and drive operational excellence by eliminating waste, increasing processing speeds and reducing customers’ labor requirements. For e-Commerce, electronics, and industrial markets we offer a broad range of protective packaging materials and automation solutions that prevent product damage, increase order fulfillment velocity, and generate savings through reductions in waste, dimensional weight and packaging labor.
Innovation, Digitalization and Automation. Sealed Air operates Innovation centers in the U.S. and Europe, and a global network of 39 packaging labs and design centers staffed with an extensive team of scientists, engineers, designers and industry application experts. Our research and development efforts are focused on developing sustainable, innovative solutions to improve our customers’ profitability, and help them deliver outstanding customer experience to their customers. We are investing in digitalization and automation to build an ecosystem of connected machines, people and automated processes.
Sustainability in everything we do. Sustainability is top of mind for our constituents. We focus on reducing climate-related emissions, water use, energy use and waste in our operations and throughout the value chain while innovating and manufacturing high performance packaging. We are involved in worldwide collaborations with objectives to increase recycling, reusability and recycled content. Our sustainability strategy focuses on materials, design, recovery and education to lead industry transformation towards a circular economy.
Global Reach. Sealed Air serves a diverse global customer base with a sales and distribution network reaching 124 countries/regions. In 2019, 48% of net sales were from outside the U.S. This scale and reach enable us to partner with customers as they expand their business on a global basis. Our broad geographic presence and extensive distribution network position us to capitalize on growth opportunities in markets around the world.
| 3 |
Diversified Customer Base. Our customers include the world’s leading food processors, e-Commerce and industrial and electronics manufacturers. We leverage extensive knowledge of our customers’ business when innovating new solutions, and partner with customers to effectively implement our solutions to improve their operations. Our customer base is diverse, with no single customer or affiliated group of customers representing more than 10% of net sales in 2019.
Operational Excellence. We have been optimizing our manufacturing processes and distribution network. These efforts have resulted in plant productivity improvements, network efficiencies, and procurement savings. Operational disciplines are becoming embedded in the organization and demonstrating sustained results.
Reinvent SEE Strategy
In 2018, we completed a thorough assessment of our entire organization and the market opportunities available across the global packaging industry. This assessment confirmed Sealed Air is well positioned to continue delivering organic growth. It also reinforced the need to grow market share and move into adjacent markets with greater speed and efficiency, as we accelerate returns on our highly differentiated innovations. Acting on these findings, Sealed Air formulated and announced its Reinvent SEE Strategy and complementary restructuring program in 2018.
The execution of our Reinvent SEE strategy is well underway and ahead of schedule. The objective is to transform how we innovate, buy, make, and solve customers’ most critical packaging challenges. Throughout the process, our behaviors are focused on the 4P'SSM of Reinvent SEE:
Performance. Achieving world-class performance by driving growth above the markets we serve and increasing our operating leverage while maintaining a disciplined investment approach.
People. Developing a One SEE high performance culture by instilling a strong service culture and developing, retaining and attracting the best and brightest workforce.
Products. Focusing on increasing our innovation rate. Offer our customers the best products at the right price and make them sustainable.
Processes. Embedding One SEE operational excellence into everything we do by eliminating waste, simplifying processes, automating and removing people from harm’s way.
Sustainability. Leaving our world better than we found it by reducing our resource intensity, diverting waste from landfills and improving employee safety.
Segments
We report our segment information in accordance with the provisions of Financial Accounting Standards Board Accounting Standards Codification Topic 280, “Segment Reporting,” (“FASB ASC Topic 280”).
See Note 6, “Segments,” of the Notes to Consolidated Financial Statements for further information.
Recent Developments
On August 1, 2019 the Company acquired 100% of the limited liability company interest in Automated Packaging Systems, LLC, formerly Automated Packaging Systems, Inc. (“Automated”), a leading manufacturer of automated bagging systems. The acquisition is included in our Product Care reporting segment. Automated offers growth opportunities and allows us to further penetrate adjacent markets. Consideration exchanged for Automated was $445.7 million in cash.
On August 1, 2018, we acquired AFP, Inc., a leading, privately held fabricator of foam, corrugated, molded pulp and wood packaging solutions, to join our Product Care division. This acquisition further expands our protective packaging solutions in the electronics, transportation and industrial markets with custom-engineered applications. We acquired 100% of AFP shares for an estimated consideration of $74.1 million, excluding $3.3 million of cash acquired.
On October 2, 2017, we acquired Fagerdala Singapore Pte Ltd. (“Fagerdala”), a manufacturer and fabricator of polyethylene foam based in Singapore, to join our Product Care division. We acquired 100% of Fagerdala shares for estimated consideration of S$144.7 million, or $106.2 million, net of cash acquired of $13.3 million. We acquired Fagerdala to leverage
| 4 |
its manufacturing footprint in Asia, expertise in foam manufacturing and fabrication, and commercial organization to expand our presence across multiple industries utilizing fulfillment to distribute goods.
On March 25, 2017, we entered into a definitive agreement to sell our Diversey Care division and the food hygiene and cleaning business within our Food Care division (collectively, “Diversey”) for gross proceeds of USD equivalent of $3.2 billion. The transaction was completed on September 6, 2017.
See Note 5, “Discontinued Operations, Divestitures and Acquisitions,” of the Notes to Consolidated Financial Statements for further information on these transactions.
Descriptions of the Reportable Segments
Food Care Segment
Food Care largely serves perishable food processors, predominantly in chilled, smoked and processed meat, poultry and dairy-solid markets worldwide, and maintains positions in target applications. Food Care provides integrated packaging materials, equipment, and automation solutions and services to increase operational efficiency, extend shelf life and reduce resource use throughout the supply chain with innovative, sustainable packaging that enables customers to reduce costs and enhance their brands in the marketplace.
Food Care solutions are well aligned to capitalize on global market dynamics driven by continued urbanization, global growth of middle class, the e-food movement, growing consumer preference for smaller portions and healthier food choices, increasing labor scarcity and demand for more sustainable packaging. Our solutions, innovative materials and proven equipment and services preserve nutrition while enhancing food safety. Food Care technologies and continued investment in innovation positions it not only to address, but to be a global provider of solutions for sustainable packaging. Food Care solutions are marketed under the Cryovac® trademark and other highly recognized trade names including Cryovac Grip & Tear®, Cryovac Darfresh®, Cryovac Mirabella®, Simple Steps® and Optidure™.
Food Care applications are largely sold direct to customers by our sales, marketing and customer service personnel throughout the world.
Product Care Segment
Product Care packaging solutions are utilized across many global markets and are especially valuable to e-Commerce, electronics and industrial manufacturing. Product Care solutions are designed to protect valuable goods in shipping, and drive operational excellence for our customers, increasing their order fulfillment velocity while minimizing material usage, dimensional weight and packaging labor requirements. The breadth of Product Care’s solutions portfolio, extensive packaging engineering and technical services, and global reach uniquely supports the needs of multinational customers who require performance excellence, consistency and reliability of supply wherever they operate around the globe. Recent acquisitions of Fagerdala in 2017 and AFP, Inc. in 2018 enabled us to further expand our protective packaging solutions in electronics, transportation and industrial markets with turnkey, custom-engineered, fabricated solutions. The 2019 acquisition of Automated, a leading manufacturer of automated bagging systems, offers growth opportunities and allows us to further penetrate adjacent markets.
Product Care benefits from the continued expansion of e-Commerce, increasing freight costs, scarcity of labor, and increasing demand for more sustainable packaging. Product Care solutions are sold direct as well as through supply distributors that sell to business/industrial end-users. Product Care solutions are additionally sold directly to fabricators, original equipment manufacturers, contract manufacturers, third-party logistics partners, e-commerce/fulfillment operations, and at various retail centers. Product Care solutions are marketed under industry-leading brands including Bubble Wrap® brand inflatable packaging, Sealed Air® brand performance shrink films and Autobag® brand bagging systems. Product Care product families include additional well known tradenames including Instapak® polyurethane foam packaging solutions and Korrvu® suspension and retention packaging. Solutions are sold globally and supported by a network of 39 American Society for Testing and Materials International (“ASTM”)-approved Product Care design and testing centers, and one of the industry’s largest sales and service teams.
Sustainability
As a leader in the packaging industry, we are committed to delivering essential solutions that minimize food waste, maximize food safety, and protect valuable goods shipped around the world. Analysis by our leadership team and Board of
| 5 |
Directors of anticipated issues, risks and opportunities guide our strategy. Our innovation strategy and sustainability goals are aligned as it relates to waste reduction, recyclability and reusability. We are investing in our materials to lighten the weight and increase recycled and/or renewable content, while maintaining the highest performance standards of Sealed Air brands. We believe that our commitment to sustainability differentiates us from competitors.
In 2014, we launched an ambitious plan to achieve a set of 2020 Sustainability Goals within our own internal operations, most of which have been met or are ahead of schedule. We sought to embed sustainability into the fabric of our operational excellence by reducing greenhouse gas emissions, energy and water intensity of our operations and by diverting product and process waste from landfills. We hold our suppliers to the same high standards we have for our own operations.
In late 2018, we announced our 2025 Sustainability and Plastics Pledge that will increase plastics circularity in the packaging industry through the following key initiatives:
Investment in Innovation. Dedicating significant R&D resources to design and advance packaging solutions to be recyclable or reusable and contain more recycled and/or renewable content.
Eliminate Plastic Waste. Achieving ambitious targets of recycled content across all packaging solutions which maximize post-consumer recycled content.
Collaborate for Change. Aligning with strategic partners to combine resources, expertise and corporate voices to find impactful ways to create a circular economy which includes technology investments to facilitate the reuse, collection and recycling of plastic. Two of our leading partners are the Alliance to End Plastic Waste and the Materials Recovery for the Future program.
Global Operations
We operate through our subsidiaries and have a presence in the U.S. and the 47 other countries/regions listed below, enabling us to distribute our products to our customers in 124 countries/regions.
Argentina | Denmark | Israel | Philippines | Taiwan | ||||
Australia | Finland | Italy | Poland | Thailand | ||||
Belgium | France | Japan | Portugal | Turkey | ||||
Brazil | Germany | Luxembourg | Russia | Ukraine | ||||
Canada | Greece | Malaysia | Singapore | United Arab Emirates | ||||
Chile | Guatemala | Mexico | South Africa | United Kingdom | ||||
China | Hong Kong | Netherlands | South Korea | Uruguay | ||||
Colombia | Hungary | New Zealand | Spain | |||||
Costa Rica | India | Norway | Sweden | |||||
Czech Republic | Ireland | Peru | Switzerland | |||||
We face risks inherent in these international operations, such as currency fluctuations, inflation and political instability. Information on currency exchange risk appears in Part II, Item 7A of this Annual Report on Form 10-K, which information is incorporated herein by reference. Other risks attendant to our international operations are set forth in Part I, Item 1A “Risk Factors,” of this Annual Report on Form 10-K, which information is incorporated herein by reference. Information on the impact of currency exchange on our Consolidated Financial Statements appears in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Financial information showing net sales for the year ended December 31, 2019 and total long-lived assets by geographic region as of December 31, 2019 appears in Note 6, “Segments,” which information is incorporated herein by reference. We maintain programs to comply with the various laws, rules and regulations related to the protection of the environment that we may be subject to in the many countries/regions in which we operate. See Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” under the caption “Environmental Matters.”
Raw Materials and Purchasing
Suppliers provide raw materials, packaging components, contract manufactured goods, equipment and other direct materials, such as inks, films and paper. Our principal raw materials are polyolefin and other petrochemical-based resins, as well as paper and wood pulp products. Raw materials represent approximately one-third of our consolidated cost of sales. We also purchase corrugated materials, cores for rolls of products such as films and Bubble Wrap® brand cushioning, inks for printed materials, and blowing agents used in the expansion of foam packaging products. In addition, we offer a wide variety of
| 6 |
specialized packaging equipment, some of which we manufacture or have manufactured to our specifications, some of which we assemble and some of which we purchase from suppliers. Equipment and accessories include industrial and food packaging equipment.
The vast majority of the raw materials required for the manufacture of our products and all components related to our equipment and accessories generally have been readily available on the open market, in most cases are available from several suppliers and are available in amounts sufficient to meet our manufacturing requirements. However, in some regions we have some sole-source suppliers, and the lack of availability of supplies could have a material negative impact on our consolidated financial condition or results of operations. Natural disasters such as hurricanes, as well as political instability and terrorist activities, may negatively impact the production or delivery capabilities of refineries and natural gas and petrochemical suppliers and suppliers of other raw materials. Due to by-product/co-product chemical relationships to the automotive and housing markets, several materials may become difficult to source. These factors could lead to increased prices for our raw materials, curtailment of supplies and allocation of raw materials by our suppliers. We purchase some materials used in our packaging products from materials recycled in our manufacturing operations or obtained through participation in recycling programs. Although we purchase some raw materials under long-term supply arrangements with third parties, these arrangements follow market forces and are in line with our overall global purchasing strategy, which seeks to balance the cost of acquisition and availability of supply.
We have a centralized supply chain organization, which includes centralized management of purchasing and logistic activities. Our objective is to leverage our global scale to achieve purchasing efficiencies and reduce our total delivered cost across all our regions. We do this while adhering to strategic performance metrics and stringent purchasing practices.
Competition
There are other manufacturers of Food Care's products, some that operate across multiple regions and others that operate in a single region or single country. Competing manufacturers produce a wide variety of food packaging based on plastic, metals and other materials. We believe that we are one of the leading suppliers of flexible food packaging materials and related systems in the principal geographic areas in which we offer those products.
Product Care competes against similar products made by other manufacturers and with alternative packaging materials that customers use to provide protection against damage to their products during shipment and storage. Among the competitive materials are paper packaging, expanded plastics, corrugated die cuts, strapping, envelopes, reinforced bags, and corrugated boxes as well as various types of molded foam plastics, fabricated foam plastics, mechanical shock mounts, wood blocking and bracing systems, and an assortment of automated packaging and fulfillment systems. We believe that we are one of the leading suppliers of air cellular cushioning materials containing a barrier layer, inflatable packaging, suspension and retention packaging, shrink films for industrial and consumer applications, protective mailers, polyethylene foam and polyurethane foam packaging systems in the principal geographic areas in which we sell these products.
Some of our competitors in both Food Care and Product Care have been consolidating in recent years or have been involved in significant merger and acquisition activity, and we believe this trend may continue. Such consolidation could have an adverse impact on the pricing of our products and services and our ability to retain customers, which could in turn adversely affect our business, consolidated financial condition or results of operations.
Seasonality
Historically, net sales in our Food Care segment have tended to be slightly lower in the first quarter and slightly higher towards the end of the third quarter through the fourth quarter, due to holiday events. Net sales in our Product Care segment have also tended to be slightly lower in the first quarter and higher in the mid-third quarter and through the fourth quarter due to the holiday shopping season. On a consolidated basis, there is little seasonality in the business, with net sales slightly lower in the first quarter and slightly higher towards the end of the third quarter through the fourth quarter. Our consolidated net earnings typically trend directionally the same as our net sales seasonality, though may be difficult to predict if significant one-time transactions, events or non-recurring charges were to impact our business. Cash flow from operations has tended to be lower in the first quarter and higher in the fourth quarter, reflecting seasonality of sales and working capital changes, including the timing of certain annual incentive compensation payments.
Other factors may outweigh the effects of seasonal changes in our net earnings results including, but not limited to, changes in raw materials and other costs, foreign exchange rates, interest rates, taxes and the timing and amount of acquisition synergies and restructuring and other non-recurring charges.
| 7 |
Research and Development Activities
We are advancing science and technology and creating new intellectual property which underpins the development of new solutions for our customers, including new, sustainable packaging materials, equipment automation and integration, applications knowledge, and support for our digital solutions. We maintain key external partnerships and are constantly searching for new partnerships that bring unique value, including licensing or acquiring new technologies developed by others. Our technical capabilities encompass a broad range of disciplines including food science, materials science, chemistry and chemical engineering, mechanical engineering, electrical and software engineering, microbiology, package design and engineering and equipment engineering.
In order to best position ourselves for delivering innovative solutions that are compatible with our strategic intent, we rationalized our portfolio of innovation pipelines and focused our efforts to deliver projects that have faster speed to market and that have better chance of profitable growth. Therefore, our research and development expense was $77 million in 2019, $81 million in 2018 and $92 million in 2017.
Our research and development activities are focused on end-use applications. As a result, we operate:
• | four comprehensive Packaging Development and Innovation Centers located in the U.S., Italy, and Singapore; |
• | seven Equipment Design Centers in the U.S., France, Switzerland, Italy and Singapore targeting innovation in equipment and digital solutions; and |
• | 39 Package Design and Applications Centers for Product Care globally. |
In addition, we are expanding our R&D capabilities through acquisitions made in 2019, which included R&D teams and facilities.
Patents and Trademarks
We own or are the licensee of approximately 2,850 U.S. and foreign patents and patent applications, and approximately 2,600 U.S. and foreign trademark registrations and trademark applications that relate to many of our products, manufacturing processes and equipment. We believe that our patents and trademarks collectively provide a competitive advantage. We file annually an average of approximately 270 U.S. and foreign patent applications and approximately 40 U.S. and foreign trademark applications. None of our reportable segments is dependent upon any single patent or trademark alone. Rather, we believe that our success depends primarily on our sales and service, marketing, engineering and manufacturing skills and on our ongoing research and development efforts. We believe that the expiration or unenforceability of any of our patents, applications, licenses or trademark registrations would not be material to our business or consolidated financial condition.
Environmental, Health and Safety Matters
As a manufacturer, we are subject to various laws, rules and regulations in the countries/regions, jurisdictions and localities in which we operate. These cover: the safe storage and use of raw materials and production chemicals; the release of materials into the environment; standards for the treatment, storage and disposal of solid and hazardous wastes; or otherwise relate to the protection of the environment. We have an environmental management system that aids in our management of environmental, health and safety matters pertaining to our operations. Key elements of this environmental management system are implemented throughout our operations. We believe that compliance with current environmental and workplace health and safety laws and regulations has not had a material effect on our capital expenditures or consolidated financial condition.
In some jurisdictions in which our packaging products are sold or used, laws and regulations have been adopted or proposed that seek to regulate, among other things, minimum levels of recycled or reprocessed content and, more generally, the sale or disposal of packaging materials. We maintain programs designed to comply with these laws and regulations and to monitor their evolution. Various federal, state, local and foreign laws and regulations regulate some of our products and require us to register certain products and comply with specified requirements. We are also subject to various federal, state, local and foreign laws and regulations that regulate products manufactured and sold by us for controlling microbial growth on humans, animals and processed foods. In the U.S., these requirements are generally administered by the U.S. Food and Drug Administration (“FDA”). To date, the cost of complying with product registration requirements and FDA compliance has not had a material adverse effect on our business, consolidated financial condition, results of operations or cash flows.
Our emphasis on environmental, health and safety compliance provides us with risk reduction opportunities and cost savings through asset protection and protection of employees. We have a policy in place that guides the Company in environmental, health and safety matters including training, materials conservation, communications, targets and transparency.
| 8 |
Employees
As of December 31, 2019, we had approximately 16,500 employees worldwide. Approximately 7,000 of these employees were in the U.S., with approximately 100 of these employees covered by collective bargaining agreements. Of the approximately 9,500 employees who were outside the U.S., approximately 4,700 were covered by collective bargaining agreements. Of our 4,800 employees covered by collective bargaining agreements, approximately 35%, primarily outside the U.S., will expire within the next year and we will be engaged in negotiations to attain new agreements. Many of the covered employees are represented by works councils or industrial boards, as is customary in the jurisdictions in which they are employed. We believe that our employee relations are satisfactory.
Available Information
Our Internet address is www.sealedair.com. We make available, free of charge, on or through our website, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports that we file or furnish pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, or the Exchange Act, as soon as reasonably practicable after we electronically file these materials with, or furnish them to, the Securities and Exchange Commission (“SEC”). The SEC maintains an Internet site that contains these filings and they can be accessed via the Internet address https://www.sec.gov. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this Form 10-K.
| 9 |
Item 1A. Risk Factors
Introduction
The risks described below should be carefully considered before making an investment decision. These are the most significant risk factors, but they are not the only risk factors that should be considered in making an investment decision. This Form 10-K also contains and may incorporate by reference forward-looking statements that involve risks and uncertainties. See the “Cautionary Notice Regarding Forward-Looking Statements,” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of this Form 10-K. Our business, consolidated financial condition or results of operations could be materially adversely affected by any of these risks. The trading price of our securities could decline due to any of these risks, and investors in our securities may lose all or part of their investment.
Uncertain global economic conditions have had and could continue to have an adverse effect on our consolidated financial condition and results of operations.
Uncertain global economic conditions have had and may continue to have an adverse impact on our business in the form of lower net sales due to weakened demand, unfavorable changes in product price/mix, or lower profit margins. For example, global economic downturns have adversely impacted some of our end-users and customers, such as food processors, distributors, supermarket retailers, restaurants, industrial manufacturers, retail establishments, business service contractors and e-commerce and mail order fulfillment firms, and other end-users that are particularly sensitive to business and consumer spending.
During economic downturns or recessions, there can be a heightened competition for sales and increased pressure to reduce selling prices as our customers may reduce their volume of purchases from us. If we lose significant sales volume or reduce selling prices significantly, then there could be a negative impact on our consolidated financial condition or results of operations, profitability and cash flows.
Also, reduced availability of credit may adversely affect the ability of some of our customers and suppliers to obtain funds for operations and capital expenditures. This could negatively impact our ability to obtain necessary supplies as well as our sales of materials and equipment to affected customers. This also could result in reduced or delayed collections of outstanding accounts receivable.
We may face risks related to health epidemics or outbreaks of communicable diseases. The outbreak of such a communicable disease could result in a widespread health crisis that could adversely affect general commercial activity and the economies and financial markets of many countries. For example, the recent outbreak in China of the Coronavirus Disease 2019 (COVID-19) which has been declared by the World Health Organization to be a “public health emergency of international concern,” has spread across the globe and is impacting worldwide economic activity. A public health epidemic, including COVID-19, poses the risk that we or our employees, contractors, suppliers, customers and other business partners may be prevented from conducting business activities for an indefinite period of time, including due to shutdowns that may be requested or mandated by governmental authorities. While it is not possible at this time to estimate the impact that COVID-19 could have on our business, the continued spread of COVID-19 and the measures taken by the governments of countries affected could disrupt the supply chain and the manufacture or shipment of our products and adversely impact our business, financial condition or results of operations.
The global nature of our operations exposes us to numerous risks that could materially adversely affect our consolidated financial condition and results of operations.
We operate in 48 countries/regions, and our products are distributed to 124 countries around the world. A large portion of our manufacturing operations are located outside of the U.S. and approximately one-half of our net sales are generated outside of the U.S. These operations, particularly in developing regions, are subject to various risks that may not be present or as significant for our U.S. operations. Economic uncertainty in some of the geographic regions in which we operate, including developing regions, could result in the disruption of commerce and negatively impact cash flows from our operations in those areas.
Risks inherent in our international operations include:
• | foreign currency exchange controls and tax rates; |
• | foreign currency exchange rate fluctuations, including devaluations; |
| 10 |
• | adverse impacts resulting from regional or global human health related illness such as the recent outbreak of COVID-19 which may impact travel, trade and the overall economic conditions of regions with the greatest concentration of transmission, specifically parts of China and may impact other geographic areas in which we have operations. The COVID-19 has and may continue to have an impact on ports and trade into and out of China. We have eight manufacturing facilities in China. Additionally, China accounted for approximately 3% of sales in 2019; |
• | the potential for changes in regional and local economic conditions, including local inflationary pressures or impacts resulting from the United Kingdom's exit from the European Union; |
• | restrictive governmental actions such as those on transfer or repatriation of funds and trade protection matters, including antidumping duties, tariffs, embargoes and prohibitions or restrictions on acquisitions or joint ventures; |
• | changes in laws and regulations, including the laws and policies of the U.S. affecting trade and foreign investment; |
• | the difficulty of enforcing agreements and collecting receivables through certain foreign legal systems; |
• | variations in protection of intellectual property and other legal rights; |
• | more expansive legal rights of foreign unions or works councils; |
• | changes in labor conditions and difficulties in staffing and managing international operations; |
• | import and export delays caused, for example, by an extended strike at the port of entry, could cause a delay in our supply chain operations; |
• | social plans that prohibit or increase the cost of certain restructuring actions; |
• | the potential for nationalization of enterprises or facilities; |
• | unsettled political conditions and possible terrorist attacks against U.S. or other interests; and |
• | there are potential tax inefficiencies and tax costs in repatriating funds from our non-U.S. subsidiaries. |
These and other factors may have a material adverse effect on our international operations and, consequently, on our consolidated financial condition or results of operations.
Fluctuations between foreign currencies and the US Dollar could materially impact our consolidated financial condition or results of operations.
Approximately 48% of our net sales in 2019 were generated outside the U.S. We translate sales and other results denominated in foreign currency into US Dollars for our Consolidated Financial Statements. As a result, the Company is exposed to currency fluctuations both in receiving cash from its international operations and in translating its financial results back to US Dollars. During periods of a strengthening US Dollar, our reported international sales and net earnings could be reduced because foreign currencies may translate into fewer US Dollars. Foreign exchange rates can also impact the competitiveness of products produced in certain jurisdictions and exported for sale into other jurisdictions. These changes may impact the value received for the sale of our goods versus those of our competitors. The Company cannot predict the effects of exchange rate fluctuations on its future operating results. As exchange rates vary, the Company's results of operations and profitability may be harmed. While we use financial instruments to hedge certain foreign currency exposures, this does not insulate us completely from foreign currency effects and exposes us to counterparty credit risk for non-performance. See Note 15, “Derivatives and Hedging Activities,” of the Notes to Consolidated Financial Statements. Such hedging activities may be ineffective or may not offset more than a portion of the adverse financial effect resulting from foreign currency variations. The gains or losses associated with hedging activities may negatively impact the Company's results of operations.
In all jurisdictions in which we operate, we are also subject to laws and regulations that govern foreign investment, foreign trade and currency exchange transactions. These laws and regulations may limit our ability to repatriate cash as dividends or otherwise to the U.S. and may limit our ability to convert foreign currency cash flows into US Dollars.
We have recognized foreign exchange losses related to the currency devaluations in Argentina and its designation as a highly inflationary economy under U.S. GAAP. See Note 2, “Summary of Significant Accounting Policies and Recently Issued Accounting Standards,” of the Notes to Consolidated Financial Statements.
Raw material pricing, including how our selling prices reflect the cost of raw materials, availability and allocation by suppliers as well as energy-related costs may negatively impact our results of operations, including our profit margins.
We use petrochemical-based raw materials to manufacture many of our products. The prices for these raw materials are cyclical and increases in market demand or fluctuations in the global trade for petrochemical-based raw materials and energy could increase our costs. While, historically we have been able to successfully manage the impact of higher raw material costs by increasing our selling prices, if we are unable to minimize the effects of increased raw material costs through sourcing,
| 11 |
pricing or other actions, our business, consolidated financial condition or results of operations may be materially adversely affected. A portion of our sales prices are determined using formula based pricing which reflects changes in underlying raw material indices. Formula based pricing lags raw material cost movement by approximately six months. We may experience a benefit (when resin prices decrease) or detriment (when resin prices increase) to our cost of goods sold before those price changes are reflected in our selling prices. As such, trends in raw material pricing may have a negative impact on future profit margins. We also have some sole-source suppliers, and the lack of availability of supplies could have a material adverse effect on our consolidated financial condition or results of operations.
Natural disasters such as hurricanes, as well as political instability and terrorist activities, may negatively impact the production or delivery capabilities of refineries and natural gas and petrochemical suppliers and suppliers of other raw materials in the future. These factors could lead to increased prices for our raw materials, curtailment of supplies and allocation of raw materials by our suppliers and harm relations with our customers which could have a material adverse effect on our consolidated financial condition or results of operations.
Unfavorable customer responses to price increases could have a material adverse impact on our sales and earnings.
From time to time, and especially in periods of rising raw material costs, we increase the prices of our products. Significant price increases could impact our earnings depending on, among other factors, the pricing by competitors of similar products and the response by the customers to higher prices. Such price increases may result in lower volume of sales and a subsequent decrease in gross margin and adversely impact earnings.
Demand for our products could be adversely affected by changes in consumer preferences or if we are not able to innovate and bring new products to market.
Our sales depend heavily on the volumes of sales by our customers in food processing and service industries, the industrial manufacturing and electronics sections, and e-Commerce. Consumer preferences for food and durable goods packaging can influence our sales. Consumer preferences for fresh and unpackaged foods and the global e-Commerce and industrial market change over time. Changes in consumer behavior, including changes driven by cost, availability, durability, sustainability, innovation, or various health-related concerns and perceptions, could negatively impact demand for our products.
Innovation is key to our strategy. Our performance and prospects for future growth could be adversely affected if new products do not meet sales or margin expectations and we are not able to meet our innovation rate goals. Our customers' preferences continue to trend towards sustainable packaging solutions. We believe that we are well positioned to offer these solutions to our customers, but our success is dependent on continued innovation in sustainability and our ability to bring new products to market in an efficient manner.
Our competitive advantage is due in part to our ability to develop and introduce new and sustainable products in a timely manner at favorable margins. The development and introduction cycle of new products can be lengthy and involve high levels of investment. New products may not meet sales or margin expectations due to many factors, including our inability to (i) accurately predict demand, end-user preferences and evolving industry and regulatory standards; (ii) resolve technical and technological challenges in a timely and cost-effective manner; or (iii) achieve manufacturing efficiencies.
We experience competition in the markets for our products and services and in the geographic areas in which we operate.
Our packaging products compete with similar products made by other manufacturers and with a number of other types of materials or products. We compete on the basis of performance characteristics of our products, as well as service, price and innovations in technology. A number of competing domestic and foreign companies are well-established.
Customers in the e-commerce and food service industry and peers in the packaging industry have been consolidating in recent years, and we believe this trend may continue. Such consolidation could have an adverse impact on the pricing of our products and services and our ability to retain customers, which could in turn adversely affect our business, consolidated financial condition or results of operations.
Our inability to maintain a competitive advantage could result in lower prices or lower sales volumes for our products. Additionally, we may not successfully implement our pricing actions. These factors may have an adverse impact on our consolidated financial condition or results of operations.
| 12 |
Large-scale animal health issues as well as other health issues affecting the food industry and disruptive forces of nature, such as significant regional droughts, prolonged severe weather conditions, floods, and natural disasters may lead to decreased revenues.
We manufacture and sell food packaging products, among other products. Various forces of nature affecting the food industry have in the past and may in the future have a negative effect on the sales of food packaging products. Outbreaks of animal diseases may lead governments to restrict exports and imports of potentially affected animals and food products, leading to decreased demand for our products and possibly also to the culling or slaughter of significant numbers of the animal population otherwise intended for food supply. Recently, African Swine Fever, a viral disease affecting both domestic and wild pigs, has spread throughout China, South Korea and Vietnam as well as within parts of the European Union and has disrupted pork production. Other disruptive forces of nature such as droughts, floods and other severe weather can lead to agricultural market impacts resulting in reduced herd size or modifications to the traditional herd cycles which could affect demand for our products. Severe wildfires in Australia in late 2019 and early 2020 may have a negative impact on cattle and beef production in the region. Also, consumers may change their eating habits as a result of perceived problems with certain types of food. These factors may lead to reduced sales of food packaging products, which could have a material adverse effect on our consolidated financial condition or results of operations.
We are involved in ongoing investigations by the U.S. Attorney's Office ("USAO") and U.S. Securities and Exchange Commission, the results of which could adversely impact our business and results of operations and our ability to comply with certain obligations imposed by federal securities laws and other applicable rules.
The Company has received from the staff of the SEC subpoenas for documents and requests for information in connection with the SEC's previously disclosed investigation. Those subpoenas and requests seek documents and information regarding the Company's accounting for income taxes, its financial reporting and disclosures, the process by which the Company selected its former independent audit firm which audited the fiscal years of 2015 through 2018, the independence of that audit firm, and other matters. The Company has also received a Grand Jury subpoena from the USAO seeking documents relating to the termination of our former CFO and relating to the process by which the Company selected its previous independent audit firm. The Company is fully cooperating with the SEC and the USAO. However, we cannot predict the outcome or duration of either of those investigations and there can be no guarantee as to the amount of internal and external resources we may need to devote to responding to any further requests we may receive from the SEC and/or the USAO. In addition, if the SEC and/or the USAO were to charge the Company with violations, we could potentially be subject to fines, penalties or other adverse consequences, and our business and financial condition could be adversely impacted. Finally, any determination that the Company’s previous audit firm was not independent during the years it audited could require that certain of our historical financial statements be re-audited by a different registered public accounting firm which could affect our ability to comply with certain reporting obligations imposed by federal securities laws.
We are the subject of various legal proceedings, and may be subject to future claims and litigation, that could have a material adverse effect on our business and results of operations.
We are involved from time to time in various legal proceedings, including the securities class action lawsuit, stockholder derivative action and other actions described in Part I, Item 3, Legal Proceedings. Litigation, in general, and securities, derivative actions and class action litigation, in particular, can be expensive and disruptive. Some of these proceedings may involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. Litigation and other adverse legal proceedings could materially adversely affect our businesses, operating results and/or cash flows because of reputational harm to us caused by such proceedings, the cost of defending such proceedings, the cost of settlement or judgments against us or the changes in our operations that could result from such proceedings.
Concerns about the impact that plastic materials have on the environment, along with changes in legal, regulatory, customer preferences or market measures to address these concerns, may negatively affect our business and operations.
Public attention to plastic waste and its associated environmental impact continues to increase. Some jurisdictions have laws and regulations that govern the registration and labeling of some of our products. Customer preferences and buying behaviors may change as a result of public attention to plastic waste and current and future regulations, such as those recently announced in the EU Parliament and in China. Currently, single-use plastic ban proposals have focused on specific items such as grocery bags, cutlery, beverage straws and stir sticks, expanded polystyrene or oxo-degradable plastic. At present, none of the products we manufacture have been banned.
| 13 |
We maintain programs designed to comply with laws and regulations and to monitor their evolution. We also continue to innovate our packaging solutions to meet recyclability or reusability requirements, address cube optimization to eliminate non-recyclable plastic waste, and increase the use of recycled and/or renewable materials. However, while we believe that we are well positioned to meet sustainability and recyclability demands of our customers with innovative solutions and new formulations of our materials, ongoing development of government policies to restrict waste imports, to ban single use plastics and to increase recycling and recovery, and changes in customer preferences may have an adverse effect on our business, consolidated financial condition or results of operations.
Our operations are subject to a variety of environmental laws that expose us to regulatory scrutiny, potential financial liability and increased operating costs.
Our operations are subject to a number of federal, state, local and foreign environmental, health and safety laws and regulations that govern, among other things, the manufacture of our products, the discharge of pollutants into the air, soil and water and the use, handling, transportation, storage and disposal of hazardous materials.
Many jurisdictions require us to have operating permits for our production and warehouse facilities and operations. Any failure to obtain, maintain or comply with the terms of these permits could result in fines or penalties, revocation or nonrenewal of our permits, or orders to cease certain operations, and may have a material adverse effect on our business, financial condition, results of operations and cash flows.
We generate, use and dispose of hazardous materials in our manufacturing processes. In the event our operations result in the release of hazardous materials into the environment, we may become responsible for the costs associated with the investigation and remediation of sites at which we have released pollutants, or sites where we have disposed or arranged for the disposal of hazardous wastes, even if we fully complied with environmental laws at the time of disposal. We have been, and may continue to be, responsible for the cost of remediation at some locations.
We are also subject to various federal, state, local and foreign laws and regulations that regulate products manufactured and sold by us for controlling microbial growth on humans, animals and processed foods. In the U.S., these requirements are generally administered by the FDA. We maintain programs designed to comply with these laws and regulations and to monitor their evolution. To date, the cost of complying with product registration requirements and FDA compliance has not had a material adverse effect on our business, consolidated financial condition, results of operations or cash flows.
We cannot predict with reasonable certainty the future cost to us of environmental compliance, product registration, or environmental remediation. Environmental laws have become more stringent and complex over time. Our environmental costs and operating expenses will be subject to evolving regulatory requirements and will depend on the scope and timing of the effectiveness of requirements in these various jurisdictions. As a result of such requirements, we may be subject to an increased regulatory burden, and we expect significant future environmental compliance obligations in our operations. Increased compliance costs, increasing risks and penalties associated with violations, or our inability to market some of our products in certain jurisdictions may have a material adverse effect on our business, consolidated financial condition or results of operations.
Cyber risk and the failure to maintain the integrity of our operational or security systems or infrastructure, or those of third parties with which we do business, could have a material adverse effect on our business, consolidated financial condition and results of operations.
We are subject to an increasing number of information technology vulnerabilities, threats and targeted computer crimes which pose a risk to the security of our systems and networks and the confidentiality, availability and integrity of our data. Disruptions or failures in the physical infrastructure or operating systems that support our businesses and customers, or cyber attacks or security breaches of our networks or systems, could result in the loss of customers and business opportunities, legal liability, regulatory fines, penalties or intervention, reputational damage, reimbursement or other compensatory costs, and additional compliance costs, any of which could materially adversely affect our business, consolidated financial condition and results of operations. While we attempt to mitigate these risks, our systems, networks, products, solutions and services remain potentially vulnerable to advanced and persistent threats.
We also maintain and have access to sensitive, confidential or personal data or information in certain of our businesses that is subject to privacy and security laws, regulations and customer controls. Despite our efforts to protect such sensitive, confidential or personal data or information, our facilities and systems and those of our customers and third-party service providers may be vulnerable to security breaches, theft, misplaced or lost data, programming and/or human errors that could lead to the compromising of sensitive, confidential or personal data or information, improper use of our systems, software
| 14 |
solutions or networks, unauthorized access, use, disclosure, modification or destruction of information, defective products, production downtimes and operational disruptions, which in turn could adversely affect our business, consolidated financial condition and results of operations.
The regulatory environment surrounding cybersecurity and data privacy is increasingly demanding, with new and changing regulations, such as the European Union’s General Data Protection Regulation (GDPR). We could be required to expend additional resources to comply with any such regulations, and failure to comply could subject us to significant penalties or claims.
We may not be able to complete future acquisitions or acquired businesses may underperform relative to our expectations. Furthermore, we may not be able to successfully integrate these businesses without significant use of resources or diversion of management’s attention.
Successful acquisition and integration of target companies may be limited by the availability of suitable acquisition candidates, the ability to obtain necessary third-party approvals and availability of financial resources. Acquisitions involve numerous risks, including difficulty determining valuation, integration of acquired operations, technologies, services and products, key personnel turnover, and the diversion of management's attention from other business matters. Ultimately, we may be unable to achieve the expected benefits and synergies which could adversely affect our business.
We may be required to make payments or unable to collect payments owed to us under agreements or other claims or litigation associated with previous acquisition or divestiture activity.
We have made various acquisitions and divestitures as part of executing our business strategy. From time to time this activity may result in the future settlement of amounts with the counterparty. Examples of these items include but are not limited to purchase price adjustments, transition service agreements, clawback agreements or contingent considerations.
The settlement of activity associated with previous acquisitions or divestitures, may result in us making cash payments, including amounts beyond what has been accrued on our Consolidated Balance Sheets, or recognizing a loss on receivables recorded on our Consolidated Balance Sheets. This may also result in higher legal fees and a negative impact on future cash flow.
We may not achieve or be able to sustain all of the expected benefits from our restructuring program.
Over time, we have implemented a number of restructuring programs, including various cost savings and reorganization initiatives. Currently the Company is in the midst of a restructuring program as part our Reinvent SEE strategy. We have made certain assumptions in estimating the anticipated savings we expect to achieve under such programs, which include the estimated savings from the elimination of certain headcount and the consolidation of facilities. We have also made assumptions on the expected cash spend to achieve the anticipated savings. These assumptions may turn out to be incorrect due to a variety of factors. In addition, our ability to realize and sustain the expected benefits from these programs is subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. If we are unsuccessful in implementing these programs, do not achieve our expected results or are unable to maintain the savings on a long-term basis, our consolidated results of operations and cash flows could be adversely affected or our business operations could be disrupted.
Product liability claims or regulatory actions could adversely affect our financial results or harm our reputation or the value of our brands.
Claims for losses or injuries purportedly caused by some of our products arise in the ordinary course of our business. In addition to the risk of substantial monetary judgments, product liability claims or regulatory actions could result in negative publicity that could harm our reputation in the marketplace or adversely impact the value of our brands or our ability to sell our products in certain jurisdictions. We could also be required to recall possibly defective products, or voluntarily do so, which could result in adverse publicity and significant expenses. Although we maintain product liability insurance coverage, potential product liabilities claims could be excluded or exceed coverage limits under the terms of our insurance policies or could result in increased costs for such coverage.
| 15 |
Changes in U.S. trade policies and regulations, as well as the overall uncertainty surrounding international trade relations, could materially adversely affect our consolidated financial condition and results of operations.
Continued developments and recent changes in U.S. trade policies, including tariffs on imports from China generally, have had, and we expect that they will continue to have, an adverse effect on our costs of products sold and margins in our North America region. In January 2020, the United States Congress ratified the United States-Mexico-Canada Agreement (USMCA), which is intended to replace the North American Free Trade Agreement (NAFTA). Mexico has previously ratified the agreement and Canada's parliament is expected to do the same. The effective date of the trade agreement is not yet known. Additionally, in January 2020, the United States and China signed an Economic and Trade Agreement which relaxes some of the tariffs that had been imposed on imports between the two countries. However, the agreement has been referred to as "Phase 1" and the U.S. Administration continues to seek additional reforms. Despite the recent events which have eased some concerns related to the U.S. trade policies, uncertainty remains on future trade deals or continued tariffs placed on imports and exports to and from other countries. Additional tariffs and changes to the U.S. trade policies would likely adversely impact our business. Furthermore, other countries may change their own trade policies, including the imposition of additional tariffs and quotas, which could also adversely affect our business outside the U.S.
In order to mitigate the impact of these trade-related increases on our costs of products sold, we may increase prices in certain markets and, over the longer term, make changes in our supply chain and, potentially, our U.S. manufacturing strategy. Implementing price increases may cause our customers to find alternative sources for their products. We may be unable to successfully pass on these costs through price increases; adjust our supply chain without incurring significant costs; or locate alternative suppliers for raw materials or finished goods at acceptable costs or in a timely manner. Further, the uncertainty surrounding U.S. trade policy makes it difficult to make long-term strategic decisions regarding the best way to respond to these pressures and could also increase the volatility of currency exchange rates. Our inability to effectively manage the negative impacts of changing U.S. and foreign trade policies could materially adversely impact our consolidated financial condition and results of operations.
Political and economic instability and risk of government actions affecting our business and our customers or suppliers may adversely impact our business, results of operations and cash flows.
We are exposed to risks inherent in doing business in each of the countries or regions in which we or our customers or suppliers operate including: civil unrest, acts of terrorism, sabotage, epidemics, force majeure, war or other armed conflict and related government actions, including sanctions/embargoes, the deprivation of contract rights, the inability to obtain or retain licenses required by us to operate our plants or import or export our goods or raw materials, the expropriation or nationalization of our assets, and restrictions on travel, payments or the movement of funds. Geopolitical events including, but not limited to, the U.S. Presidential election in 2020 or the U.K.'s exit from the European Union may have a negative impact on the global industrial macro-economic environment.
A major loss of or disruption in our manufacturing and distribution operations or our information systems and telecommunication resources could adversely affect our business, consolidated financial condition or results of operations.
If we were to experience a natural disaster, such as a hurricane, tornado, earthquake or other severe weather event, a casualty loss from an event such as a fire or flood, at one of our larger strategic facilities, or experience adverse impacts, such as plant shutdowns or travel restrictions due to regional or global human health related illness or if such events were to affect a key supplier, our supply chain or our information systems and telecommunication resources, then there could be a material adverse effect on our consolidated financial condition or results of operations. We are dependent on internal and third-party information technology networks and systems, including the Internet, to process, transmit and store electronic information. In particular, we depend on our information technology infrastructure for fulfilling and invoicing customer orders, applying cash receipts, and placing purchase orders with suppliers, making cash disbursements, and conducting digital marketing activities, data processing and electronic communications among business locations.
We also depend on telecommunication systems for communications between company personnel and our customers and suppliers. Future system disruptions, security breaches or shutdowns could significantly disrupt our operations or result in lost or misappropriated information and may have a material adverse effect on our business, consolidated financial condition or results of operations.
| 16 |
If we are unable to retain key employees and other personnel, our consolidated financial condition or results of operations may be adversely affected.
Our success depends largely on the efforts and abilities of our management team and other key personnel. Their experience and industry contacts significantly benefit us, and we need their expertise to execute our business strategies. If any of our senior management or other key personnel cease to work for us and we are unable to successfully replace any departing senior management or key personnel, our business, consolidated financial condition or results of operations may be materially adversely affected.
We could experience disruptions in operations and/or increased labor costs.
In Europe and Latin America, most of our employees are represented by either labor unions or workers' councils and are covered by collective bargaining agreements that are generally renewable on an annual basis. As is the case with any negotiation, we may not be able to negotiate acceptable new collective bargaining agreements, which could result in strikes or work stoppages by affected workers. Renewal of collective bargaining agreements could also result in higher wages or benefits paid to union members. A disruption in operations or higher ongoing labor costs could materially affect our business.
We may not be able to generate sufficient cash to service all of our indebtedness and may be forced to take other actions to satisfy our obligations under our indebtedness, which may not be successful.
Our ability to make scheduled payments on time or refinance our debt obligations depends on our financial condition and operating performance, which are subject to prevailing economic and competitive conditions and to certain financial, business, legislative, regulatory and other factors beyond our control. We may be unable to maintain a level of cash flows from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on our indebtedness.
If our cash flows and capital resources are insufficient to fund our debt service obligations, we could face substantial liquidity problems and could be forced to reduce or delay investments and capital expenditures or to dispose of material assets or operations, seek additional debt or equity capital or restructure or refinance our indebtedness. We may not be able to affect any such alternative measures on commercially reasonable terms or at all and, even if successful, those alternative actions may not allow us to meet our scheduled debt service obligations. The credit agreement governing the senior secured credit facilities, the indentures that govern our senior notes and the agreements covering our accounts receivable securitization programs restrict our ability to dispose of assets and use the proceeds from those dispositions and may also restrict our ability to raise debt or equity capital to be used to repay other indebtedness when it becomes due. We may not be able to consummate those dispositions or to obtain proceeds in an amount sufficient to meet any debt service obligations then due.
In addition, we conduct a substantial portion of our operations through our subsidiaries, certain of which are not guarantors of our indebtedness. Accordingly, repayment of our indebtedness is dependent on the generation of cash flow by our subsidiaries and their ability to make such cash available to us, by dividend, debt repayment or otherwise. Unless they are guarantors of our indebtedness, our subsidiaries do not have any obligation to pay amounts due on indebtedness or to make funds available for that purpose. Our subsidiaries may not be able to, or may not be permitted to, make distributions to enable us to make payments in respect of our indebtedness. Each subsidiary is a distinct legal entity, and, under certain circumstances, legal and contractual restrictions may limit our ability to obtain cash from our subsidiaries. The indenture governing certain of our senior notes and the credit agreement governing the senior secured credit facilities limit the ability of certain of our subsidiaries to incur consensual restrictions on their ability to pay dividends or make other intercompany payments to us. These limitations are subject to qualifications and exceptions. In the event that we do not receive distributions from our subsidiaries, we may be unable to make required principal and interest payments on our indebtedness.
Our inability to generate sufficient cash flows to satisfy our debt obligations, or to refinance our indebtedness on commercially reasonable terms or at all, would materially and adversely affect our financial position and results of operations.
If we cannot make scheduled payments on our debt, we will be in default, the lenders under the senior secured credit facilities could terminate their commitments to loan money, the lenders could foreclose against the assets securing their borrowings and we could be forced into bankruptcy or liquidation.
| 17 |
The terms of our credit agreement governing our senior secured credit facilities, our accounts receivable securitization programs and the indentures governing our senior notes restrict our current and future operations, particularly our ability to respond to changes or to take certain actions.
The indentures governing our senior notes and the credit agreement governing our senior secured credit facilities and accounts receivable securitization programs contain a number of restrictive covenants that impose significant operating and financial restrictions on us and may limit our ability to engage in acts that may be in our long-term best interest, including restrictions on our ability to:
• | incur additional indebtedness; |
• | pay dividends or make other distributions or repurchase or redeem capital stock; |
• | prepay, redeem or repurchase certain debt; |
• | make loans and investments; |
• | sell assets; |
• | incur liens; |
• | enter into transactions with affiliates; |
• | alter the businesses we conduct; |
• | enter into agreements restricting our subsidiaries’ ability to pay dividends; and |
• | consolidate, merge or sell all or substantially all of our assets. |
In addition, the restrictive covenants in the credit agreement governing our senior credit facilities require us to maintain a specified net leverage ratio. Our ability to meet this financial ratio can be affected by events beyond our control.
A breach of the covenants under the indenture governing our senior notes or under the credit agreement governing our senior secured credit facilities could result in an event of default under the applicable indebtedness. Such a default may allow the creditors to accelerate the related debt and may result in the acceleration of any other debt to which a cross-acceleration or cross-default provision applies. In addition, an event of default under the credit agreement governing our senior secured credit facilities would permit the lenders under our senior secured credit facilities to terminate all commitments to extend further credit under those facilities. Furthermore, if we were unable to repay the amounts due and payable under our senior secured credit facilities, those lenders could proceed against the collateral granted to them to secure that indebtedness. In the event our lenders or note holders accelerate the repayment of our borrowings, we and our subsidiaries may not have sufficient assets to repay that indebtedness. As a result of these restrictions, we may be:
• | limited in how we conduct our business; |
• | unable to respond to changing market conditions; |
• | unable to raise additional debt or equity financing to operate during general economic or business downturns or to repay other indebtedness when it becomes due; or |
• | unable to compete effectively or to take advantage of new business opportunities. |
In addition, amounts available under our accounts receivable securitization programs and/or utilization of our supply chain financing programs can be impacted by a number of factors, including but not limited to our credit ratings, accounts receivable or payable balances, the creditworthiness of us or our customers, our receivables collection experience and/or our trade payable payment history.
Our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly.
Borrowings under our senior secured credit facilities are at variable rates of interest and expose us to interest rate risk. If interest rates increase, our debt service obligations on the variable rate indebtedness will increase even though the amount borrowed remained the same, and our net income and cash flows, including cash available for servicing our indebtedness, will correspondingly decrease. As of December 31, 2019, we had $700 million of long-term borrowings under our senior secured credit facilities at variable interest rates. A 1/8% increase or decrease in the assumed interest rates on the senior secured credit facilities would result in a $0.9 million increase or decrease in annual interest expense. In the future, we may enter into interest rate swaps that involve the exchange of floating for fixed rate interest payments in order to reduce interest rate volatility. However, we may not maintain interest rate swaps with respect to all of our variable rate indebtedness, and any swaps we enter into may not fully mitigate our interest rate risk.
| 18 |
The full realization of our deferred tax assets may be affected by a number of factors, including our earnings in the U.S. and the feasibility of on-going planning strategies.
We have deferred tax assets including state and foreign net operating loss carryforwards, accruals not yet deductible for tax purposes, employee benefit items and other items. We have established valuation allowances to reduce the deferred tax assets to an amount that is more likely than not to be realized. Our ability to utilize the deferred tax assets depends in part upon our ability to generate future taxable income within each respective jurisdiction during the periods in which these temporary differences reverse or our ability to carryback any losses created by the deduction of these temporary differences. We expect to realize the assets over an extended period. If we are unable to generate sufficient future taxable income in the U.S. and/or certain foreign jurisdictions, or if there is a significant change in the time period within which the underlying temporary differences become taxable or deductible, we could be required to increase our valuation allowances against our deferred tax assets. Our effective tax rate would increase if we were required to increase our valuation allowances against our deferred tax assets.
The U.S. Internal Revenue Service (the “IRS”) has indicated that it intends to disallow our deduction of the approximately $1.49 billion for the payments made pursuant to the Settlement agreement (as defined below).
In the past, we have reduced taxable income by approximately $1.49 billion for the payments made pursuant to the Settlement agreement and thus have reduced our US federal tax liability by approximately $525 million. The IRS has proposed to disallow, as deductible expense, the entirety of the $1.49 billion settlement payments. Although we believe that we have meritorious defenses to the proposed disallowance and are protesting it with the IRS, this matter could take several years to resolve and there can be no assurance that it will be resolved in the Company's favor. An unfavorable resolution of this matter could have a material adverse effect on our consolidated financial condition and results of operations, including cash flows.
Disruption and volatility of the financial and credit markets could affect our external liquidity sources.
Our principal sources of liquidity are accumulated cash and cash equivalents, short-term investments, cash flow from operations and amounts available under our lines of credit, including our senior secured credit facilities and our accounts receivable securitization programs. We may be unable to refinance any of our indebtedness, including our senior notes, our accounts receivable securitization programs and our senior secured credit facilities, on commercially reasonable terms or at all.
Additionally, conditions in financial markets could affect financial institutions with which we have relationships and could result in adverse effects on our ability to utilize fully our committed borrowing facilities. For example, a lender under the senior secured credit facilities may be unwilling or unable to fund a borrowing request, and we may not be able to replace such lender.
Our annual effective income tax rate can change materially as a result of changes in our geographic mix of U.S. and foreign earnings and other factors, including changes in tax laws and changes made by regulatory authorities.
Our overall effective income tax rate is equal to our total tax expense as a percentage of total earnings before tax. However, income tax expense and benefits are not recognized on a global basis but rather on a jurisdictional or legal entity basis. Losses in one jurisdiction may not be used to offset profits in other jurisdictions and may cause an increase in our tax rate. Changes in the mix of earnings (or losses) between jurisdictions and assumptions used in the calculation of income taxes, among other factors, could have a significant effect on our overall effective income tax rate.
We are subject to taxation in multiple jurisdictions. As a result, any adverse development in the tax laws of any of these jurisdictions or any disagreement with our tax positions could have a material adverse effect on our business, consolidated financial condition or results of operations.
We are subject to taxation in, and to the tax laws and regulations of, multiple jurisdictions as a result of the international scope of our operations and our corporate and financing structure. Tax laws are dynamic and subject to change as new laws are passed and new interpretations of the law are issued or applied. In 2017 the United States enacted significant tax reform, (the Tax Cuts and Jobs Act or "TCJA") and certain provisions or interpretations of the new law may adversely affect us. For example, the one-time mandatory tax on previously deferred foreign earnings of foreign subsidiaries, or “Transition Tax”, involved complex calculations and had a material impact on our financial results in 2018. Many countries in the European Union, as well as a number of other countries and organizations such as the Organization for Economic Cooperation and Development, are actively considering changes to existing tax laws that, if enacted, could increase our tax obligations in countries where we do business. Additional changes in tax laws could increase our overall taxes and our business, consolidated financial condition or results of operations could be adversely affected in a material way. The tax authorities in any applicable
| 19 |
jurisdiction, including the U.S., may disagree with the positions we have taken or intend to take regarding the tax treatment or characterization of any of our transactions. If any applicable tax authorities, including U.S. tax authorities, were to successfully challenge the tax treatment or characterization of any of our transactions, it could have a material adverse effect on our business, consolidated financial condition or results of our operations.
Our insurance policies may not cover all operating risks and a casualty loss beyond the limits of our coverage could materially and adversely impact our business.
Our business is subject to operating hazards and risks relating to handling, storing, transporting and use of the products we sell. We maintain insurance policies in amounts and with coverage and deductibles that we believe are reasonable and prudent. Nevertheless, our insurance coverage may not be adequate to protect us from all liabilities and expenses that may arise from claims for personal injury or death or property damage arising in the ordinary course of business, and our current levels of insurance may not be maintained or available in the future at economical prices. If a significant liability claim is brought against us that are not adequately covered by insurance, we may have to pay the claim with our own funds, which could have a material adverse effect on our business, consolidated financial condition or results of operations.
If we are not able to protect our trade secrets or maintain our trademarks, patents and other intellectual property, we may not be able to prevent competitors from developing similar products or from marketing their products in a manner that capitalizes on our trademarks, and this loss of a competitive advantage could decrease our profitability and liquidity.
Our ability to compete effectively with other companies depends, in part, on our ability to maintain the proprietary nature of our owned and licensed intellectual property. If we were unable to maintain the proprietary nature of our intellectual property and our significant current or future products, the resulting loss of associated competitive advantage could lead to decreased sales or increased operating costs, either of which could have a material adverse effect on our business, consolidated financial condition or results of operations.
We rely on trade secrets to maintain our competitive position, including protecting the formulation and manufacturing techniques of many of our products. As such, we have not sought U.S. or international patent protection for some of our principal product formulas and manufacturing processes. Accordingly, we may not be able to prevent others from developing products that are similar to or competitive with our products.
We own a large number of patents and pending patent applications on our products, aspects thereof, methods of use and/or methods of manufacturing. There is a risk that our patents may not provide meaningful protection and patents may never be issued for our pending patent applications.
We own, or have licenses to use, all of the material trademark and trade name rights used in connection with the packaging, marketing and distribution of our major products both in the U.S. and in other countries/regions where our products are principally sold. Trademark and trade name protection is important to our business. Although most of our trademarks are registered in the U.S. and in the foreign countries/regions in which we operate, we may not be successful in asserting trademark or trade name protection. In addition, the laws of some foreign countries/regions may not protect our intellectual property rights to the same extent as the laws of the U.S. The costs required to protect our trademarks and trade names may be substantial.
We cannot be certain that we will be able to assert these intellectual property rights successfully in the future or that they will not be invalidated, circumvented or challenged. Other parties may infringe on our intellectual property rights and may thereby dilute the value of our intellectual property in the marketplace. Third parties, including competitors, may assert intellectual property infringement or invalidity claims against us that could be upheld. Intellectual property litigation, which could result in substantial cost to and diversion of effort by us, may be necessary to protect our trade secrets or proprietary technology or for us to defend against claimed infringement of the rights of others and to determine the scope and validity of others’ proprietary rights. We may not prevail in any such litigation, and if we are unsuccessful, we may not be able to obtain any necessary licenses on reasonable terms or at all.
Any failure by us to protect our trademarks and other intellectual property rights may have a material adverse effect on our business, consolidated financial condition or results of operations.
As a result of acquisitions, we may record a significant amount of goodwill and other identifiable intangible assets and we may never realize the full carrying value of the related assets.
As a result of acquisitions, we may record a significant amount of goodwill and other identifiable intangible assets, including customer relationships, trademarks and developed technologies.
| 20 |
We test goodwill and intangible assets with indefinite useful lives for possible impairment annually during the fourth quarter of each fiscal year or more frequently if events or changes in circumstances indicate that the asset might be impaired. Amortizable intangible assets are periodically reviewed for possible impairment whenever there is evidence that events or changes in circumstances indicate that the carrying value may not be recoverable. Impairment may result from, among other things, (i) a decrease in our expected net earnings; (ii) adverse equity market conditions; (iii) a decline in current market multiples; (iv) a decline in our common stock price; (v) a significant adverse change in legal factors or business climates; (vi) an adverse action or assessment by a regulator; (vii) heightened competition; (viii) strategic decisions made in response to economic or competitive conditions; or (ix) a more-likely-than-not expectation that a reporting unit or a significant portion of a reporting unit will be sold or disposed of. In the event that we determine that events or circumstances exist that indicate that the carrying value of goodwill or identifiable intangible assets may no longer be recoverable, we might have to recognize a non-cash impairment of goodwill or other identifiable intangible assets, which could have a material adverse effect on our consolidated financial condition or results of operations.
Although the Settlement agreement (as defined below) has been implemented and we have been released from the various asbestos-related, fraudulent transfer, successor liability, and indemnification claims made against us arising from a 1998 transaction with Grace (as defined below), if the courts were to refuse to enforce the injunctions or releases contained in the Plan (as defined below) and the Settlement agreement with respect to any claims and if Grace were unwilling or unable to defend and indemnify us for such claims, then we could be required to pay substantial damages, which could have a material adverse effect on our consolidated financial condition and results of operations. We were also a defendant in a number of asbestos-related actions in Canada arising from Grace’s activities in Canada prior to the 1998 transaction.
On March 31, 1998, we completed a multi-step transaction (the “Cryovac transaction”) involving W.R. Grace & Co. (“Grace”) which brought the Cryovac packaging business and the former Sealed Air’s business under the common ownership of the Company. As part of that transaction, Grace and its subsidiaries retained all liabilities arising out of their operations before the Cryovac transaction (including asbestos-related liabilities), other than liabilities relating to Cryovac’s operations, and agreed to indemnify the Company with respect to such retained liabilities. Beginning in 2000, we were served with a number of lawsuits alleging that the Cryovac transaction was a fraudulent transfer or gave rise to successor liability or both, and that as a result we were responsible for alleged asbestos liabilities of Grace and its subsidiaries. On April 2, 2001, Grace and a number of its subsidiaries filed petitions for reorganization under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”). In connection with Grace’s Chapter 11 case, the Bankruptcy Court issued orders staying all asbestos actions against the Company (the “Preliminary Injunction”) but granted the official committees appointed to represent asbestos claimants in Grace’s Chapter 11 case (the “Committees”) permission to pursue fraudulent transfer, successor liability, and other claims against the Company and its subsidiary Cryovac, Inc. based upon the Cryovac transaction. In November 2002, we reached an agreement in principle with the Committees to resolve all current and future asbestos-related claims made against us and our affiliates, as well as indemnification claims by Fresenius Medical Care Holdings, Inc. and affiliated companies, in each case, in connection with the Cryovac transaction (as memorialized by the parties and approved by the Bankruptcy Court, the “Settlement agreement”). A definitive Settlement agreement was entered into as of November 10, 2003 consistent with the terms of the agreement in principle. On June 27, 2005, the Bankruptcy Court approved the Settlement agreement and the Settlement agreement was subsequently incorporated into the plan of reorganization for Grace filed in September 2008 (as filed and amended from time to time, the "Plan"). Subsequently, the Bankruptcy Court (in January and February 2011) and the United States District Court for the District of Delaware (in January and June 2012) entered orders confirming Grace’s plan of reorganization in its entirety.
On February 3, 2014 (the “Effective Date”), in accordance with the Plan, Grace emerged from bankruptcy. In accordance with the Plan and the Settlement agreement, on the Effective Date, Cryovac, Inc. made aggregate cash payments in the amount of $929.7 million to the WRG Asbestos PI Trust (the “PI Trust”) and the WRG Asbestos PD Trust (the “PD Trust”) and transferred 18 million shares of Sealed Air common stock to the PI Trust. Among other things, the Plan incorporated and implemented the Settlement agreement and provided for the establishment of two asbestos trusts under Section 524(g) of the U.S. Bankruptcy Code to which present and future asbestos-related personal injury and property damage claims are channeled. The Plan also provided injunctions and releases with respect to asbestos claims and certain other claims for our benefit. In addition, under the Plan and the Settlement agreement, Grace is required to indemnify us with respect to asbestos and certain other liabilities. Notwithstanding the foregoing, and although we believe the possibility to be remote, if any courts were to refuse to enforce the injunctions or releases contained in the Plan and the Settlement agreement with respect to any claims, and if, in addition, Grace were unwilling or unable to defend and indemnify us for such claims, then we could be required to pay substantial damages, which could have a material adverse effect on our consolidated financial condition and results of operations.
Item 1B. Unresolved Staff Comments
None.
| 21 |
Item 2. | Properties |
We manufacture products in 107 facilities, with 15 of those facilities serving both of our business segments. The following table shows our manufacturing facilities by geographic region and our business segment reporting structure:
Geographic Region | Number of Manufacturing Facilities | Food Care Manufacturing Facilities | Product Care Manufacturing Facilities | ||||||
North America | 44 | 10 | 37 | ||||||
Europe, Middle East and Africa ("EMEA") | 29 | 11 | 24 | ||||||
South America | 6 | 6 | 1 | ||||||
Asia, Australia and New Zealand ("APAC") | 28 | 9 | 24 | ||||||
Total | 107 | 36 | 86 | ||||||
Other Property Information
We own the large majority of our manufacturing facilities. Some of these facilities are subject to secured or other financing arrangements. We lease the balance of our manufacturing facilities, which are generally smaller sites. Our manufacturing facilities are usually located in general purpose buildings that house our specialized machinery for the manufacture of one or more products. Because of the relatively low density of our air cellular, polyethylene foam and protective mailer products, we realize significant freight savings by locating our manufacturing facilities for these products near our customers and distributors.
We also occupy facilities containing sales, distribution, technical, warehouse or administrative functions at a number of locations in the U.S. and in many foreign countries/regions. Some of these facilities are located on the manufacturing sites that we own and some of these are leased. Stand-alone facilities of these types are generally leased. Our global headquarters is located in an owned property in Charlotte, North Carolina. For a list of those countries and regions outside of the U.S. where we have operations, see "Global Operations" above.
We believe that our manufacturing, warehouse, office and other facilities are well maintained, suitable for their purposes and adequate for our needs.
| 22 |
Item 3. Legal Proceedings
The information set forth in Note 20, “Commitments and Contingencies,” of the Notes to Consolidated Financial Statements under the captions “Settlement Agreement Tax Deduction” and “Environmental Matters” is incorporated herein by reference.
On November 1, 2019, purported Company stockholder UA Local 13 & Employers Group Insurance Fund filed a putative class action complaint in the United States District Court for the Southern District of New York against the Company and certain of its current and former officers. The complaint alleges violations of Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5 thereunder based on allegedly false and misleading statements and omissions concerning the Company’s tax deduction in connection with its 2014 settlement for asbestos-related liabilities related to the Cryovac acquisition and the Company’s subsequent hiring of Ernst & Young LLP as its independent auditors. The plaintiff seeks to represent a class of purchasers of the Company’s common stock between November 5, 2014 and August 6, 2018. The complaint seeks, among other things, unspecified compensatory damages, including interest, and attorneys’ fees and costs.
On November 8, 2019, a lawsuit was filed in the Delaware Court of Chancery against the Company by an alleged stockholder of the Company. The complaint seeks an order permitting the plaintiff to inspect certain of the Company’s books and records related to the Company's accounting for income taxes, its financial reporting and disclosures, the process by which the Company selected its former independent audit firm which audited the fiscal years of 2015 through 2018, the independence of that audit firm, and other matters.
On January 14, 2020, a stockholder derivative lawsuit was filed in the United States District Court for the District of Delaware by an alleged stockholder of the Company, purportedly on the Company’s behalf. The suit was brought against certain of the Company’s current and former directors and officers and against the Company, as a nominal defendant. The complaint contains allegations against the individual defendants under Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5 thereunder similar to those in the class action complaint discussed above, as well as allegations of violations of Section 14(a) under the Exchange Act. The complaint also alleges breach of fiduciary duty, unjust enrichment and waste of corporate assets by the individual defendants for, among other things, failure to correct the alleged false and misleading statements, insider sales of the company’s stock, compensation benefiting from the alleged artificially inflated stock value, company repurchases of shares based on the alleged inflated stock value, and costs in connection with lawsuits and internal investigations. The complaint seeks unspecified damages for Sealed Air, restitution, and reformation and improvement of Sealed Air’s corporate governance and internal procedures regarding compliance with laws.
The Company has received from the staff of the SEC subpoenas for documents and requests for information in connection with the SEC's previously disclosed investigation. Those subpoenas and requests seek documents and information regarding the Company's accounting for income taxes, its financial reporting and disclosures, the process by which the Company selected its former independent audit firm which audited the fiscal years of 2015 through 2018, the independence of that audit firm, and other matters.
Following the announcement on June 20, 2019 that the Company had terminated the employment of William G. Stiehl as Chief Financial Officer, the Company received a Grand Jury subpoena from the United States Attorney's Office for the Western District of North Carolina (the "U.S. Attorney's Office") seeking documents relating to that termination and relating to the process by which the Company selected its former independent audit firm for the fiscal years of 2015 through 2018.
The Company is fully cooperating with the SEC and the U.S. Attorney's Office and cannot predict the outcome or duration of either of those investigations.
We are also involved in various other legal actions incidental to our business. We believe, after consulting with counsel, that the disposition of these other legal proceedings and matters will not have a material effect on our consolidated financial condition or results of operations including potential impact to cash flows.
| 23 |
Item 4. Mine Safety Disclosures.
Not applicable.
| 24 |
Information About Our Executive Officers
The information appearing in the table below sets forth the current position or positions held by each of our executive officers, the officer’s age as of January 31, 2020, the year in which the officer was first elected to the position currently held with us or with the former Sealed Air Corporation, now known as Sealed Air Corporation (US) and a wholly-owned subsidiary of the Company, and the year in which such person was first elected an officer. All of our officers serve at the pleasure of the Board of Directors.
There are no family relationships among any of our executive officers or directors.
Name and Current Position | Age as of January 31, 2020 | First Elected to Current Position | First Elected an Executive Officer | ||||
Edward L. Doheny II President and Chief Executive Officer | 57 | 2018 | 2017 | ||||
James M. Sullivan Senior Vice President and Chief Financial Officer | 59 | 2019 | 2019 | ||||
Emile Z. Chammas Senior Vice President, Chief Manufacturing and Supply Chain Officer & Chief Transformation Officer | 51 | 2019 | 2010 | ||||
Karl R. Deily Senior Vice President, Chief Commercial Officer | 62 | 2019 | 2006 | ||||
Susan C. Edwards Vice President, Chief Human Resources Officer | 57 | 2019 | 2019 | ||||
Michael A. Leon Chief Accounting Officer and Controller | 39 | 2018 | 2018 | ||||
Mr. Doheny joined Sealed Air as Chief Operating Officer and CEO-Designate in September 2017 and was elected a Director of Sealed Air Corporation. He became President and CEO effective January 1, 2018. Prior to joining the Company in September 2017, Mr. Doheny served as President and Chief Executive Officer and a Director of Joy Global Inc., a manufacturer and servicer of high productivity mining equipment, from 2013 through 2017. Mr. Doheny also served as the Executive Vice President of Joy Global and President and Chief Operating Officer of its Underground Mining Machinery business from 2006 to 2013, where he had global responsibility for the company's underground mining machinery business. Prior to joining Joy Global, Mr. Doheny had a 21-year career with Ingersoll-Rand Corporation holding a series of senior executive positions of increasing responsibility, including President of Industrial Technologies from 2003 to 2005 and President of the Air Solutions Group from 2000 to 2003.
The Company appointed Mr. Sullivan as Senior Vice President and Chief Financial Officer effective June 24, 2019. Mr. Sullivan joined the Company with more than 20 years of experience in leadership roles in the industrial and manufacturing sectors. He most recently served as the Executive Vice President and CFO of Joy Global from 2012 to 2017, where he oversaw the company’s global finance and accounting organization. Prior to joining Joy Global, Mr. Sullivan served as the Executive Vice President and CFO of Solutia, a chemical manufacturing company, from 2004 until its acquisition by Eastman Chemical Company in 2012. Prior to being appointed Solutia's CFO, Mr. Sullivan spent five years as Solutia’s Vice President and Controller.
In 2019, Mr. Chammas' responsibilities were expanded to include Chief Transformation Officer in addition to his previously existing role of leading Sealed Air's manufacturing and supply chain operations. As the Chief Transformation Officer, Mr. Chammas has company-wide leadership of the Reinvent SEE strategy. Mr. Chammas has led the Company's manufacturing and supply chain operations since November 2010. Prior to joining the Company, Mr. Chammas was the Vice President, Worldwide Supply Chain, for the Wm. Wrigley Jr. Company, a confectionery company, from 2008 through 2010, and served in management positions of increasing responsibility in supply chain, operations and procurement with the Wm. Wrigley Jr. Company from 2002 through 2008.
In 2019, Mr. Deily was appointed as the Chief Commercial Officer, in which he leads the Company's commercial organization, including the Food Care and Product Care businesses, and is responsible for the Company’s Corporate Innovation and Sustainability strategy. Mr. Deily joined Sealed Air in 1981, starting his career with Cryovac in research and development (R&D) working in the applications development group. After 14 years in R&D, he served in various marketing and business leadership roles for both North America and the business globally. Most recently, Mr. Deily served as President of Food Care, a position he held since 2006.
| 25 |
Ms. Edwards was appointed as an executive officer of the Company in 2019; she currently serves as Vice President and Chief Human Resources Officer for Sealed Air. She has had responsibility for the Company's global human resource function, including under her previous title, Vice President, Human Resources, since January 2017. Ms. Edwards initially joined Sealed Air in 2011 as Vice President, Global HR Business Partner of Food Care. From 2014 through 2017, she served as Vice President, HR Business Partners. Prior to joining the Company, Ms. Edwards held leadership roles for several global corporations including CIRCOR International, where she was responsible for strategic HR and integration leadership from 2009 until 2011. Prior to CIRCOR, she held many roles with increasing responsibility at Snap-on Incorporated from 2001 until 2009 culminating with her role as the Vice President of Rapid Continuous Improvement.
Mr. Leon was appointed as the Chief Accounting Officer and Controller effective June 7, 2018. Prior to the appointment, he served as the Company’s Assistant Corporate Controller since December 2014. Before joining the Company, Mr. Leon held various accounting and finance positions with increasing levels of responsibilities at a Big 4 public accounting firm and at several diversified global manufacturing companies, including SPX Corporation from 2012 to 2014, and United Technologies Corporation and its predecessor company, Goodrich Corporation, from 2006 to 2012. He has extensive financial and accounting experience, including financial reporting, financial planning and analysis, mergers and acquisitions, and internal audit, among others.
| 26 |
PART II
Item 5. | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities |
Market Information and Holders
Our common stock is listed on the New York Stock Exchange with the trading symbol SEE. As of February 11, 2020, there were approximately 3,341 holders of record of our common stock.
Common Stock Performance Comparisons
The following graph shows, for the five years ended December 31, 2019, the cumulative total return on an investment of $100 assumed to have been made on December 31, 2014 in our common stock. The graph compares this return (“SEE”) with that of comparable investments assumed to have been made on the same date in: (a) the Standard & Poor’s 500 Stock Index (“Composite S&P 500”) and (b) a market capitalization-weighted self-constructed peer group (“Peer Group”).
The Peer Group includes us and the following companies: AptarGroup, Inc.; Ashland Global Holdings Inc.; Avery Dennison Corporation; Axalta Coating Systems Ltd.; Ball Corporation; Berry Global Group, Inc.; Celanese Corporation; Crown Holdings, Inc.; Graphic Packaging Holding Company; Greif, Inc.; Maple Leaf Foods Inc.; Owens-Illinois, Inc.; Packaging Corporation of America; PolyOne Corporation; Silgan Holdings Inc.; and Sonoco Products Company. Bemis Company, Inc. was previously included in our peer group and has been removed due to the acquisition by Amcor PLC in 2019. The Peer Group is consistent with the peer companies used by the Organization and Compensation Committee of our Board of Directors ("Compensation Committee") in connection with certain aspects of our executive compensation programs. The Compensation Committee includes companies primarily in the materials sector that are comparable to Sealed Air based on sales, percentage of sales outside of the United States, number of employees and market capitalization.
Total return for each assumed investment assumes the reinvestment of all dividends on December 31 of the year in which the dividends were paid.
| 27 |
Recent Sales of Unregistered Securities
Not applicable.
Issuer Purchases of Equity Securities
The table below sets forth the total number of shares of our common stock, par value $0.10 per share, that we repurchased in each month of the quarter ended December 31, 2019, the average price paid per share and the maximum number of shares that may yet be purchased under our publicly announced plans or programs.
Period | Total Number of Shares Purchased(i) | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Announced Plans or Programs | Maximum Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs | ||||||||||
(a) | (b) | (c) | (d) | |||||||||||
Balance as of September 30, 2019 | $ | 707,648,181 | ||||||||||||
October 1, 2019 through October 31, 2019 | — | $ | — | — | 707,648,181 | |||||||||
November 1, 2019 through November 30, 2019 | 141 | $ | — | — | 707,648,181 | |||||||||
December 1, 2019 through December 31, 2019 | — | $ | — | — | 707,648,181 | |||||||||
Total | 141 | — | $ | 707,648,181 | ||||||||||
(i) | On May 2, 2018, the Board of Directors increased the total authorization to repurchase the Company's issued and outstanding stock to $1.0 billion. This program has no expiration date and replaced the previous authorizations. We |
| 28 |
from time to time acquire shares by means of (i) open market transactions, including through plans complying with Rule 10b5-1 under the Exchange Act, as amended, and privately negotiated transactions, including accelerated share repurchase programs, pursuant to our publicly announced program described above and (ii) shares withheld from restricted share awards under our Omnibus Incentive Plan pursuant to the provision thereof that permits tax withholding obligations or other legally required charges to be satisfied by having us withhold shares from an award under that plan. We report price calculations in column (b) in the table above only for shares purchased as part of our publicly announced program, when applicable. For shares withheld for minimum tax withholding obligations or other legally required charges, we withhold shares at a price equal to their fair market value.
Period | Shares withheld for tax obligations and charges | Average withholding price for shares in column “a” | |||||
(a) | (b) | ||||||
October 2019 | — | $ | — | ||||
November 2019 | 141 | $ | 41.79 | ||||
December 2019 | — | $ | — | ||||
Total | 141 | ||||||
| 29 |
Item 6. Selected Financial Data
Year Ended December 31, | ||||||||||||||||||||
(In millions, except share data) | 2019 | 2018 | 2017 | 2016 | 2015 | |||||||||||||||
Consolidated Statements of Operations Data(1): | ||||||||||||||||||||
Net sales | $ | 4,791.1 | $ | 4,732.7 | $ | 4,461.6 | $ | 4,211.3 | $ | 4,410.3 | ||||||||||
Gross profit | 1,564.8 | 1,502.1 | 1,412.1 | 1,401.0 | 1,449.2 | |||||||||||||||
Operating profit | 578.5 | 656.3 | 571.3 | 628.9 | 624.9 | |||||||||||||||
Earnings before income tax provision | 370.3 | 457.8 | 393.3 | 387.9 | 291.4 | |||||||||||||||
Net earnings from continuing operations | 293.7 | 150.3 | 62.8 | 292.3 | 158.8 | |||||||||||||||
(Loss) Gain on sale of discontinued operations, net of tax(2) | (30.7 | ) | 42.8 | 640.7 | — | — | ||||||||||||||
Net earnings from discontinued operations, net of tax(2) | — | — | 111.4 | 194.1 | 176.6 | |||||||||||||||
Net earnings | $ | 263.0 | $ | 193.1 | $ | 814.9 | $ | 486.4 | $ | 335.4 | ||||||||||
Basic and diluted net earnings per common share: | ||||||||||||||||||||
Basic | ||||||||||||||||||||
Continuing operations | $ | 1.90 | $ | 0.94 | $ | 0.34 | $ | 1.50 | $ | 0.78 | ||||||||||
Discontinued operations(2) | (0.20 | ) | 0.27 | 3.99 | 0.99 | 0.85 | ||||||||||||||
Net earnings per common share—basic | $ | 1.70 | $ | 1.21 | $ | 4.33 | $ | 2.49 | $ | 1.63 | ||||||||||
Diluted | ||||||||||||||||||||
Continuing operations | $ | 1.89 | $ | 0.94 | $ | 0.33 | $ | 1.48 | $ | 0.77 | ||||||||||
Discontinued operations(2) | (0.20 | ) | 0.26 | 3.96 | 0.98 | 0.85 | ||||||||||||||
Net earnings per common share—diluted | $ | 1.69 | $ | 1.20 | $ | 4.29 | $ | 2.46 | $ | 1.62 | ||||||||||
Dividends per common share | $ | 0.64 | $ | 0.64 | $ | 0.64 | $ | 0.61 | $ | 0.52 | ||||||||||
Consolidated Balance Sheets Data: | ||||||||||||||||||||
Total assets(3) | $ | 5,765.2 | $ | 5,050.2 | $ | 5,280.3 | $ | 7,415.5 | $ | 7,395.1 | ||||||||||
Long-term debt, less current portion | 3,698.6 | 3,236.5 | 3,230.5 | 3,762.6 | 4,076.7 | |||||||||||||||
Total stockholders’ (deficit) equity | (196.2 | ) | (348.6 | ) | 152.3 | 609.7 | 527.0 | |||||||||||||
Consolidated Cash Flows Data(1): | ||||||||||||||||||||
Net cash provided by operating activities | $ | 511.1 | $ | 428.0 | $ | 424.4 | $ | 906.9 | $ | 982.1 | ||||||||||
Net cash (used in) provided by investing activities | (665.6 | ) | (266.7 | ) | 1,786.1 | (314.8 | ) | (60.0 | ) | |||||||||||
Net cash provided by (used in) financing activities | 139.9 | (478.3 | ) | (1,889.7 | ) | (544.5 | ) | (788.7 | ) | |||||||||||
Other Financial Data: | ||||||||||||||||||||
Depreciation and amortization | $ | 150.8 | $ | 131.2 | $ | 149.3 | $ | 214.0 | $ | 213.3 | ||||||||||
Share-based incentive compensation | 32.9 | 29.2 | 44.9 | 59.9 | 61.2 | |||||||||||||||
Capital expenditures | (189.7 | ) | (168.6 | ) | (183.8 | ) | (275.7 | ) | (184.0 | ) | ||||||||||
(1) | See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” for a discussion of the factors that contributed to our consolidated operating results and our consolidated cash flows for the three years ended December 31, 2019. |
(2) | Operating results for the Diversey Care division and the Food Hygiene and Cleaning business within our Food Care division were reclassified to discontinued operations in 2014 through the sale on September 6, 2017. The related assets and liabilities were reclassified to assets and liabilities held for sale in the table above as of December 31, 2015. See Note 5, "Discontinued Operations, Divestitures and Acquisitions," of the Notes to Consolidated Financial Statements for further information about the sale of the Diversey Care division and the Food Hygiene and Cleaning business within our Food Care division. |
(3) | See Note 5, "Discontinued Operations, Divestitures and Acquisitions," of the Notes to Consolidated Financial Statements for further information on assets acquired through recent acquisitions and Note 2 "Summary of Significant Accounting Policies and Recently Issued Accounting Standards," of the Notes to Consolidated Financial Statements for more information on assets recognized as a result of our adoption of ASU 2016-02, Leases (Topic 842). |
| 30 |
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The information in this MD&A should be read together with our Consolidated Financial Statements and related notes set forth in Part II, Item 8, as well as the discussion included in Part I, Item 1A, “Risk Factors,” of this Annual Report on Form 10-K. All amounts and percentages are approximate due to rounding and all dollars are in millions, except per share amounts.
Non-U.S. GAAP Information
We present financial information that conforms to U.S. GAAP. We also present financial information that does not conform to U.S. GAAP, as our management believes it is useful to investors. In addition, non-U.S. GAAP measures are used by management to review and analyze our operating performance and, along with other data, as internal measures for setting annual budgets and forecasts, assessing financial performance, providing guidance and comparing our financial performance with our peers. It does not purport to represent any similarly titled U.S. GAAP information and is not an indicator of our performance under U.S. GAAP. Investors are cautioned against placing undue reliance on these non-U.S. GAAP measures. Further, investors are urged to review and consider carefully the adjustments made by management to the most directly comparable U.S. GAAP financial measure to arrive at these non-U.S. GAAP financial measures, described below.
Our management assesses our financial results both on a U.S. GAAP basis and on a non-U.S. GAAP basis, as management believes it is useful to investors. Non-U.S. GAAP financial measures also provide management with additional means to understand and evaluate the core operating results and trends in our ongoing business by eliminating certain expenses and/or gains (which may not occur in each period presented) and other items that management believes might otherwise make comparisons of our ongoing business with prior periods and peers more difficult, obscure trends in ongoing operations or reduce management’s ability to make useful forecasts.
Our non-U.S. GAAP financial measures may also be considered in calculations of our performance measures set by the Organization and Compensation Committee of our Board of Directors for purposes of determining incentive compensation. The non-U.S. GAAP financial metrics exclude items that we consider to be certain specified items (“Special Items”), such as restructuring charges and restructuring associated costs, certain transaction and other charges related to acquisitions and divestitures, gains and losses related to acquisitions and divestitures, special tax items or tax benefits (collectively, “Tax Special Items”) and certain other items. We evaluate unusual or Special Items on an individual basis. Our evaluation of whether to exclude an unusual or special item for purposes of determining our non-U.S. GAAP financial measures considers both the quantitative and qualitative aspects of the item, including among other things (i) its nature, (ii) whether or not it relates to our ongoing business operations, and (iii) whether or not we expect it to occur as part of our normal business on a regular basis.
Our calculation of these non-U.S. GAAP measures may not be comparable to similarly titled measures of other companies due to potential differences between companies in the method of calculation. As a result, the use of these non-U.S. GAAP measures has limitations and should not be considered superior to, in isolation from, or as a substitute for, related U.S. GAAP measures.
When we present forward-looking guidance, we do not also provide guidance for the most directly comparable U.S. GAAP financial measures, as they are not available without unreasonable effort due to the high variability, complexity, and low visibility with respect to certain Special Items, including gains and losses on the disposition of businesses, the ultimate outcome of certain legal or tax proceedings, foreign currency gains or losses resulting from the volatile currency market in Argentina, and other unusual gains and losses. These items are uncertain, depend on various factors, and could be material to our results computed in accordance with U.S. GAAP.
Adjusted EBITDA and Adjusted EBITDA Margin
Adjusted EBITDA is defined as Earnings before Interest Expense, Taxes, Depreciation and Amortization, adjusted to exclude the impact of Special Items. Management uses Adjusted EBITDA as one of many measures to assess the performance of the business. Additionally, Adjusted EBITDA is the performance metric used by the Company's chief operating decision maker to evaluate performance of our reportable segments. Adjusted EBITDA is also a metric used to determine performance in the Company's Annual Incentive Plan. We do not believe there are estimates underlying the calculation of Adjusted EBITDA, other than those inherent in our U.S. GAAP results of operations, which would render the use and presentation of Adjusted EBITDA misleading. While the nature and amount of individual Special Items vary from period to period, we believe our calculation of Adjusted EBITDA is applied consistently to all periods and, in conjunction with other U.S. GAAP and non-U.S. GAAP measures, provides a useful and consistent comparison of our Company's performance to other periods. In our evaluation of Adjusted EBITDA, management assumes that gain/losses related to Special Items may not be reflective of our core operating results.
| 31 |
The following table shows a reconciliation of U.S. GAAP Net Earnings from continuing operations to non-U.S. GAAP Total Company Adjusted EBITDA from continuing operations:
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Net earnings from continuing operations | $ | 293.7 | $ | 150.3 | $ | 62.8 | ||||||
Interest expense, net | 184.1 | 177.9 | 184.2 | |||||||||
Income tax provision | 76.6 | 307.5 | 330.5 | |||||||||
Depreciation and amortization, net of adjustments(1) | 184.5 | 159.0 | 158.3 | |||||||||
Special Items: | ||||||||||||
Restructuring charges | 41.9 | 47.8 | 12.1 | |||||||||
Other restructuring associated costs | 60.3 | 15.8 | 14.3 | |||||||||
Foreign currency exchange loss due to highly inflationary economies | 4.6 | 2.5 | — | |||||||||
Loss on debt redemption and refinancing activities | 16.1 | 1.9 | — | |||||||||
Charges related to acquisition and divestiture activity | 14.9 | 34.2 | 84.1 | |||||||||
Charges related to the Novipax settlement agreement | 59.0 | — | — | |||||||||
Gain from class-action litigation settlement | — | (14.9 | ) | — | ||||||||
Curtailment related to retained Diversey retirement plans | — | — | (13.5 | ) | ||||||||
Other Special Items(2) | 29.1 | 7.5 | 0.5 | |||||||||
Pre-tax impact of Special Items | 225.9 | 94.8 | 97.5 | |||||||||
Non-U.S. GAAP Total Company Adjusted EBITDA from continuing operations | $ | 964.8 | $ | 889.5 | $ | 833.3 | ||||||
(1) | Includes depreciation and amortization adjustments of $(0.8) million and $(2.4) million for the years ended December 31, 2019 and 2018, respectively. |
(2) | Other Special Items for the years ended December 31, 2019 and 2018, primarily included fees related to professional services, mainly legal fees, directly associated with Special Items or events that are considered one-time or infrequent in nature. |
The Company may also assess performance using Adjusted EBITDA Margin. Adjusted EBITDA Margin is calculated as Adjusted EBITDA divided by net trade sales. We believe that Adjusted EBITDA Margin is one useful measure to assess the profitability of sales made to third parties and the efficiency of our core operations.
Adjusted Net Earnings and Adjusted Earnings Per Share
Adjusted Net Earnings and Adjusted Earnings Per Share (“Adjusted EPS”) are also used by the Company to measure total company performance. Adjusted Net Earnings is defined as U.S. GAAP net earnings from continuing operations excluding the impact of Special Items and the expense or benefit from any special taxes or Tax Special Items. Adjusted EPS is defined as our Adjusted Net Earnings divided by the number of diluted shares outstanding. We believe that Adjusted Net Earnings and Adjusted EPS are useful measurements of Company performance, along with other U.S. GAAP and non-U.S. GAAP measures, because they incorporate non-cash items of depreciation and amortization, including stock-based compensation, which impact the overall performance and Net Earnings of our business. Additionally, Adjusted Net Earnings and Adjusted EPS reflect the impact of our Adjusted Tax Rate and interest expense on a net and per share basis. While the nature and amount of individual Special Items vary from period to period, we believe our calculation of Adjusted Net Earnings and Adjusted EPS is applied consistently to all periods and, in conjunction with other U.S. GAAP and non-U.S. GAAP measures, provide a useful and consistent comparison of our Company's performance to other periods. In our evaluation of Adjusted Net Earnings and Adjusted EPS, management assumes that gain/losses related to Special Items and Tax Special Items may not be reflective of our core operating results.
The following table shows a reconciliation of U.S. GAAP Net Earnings and Diluted Earnings per Share from continuing operations to Non-U.S. GAAP Adjusted Net Earnings and Adjusted EPS from continuing operations.
| 32 |
Year Ended December 31, | ||||||||||||||||||||||||
2019 | 2018 | 2017 | ||||||||||||||||||||||
(In millions, except per share data) | Net Earnings | Diluted EPS | Net Earnings | Diluted EPS | Net Earnings | Diluted EPS | ||||||||||||||||||
U.S. GAAP net earnings and diluted EPS from continuing operations(1) | $ | 293.7 | $ | 1.89 | $ | 150.3 | $ | 0.94 | $ | 62.8 | $ | 0.33 | ||||||||||||
Special Items(2) | 145.0 | 0.93 | 250.6 | 1.56 | 279.8 | 1.48 | ||||||||||||||||||
Non-U.S. GAAP adjusted net earnings and adjusted EPS available from continuing operations | $ | 438.7 | $ | 2.82 | $ | 400.9 | $ | 2.50 | $ | 342.6 | $ | 1.81 | ||||||||||||
Weighted average number of common shares outstanding – Diluted | 155.2 | 160.2 | 188.9 | |||||||||||||||||||||
(1) | Net earnings per common share are calculated under the two-class method. |
(2) | Includes Pre-tax Special Items, less Tax Special Items and the tax impact of Special Items as seen in the following calculation of non-U.S. GAAP Adjusted income tax rate. |
Adjusted Tax Rate
We also present our adjusted income tax rate (“Adjusted Tax Rate”). The Adjusted Tax Rate is a measure of our U.S. GAAP effective tax rate, adjusted to exclude the tax impact from the Special Items that are excluded from our Adjusted Net Earnings and Adjusted EPS metrics as well as expense or benefit from any special taxes or Tax Special Items. The Adjusted Tax Rate is an indicator of the taxes on our core business. The tax circumstances and effective tax rate in the specific countries where the excluded or Special Items occur will determine the impact (positive or negative) to the Adjusted Tax Rate. While the nature and amount of Tax Special Items vary from period to period, we believe our calculation of the Adjusted Tax Rate is applied consistently to all periods and, in conjunction with evaluation of our U.S. GAAP effective income tax rate, provide a useful and consistent comparison of the impact that tax expense has on our Company's performance. In our evaluation of our Adjusted Tax Rate, management assumes that Tax Special Items may not be reflective of our tax on our core operations.
The following table shows our calculation of the non-U.S. GAAP Adjusted income tax rate:
Year Ended December 31, | ||||||||||||
(In millions, except per share data) | 2019 | 2018 | 2017 | |||||||||
U.S. GAAP Earnings before income tax provision from continuing operations | $ | 370.3 | $ | 457.8 | $ | 393.3 | ||||||
Pre-tax impact of Special Items | 225.9 | 94.8 | 97.5 | |||||||||
Non-U.S. GAAP Adjusted Earnings before income tax provision from continuing operations | $ | 596.2 | $ | 552.6 | $ | 490.8 | ||||||
U.S. GAAP Income tax provision from continuing operations | $ | 76.6 | $ | 307.5 | $ | 330.5 | ||||||
Tax Special Items(1) | 25.5 | (178.3 | ) | (208.1 | ) | |||||||
Tax impact of Special Items(2) | 55.4 | 22.5 | 25.8 | |||||||||
Non-U.S. GAAP Adjusted Income tax provision from continuing operations | $ | 157.5 | $ | 151.7 | $ | 148.2 | ||||||
U.S. GAAP Effective income tax rate | 20.7 | % | 67.2 | % | 84.0 | % | ||||||
Non-U.S. GAAP Adjusted income tax rate | 26.4 | % | 27.5 | % | 30.2 | % | ||||||
(1) | For the year ended December 31, 2019, Tax Special Items reflects net benefits from tax optimization initiatives and research and development credits. For the year ended December 31, 2018, the Tax Special Items included $222 million of expense for the one-time tax on unrepatriated earnings (U.S. Tax Reform Transition Tax), partially offset by the release of valuation allowances associated with tax initiatives. For the year ended December 31, 2017, the Tax Special Items include the impact of the sale of Diversey, the revaluation of deferred tax assets as a result of the TCJA and an increase in unrecognized tax benefits in foreign jurisdictions. |
| 33 |
(2) | The tax rate used to calculate the tax impact of Special Items is based on the jurisdiction in which the charge was recorded. |
Net Sales by Geographic Region and Net Sales by Segment
In our “Net Sales by Geographic Region,” “Net Sales by Segment” and in some of the discussions and tables that follow, we exclude the impact of foreign currency translation when presenting net sales information, which we define as “constant dollar” and we exclude acquisitions in the first year after closing, divestiture activity and the impact of foreign currency translation when presenting net sales information, which we define as "organic." Changes in net sales excluding the impact of foreign currency translation are non-U.S. GAAP financial measures. As a worldwide business, it is important that we take into account the effects of foreign currency translation when we view our results and plan our strategies. Nonetheless, we cannot control changes in foreign currency exchange rates. Consequently, when our management looks at our financial results to measure the core performance of our business, we may exclude the impact of foreign currency translation by translating our current period results at prior period foreign currency exchange rates. We also may exclude the impact of foreign currency translation when making incentive compensation determinations. As a result, our management believes that these presentations are useful internally and may be useful to investors.
Refer to these specific tables presented later in our Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Business and Reportable Segments
Sealed Air is in business to protect, to solve critical packaging challenges and to leave our world better than we found it. Our portfolio of leading packaging solutions includes Cryovac® brand food packaging, Sealed Air® brand protective packaging and Bubble Wrap® brand packaging, which collectively enable a safer, more efficient food supply chain and protect valuable goods shipped around the world. We serve an array of end markets including food and beverage processing, food service, retail, and commercial and consumer applications. In the markets we serve, we leverage our iconic brands, leading market positions, differentiated technologies, global scale/market access, and well-established customer relationships.
The Company’s segment reporting structure consists of two reportable segments, Food Care and Product Care, and a Corporate category. The Company’s Food Care and Product Care segments are considered reportable segments under FASB ASC Topic 280. Our reportable segments are aligned with similar groups of products and customers. Corporate includes certain costs that are not allocated to or monitored by the reportable segments' management. See Note 6, “Segments,” of the Notes to the Consolidated Financial Statements for further information.
Executive Summary of 2019
Sealed Air continues to execute on its Reinvent SEE strategy that is transforming how the Company innovates, operates and solves our customers' most critical challenges. Through our focus on the 4P'SSM of Reinvent SEE, Performance, People, Products, Process and Sustainability, we are leveraging our recognized Cyrovac® and BubbleWrap® brands to fuel future growth opportunities in core and adjacent markets. We believe our efforts to increase recyclability, reusability and recycled or renewable content creates a competitive advantage. The 4P’SSM of Reinvent SEE are driving structural changes throughout the organization with a focus on productivity improvements.
During the year, Reinvent SEE structural changes include $168 million in benefits, of which $67 million was reflected in restructuring savings to delayer and simplify the organization, $64 million benefited operating costs and $37 million favorably impacted price/cost spread. Operating costs benefits were largely driven by material substitution and alternate raw material qualifications, savings on indirect spend, SG&A efficiencies, logistics process improvements, yield improvements and gauge optimization. Additionally, we are seeing benefits from manufacturing network optimization reflected in these operating costs. Price/cost spread benefits reflect procurement savings and value capture initiatives on price.
For the year ended December 31, 2019, we incurred approximately $102 million, or $76 million net of tax, in restructuring and restructuring associated charges primarily related to our Reinvent SEE initiatives. Cash payments, including restructuring payments related to Reinvent SEE and legacy programs, were $91 million. Given the success to date, and the Reinvent SEE initiatives being implemented, we now anticipate that over the 3-year period of the program (2019-2021) we will realize approximately $330 million in benefits, which is an increase of $80 million compared to previous estimates. The full year benefits on Adjusted EBITDA from Reinvent SEE were partially offset by negative foreign currency and higher expense associated with labor inflation, incentive compensation and investments in the business. See Note 12, “Restructuring
| 34 |
Activities,” of the Notes to Consolidated Financial Statements for additional details regarding each of the Company’s restructuring programs.
The R&D and capital investments we are making in the business are aligned with our sustainability goals. Through our 2025 Sustainability Pledge, we expect to deliver approximately 50% of our product offerings containing recyclable or reusable solutions by 2023 and are targeting 100% by 2025. By applying materials science, we are designing and advancing packaging materials to be recyclable or reusable and contain more recycled or renewable content. We are involved in collaborations with partners worldwide to increase circularity. For example, in Food Care, the majority of our Case Ready portfolio already meets recyclability requirements. We continue to innovate our materials to lighten the weight and/or increase recyclable or renewable content, while at the same time, maintaining the high-performance standards our Cryovac® brand food packaging represents around the world. In Product Care, our fully recyclable cushioned mailer portfolio and our paper-based products are gaining traction in EMEA. In 2019, we launched new recyclable BubbleWrap® brand cushioning in North America with 90% recycled content. Both our BubbleWrap® brand cushioning and our Stealthwrap® shrink film were certified for store-drop off recycling in 2019. Stealthwrap® automated packaging system replaces larger, heavier, secondary boxes and provides improved efficiency by reducing dimensional weigh during distribution.
In 2019, we completed the acquisition of Automated Packaging Systems (“Automated”) and the integration is underway. Known for its Autobag® brand, Automated provides unique and innovative solutions, complete with automated equipment, advanced materials, engineering, and field service. Automated is complementary to our protective packaging solutions for e-commerce and fulfillment operations and offers us adjacent opportunities in the food packaging sector, including e-foods, produce, snack foods, and portion-controlled meals. Since the acquisition was closed on August 1, 2019, Automated generated $117 million in net sales and contributed $13 million in Adjusted EBITDA through December 31, 2019. We have already identified cross-selling opportunities and have begun to realize operating cost efficiencies. The Company has recognized integration related expenses of approximately $9 million in 2019. Transaction related expenses were approximately $3 million for the year ended December 31, 2019. Net consideration transferred for the purchase of Automated was $446 million. See Note 5, “Discontinued Operations, Divestitures and Acquisitions,” of the Notes to Consolidated Financial Statements for additional details regarding each of the Company’s acquisitions.
In 2019, the Company's overall net sales increased $58 million or 1%, primarily driven by contributions from our acquisition of Automated in 2019 and the incremental benefit from our acquisition of AFP in 2018. Foreign currency had a negative impact on net sales of $137 million or 3%. Excluding currency headwinds, Food Care net sales increased $80 million or 3% due to favorable volume and pricing trends and contribution from two acquisitions. In Product Care, net sales increased $86 million or 5%, including $178 million from the Automated and AFP acquisitions noted above. Contributions from acquisitions were offset by weakness in our protective packaging markets, particularly where we have exposure to the industrial and manufacturing slowdown and ongoing trade disputes, resulting in volume decline of $72 million or 4%. See Note 3, “Revenue Recognition, Contracts with Customers,” of the Notes to Consolidated Financial Statements for additional details regarding revenue recognition.
Business Environment and Overview
We employ sales, marketing and customer service personnel throughout the world who sell and market our products to and through a large number of distributors, fabricators, converters, e-commerce and mail order fulfillment firms, and contract packaging firms as well as directly to end-users such as food processors, food service businesses, supermarket retailers, lodging, retail pharmaceutical companies, healthcare facilities, medical device manufacturers, and other manufacturers. We have no material long-term contracts for the distribution of our products. In 2019, no customer or affiliated group of customers accounted for 10% or more of our consolidated net sales. Additionally, in 2019, no customer or affiliated group of customers accounted for more than 10% of net sales in either of our reporting segments.
Historically, net sales in our Food Care segment have tended to be slightly lower in the first quarter and slightly higher towards the end of the third quarter through the fourth quarter, due to holiday events. Net sales in our Product Care segment have also tended to be slightly lower in the first quarter and higher in the mid-third quarter and through the fourth quarter due to the holiday shopping season. On a consolidated basis, there is little seasonality in the business with net sales slightly lower in the first quarter and slightly higher towards the end of the third quarter through the fourth quarter. Our consolidated net earnings typically trend directionally the same as our net sales seasonality though may be difficult to predict if significant one-time transactions, events or non-recurring charges were to impact our business. Cash flow from operations tends to be higher in the second half of the year, reflecting seasonality of sales and working capital changes, including the timing of certain annual incentive compensation payments.
| 35 |
Other factors may outweigh the effects of seasonal changes in our net earnings results including, but not limited to, changes in raw materials and other costs, foreign exchange rates, interest rates, taxes and the timing and amount of acquisition synergies and restructuring and other non-recurring charges.
Competition for most of our packaging products is based primarily on packaging performance characteristics, automation, service and price. Since competition is also based upon innovations in packaging technology, we maintain ongoing research and development programs to enable us to maintain technological leadership. Competition is both global and regional in scope and includes numerous small, local competitors with limited product portfolios and geographic reach. For more details, see “Competition” included in Part I, Item 1 “Business.”
Our net sales are sensitive to developments in our customers’ business or market conditions, changes in the global economy, and the effects of foreign currency translation. Our costs can vary materially due to changes in input costs, including petrochemical-related costs (primarily resin costs), which are not within our control. Consequently, our management focuses on reducing those costs that we can control and using petrochemical-based and other raw materials as efficiently as possible. We also believe that our global presence helps to insulate us from localized changes in business conditions.
We manage our businesses to generate substantial operating cash flow. We believe that our operating cash flow will permit us to continue to spend on innovative research and development and to invest in our business by means of capital expenditures for property, equipment and acquisitions. Moreover, we expect that our ability to generate substantial operating cash flow should provide us with the flexibility to repay debt and to return capital to our stockholders.
Recent Events and Trends
The Coronavirus Disease 2019 (COVID-19) is having an impact on overall economic conditions. Currently, the greatest impact is in China and Asia Pacific, which has the highest concentration of transmission. We have eight manufacturing facilities in China with approximately 1,100 employees. China accounted for approximately 3% of sales in 2019. COVID-19 may impact other geographic areas in which we have operations. Our top priority is to protect our people and their families, our customers, and our operations from any adverse impacts. We are taking all precautionary measures as directed by health authorities and the local government. COVID-19 has and may continue to have an impact on ports and trade into and out of China and Hong Kong as well as travel in the region and globally. Sealed Air has set up a special management committee covering all businesses and sites in the region. The committee is taking the necessary precautionary measures to protect the health and safety of our employees and following the guidance provided by local health authorities. Given the interconnectivity of the global supply chain and global economy or the rate of future global transmission, the impact of COVID-19 may extend beyond the Asia Pacific region.
| 36 |
Highlights of Financial Performance
Below are the highlights of our financial performance for the three years ended December 31, 2019, 2018 and 2017.
Year Ended December 31, | % Change | |||||||||||||||||
(In millions, except per share amounts) | 2019 | 2018 | 2017 | 2019 vs. 2018 | 2018 vs. 2017 | |||||||||||||
Net sales | $ | 4,791.1 | $ | 4,732.7 | $ | 4,461.6 | 1.2 | % | 6.1 | % | ||||||||
Gross profit | $ | 1,564.8 | $ | 1,502.1 | $ | 1,412.1 | 4.2 | % | 6.4 | % | ||||||||
As a % of net sales | 32.7 | % | 31.7 | % | 31.7 | % | ||||||||||||
Operating profit | $ | 578.5 | $ | 656.3 | $ | 571.3 | (11.9 | )% | 14.9 | % | ||||||||
As a % of net sales | 12.1 | % | 13.9 | % | 12.8 | % | ||||||||||||
Net earnings from continuing operations | $ | 293.7 | $ | 150.3 | $ | 62.8 | 95.4 | % | # | |||||||||
(Loss) Gain on sale of discontinued operations, net of tax | (30.7 | ) | 42.8 | 640.7 | # | (93.3 | )% | |||||||||||
Net earnings from discontinued operations, net of tax | — | — | 111.4 | # | # | |||||||||||||
Net earnings | $ | 263.0 | $ | 193.1 | $ | 814.9 | 36.2 | % | (76.3 | )% | ||||||||
Basic: | ||||||||||||||||||
Continuing operations | $ | 1.90 | $ | 0.94 | $ | 0.34 | # | # | ||||||||||
Discontinued operations | (0.20 | ) | 0.27 | 3.99 | # | (93.2 | )% | |||||||||||
Net earnings per common share - basic | $ | 1.70 | $ | 1.21 | $ | 4.33 | 40.5 | % | (72.1 | )% | ||||||||
Diluted: | ||||||||||||||||||
Continuing operations | $ | 1.89 | $ | 0.94 | $ | 0.33 | # | # | ||||||||||
Discontinued operations | (0.20 | ) | 0.26 | 3.96 | # | (93.4 | )% | |||||||||||
Net earnings per common share - diluted | $ | 1.69 | $ | 1.20 | $ | 4.29 | 40.8 | % | (72.0 | )% | ||||||||
Weighted average number of common shares outstanding: | ||||||||||||||||||
Basic | 154.3 | 159.4 | 186.9 | |||||||||||||||
Diluted | 155.2 | 160.2 | 188.9 | |||||||||||||||
Non-U.S. GAAP Total Company Adjusted EBITDA from continuing operations(1) | $ | 964.8 | $ | 889.5 | $ | 833.3 | 8.5 | % | 6.7 | % | ||||||||
Non-U.S. GAAP Adjusted EPS from continuing operations(2) | $ | 2.82 | $ | 2.50 | $ | 1.81 | 12.8 | % | 38.1 | % | ||||||||
# Denotes a variance greater than or equal to 100% or equal to or less than (100)%.
(1) | See "Non-U.S. GAAP Information” for a reconciliation of U.S. GAAP net earnings from continuing operations to non-U.S. GAAP Total Company Adjusted EBITDA from continuing operations. |
(2) | See “Non-U.S. GAAP Information” for a reconciliation of U.S. GAAP net earnings and diluted earnings per share from continuing operations to our non-U.S. GAAP Adjusted Net Earnings and Adjusted EPS from continuing operations. |
Foreign Currency Translation Impact on Consolidated Financial Results
Since we are a U.S. domiciled company, we translate our foreign currency-denominated financial results into US Dollars. Due to the changes in the value of foreign currencies relative to the US Dollar, translating our financial results from foreign currencies to US Dollars may result in a favorable or unfavorable impact. Historically, the most significant currencies that have impacted the translation of our consolidated financial results are the euro, the Australian dollar, the Mexican peso, the British pound, the Canadian dollar, the Brazilian real and the Chinese Renminbi.
The following table presents the approximate favorable or (unfavorable) impact foreign currency translation had on certain of our consolidated financial results:
| 37 |
(In millions) | 2019 vs. 2018 | 2018 vs. 2017 | ||||||
Net sales | $ | (137.2 | ) | $ | (43.4 | ) | ||
Cost of sales | 98.4 | 31.7 | ||||||
Selling, general and administrative expenses | 16.3 | 1.0 | ||||||
Net earnings | (15.7 | ) | (8.2 | ) | ||||
Non-U.S. GAAP Adjusted EBITDA | (25.3 | ) | (11.1 | ) | ||||
Net Sales by Geographic Region
As part of the Company's Reinvent SEE strategy, we have evaluated and made adjustments to our regional operating model. As of January 1, 2019, our geographic regions are: North America, EMEA, South America and APAC. Our North American operations include Canada, the United States, Mexico and Central America. Mexico and Central America were previously included in Latin America.
The following tables present the components of the change in net sales by geographic region for the year ended December 31, 2019 compared with 2018 and for the year ended December 31, 2018 compared with 2017.
(In millions) | North America | EMEA | South America | APAC | Total | ||||||||||||||||||||||||||||||
2018 Net Sales | $ | 2,734.9 | 57.8 | % | $ | 1,038.5 | 21.9 | % | $ | 229.5 | 4.8 | % | $ | 729.8 | 15.4 | % | $ | 4,732.7 | |||||||||||||||||
Price | (7.3 | ) | (0.3 | )% | 1.0 | 0.1 | % | 49.4 | 21.5 | % | (0.6 | ) | (0.1 | )% | 42.5 | 0.9 | % | ||||||||||||||||||
Volume(1) | (42.8 | ) | (1.5 | )% | (3.8 | ) | (0.4 | )% | 11.6 | 5.1 | % | (6.9 | ) | (0.9 | )% | (41.9 | ) | (0.9 | )% | ||||||||||||||||
Total organic change (non-U.S. GAAP) | (50.1 | ) | (1.8 | )% | (2.8 | ) | (0.3 | )% | 61.0 | 26.6 | % | (7.5 | ) | (1.0 | )% | 0.6 | — | % | |||||||||||||||||
Acquisition | 147.5 | 5.4 | % | 24.1 | 2.4 | % | 0.2 | 0.1 | % | 23.2 | 3.2 | % | 195.0 | 4.1 | % | ||||||||||||||||||||
Total constant dollar change (non-U.S. GAAP) | 97.4 | 3.6 | % | 21.3 | 2.1 | % | 61.2 | 26.7 | % | 15.7 | 2.2 | % | 195.6 | 4.1 | % | ||||||||||||||||||||
Foreign currency translation | (4.2 | ) | (0.2 | )% | (49.4 | ) | (4.8 | )% | (56.9 | ) | (24.8 | )% | (26.7 | ) | (3.7 | )% | (137.2 | ) | (2.9 | )% | |||||||||||||||
Total change (U.S. GAAP) | 93.2 | 3.4 | % | (28.1 | ) | (2.7 | )% | 4.3 | 1.9 | % | (11.0 | ) | (1.5 | )% | 58.4 | 1.2 | % | ||||||||||||||||||
2019 Net Sales | $ | 2,828.1 | 59.0 | % | $ | 1,010.4 | 21.1 | % | $ | 233.8 | 4.9 | % | $ | 718.8 | 15.0 | % | $ | 4,791.1 | |||||||||||||||||
(In millions) | North America | EMEA | South America | APAC | Total | ||||||||||||||||||||||||||||||
2017 Net Sales | $ | 2,591.5 | 58.1 | % | $ | 983.4 | 22.0 | % | $ | 231.8 | 5.2 | % | $ | 654.9 | 14.7 | % | $ | 4,461.6 | |||||||||||||||||
Price | 65.7 | 2.5 | % | 11.7 | 1.2 | % | 39.9 | 17.2 | % | (1.4 | ) | (0.2 | )% | 115.9 | 2.6 | % | |||||||||||||||||||
Volume(1) | 38.4 | 1.5 | % | 18.6 | 1.9 | % | 15.1 | 6.5 | % | 12.7 | 1.9 | % | 84.8 | 1.9 | % | ||||||||||||||||||||
Total organic change (non-U.S. GAAP) | 104.1 | 4.0 | % | 30.3 | 3.1 | % | 55.0 | 23.7 | % | 11.3 | 1.7 | % | 200.7 | 4.5 | % | ||||||||||||||||||||
Acquisition | 43.8 | 1.7 | % | — | — | % | 1.4 | 0.6 | % | 68.6 | 10.5 | % | 113.8 | 2.5 | % | ||||||||||||||||||||
Total constant dollar change (non-U.S. GAAP) | 147.9 | 5.7 | % | 30.3 | 3.1 | % | 56.4 | 24.3 | % | 79.9 | 12.2 | % | 314.5 | 7.0 | % | ||||||||||||||||||||
Foreign currency translation | (4.5 | ) | (0.2 | )% | 24.8 | 2.5 | % | (58.7 | ) | (25.3 | )% | (5.0 | ) | (0.8 | )% | (43.4 | ) | (0.9 | )% | ||||||||||||||||
Total change (U.S. GAAP) | 143.4 | 5.5 | % | 55.1 | 5.6 | % | (2.3 | ) | (1.0 | )% | 74.9 | 11.4 | % | 271.1 | 6.1 | % | |||||||||||||||||||
2018 Net Sales | $ | 2,734.9 | 57.8 | % | $ | 1,038.5 | 21.9 | % | $ | 229.5 | 4.8 | % | $ | 729.8 | 15.4 | % | $ | 4,732.7 | |||||||||||||||||
(1) | Our volume reported above includes the net impact of changes in unit volume as well as the period-to-period change in the mix of products sold. |
| 38 |
Net Sales by Segment
The following tables present the components of change in net sales by our segment reporting structure for the year ended December 31, 2019 compared with 2018 and for the year ended December 31, 2018 compared with 2017.
(In millions) | Food Care | Product Care | Total Company | ||||||||||||||||||
2018 Net Sales | $ | 2,908.1 | 61.4 | % | $ | 1,824.6 | 38.6 | % | $ | 4,732.7 | |||||||||||
Price | 32.7 | 1.1 | % | 9.8 | 0.5 | % | 42.5 | 0.9 | % | ||||||||||||
Volume(1) | 30.3 | 1.1 | % | (72.2 | ) | (3.9 | )% | (41.9 | ) | (0.9 | )% | ||||||||||
Total organic change (non-U.S. GAAP) | 63.0 | 2.2 | % | (62.4 | ) | (3.4 | )% | 0.6 | — | % | |||||||||||
Acquisitions | 16.6 | 0.5 | % | 178.4 | 9.8 | % | 195.0 | 4.1 | % | ||||||||||||
Total constant dollar change (non-U.S. GAAP) | 79.6 | 2.7 | % | 116.0 | 6.4 | % | 195.6 | 4.1 | % | ||||||||||||
Foreign currency translation | (107.2 | ) | (3.6 | )% | (30.0 | ) | (1.7 | )% | (137.2 | ) | (2.9 | )% | |||||||||
Total change (U.S. GAAP) | (27.6 | ) | (0.9 | )% | 86.0 | 4.7 | % | 58.4 | 1.2 | % | |||||||||||
2019 Net Sales | $ | 2,880.5 | 60.1 | % | $ | 1,910.6 | 39.9 | % | $ | 4,791.1 | |||||||||||
(In millions) | Food Care | Product Care | Total Company | ||||||||||||||||||
2017 Net Sales | $ | 2,815.2 | 63.1 | % | $ | 1,646.4 | 36.9 | % | 4,461.6 | ||||||||||||
Price | 78.7 | 2.8 | % | 37.2 | 2.3 | % | $ | 115.9 | 2.6 | % | |||||||||||
Volume(1) | 66.7 | 2.4 | % | 18.1 | 1.1 | % | 84.8 | 1.9 | % | ||||||||||||
Total organic change (non-U.S. GAAP) | 145.4 | 5.2 | % | 55.3 | 3.4 | % | 200.7 | 4.5 | % | ||||||||||||
Acquisitions | — | — | % | 113.8 | 6.9 | % | 113.8 | 2.5 | % | ||||||||||||
Total constant dollar change (non-U.S. GAAP) | 145.4 | 5.2 | % | 169.1 | 10.3 | % | 314.5 | 7.0 | % | ||||||||||||
Foreign currency translation | (52.5 | ) | (1.9 | )% | 9.1 | 0.5 | % | (43.4 | ) | (0.9 | )% | ||||||||||
Total change (U.S. GAAP) | 92.9 | 3.3 | % | 178.2 | 10.8 | % | 271.1 | 6.1 | % | ||||||||||||
2018 Net Sales | $ | 2,908.1 | 61.4 | % | $ | 1,824.6 | 38.6 | % | $ | 4,732.7 | |||||||||||
(1) | Our volume reported above includes the net impact of changes in unit volume as well as the period-to-period change in the mix of products sold. |
Food Care
2019 compared with 2018
As reported, net sales decreased $28 million, or 1%, in 2019 compared with 2018. Foreign currency had a negative impact of $107 million. On a constant dollar basis, net sales increased $80 million, or 3%, in 2019 compared with 2018 primarily due to the following:
• | favorable price of $33 million, primarily in South America driven by US dollar-based indexed pricing, partially offset by North America, which was driven by formula-based pricing; |
• | higher volume of $30 million, primarily in North America, South America and APAC, partially offset by EMEA; and |
• | contributions from acquisition activities of $17 million. |
2018 compared with 2017
As reported, net sales increased $93 million, or 3% in 2018 compared with 2017. On a constant dollar basis, net sales increased $145 million, or 5% in 2018 compared with 2017 primarily due to the following:
| 39 |
• | favorable price of approximately $79 million, primarily in South America driven by US dollar-based indexed pricing and North America; and |
• | higher volume of approximately $67 million across all regions. |
Product Care
2019 compared with 2018
As reported, net sales increased $86 million, or 5%, in 2019 compared with 2018. On a constant dollar basis, net sales increased $116 million, or 6% in 2019 compared with 2018 primarily due to the following:
• | $178 million increase in sales due to acquisitions of Automated Packaging Systems and AFP through the first 12 months in which they were under Sealed Air ownership; and |
• | favorable price of $10 million, primarily in North America; |
This was partially offset by:
• | lower volume of $72 million, primarily driven by macroeconomic headwinds, particularly in the industrial sector. |
2018 compared with 2017
As reported, net sales increased $178 million, or 11%, in 2018 compared with 2017, of which $9 million was due to positive currency impact. On a constant dollar basis, net sales increased $169 million, or 10% in 2018 compared with 2017 primarily due to the following:
• | $114 million increase in sales due to the acquisitions of Fagerdala and AFP; |
• | favorable price of $37 million primarily in North America; and |
• | higher volumes of $18 million primarily in North America and EMEA. |
Cost of Sales
Cost of sales for three years ended December 31, were as follows:
Year Ended December 31, | 2019 vs. 2018 | 2018 vs. 2017 | ||||||||||||||||
(In millions) | 2019 | 2018 | 2017 | % Change | % Change | |||||||||||||
Net sales | $ | 4,791.1 | $ | 4,732.7 | $ | 4,461.6 | 1.2 | % | 6.1 | % | ||||||||
Cost of sales | 3,226.3 | 3,230.6 | 3,049.5 | (0.1 | )% | 5.9 | % | |||||||||||
As a % of net sales | 67.3 | % | 68.3 | % | 68.3 | % | ||||||||||||
2019 compared with 2018
As reported, cost of sales was relatively flat in 2019 as compared to 2018. Cost of sales was impacted by favorable foreign currency translation of $98 million. On a constant dollar basis, cost of sales increased $94 million, or 3%, primarily on a higher sales base. As a percentage of net sales, cost of sales decreased by 100 basis points, from 68.3% for the year ended December 31, 2018 to 67.3% for the year ended December 31, 2019, primarily due to improvements resulting from our Reinvent SEE initiatives, including productivity improvements and restructuring savings, as well as lower input costs benefiting our price/cost spread.
2018 compared with 2017
As reported, cost of sales increased by $181 million, or 6%, in 2018 as compared to 2017. Cost of sales was impacted by favorable foreign currency translation of $32 million. On a constant dollar basis, cost of sales increased $213 million, or 7.0%, primarily due to higher raw material costs on increased sales volumes, non-material inflation and freight costs and increased costs due to acquisitions. Cost of sales as a percentage of our net sales was consistent in both years.
| 40 |
Selling, General and Administrative Expenses
Selling, general and administrative (“SG&A”) expenses for three years ended December 31, are included in the table below.
Year Ended December 31, | 2019 vs. 2018 | 2018 vs. 2017 | ||||||||||||||||
(In millions) | 2019 | 2018 | 2017 | % Change | % Change | |||||||||||||
Selling, general and administrative expenses | $ | 915.5 | $ | 782.3 | $ | 815.6 | 17.0 | % | (4.1 | )% | ||||||||
As a % of net sales | 19.1 | % | 16.5 | % | 18.3 | % | ||||||||||||
2019 compared with 2018
As reported, SG&A expenses increased $133 million, or 17%, in 2019 as compared to 2018. SG&A expenses were impacted by favorable foreign currency translation of $16 million. On a constant dollar basis, SG&A expenses increased approximately $150 million, or 19%. The increase in SG&A expenses is a result of $60 million in restructuring associated charges primarily related to our Reinvent SEE initiatives, a $59 million charge related to a settlement agreement with Novipax (See Note 20, “Commitments and Contingencies,” of the Notes to Consolidated Financial Statements for additional details regarding the Novipax settlement), incremental SG&A expense from recent acquisitions, including Automated and AFP, of $39 million and approximately $11 million due to higher incentive compensation expense. Restructuring associated charges described above primarily relate to fees paid to third-party consultants in support of Reinvent SEE and costs related to property consolidations resulting from Reinvent SEE.
These expenses were partially offset by benefits attributable to our Reinvent SEE initiatives.
2018 compared with 2017
As reported, SG&A expenses decreased $33 million, or 4%, in 2018 as compared to 2017. SG&A expenses were impacted by favorable foreign currency translation of $1 million. On a constant dollar basis, SG&A expenses decreased $34 million, or 4%. This was primarily driven by higher costs in the prior year due to the sale of Diversey.
Amortization Expense of Intangible Assets Acquired
Amortization expense of intangible assets acquired for the years ended December 31, were as follows:
Year Ended December 31, | 2019 vs. 2018 | 2018 vs. 2017 | ||||||||||||||||
(In millions) | 2019 | 2018 | 2017 | % Change | % Change | |||||||||||||
Amortization expense of intangible assets acquired | $ | 28.9 | $ | 15.7 | $ | 13.1 | 84.1 | % | 19.8 | % | ||||||||
As a % of net sales | 0.6 | % | 0.3 | % | 0.3 | % | ||||||||||||
The increase in amortization expense of intangibles for the year ended December 31, 2019 was primarily related to the acquisition of Automated. The most significant impact on year over year increase in amortization expense was backlog acquired in the Automated purchase which was amortized over 5 months. The Company also acquired intangibles related to technology, trademarks and tradenames and customer relationships from Automated.
The increase in amortization expense of intangibles for the year ended December 31, 2018 compared to the year ended December 31, 2017 was primarily related to the acquisition of Fagerdala.
See Note 5, “Discontinued Operations, Divestitures and Acquisitions,” of the Notes to Consolidated Financial Statements for additional details regarding the Company's recent acquisitions.
Reinvent SEE Strategy and Restructuring Activities
See Note 12, “Restructuring Activities,” of the Notes to Consolidated Financial Statements for additional details regarding the Company’s restructuring programs discussed below.
| 41 |
In December 2018 the Sealed Air Board of Directors approved a three-year restructuring program related to Reinvent SEE.
Sealed Air has combined the program associated with Reinvent SEE with its previously existing restructuring program (as combined, “Program”) which was largely related to the elimination of stranded costs following the sale of Diversey. For the year ended December 31, 2019, the Program generated incremental cost savings of $64 million related to reductions in operating costs, $67 million related to restructuring actions and $37 million related to actions impacting price cost spread. We now expect the Program to generate incremental cost savings of approximately $330 million by the end of 2021. We expect remaining Program spend between $80 and $110 million, primarily incurred in 2020.
For the year ended December 31, 2019, we recorded restructuring expense of $42 million. Restructuring activities are diversified across all four regions. In 2019, restructuring had the largest impact on our second quarter results, during which we recognized approximately 70% of the restructuring expense recorded during the year. During the fourth quarter, we recorded a net restructuring reversal of $2 million. The reversal was related to management's fourth quarter decision to no longer cease operations in one of our manufacturing facilities as well as the reversal of a number of headcount-reduction accruals incurred earlier in the year.
We also recorded $60 million in restructuring associated costs for the year ended December 31, 2019. Restructuring associated costs primarily relate to fees paid to third-party consultants in support of Reinvent SEE and costs associated with property consolidations and machinery and equipment relocations resulting from Reinvent SEE.
The actual timing of future costs and cash payments related to the Program described above are subject to change due to a variety of factors that may cause a portion of the costs, spending and benefits to occur later than expected. In addition, changes in foreign exchange rates may impact future costs, spending, benefits and cost synergies.
Interest Expense, net
Interest expense, net includes the stated interest rate on our outstanding debt, as well as the net impact of capitalized interest, interest income, the effects of terminated interest rate swaps and the amortization of capitalized senior debt issuance costs and credit facility fees, bond discounts, and terminated treasury locks.
Interest expense, net for the years ended December 31, was as follows:
Year Ended December 31, | 2019 vs. 2018 | 2018 vs. 2017 | ||||||||||||||||||
(In millions) | 2019 | 2018 | 2017 | Change | Change | |||||||||||||||
Interest expense on our various debt instruments: | ||||||||||||||||||||
Term Loan A due July 2017(1) | $ | — | $ | — | $ | 3.6 | $ | — | $ | (3.6 | ) | |||||||||
Term Loan A due July 2022(2) | 6.8 | — | — | 6.8 | — | |||||||||||||||
Term Loan A due July 2023(3) | 8.5 | 8.9 | 18.6 | (0.4 | ) | (9.7 | ) | |||||||||||||
Revolving credit facility due July 2023(3) | 1.4 | 1.9 | 2.4 | (0.5 | ) | (0.5 | ) | |||||||||||||
6.50% Senior Notes due December 2020(4) | 25.4 | 28.1 | 28.1 | (2.7 | ) | — | ||||||||||||||
4.875% Senior Notes due December 2022 | 21.5 | 21.5 | 21.5 | — | — | |||||||||||||||
5.25% Senior Notes due April 2023 | 23.1 | 23.1 | 23.0 | — | 0.1 | |||||||||||||||
4.50% Senior Notes due September 2023 | 20.7 | 21.8 | 21.0 | (1.1 | ) | 0.8 | ||||||||||||||
5.125% Senior Notes due December 2024 | 22.4 | 22.4 | 22.3 | — | 0.1 | |||||||||||||||
5.50% Senior Notes due September 2025 | 22.4 | 22.4 | 22.3 | — | 0.1 | |||||||||||||||
4.00% Senior Notes due December 2027(4) | 1.7 | — | — | 1.7 | — | |||||||||||||||
6.875% Senior Notes due July 2033 | 31.1 | 31.0 | 31.0 | 0.1 | — | |||||||||||||||
Other interest expense | 19.4 | 18.2 | 18.3 | 1.2 | (0.1 | ) | ||||||||||||||
Less: capitalized interest | (8.4 | ) | (6.3 | ) | (10.3 | ) | (2.1 | ) | 4.0 | |||||||||||
Less: interest income | (11.9 | ) | (15.1 | ) | (17.6 | ) | 3.2 | 2.5 | ||||||||||||
Total | $ | 184.1 | $ | 177.9 | $ | 184.2 | $ | 6.2 | $ | (6.3 | ) | |||||||||
(1) | We repaid the notes upon maturity in July 2017. |
| 42 |
(2) | On August 1, 2019, Sealed Air Corporation, on behalf of itself and certain of its subsidiaries, and Sealed Air Corporation (US) entered into an amendment to its existing senior secured credit facility with Bank of America, N.A., as agent, and the other financial institutions party thereto. The amendment provided for a new incremental term facility in an aggregate principal amount of up to $475 million, to be used, in part, to finance the acquisition of Automated. See Note 14, "Debt and Credit Facilities," of the Notes to Consolidated Financial Statements for further details. |
(3) | On July 12, 2018, the Company and certain of its subsidiaries entered into a third amended and restated credit agreement with respect to its existing senior secured credit facility. See Note 14, “Debt and Credit Facilities,” of the Notes to Consolidated Financial Statements for further details. |
(4) | In November 2019, the Company issued $425 million of 4.00% Senior Notes due 2027 and used the proceeds to retire the existing $425 million of 6.50% Senior Notes due 2020. See Note 14, "Debt and Credit Facilities," of the Notes to Consolidated Financial Statements for further details. |
Other (Expense) Income, net
Brazil Tax Credits
Cryovac Brasil Ltda., a Sealed Air subsidiary, received a final decision from the Brazilian court regarding a claim in which Sealed Air contended that certain indirect taxes paid were calculated on an incorrect amount. As a result of this case, the Company expects to receive credits on indirect tax payments in future periods. During the second quarter of 2019, the Company filed a return claim for the tax years of 2015 through 2018; as such, the Company has recorded $4.8 million to other (expense) income, net on the Consolidated Statements of Operations in the second quarter. Pending future and final judicial decisions to be made by the Brazilian Supreme Court, the Company may be able to claim an overpayment of indirect taxes paid prior to 2015, including for the tax years 2010 - 2014 for which the Company has prepared documentation. Subsequent claims may result in material future credits; however, these amounts cannot be estimated at this time. The Company will record income for future credits once the amounts are realizable.
Loss on debt redemption
In November 2019, Sealed Air issued $425 million of 4.00% Senior Notes due December 2027. The proceeds were used to repurchase $425 million 6.50% Senior Notes due December 2020. We recognized a $16 million pre-tax loss on the transaction. The loss was primarily driven by the breakage fee on the bond redemption. See Note 14, "Debt and Credit Facilities," of the Notes to Consolidated Financial Statements for further details.
See Note 23, “Other (Expense) Income, net,” of the Notes to Consolidated Financial Statements for the components and discussion of other income, net.
Income Taxes
The table below shows our effective income tax rate (“ETR”).
Year Ended | Effective Tax Rate | ||
2019 | 20.7 | % | |
2018 | 67.2 | % | |
2017 | 84.0 | % | |
Our effective income tax rate for the year ended December 31, 2019 was 20.7%. The difference between the Company's effective income tax rate and the U.S. statutory rate of 21% relates primarily to benefits related to tax optimization initiatives associated with Reinvent SEE and restructuring activities, prior year research credits and a reduction in the valuation allowance offset by expense related to unrecognized tax benefits and the global intangible low-taxed income (“GILTI”) provisions.
Our effective income tax rate for the year ended December 31, 2018 was 67.2%. The TCJA had a significant impact on our income tax expense for the year ended December 31, 2018. The 2018 effective tax rate includes the benefit of a lower U.S. corporate income tax rate of 21% and also reflects $222 million of expense for tax related to the one-time mandatory tax on previously deferred foreign earnings of U.S subsidiaries under TCJA ("Transition Tax"). The difference between the Company’s effective income tax rate and the U.S. statutory rate of 21% relates primarily to the Transition Tax associated with
| 43 |
the TCJA, the (“GILTI”) provision enacted as part of the TCJA, state income taxes, and foreign earnings subject to higher tax rates, offset by tax benefit for reduction in valuation allowance related to tax initiatives.
Our effective income tax rate for the year ended December 31, 2017 was 84.0%. The annual effective income tax rate is higher than the statutory rate primarily as a result of expense related to the sale of Diversey, the revaluation of deferred tax assets as a result of the TCJA and an increase in unrecognized foreign tax benefits.
Our effective income tax rate depends upon the realization of our net deferred tax assets. We have deferred tax assets related to accruals not yet deductible for tax purposes, state and foreign net operating loss carryforwards, tax credits, employee benefit items, intangibles and other items.
The Internal Revenue Service (the “IRS”) is currently auditing the 2011-2014 consolidated U.S. federal income tax returns of the Company. Included in the audit of the 2014 return is the examination by the IRS with respect to the Cryovac Settlement agreement deduction and the proposed adjustment to disallow the entire amount paid under the Settlement Agreement. The outcome of the examination may require us to record additional tax expense and result in significant cash outflows.
We have established valuation allowances to reduce our deferred tax assets to an amount that is more likely than not to be realized. Our ability to utilize our deferred tax assets depends in part upon our ability to carryback any losses created by the deduction of these temporary differences, the future income from existing temporary differences, and the ability to generate future taxable income within the respective jurisdictions during the periods in which these temporary differences reverse. If we are unable to generate sufficient future taxable income in the U.S. and certain foreign jurisdictions, or if there is a significant change in the time period within which the underlying temporary differences become taxable or deductible, we could be required to increase our valuation allowances against our deferred tax assets. Conversely, if we have sufficient future taxable income in jurisdictions where we have valuation allowances, we may be able to reverse those valuation allowances. We reported a net decrease in our valuation allowance for the year ended December 31, 2019, primarily related to foreign net operating losses. See Note 19, "Income Taxes," of the Notes to Consolidated Financial Statements for additional information.
We reported a net expense for unrecognized tax benefits in the year ended December 31, 2019 of $36 million, primarily related to North America tax positions. Interest and penalties on tax assessments are included in income tax expense.
Net Earnings from Continuing Operations
Net earnings from continuing operations for the years ended December 31, are included in the table below.
Year Ended December 31, | % Change | |||||||||||||||||
(In millions) | 2019 | 2018 | 2017 | 2019 vs. 2018 | 2018 vs. 2017 | |||||||||||||
Net earnings from continuing operations | $ | 293.7 | $ | 150.3 | $ | 62.8 | 95.4 | % | 139.3 | % | ||||||||
For 2019, net earnings were unfavorably impacted by $145 million of Special Items after tax, which were primarily the result of restructuring and other restructuring associated costs primarily related to Reinvent SEE of $102 million ($76 million net of taxes), a $59 million ($44 million net of taxes) charge related to the Novipax settlement, loss on debt redemption and refinancing activities of $16 million ($12 million net of taxes) and charges related to acquisition integrations and divestiture activities of $15 million ($11 million net of taxes).
For 2018, net earnings were unfavorably impacted by $251 million of Special Items. Special Items primarily related to Tax Special Items including $222 million of expense for the one-time Transition Tax, partially offset by the release of valuation allowances associated with tax initiatives. In addition, net earnings were unfavorably impacted by Special Items expenses primarily related to restructuring and other restructuring associated costs of $64 million ($50 million net of taxes), charges related to the sale of Diversey of $21 million ($14 million net of taxes) and charges related to acquisition integrations and divestiture activities of $13 million ($10 million net of taxes), partially offset by gain on class-action litigation proceeds of $15 million ($12 million net of taxes).
For 2017, net earnings were unfavorably impacted by $280 million of Special Items, primarily related to Tax Special Items related to the sale of Diversey of $152 million, charges related to the sale of Diversey of $55 million ($29 million net of taxes) related to professional fees and restructuring, restructuring and other restructuring associated costs related to our restructuring program of $26 million ($21 million net of taxes) and other charges related to our acquisition and divestiture activity of $16 million ($13 million net of taxes).
| 44 |
(Loss) Gain on Sale of Discontinued Operations, net of tax
(Loss) gain on sale of discontinued operations, net of tax for the years ended December 31, are included in the table below.
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
(Loss) Gain on sale of discontinued operations, net of tax | $ | (30.7 | ) | $ | 42.8 | $ | 640.7 | |||||
During 2017, we completed the sale of our Diversey Care division and recorded a net gain on the sale of Diversey of $641 million, net of taxes. During 2018, we recorded an additional net gain on the sale of Diversey of $43 million, net of taxes, which was related to the final net working capital settlement as well as the release of tax indemnity reserves upon expiration of the statute of limitations. During 2019, we recorded a net loss of $31 million on sale of discontinued operations. This loss relates primarily to changes in balance sheet positions associated with the sale of Diversey including tax-related indemnification reserves and other receivable or payable positions arising from the sale.
Adjusted EBITDA by Segment
The Company evaluates performance of the reportable segments based on the results of each segment. The performance metric used by the Company's chief operating decision maker to evaluate performance of our reportable segments is Adjusted EBITDA. We allocate and disclose depreciation and amortization expense to our segments, although depreciation and amortization are not included in the segment performance metric Adjusted EBITDA. We also allocate and disclose restructuring and other charges and impairment of goodwill and other intangible assets by segment, although it is not included in the segment performance metric Adjusted EBITDA since restructuring and other charges and impairment of goodwill and other intangible assets are categorized as Special Items. The accounting policies of the reportable segments and Corporate are the same as those applied to the Consolidated Financial Statements.
See "Non-U.S. GAAP Information” for a reconciliation of U.S. GAAP net earnings from continuing operations to non-U.S. GAAP Total Company Adjusted EBITDA from continuing operations.
Year Ended December 31, | % Change | |||||||||||||||||
(In millions) | 2019 | 2018 | 2017 | 2019 vs. 2018 | 2018 vs. 2017 | |||||||||||||
Food Care | $ | 629.3 | $ | 577.8 | $ | 538.1 | 8.9 | % | 7.4 | % | ||||||||
Adjusted EBITDA Margin | 21.8 | % | 19.9 | % | 19.1 | % | ||||||||||||
Product Care | 349.9 | 318.6 | 292.2 | 9.8 | % | 9.0 | % | |||||||||||
Adjusted EBITDA Margin | 18.3 | % | 17.5 | % | 17.7 | % | ||||||||||||
Corporate | (14.4 | ) | (6.9 | ) | 3.0 | 108.7 | % | (330.0 | )% | |||||||||
Non-U.S. GAAP Total Company Adjusted EBITDA from continuing operations | $ | 964.8 | $ | 889.5 | $ | 833.3 | 8.5 | % | 6.7 | % | ||||||||
Adjusted EBITDA Margin | 20.1 | % | 18.8 | % | 18.7 | % | ||||||||||||
The following is a discussion of the factors that contributed to the change in Adjusted EBITDA by segment in the year ended December 31, as compared with the prior year.
Food Care
2019 compared with 2018
On a reported basis, Adjusted EBITDA increased $52 million in 2019 as compared to 2018. Adjusted EBITDA was impacted by unfavorable foreign currency translation of $21 million. On a constant dollar basis, Adjusted EBITDA increased $73 million, or 13%, in 2019 compared with the same period in 2018 primarily due to the impact of:
• | Reinvent SEE benefits of $109 million driven by actions reducing operating costs by $50 million, restructuring savings of $39 million and improvements to price cost spread of $20 million; |
| 45 |
• | other price cost spread drivers of $20 million; and |
• | business growth including $10 million from higher volume. |
These were partially offset by:
• | higher operating costs of $66 million, including labor inflation, higher incentive compensation, investments in the business and other manufacturing costs. |
2018 compared with 2017
On a reported basis, Adjusted EBITDA increased $40 million in 2018 as compared to 2017. Adjusted EBITDA was impacted by unfavorable foreign currency translation of $14 million. On a constant dollar basis, Adjusted EBITDA increased $53 million or 10% in 2018 compared with the same period in 2017 primarily due to the impact of:
• | favorable mix and price/cost spread of $33 million; |
• | $28 million of restructuring savings; and |
• | positive volume trends of $21 million. |
These were partially offset by:
• | higher non-material manufacturing costs and other costs of $28 million, including salary and wage inflation. |
Product Care
2019 compared with 2018
On a reported basis, Adjusted EBITDA increased $31 million in 2019 as compared to 2018. Adjusted EBITDA was impacted by unfavorable foreign currency translation of $6 million. On a constant dollar basis, Adjusted EBITDA increased $37 million, or 12%, in 2019 compared with the same period in 2018 primarily due to the impact of:
• | Reinvent SEE benefits of $59 million driven by restructuring savings of $28 million, improvements to price cost spread of $17 million and actions reducing operating costs by $14 million; |
• | other price cost spread drivers of $26 million; and |
• | contributions from recent acquisitions of $14 million, which is net of the $6 million one-time non-cash inventory step-up charge associated with the Automated acquisition. |
These were partially offset by:
• | higher operating costs of approximately $34 million, including labor inflation, higher incentive compensation expense, other manufacturing costs and investment in the business; and |
• | lower volume of $28 million, primarily driven by macroeconomic headwinds, particularly in the industrial sector. |
2018 compared with 2017
On a reported basis, Adjusted EBITDA increased $26 million in 2018 as compared to 2017. Adjusted EBITDA was impacted by favorable foreign currency translation of $3 million. On a constant dollar basis, Adjusted EBITDA increased $24 million, or 8%, in 2018 compared with the same period in 2017 primarily due to the impact of:
• | favorable price/cost spread of more than $15 million; |
• | restructuring savings of more than $15 million; and |
• | positive volume trends of $2 million. |
This was partially offset by:
• | higher operating costs of $9 million primarily driven by higher non-material manufacturing costs and other costs including salary and wage inflation offset by income from the acquisition of Fagerdala and AFP. |
| 46 |
Corporate
2019 compared with 2018
Corporate expenses increased by $8 million on an as reported basis and $9 million on a constant dollar basis as compared with the same period in 2018, primarily driven by currency transaction losses associated with emerging market currencies strengthening against the US Dollar.
2018 compared with 2017
Corporate expenses increased by $10 million on an as reported basis and constant dollar basis as compared with the same period in 2017, primarily due to foreign currency losses.
Liquidity and Capital Resources
Principal Sources of Liquidity
Our primary sources of cash are the collection of trade receivables generated from the sales of our products and services to our customers and amounts available under our existing lines of credit, including our Amended and Restated Senior Secured Credit Facility, and our accounts receivable securitization programs. Our primary uses of cash are payments for operating expenses, investments in working capital, capital expenditures, interest, taxes, stock repurchases, dividends, debt obligations, restructuring expenses and other long-term liabilities. We believe that our current liquidity position and future cash flows from operations will enable us to fund our operations, including all of the items mentioned above, in the next twelve months.
As of December 31, 2019, we had cash and cash equivalents of $262 million, of which approximately $244 million, or 93%, was located outside of the U.S. As of December 31, 2019, we had an immaterial amount of cash trapped outside of the U.S. Our U.S. cash balances and committed liquidity facilities available to U.S. borrowers are sufficient to fund our U.S. operating requirements and capital expenditures, current debt obligations and dividends. The Company does not expect that in the near term cash located outside of the U.S. will be needed to satisfy its obligations, dividends and other demands for cash in the U.S.
Material Commitments and Contingencies
Cryovac Transaction Commitments and Contingencies
The information set forth in Note 20, “Commitments and Contingencies,” of the Notes to Consolidated Financial Statements under the caption “Cryovac Transaction Commitments and Contingencies” is incorporated herein by reference.
Contractual Obligations
The following table summarizes our principal contractual obligations and sets forth the amounts of required or contingently required cash outlays in 2020 and future years:
Payments Due by Years | ||||||||||||||||||||
(In millions) | Total | 2020 | 2021-2022 | 2023-2024 | Thereafter | |||||||||||||||
Contractual Obligations | ||||||||||||||||||||
Short-term borrowings | $ | 98.9 | $ | 98.9 | $ | — | $ | — | $ | — | ||||||||||
Current portion of long-term debt(1) | 18.4 | 18.4 | — | — | — | |||||||||||||||
Long-term debt(1) | 3,729.2 | — | 938.9 | 1,499.8 | 1,290.5 | |||||||||||||||
Total debt | $ | 3,846.5 | $ | 117.3 | $ | 938.9 | $ | 1,499.8 | $ | 1,290.5 | ||||||||||
Interest payments due on long-term debt(2) | 1,057.2 | 180.4 | 342.7 | 204.7 | 329.4 | |||||||||||||||
Operating leases | 105.4 | 30.6 | 40.0 | 18.7 | 16.1 | |||||||||||||||
First quarter 2020 quarterly cash dividend declared | 24.8 | 24.8 | — | — | — | |||||||||||||||
Other principal contractual obligations | 86.2 | 35.6 | 31.4 | 19.2 | — | |||||||||||||||
Total contractual cash obligations(3) | $ | 5,120.1 | $ | 388.7 | $ | 1,353.0 | $ | 1,742.4 | $ | 1,636.0 | ||||||||||
| 47 |
(1) | Current portion of long-term debt is exclusive of present value discounting for finance lease obligations of $1.7 million. The long-term debt is exclusive of capitalized lender fees of $22.2 million, present value discounting for finance lease obligations of $6.1 million, and debt discounts of $2.3 million. |
(2) | Includes interest payments required under our senior notes issuances and Amended Credit Facility only. The interest payments included above for our Term Loan A were calculated using the following assumptions: |
• | interest rates based on stated LIBOR rates as of December 31, 2019; and |
• | all non-US Dollar balances are converted using exchange rates as of December 31, 2019. |
(3) | Obligations related to defined benefit pension plans and other post-employment benefit plans have been excluded from the table above, due to factors such as the retirement of employees, the performance of plan assets and economic and actuarial assumptions, as it is not reasonably possible to estimate when these obligations will become due. Refer to Note 17, “Profit Sharing, Retirement Savings Plans and Defined Benefit Pension Plans,” and Note 18, “Other Post-Employment Benefits and Other Employee Benefit Plans,” of the Notes to Consolidated Financial Statements for additional information related to these plans. |
Short-term Borrowings, Current Portion of Long-Term Debt and Long-Term Debt
Short-term borrowings, current portion of long-term debt and long-term debt represent the principal amount of the debt required to be repaid in each period.
Operating Leases
The contractual operating lease obligations listed in the table above represent estimated future minimum annual rental commitments primarily under non-cancelable real and personal property leases as of December 31, 2019.
Other Principal Contractual Obligations
Other principal contractual obligations include agreements to purchase an estimated amount of goods, including raw materials, or services, including energy, in the normal course of business. These obligations are enforceable and legally binding and specify all significant terms, including fixed or minimum quantities to be purchased, minimum or variable price provisions and the approximate timing of the purchase. The amounts included in the table above represent estimates of the minimum amounts we are obligated to pay, or reasonably likely to pay under these agreements. We may purchase additional goods or services above the minimum requirements of these obligations and, as a result use additional cash.
Liability for Unrecognized Tax Benefits
At December 31, 2019, we had liabilities for unrecognized tax benefits and related interest of $384 million. Given the inherent uncertainty regarding the timing of future cash outflows associated with some of our liabilities for unrecognized tax benefits, we are not able to make reasonable estimates of the period of cash settlement with the respective taxing authority. As such, these amounts are not included in the contractual obligations table above. See Note 19, “Income Taxes,” of the Notes to Consolidated Financial Statements for further discussion.
Off-Balance Sheet Arrangements
We have reviewed our off-balance sheet arrangements and have determined that none of those arrangements has a material current effect or is reasonably likely to have a material future effect on our Consolidated Financial Statements, liquidity, capital expenditures or capital resources.
Income Tax Payments
We expect tax payments to be approximately $100 million in 2020. These amounts are not included in the contractual obligations table above as future payments are uncertain and dependent on a number of factors including the amount of future taxable income and the results of on-going IRS examinations.
Contributions to Defined Benefit Pension Plans
We maintain defined benefit pension plans for some of our U.S. and our non-U.S. employees. We currently expect our contributions to these plans to be approximately $20 million in 2020. Additionally, we expect benefits related to our defined
| 48 |
benefit pension plan paid directly by the Company to be $4 million in 2020. These payments are not included in the contractual obligations table above as future contributions are uncertain and rely on a number of factors including performance of underlying assets, future cash out flows of the plans, actuarial assumptions and funding discussions with boards charged with governance for some of our international plans. Refer to Note 17, “Profit Sharing, Retirement Savings Plans and Defined Benefit Pension Plans,” of the Notes to Consolidated Financial Statements for additional information related to these plans.
Environmental Matters
We are subject to loss contingencies resulting from environmental laws and regulations, and we accrue for anticipated costs associated with investigatory and remediation efforts when an assessment has indicated that a loss is probable and can be reasonably estimated. These accruals do not take into account any discounting for the time value of money and are not reduced by potential insurance recoveries, if any. We do not believe that it is reasonably possible that the liability in excess of the amounts that we have accrued for environmental matters will be material to our consolidated financial position and results of operations. We reassess environmental liabilities whenever circumstances become better defined or we can better estimate remediation efforts and their costs. We evaluate these liabilities periodically based on available information, including the progress of remedial investigations at each site, the current status of discussions with regulatory authorities regarding the methods and extent of remediation and the apportionment of costs among potentially responsible parties. As some of these issues are decided (the outcomes of which are subject to uncertainties) or new sites are assessed and costs can be reasonably estimated, we adjust the recorded accruals, as necessary. We believe that these exposures are not material to our consolidated financial condition and results of operations. We believe that we have adequately reserved for all probable and estimable environmental exposures.
Cash and Cash Equivalents
The following table summarizes our accumulated cash and cash equivalents:
December 31, | ||||||||
(In millions) | 2019 | 2018 | ||||||
Cash and cash equivalents | $ | 262.4 | $ | 271.7 | ||||
See “Analysis of Historical Cash Flow” below.
Accounts Receivable Securitization Programs and Accounts Receivable Factoring Agreements
At December 31, 2019, we had $127 million available to us under the U.S. and European programs of which we had no borrowings under the European or U.S. programs. At December 31, 2018, we had $150 million available to us under the U.S. and European programs of which we had $84 million borrowed under the European program.
During the fourth quarter of 2019, we renegotiated the U.S. Accounts Receivable Securitization program. As a result, our maximum purchase limit for receivable interests decreased from $60 million under the old program to $50 million under the new program. At the same time, we established a new Accounts Receivable Factoring program under which we sell outstanding receivables to the financial institution. The sales of these receivables are accounted for in accordance with ASC 860, "Transfers and Servicing" ("ASC 860"). ASC 860 allows for the ownership transfer of accounts receivable to qualify for true-sale treatment when the appropriate criteria is met, which permits the Company to present the balances sold under the program to be excluded from trade receivables, net of allowance for doubtful accounts on the Consolidated Balance Sheets. As of December 31, 2019, the utilization under new factoring program was $10 million. The securitization programs and factoring program are renewed annually.
See Note 10, “Accounts Receivable Securitization Programs,” and Note 11, "Accounts Receivable Factoring Agreements" of the Notes to Consolidated Financial Statements for information concerning these programs.
Supply Chain Financing Programs
As part of our ongoing efforts to manage our working capital and improve our cash flow, we work with suppliers to optimize our purchasing terms and conditions, including extending payment terms. We also facilitate a voluntary supply chain financing program to provide some of our suppliers with the opportunity to sell receivables due from us (our trade payables) to participating financial institutions at the sole discretion of both the suppliers and the financial institutions. These programs are administered by participating financial institutions. Should the supplier choose to participate in the program, it will receive
| 49 |
payment from the financial institution in advance of agreed payment terms; our responsibility is limited to making payments to the respective financial institutions on the terms originally negotiated with our supplier. The range of payment terms are consistent regardless of a vendor's participation in the program. We monitor our days payable outstanding relative to our peers and industry trends in order to assess our conclusion that these programs continue to be trade payable programs and not indicative of borrowing arrangements. The liabilities continue to be presented as trade payables in our consolidated balance sheets until they are paid and are reflected as cash flow from operating activities when settled.
These supply chain financing programs were implemented starting in 2016. We believe they had the greatest benefit to cash provided by trade payables within cash provided by operating activities and free cash flow in 2016 and 2017, as these programs were being implemented. These programs did not significantly improve cash provided by operating activities or free cash flow for the year ended December 31, 2019 compared to prior years.
Lines of Credit
At December 31, 2019 and 2018, we had a $1 billion revolving credit facility and $89 million and $140 million of outstanding borrowings under the facility, respectively. At December 31, 2019 and 2018, we had $10 million and $9 million, respectively, available under various lines of credit extended to our subsidiaries. See Note 14, “Debt and Credit Facilities,” of the Notes to Consolidated Financial Statement for further details.
LIBOR Phase Out
In July 2017, the United Kingdom's Financial Conduct Authority, which regulates LIBOR, announced that it intends to phase out LIBOR by the end of 2021. An alternative to LIBOR has been contemplated in many of our LIBOR-linked instruments and other financial obligations, including our Secured Credit Facility. We do not expect the phase-out of LIBOR to have a material disruption or impact on our financing or liquidity.
Covenants
Each issue of our outstanding senior notes imposes limitations on our operations and those of specified subsidiaries. The Third Amended and Restated Credit Agreement contains customary affirmative and negative covenants for credit facilities of this type, including limitations on our indebtedness, liens, investments, restricted payments, mergers and acquisitions, dispositions of assets, transactions with affiliates, amendment of documents and sale leasebacks, and a covenant specifying a maximum permitted ratio of Consolidated Net Debt to Consolidated EBITDA (as defined in the Third Amended and Restated Credit Agreement). We were in compliance with the above financial covenants and limitations at December 31, 2019 and 2018.
See “Covenants” in Note 14, “Debt and Credit Facilities,” of the Notes to Consolidated Financial Statements.
Debt Ratings
Our cost of capital and ability to obtain external financing may be affected by our debt ratings, which the credit rating agencies review periodically. Below is a table that details our credit ratings by the various types of debt by rating agency.
Moody’s Investor Services | Standard & Poor’s | |||
Corporate Rating | Ba2 | BB+ | ||
Senior Unsecured Rating | Ba3 | BB+ | ||
Senior Secured Credit Facility Rating | Baa3 | BBB- | ||
Outlook | Stable | Stable | ||
These credit ratings are considered to be below investment grade (with the exception of the Baa3 and BBB- Senior Secured Credit Facility Rating from Moody’s Investor Services and Standard & Poor’s, respectively, which are classified as investment grade). If our credit ratings are downgraded, there could be a negative impact on our ability to access capital markets and borrowing costs could increase. A credit rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time by the rating organization. Each rating should be evaluated independently of any other rating.
Outstanding Indebtedness
At December 31, 2019 and 2018, our total debt outstanding consisted of the amounts set forth in the following table.
| 50 |
December 31, | ||||||||
(In millions) | 2019 | 2018 | ||||||
Short-term borrowings | $ | 98.9 | $ | 232.8 | ||||
Current portion of long-term debt | 16.7 | 4.9 | ||||||
Total current debt | 115.6 | 237.7 | ||||||
Total long-term debt, less current portion(1) | 3,698.6 | 3,236.5 | ||||||
Total debt | 3,814.2 | 3,474.2 | ||||||
Less: Cash and cash equivalents | (262.4 | ) | (271.7 | ) | ||||
Net debt | $ | 3,551.8 | $ | 3,202.5 | ||||
(1) | Amounts are net of unamortized discounts and debt issuance costs of $25 million and $24 million as of December 31, 2019 and 2018, respectively. |
See Note 14, “Debt and Credit Facilities,” of the Notes to Consolidated Financial Statements for further details.
Analysis of Historical Cash Flow
The following table shows the changes in our Consolidated Statements of Cash Flows in the years ended December 31, 2019, 2018 and 2017.
Year Ended December 31, | Change | |||||||||||||||||||
(In millions) | 2019 | 2018 | 2017 | 2019 vs. 2018 | 2018 vs. 2017 | |||||||||||||||
Net cash provided by operating activities | $ | 511.1 | $ | 428.0 | $ | 424.4 | $ | 83.1 | $ | 3.6 | ||||||||||
Net cash (used in) provided by investing activities | (665.6 | ) | (266.7 | ) | 1,786.1 | (398.9 | ) | (2,052.8 | ) | |||||||||||
Net cash provided by (used in) financing activities | 139.9 | (478.3 | ) | (1,889.7 | ) | 618.2 | 1,411.4 | |||||||||||||
Effect of foreign currency exchange rate changes on cash and cash equivalents | 5.3 | (5.3 | ) | (113.4 | ) | 10.6 | 108.1 | |||||||||||||
In addition to net cash provided by operating activities, we use free cash flow as a useful measure of performance and as an indication of the strength and ability of our operations to generate cash. We define free cash flow as cash provided by operating activities less capital expenditures (which is classified as an investing activity). Free cash flow is not defined under U.S. GAAP. Therefore, free cash flow should not be considered a substitute for net income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. Free cash flow does not represent residual cash available for discretionary expenditures, including certain debt servicing requirements or non-discretionary expenditures that are not deducted from this measure. We historically have generated the majority of our annual free cash flow in the second half of the year. Below are the details of free cash flow for the years ended December 31, 2019, 2018 and 2017.
Year Ended December 31, | Change | |||||||||||||||||||
(In millions) | 2019 | 2018 | 2017 | 2019 vs. 2018 | 2018 vs. 2017 | |||||||||||||||
Cash flow provided by operating activities | $ | 511.1 | $ | 428.0 | $ | 424.4 | $ | 83.1 | $ | 3.6 | ||||||||||
Capital expenditures | (189.7 | ) | (168.6 | ) | (183.8 | ) | (21.1 | ) | 15.2 | |||||||||||
Free cash flow(1) | $ | 321.4 | $ | 259.4 | $ | 240.6 | $ | 62.0 | $ | 18.8 | ||||||||||
(1) | Free cash flow was $311 million in 2018 excluding the payment of charges related to the sale of Diversey of $52 million. Free cash flow was $421 million in 2017 excluding the payment of charges related to the sale of Diversey of $181 million. |
| 51 |
Operating Activities
2019 vs. 2018
Net cash provided by operating activities improved by $83 million in the current year. This was primarily the result of stronger net earnings including non-cash add backs, improved cash provided by working capital, and lower cash tax payments in 2019 compared to 2018.
Net earnings were $263 million for the year ended December 31, 2019 compared to $193 million for the year ended December 31, 2018. Non-cash add backs to reconcile net earnings to net cash provided by operating activities were $221 million in 2019 compared to $182 million in 2018. The increase was primarily driven by $20 million of higher depreciation and amortization, due to amortization of intangibles acquired from Automated, as well as a non-cash loss recorded from the sale of discontinued operations of $31 million.
Working capital represented a source of cash of $14 million in 2019 compared to a use of cash of $20 million in 2018. Cash generation from working capital in 2019 was driven by improvements in accounts receivables, primarily on strengthened collections, and cash generated from organic inventory reduction, which excludes the change in balance resulting from the opening balance sheet acquired in acquisitions made this year. These improvements were slightly offset by a use of cash in accounts payable in 2019 of $37 million which compares to a source of cash of $43 million in 2018. The change in cash provided by/used in accounts payable primarily represents timing of payments as well as the benefits received in prior years of improvements to working capital.
Cash tax payments in 2019 were $95 million compared to $155 million in 2018. The improvement was partially the result of one-time items benefiting cash taxes paid in the year including the Novipax settlement and benefits from the purchase of Automated.
The year over year improvements were partially offset by cash payments made for Reinvent SEE including restructuring and restructuring associated payments of $91 million in 2019 compared to $12 million in 2018. The one-time cash outflow in 2019 related to the Novipax settlement payment was largely offset by a one-time payment in lieu of certain future royalty payments for patents made in 2018.
2018 vs. 2017
Net cash provided by operating activities was $428 million in 2018 compared to $424 million in 2018. Net cash provided by operating activities in 2017 included a partial year contribution from Diversey prior to its sale in September 2017.
In 2018, we generated $193 million of net earnings and had $182 million of non-cash adjustments to reconcile net earnings to net cash provided by operating activities, or $375 million.
In 2017, we had $815 million of net earnings and $255 million of non-cash adjustments to reconcile net earnings to net cash provided by operating activities, or $560 million. The net earnings less non-cash adjustments of $560 million in 2017 was offset by a $207 million decrease in income tax payables primarily as a result of an increase in cash tax payments related to the sale of Diversey.
Overall, cash generation from Diversey's operations in 2017 was largely offset by cash payments related to the sale as well as restructuring and restructuring associated payments related to stranded cost reduction made in 2017, which was a combined outflow of $230 million. Cash payments related to the sale and restructuring and restructuring associated payments made in 2018 was an outflow of $64 million.
Working capital was a use of cash of $20 million in 2018 compared to a source of cash of $17 million in 2017. Cash provided by working capital in 2018 was negatively impacted by inventory, partially offset by an increase in accounts payable. We experienced a greater benefit from accounts payable improvements in 2017.
Investing Activities
2019 vs. 2018
Net cash used in investing activities was $666 million in 2019, compared to net cash used in investing activities of $267 million in 2018. The change in net cash used in investing activities was primarily due to an increase in business acquisitions activity of $384 million, primarily due to the acquisition of Automated, offset by the cash outflow for the purchase of AFP in
| 52 |
2018; and an increase in capital expenditures of $21 million, driven by increased investment to drive growth and improve cost productivity.
2018 vs. 2017
Net cash used in investing activities was $267 million in 2018, compared to net cash provided by investing activities of $1,786 million in 2017. The change in net cash (used in) provided by investing activities was primarily due the 2017 impact of proceeds from the sale of Diversey of $2.2 billion, net of payments of debt of $777 million.
Financing Activities
2019 vs. 2018
Net cash provided by financing activities was $140 million in 2019, compared to net cash used in financing activities of $478 million in 2018. The change in net cash provided by (used in) in financing activities was primarily due to borrowing activity in 2019. Specifically, we received the proceeds from the issuance of long-term debt of $895 million, including the Term Loan A due 2022 of $475 million to fund the purchase of Automated and the issuance of $425 million of 4.00% of senior notes due 2027, which was partially offset by the $425 million repurchase of the 6.50% senior notes due 2020. Short-term borrowings was a use of cash in 2019 compared to a source of cash in 2018 representing a net change $352 million year over year. This was driven by decrease in borrowings under the European Accounts Receivable Securitization program and our revolving credit facility in 2019 compared to an increase of facility use in 2018. Additionally, share repurchases were $515 million lower in 2019 compared to 2018. We continue to evaluate our capital allocation strategy to determine the best use of cash, including decisions around share repurchases, investments in growth and operational efficiency, acquisitions and maintaining our debt-leverage ratio.
2018 vs. 2017
Net cash used in financing activities was $478 million in 2018, compared to net cash used in financing activities of $1,890 million in 2017. The change in net cash used in financing activities was primarily due to lower repurchases of common stock, which were $720 million less in 2018 compared to 2017. Additionally, in 2017 we repaid the Term Loan A due in July 2017 for $250 million plus $98 million for the Brazilian tranche of Term Loan A. Finally, in 2018 the Company had higher net proceeds from short-term borrowings of $318 million, driven by an increase in borrowings under the European Accounts receivable securitization program and revolving credit facility compared to 2017. The use of the accounts receivable securitization program and the revolving credit facility was lower in 2017 due to cash on hand resulting from proceeds of our sale of Diversey.
Changes in Working Capital
December 31, | ||||||||||||
(In millions) | 2019 | 2018 | Change | |||||||||
Working capital (current assets less current liabilities) | $ | 127.8 | $ | 66.2 | $ | 61.6 | ||||||
Current ratio (current assets divided by current liabilities) | 1.1 | x | 1.0 | x | ||||||||
Quick ratio (current assets, less inventories divided by current liabilities) | 0.7 | x | 0.7 | x | ||||||||
The $62 million, or 93%, increase in working capital from 2018 to 2019 results from lower borrowings under the Revolving credit facility and European accounts receivable securitization program of $135 million and an increase in inventory of $25 million, primarily resulting from our acquisition of Automated. Acquisitions made during the year had a negative impact on our year-end working capital balance.
These were partially offset by an increase in other current liabilities of $85 million, reflecting the timing of accrued liabilities including restructuring and higher accruals for incentive compensation, and $26 million related to the liability recorded for our short-term operating leases as a result of our adoption of ASU 2016-02, Leases (Topic 842).
See Note 2, "Summary of Significant Accounting Policies and Recently Issued Accounting Standards," and Note 4, "Leases," of the Notes to Consolidated Financial Statements for additional information on leases and our adoption of new accounting standards.
| 53 |
Changes in Stockholders’ Equity (Deficit)
The $152 million, or 44%, increase in stockholders’ equity in 2019 compared with 2018 was due to:
• | net earnings of $263 million; |
• | the effect of share-based incentive compensation of $23 million, which includes the impact of our share-based compensation expense as well as the impact of shares netting to cover the employee tax withholding amounts; |
• | stock issued for profit sharing contribution paid in stock of $22 million; |
• | cumulative translation adjustment of $16 million; and |
• | unrealized gains on derivative instruments of $5 million. |
These were partially offset by:
• | dividends paid on our common stock and dividend equivalent accruals related to unvested equity awards of $100 million; |
• | a net increase in shares held in treasury of $67 million due to the repurchase of common stock; and |
• | a net decrease in accumulated other comprehensive loss of $10 million on unrecognized pension items due primarily to market conditions impacting actuarial assumptions as of our annual pension valuation. |
We repurchased approximately 1.6 million shares of our common stock during the year ended December 31, 2019 for $67 million. See Note 21, “Stockholders’ Deficit,” of the Notes to Consolidated Financial Statements for further details.
Derivative Financial Instruments
Interest Rate Swaps
The information set forth in Note 15, “Derivatives and Hedging Activities,” of the Notes to Consolidated Financial Statements under the caption “Interest Rate Swaps” is incorporated herein by reference.
Net Investment Hedge
The information set forth in Note 15, “Derivatives and Hedging Activities,” of the Notes to Consolidated Financial Statements under the caption “Net Investment Hedge” is incorporated herein by reference.
Other Derivative Instruments
The information set forth in Note 15, “Derivatives and Hedging Activities,” of the Notes to Consolidated Financial Statements under the caption “Other Derivative Instruments” is incorporated herein by reference.
Foreign Currency Forward Contracts
At December 31, 2019, we were party to foreign currency forward contracts, which did not have a significant impact on our liquidity.
The information set forth in Note 15, “Derivatives and Hedging Activities,” of the Notes to Consolidated Financial Statements under the caption “Foreign Currency Forward Contracts Designated as Cash Flow Hedges” and "“Foreign Currency Forward Contracts Not Designated as Hedges” is incorporated herein by reference.
For further discussion about these contracts and other financial instruments, see Item 7A, “Quantitative and Qualitative Disclosures About Market Risk.”
| 54 |
Recently Issued Statements of Financial Accounting Standards, Accounting Guidance and Disclosure Requirements
We are subject to numerous recently issued statements of financial accounting standards, accounting guidance and disclosure requirements. Note 2, “Summary of Significant Accounting Policies and Recently Issued Accounting Standards,” which is contained in the Notes to Consolidated Financial Statements, describes these new accounting standards and is incorporated herein by reference.
Critical Accounting Policies and Estimates
Our discussion and analysis of our consolidated financial condition and results of operations are based upon our Consolidated Financial Statements, which are prepared in accordance with U.S. GAAP. The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities.
Our estimates and assumptions are evaluated on an ongoing basis and are based on all available evidence, including historical experience and other factors believed to be reasonable under the circumstances. To derive these estimates and assumptions, management draws from those available sources that can best contribute to its efforts. These sources include our officers and other employees, outside consultants and legal counsel, third-party experts and actuaries. In addition, we use internally generated reports and statistics, such as aging of trade receivables, as well as outside sources such as government statistics, industry reports and third-party research studies. The results of these estimates and assumptions may form the basis of the carrying value of assets and liabilities and may not be readily apparent from other sources. Actual results may differ from estimates under conditions and circumstances different from those assumed, and any such differences may be material to our Consolidated Financial Statements.
We believe the following accounting policies are critical to understanding our consolidated results of operations and affect the more significant judgments and estimates used in the preparation of our Consolidated Financial Statements. The critical accounting policies discussed below should be read together with our significant accounting policies set forth in Note 2, “Summary of Significant Accounting Policies and Recently Issued Accounting Standards,” of the Notes to Consolidated Financial Statements.
Commitments and Contingencies — Litigation
On an ongoing basis, we assess the potential liabilities and costs related to any lawsuits or claims brought against us. We accrue a liability when we believe a loss is probable and when the amount of loss can be reasonably estimated. Litigation proceedings are evaluated on a case-by-case basis considering the available information, including that received from internal and outside legal counsel, to assess potential outcomes. While it is typically very difficult to determine the timing and ultimate outcome of these actions, we use our best judgment to determine if it is probable that we will incur an expense related to the settlement or final adjudication of these matters and whether a reasonable estimation of the probable loss, if any, can be made. In assessing probable losses, we consider insurance recoveries, if any. We expense legal costs, including those legal costs expected to be incurred in connection with a loss contingency, as incurred. We have historically adjusted existing accruals as proceedings have continued, been settled or for which additional information has been provided on which to review the probability and measurability of outcomes, and will continue to do so in future periods. Due to the inherent uncertainties related to the eventual outcome of litigation and potential insurance recovery, it is possible that disputed matters may be resolved for amounts materially different from any provisions or disclosures that we have previously made.
Revenue Recognition
Our revenue earning activities primarily involve manufacturing and selling products. Revenue from contracts with customers is recognized using a five-step model consisting of the following: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the Company satisfies a performance obligation. Performance obligations are satisfied when the Company transfers control of a good or service to a customer, which can occur over time or at a point in time. The amount of revenue recognized is based on the consideration to which the Company expects to be entitled in exchange for those goods or services, including the expected value of variable consideration. The customer’s ability and intent to pay the transaction price is assessed in determining whether a contract exists with the customer. If collectability of substantially all of the consideration in a contract is not probable, consideration received is not recognized as revenue unless the consideration is nonrefundable and the Company no longer has an obligation to transfer additional goods or services to the customer or collectability becomes probable.
| 55 |
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASU 2014-09”) and issued subsequent amendments to the initial guidance, collectively, Topic 606. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.
We have the implemented the guidance using the modified retrospective method, in which the cumulative effect of initially applying the standard has been recognized as an adjustment to retained earnings in the year of adoption. For the year ending December 31, 2017, the Company recognized revenue under ASC 605, under which the following criteria were used for revenue recognition: persuasive evidence that an arrangement exists, shipment has occurred, selling price is fixed or determinable, and collection is reasonably assured.
The determination of whether an arrangement meets the definition of a contract under ASC 606 depends on whether it creates enforceable rights and obligations. While enforceability is a matter of law, we believe that enforceable rights and obligations in a contract must be substantive in order for the contract to be in scope of ASC 606. The penalty for noncompliance must be significant relative to the minimum obligation. Fixed or minimum purchase obligations were the most common examples of substantive enforceable rights present in our contracts. Sealed Air determines that the contract term is the period of enforceability outlined by the terms of the contract. This means that in many cases, the term stated in the contract is different than the period of enforceability.
Our efforts to adopt this standard focused on contract analysis at a regional level. We concluded our assessment and identified the most significant impact was on the accounting for Free on Loan equipment in our Food Care division. Whereas previously we did not recognize revenue on Free on Loan equipment, under the new standard, we allocate revenue to that equipment and account for the lease component under ASC 840, which has been superseded by ASC 842. ASC 606-10-15-4 states that a contract can be partially in scope of ASC 606 and partially in scope of another standard, in this case ASC 842. Sealed Air determined the proper accounting treatment for contracts with lease and non-lease components is to allocate the transaction price of the contract to the separate lease and non-lease components, account for the non-lease components of the contract under ASC 606 and account for the lease components of the contract under ASC 842. During the contract analysis we also evaluated how the transaction price would be allocated across the performance obligations. As a result of this review, we adjusted our equipment accrual balance, within the Food Care division, to reflect the stand-alone selling price of the equipment within our portfolio.
Leasing Activity
Sealed Air is involved in leasing activity as both a lessee and a lessor. Sealed Air is the lessor primarily for equipment used by our customers to meet their packaging needs. Sealed Air is the lessee of property used for production and for sales and administrative functions, including real property, buildings, manufacturing and office equipment, offices and automobiles.
Effective January 1, 2019, we adopted, ASU 2016-02, Leases (Topic 842), (“ASU 2016-02”) and the subsequently issued amendments to the initial guidance, collectively, Topic 842. This ASU requires an entity to recognize a right-of-use asset ("ROU") and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses now depends on classification as a finance or operating lease. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. We adopted this ASU using a modified retrospective transition method.
We elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets in transition. We also elected the practical expedient not to separate lease and non-lease components for all of our leases, which means all consideration that is fixed, or in-substance fixed, relating to the non-lease components will be captured as part of our lease components for balance sheet purposes.
We believe the most significant effect of adoption was the recognition of new ROU assets and lease liabilities on our balance sheet for our office and equipment and real estate operating leases. As of December 31, 2019, we recognized additional operating lease liabilities of $92 million based on the present value of the remaining minimum rental payments for existing operating leases and corresponding ROU assets of $90 million on our Consolidated Balance Sheets. Additionally, $28 million of assets that were included in property and equipment, net as of December 31, 2018 are now included in other non-current assets on our Consolidated Balance Sheets as of December 31, 2019.
Additionally, we now provide significant new disclosures about our leasing activities. We have formed a lease accounting center of excellence which has on-going responsibility to lead our global lease accounting and reporting under Topic 842. We have implemented a third-party lease accounting software due to the adoption of Topic 842. We have also added additional internal controls related to our lease accounting and software solution under Topic 842.
| 56 |
See Note 4, "Leases," of the Notes to the Consolidated Financial Statements for additional lease disclosures.
Impairment of Long-Lived Assets
For finite-lived intangible assets, such as customer relationships, contracts and intellectual property, and for other long-lived assets, such as property, plant and equipment, whenever impairment indicators are present, we perform a review for impairment. We calculate the undiscounted value of the projected cash flows associated with the asset, or asset group, and compare this estimated amount to the carrying amount. If the carrying amount is found to be greater, we record an impairment loss for the excess of book value over the fair value. In addition, in all cases of an impairment review, we re-evaluate the remaining useful lives of the assets and modify them as appropriate.
For indefinite–lived intangible assets, such as trademarks and trade names, each year and whenever impairment indicators are present, we determine the fair value of the asset and record an impairment loss for the excess of book value over fair value, if any. In addition, in all cases of an impairment review we re-evaluate whether continuing to characterize the asset as indefinite–lived is appropriate. We recorded no impairment to indefinite lived assets in the current year.
Goodwill
Goodwill is reviewed for possible impairment at least annually on a reporting unit level during the fourth quarter of each year. A review of goodwill may be initiated before or after conducting the annual analysis if events or changes in circumstances indicate the carrying value of goodwill may no longer be recoverable.
A reporting unit is the operating segment unless, at businesses one level below that operating segment - the “component” level - discrete financial information is prepared and regularly reviewed by management, and the component has economic characteristics that are different from the economic characteristics of the other components of the operating segment, in which case the component is the reporting unit.
In our annual impairment review, we may elect to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In a qualitative assessment, we would consider the macroeconomic conditions, including any deterioration of general economic conditions, industry and market conditions, including any deterioration in the environment where the reporting unit operates, increased competition, changes in the products/services and regulator and political developments; cost of doing business; overall financial performance, including any declining cash flows and performance in relation to planned revenues and earnings in past periods; other relevant reporting unit specific facts, such as changes in management or key personnel or pending litigation, and events affecting the reporting unit, including changes in the carrying value of net assets.
If the results of our qualitative assessment indicate it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, we are required to perform a quantitative assessment to determine the fair value of the reporting unit.
Alternatively, if an optional qualitative goodwill impairment assessment is not performed, we may perform a quantitative assessment. Under the quantitative assessment, we compare the fair value of each reporting unit to its carrying value, including the goodwill allocated to the reporting unit. If the fair value of the reporting unit exceeded its carrying value, there would be no indication of impairment. If the fair value of the reporting unit were less than the carrying value, an impairment charge would be recognized for the difference.
Under the quantitative assessment, we derive an estimate of fair values for each of our reporting units using a combination of an income approach and appropriate market approaches. Absent an indication of fair value from a potential buyer or similar specific transactions, we believe that the use of these methods provides a reasonable estimate of a reporting unit’s fair value. Fair value computed by these models is arrived at using a number of factors and inputs. There are inherent uncertainties, however, related to fair value models, the inputs and to our judgment in applying them to this analysis. Nonetheless, we believe that the combination of these methods provides a reasonable approach to estimate the fair value of our reporting units.
We believe the most significant inputs in our quantitative assessment include:
• | Forecasted future operating results: On an annual basis, the Company prepares annual and medium-term financial results projections. These projections are based on input from the Company's leadership, strategy, commercial leadership and finance teams and presented to our Board of Directors annually. Influences on this year's forecasted financial information and the fair value model include: the impact of recent acquisitions, |
| 57 |
notably Automated Packaging Systems, future expected benefits of our Reinvent SEE initiatives and overall market conditions.
• | Discount rate: Our third-party valuation specialists provide inputs into management's determination of the discount rate. The rate is dependent on a number of underlying assumptions, the most impactful of which are the risk-free rate, tax rate, equity risk premium, debt to equity ratios and pre-tax cost of debt. |
• | Long-term growth rate: Long-term growth rates are applied to the terminal year of our cash flow valuation approach. The long-term growth rates are tied to growth rates we expect to achieve beyond the years for which we have forecasted operating results. We use external data, including long-term global GDP rates, we believe is applicable to our industry and composition of global operations. |
The Company performed a quantitative assessment of the goodwill by reporting unit as of October 1, 2019. We believe it is appropriate to periodically perform the quantitative assessment for our annual impairment test, even if qualitative considerations do not indicate the fair value of a reporting unit is less than its carrying value. The periodic and timely calculation of the quantitative assessment provides better support for our qualitative assessments. Additionally, we note the changes in the Product Care reporting unit with the recent acquisitions made in 2017, 2018 and 2019 as another contributing factor to our quantitative assessment of goodwill in 2019.
None of our reporting units indicated the fair value was less than its carrying value. Based on our quantitative assessment, we believe the fair value of each of our reporting units sufficiently exceeds each reporting unit's carrying value. As part of our analysis, we performed a sensitivity analysis on the discount rate and long-term growth rate assumptions. The sensitivities lead us to the same conclusion that no impairment exists.
In the fourth quarter of 2018 and 2017, we performed a qualitative assessment. No indication of goodwill impairment was identified in 2018 or 2017.
The Company also assesses its goodwill for impairment from time to time when warranted by the facts and circumstances surrounding individual reporting units. Subsequent to our annual reporting period, we continued to assess whether there were changes in facts or circumstances that would lead us to believe goodwill may be impaired. No indication of goodwill impairment has been identified subsequent to our annual testing date.
See Note 9, “Goodwill and Identifiable Intangible Assets, net,” of the Notes to Consolidated Financial Statements for details of our goodwill balance and the goodwill review performed in 2019, 2018 and 2017 and other related information.
Pensions
For a number of our current and former U.S. employees and our international employees, we maintain defined benefit pension plans. Under current accounting standards, we are required to make assumptions regarding the valuation of projected benefit obligations and the performance of plan assets for our defined benefit pension plans.
The projected benefit obligation and the net periodic benefit cost are based on third-party actuarial assumptions and estimates that are reviewed and approved by management on a plan-by-plan basis each fiscal year. We believe the most significant assumptions are the discount rate used to measure the projected benefit obligation and the expected future rate of return on plan assets. We revise these assumptions based on an annual evaluation of long-term trends and market conditions that may have an impact on the cost of providing retirement benefits.
In determining the discount rate, we utilize market conditions and other data sources management considers reasonable based upon the profile of the remaining service life or expected life of eligible employees. The expected long-term rate of return on plan assets is determined by taking into consideration the weighted-average expected return on our asset allocation, asset return data, historical return data, and the economic environment. We believe these considerations provide the basis for reasonable assumptions of the expected long-term rate of return on plan assets. The measurement date used to determine the benefit obligation and plan assets is December 31.
At December 31, 2019, the total projected benefit obligation for our U.S. pension plan was $194 million, and the total benefit expense for the year ended December 31, 2019 was $1 million. At December 31, 2019, the total projected benefit obligation for our international pension plans was $704 million, and the total benefit income for the year ended December 31, 2019 was $2 million. The employer service cost of our pension plans is charged to Cost of sales and Selling, general and administrative expenses. All other components of benefits expense are recorded to other (expense) income, net.
| 58 |
Material changes to the principal assumptions could have a material impact on the costs and liabilities recognized on our Consolidated Financial Statements. A 25 basis point change in the assumed discount rate and a 100 basis point change in the expected long-term rate of return on plan assets would have resulted in the following increases (decreases) in the projected benefit obligation at December 31, 2019 and the expected net periodic benefit cost for the year ending December 31, 2020:
United States | 25 Basis Point Increase (in millions) | 25 Basis Point Decrease (in millions) | ||||||
Discount Rate | ||||||||
Effect on 2019 projected benefit obligation | $ | (5.1 | ) | $ | 5.3 | |||
Effect on 2020 expected net periodic benefit cost | 0.1 | (0.1 | ) | |||||
100 Basis Point Increase (in millions) | 100 Basis Point Decrease (in millions) | |||||||
Return on Assets | ||||||||
Effect on 2020 expected net periodic benefit cost | $ | (1.4 | ) | $ | 1.4 | |||
International | 25 Basis Point Increase (in millions) | 25 Basis Point Decrease (in millions) | ||||||
Discount Rate | ||||||||
Effect on 2019 projected benefit obligation | $ | (26.1 | ) | $ | 27.7 | |||
Effect on 2020 expected net periodic benefit cost | (0.1 | ) | 0.1 | |||||
100 Basis Point Increase (in millions) | 100 Basis Point Decrease (in millions) | |||||||
Return on Assets | ||||||||
Effect on 2020 expected net periodic benefit cost | $ | (6.0 | ) | $ | 6.0 | |||
Income Taxes
Estimates and judgments are required in the calculation of tax liabilities and in the determination of the recoverability of our deferred tax assets. Our deferred tax assets arise from net deductible temporary differences, tax benefit carryforwards and tax credits. We evaluate whether our taxable earnings, during the periods when the temporary differences giving rise to deferred tax assets become deductible or when tax benefit carryforwards may be utilized, should be sufficient to realize the related future income tax benefits. For those jurisdictions where the expiration dates of tax benefit carryforwards or the projected taxable earnings indicate that realization is not likely, we provide a valuation allowance.
In assessing the need for a valuation allowance, we estimate future taxable earnings, with consideration for the feasibility of ongoing planning strategies and the realizability of tax benefit carryforwards and past operating results, to determine which deferred tax assets are more likely than not to be realized in the future. Changes to tax laws, statutory tax rates and future taxable earnings can have an impact on valuation allowances related to deferred tax assets. In the event that actual results differ from these estimates in future periods, we may need to adjust the valuation allowance, which could have a material impact on our consolidated financial position and results of operations.
In calculating our worldwide provision for income taxes, we also evaluate our tax positions for years where the statutes of limitations have not expired. Based on this review, we may establish reserves for additional taxes and interest that could be assessed upon examination by relevant tax authorities. We adjust these reserves to take into account changing facts and circumstances, including the results of tax audits and changes in tax law. If the payment of additional taxes and interest ultimately proves unnecessary or less than the amount of the reserve, the reversal of the reserves would result in tax benefits being recognized in the period when we determine the reserves are no longer necessary. If an estimate of tax reserves proves to be less than the ultimate assessment, a further charge to income tax provision would result. These adjustments to reserves and related expenses could materially affect our consolidated financial position and results of operations.
We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized on the Consolidated Financial Statements from such positions are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon settlement with tax authorities. See Note 19, “Income Taxes,” of the Notes to Consolidated Financial Statements for further discussion.
| 59 |
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to market risk from changes in the conditions in the global financial markets, interest rates, foreign currency exchange rates and commodity prices and the creditworthiness of our customers and suppliers, which may adversely affect our consolidated financial condition and results of operations. We seek to minimize these risks through regular operating and financing activities and, when deemed appropriate, through the use of derivative financial instruments. We do not purchase, hold or sell derivative financial instruments for trading purposes.
Interest Rates
From time to time, we may use interest rate swaps, collars or options to manage our exposure to fluctuations in interest rates. At December 31, 2019, we had no outstanding interest rate swaps, collars or options.
The information set forth in Note 15, “Derivatives and Hedging Activities,” of the Notes to Consolidated Financial Statements under the caption “Interest Rate Swaps,” is incorporated herein by reference.
See Note 16, “Fair Value Measurements and Other Financial Instruments,” of the Notes to Consolidated Financial Statements for details of the methodology and inputs used to determine the fair value of our fixed rate debt. The fair value of our fixed rate debt varies with changes in interest rates. Generally, the fair value of fixed rate debt will increase as interest rates fall and decrease as interest rates rise. A hypothetical 10% increase in interest rates would result in a decrease of $58 million in the fair value of the total debt balance at December 31, 2019. These changes in the fair value of our fixed rate debt do not alter our obligations to repay the outstanding principal amount or any related interest of such debt.
Foreign Exchange Rates
Operations
As a large global organization, we face exposure to changes in foreign currency exchange rates. These exposures may change over time as business practices evolve and could materially impact our consolidated financial condition and results of operations in the future. See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” above for the impacts foreign currency translation had on our operations.
Argentina
Economic events in Argentina, including the default on some of its international debt obligations, have exposed us to heightened levels of foreign currency exchange risks. As of July 1, 2018, Argentina was designated as a highly inflationary economy. For the year ended December 31, 2019, we recognized $5 million of net foreign currency exchange losses in Foreign currency exchange loss due to highly inflationary economies on the Consolidated Statements of Operations, related to the designation of Argentina as a highly inflationary economy under U.S. GAAP. See Note 2, “Summary of Significant Accounting Policies and Recently Issued Accounting Standards,” of the Notes to Consolidated Financial Statements for additional information. As of December 31, 2019, 1% of our consolidated net sales were derived from our products sold in Argentina and net assets include $9 million of cash and cash equivalents domiciled in Argentina. Also, as of December 31, 2019, our Argentina subsidiaries had cumulative translation losses of $24 million.
Russia
The U.S. and the European Union (EU) have imposed sanctions on various sectors of the Russian economy and on transactions with certain Russian nationals and entities. Russia has also announced economic sanctions against the U.S. and other nations that include a ban on imports of certain products. These sanctions are not expected to have a material impact on our business as much of the operations in Russia support local production; however, they may limit the amount of future business the Company does with customers involved in activities in Russia. As of December 31, 2019, we do not anticipate these events will have a material impact to our 2020 results of operations. As of December 31, 2019, 2% of our consolidated net sales were derived from products sold into Russia and net assets include $18 million of cash and cash equivalents domiciled in Russia. Also, as of December 31, 2019, our Russia subsidiaries had cumulative translation losses of $27 million.
| 60 |
Brazil
Recent economic events in Brazil, including changes in the benchmark interest rate set by the Brazilian Central Bank, have exposed us to heightened levels of foreign currency exchange risks. However, as of December 31, 2019, we do not anticipate these events will have a material impact on our 2020 results of operations. As of December 31, 2019, 3% of our consolidated net sales were derived from products sold into Brazil and net assets include $24 million of cash and cash equivalents. Also, as of December 31, 2019, our Brazil subsidiaries had cumulative translation losses of $38 million.
United Kingdom
On January 31, 2020, the United Kingdom (UK) exited the European Union (referred to as "Brexit"). The UK has agreed to abide by EU rules during a transition period until the end of the 2020, at which point the European Union and the UK expect to have agreements in place regarding future ties including trade, customs, commerce and travel. Although the UK and the EU continue to work out terms of the final arrangements and agreements, particularly around trade, the Company has taken steps to mitigate the impact of Brexit. The exit date was delayed several times as terms of the deal were developed, providing the Company, along with our customers and suppliers, additional time to execute action plans to mitigate the impact of Brexit.
Brexit may impact the way we serve our customers in the UK and in Ireland, as we expect the UK's exit from the European Union to reduce efficiencies associated with serving customers in these countries from a central location. Over the last two years, we have deployed a cross-functional team to develop and implement changes to our operating model and legal entity structure to efficiently address challenges that may arise from Brexit including: customs processing and clearance, transit and logistics time and potential updates to terms and conditions present within our customer contracts. We continue to monitor inventory levels including any incremental stock that may be required to minimize disruptions to our business and our customers' business.
Brexit may also require us to tighten credit controls. However, for the year ended December 31, 2019, bad debt expense recognized in the UK was consistent with the year ended December 31, 2018 and was not material to the Company. In the first quarter of 2020, the Company will adopt ASU 2016-13, which requires us to measure all expected credit losses for trade receivable balances held at the reporting date based on an expected loss model which includes historical experience and current conditions. Future impacts of Brexit will be included in our analysis of current and forward looking expectations, though we believe the impact of adoption, coupled with Brexit will not have a material impact on bad debt expense.
Given the implementation of Brexit we believe that the devaluation of the Sterling has stabilized, with the value of the currency increasing in the later part of 2019. Nevertheless, any further devaluation would have a negative impact on our financial results reported in US Dollars. As of December 31, 2019, we do not anticipate these events will have a material impact on our 2020 results of operations. As of December 31, 2019, 3% of our consolidated net sales were derived from products sold into the UK, which is down from 4% in the prior year. We believe that the impact of Brexit on the country, including an overall weight on economic growth in the UK, did have an impact on net sales. Net assets in the UK include $6 million of cash and cash equivalents and $14 million in inventory. Also, as of December 31, 2019, our UK subsidiaries had cumulative translation adjustment losses of $21 million.
A large concentration of the Company's defined benefit plans is in the UK. Approximately 36% of the Company's projected benefit obligation and 47% of defined benefit plan assets are in the UK. Market volatility could have a negative impact on both our plan assets and our benefit obligations. However, we believe that the market and associated impacts on the value of our plan assets and assumptions used to determine the projected benefit obligation reflect the uncertainties related to Brexit. Our plan assets and obligations presented in our Consolidated Balance Sheets and in Note 17, "Profit Sharing, Retirement Savings Plan and Defined Benefit Plans," of the Notes to Consolidated Financial Statements are valued as of December 31, 2019. The Company and the Plans' Trustees have employed de-risking strategies in the defined benefit asset portfolios to reduce market volatility risk, interest rate risk and future cash flow risk. Our defined benefit assets in the UK are diversified between international equities, fixed income investments, and insurance buy-in contracts which all help mitigate market volatility risk.
Impact of Inflation and Currency Fluctuation
Economic and political events in certain countries have exposed us to heightened levels of inflation and foreign currency exchange risks. The effects of these could adversely impact our financial condition and results of operations. See Note 2, “Summary of Significant Accounting Policies and Recently Issued Accounting Standards,” in the Notes to Consolidated Financial Statements for details regarding the impact of inflation and currency fluctuation. Also, for a discussion of our risk factors, please refer to Part I, Item 1A, “Risk Factors.”
| 61 |
Foreign Currency Forward Contracts
We use foreign currency forward contracts to fix the amounts payable or receivable on some transactions denominated in foreign currencies. A hypothetical 10% adverse change in foreign exchange rates at December 31, 2019 would have caused us to pay approximately $32 million to terminate these contracts. Based on our overall foreign exchange exposure, we estimate this change would not materially affect our financial position and liquidity. The effect on our results of operations would be substantially offset by the impact of the hedged items.
Our foreign currency forward contracts are described in Note 15, “Derivatives and Hedging Activities,” which is contained in the Notes to Consolidated Financial Statements, is incorporated herein by reference.
Net Investment Hedge
The €400 million 4.50% notes issued in June 2015 are designated as a net investment hedge, hedging a portion of our net investment in a certain European subsidiary against fluctuations in foreign exchange rates. The decrease in the translated value of the debt was $2 million net of tax as of December 31, 2019, and is reflected in long-term debt on our Consolidated Balance Sheets.
In March 2015, we entered into a series of cross-currency swaps with a combined notional amount of $425 million, hedging a portion of the net investment in a certain European subsidiary against fluctuations in foreign exchange rates. As a result of the sale of Diversey, we terminated these cross-currency swaps in September 2017 and settled these swaps in October 2017. The fair value of the swaps on the date of termination was a liability of $62 million which was partially offset by semi-annual interest settlements of $18 million. This resulted in a net impact of $(44) million recorded in accumulated other comprehensive loss ("AOCL").
For derivative instruments that are designated and qualify as hedges of net investments in foreign operations, settlements and changes in fair values of the derivative instruments are recognized in unrealized net gains or loss on derivative instruments for net investment hedge, a component of accumulated other comprehensive loss, net of taxes, to offset the changes in the values of the net investments being hedged. Any portion of the net investment hedge that is determined to be ineffective is recorded in other income, net on the Consolidated Statements of Operations.
Other Derivative Instruments
We may use other derivative instruments from time to time to manage exposure to foreign exchange rates and to access to international financing transactions. These instruments can potentially limit foreign exchange exposure by swapping borrowings denominated in one currency for borrowings denominated in another currency.
Outstanding Debt
Our outstanding debt is generally denominated in the functional currency of the borrower or in euros as is the case with the issuance of €400 million of 4.50% senior notes due 2023. We believe that this enables us to better match operating cash flows with debt service requirements and to better match the currency of assets and liabilities. The US Dollar equivalent amount of outstanding debt denominated in a functional currency other than the U.S. dollar was $500 million and $590 million at December 31, 2019 and 2018, respectively.
Customer Credit
We are exposed to credit risk from our customers. In the normal course of business, we extend credit to our customers if they satisfy pre-defined credit criteria. We maintain an allowance for doubtful accounts for estimated losses resulting from the failure of our customers to make required payments. An additional allowance may be required if the financial condition of our customers deteriorates. The allowance for doubtful accounts is maintained at a level that management assesses to be appropriate to absorb estimated losses in the accounts receivable portfolio.
Our customers may default on their obligations to us due to bankruptcy, lack of liquidity, operational failure or other reasons. Our provision for bad debt expense was $2 million for the years ended December 31, 2019 and 2018 and less than $1 million for the year ended December 31, 2017. The allowance for doubtful accounts was $8 million and $9 million at December 31, 2019 and 2018, respectively.
| 62 |
Pensions
Many of our U.S. and International defined benefit pension plans are invested in assets which will be used to cover future benefit payments. Assets may include investments in mutual funds, collective investment trusts, index-funds, corporate bonds, government-backed bonds and insurance contracts or annuity or "buy-ins." The assets include both return seeking assets and liability-hedging assets. As the population of the plan participants age and future cash flows become more certain, we undertake asset de-risking initiatives, including the purchase of buy-in contracts, particularly in the United Kingdom. These investments provide a stream of income equal to future benefit payments for pre-defined groups of participants, however, the Company maintains the primary liability for the projected benefit obligation related to these groups. As of December 31, 2019, buy-in contracts represented $120 million, or 16% of the Company's total plan assets. Additionally, our plan assets may, from time to time, be invested in assets designed to diversify the investment portfolio and protect against equity market movements. Some of these assets may only be redeemed on a quarterly basis. As of December 31, 2019, equity diversifying assets represented $55 million, or 7% of the Company's total plan assets. Other than the buy-in contracts and equity diversifiers noted above, we believe that our plan assets are highly liquid and may be readily redeemed to cover necessary plan payments. There is a high degree of predictability of payments made from our defined benefit plans.
Based upon the annual valuation of our defined benefit pension plans at December 31, 2019, we expect net periodic benefit expense to be less than $1 million in 2020. See Note 17, “Profit Sharing, Retirement Savings Plans and Defined Benefit Pension Plans,” of the Notes to Consolidated Financial Statements for further details on our defined benefit pension plans.
Commodities
We use various commodity raw materials such as plastic resins and energy products such as electric power and natural gas in conjunction with our manufacturing processes. Generally, we acquire these components at market prices in the region in which they will be used and do not use financial instruments to hedge commodity prices. Moreover, we seek to maintain appropriate levels of commodity raw material inventories thus minimizing the expense and risks of carrying excess inventories. We do not typically purchase substantial quantities in advance of production requirements. As a result, we are exposed to market risks related to changes in commodity prices of these components.
| 63 |
Item 8. Financial Statements and Supplementary Data
The following Consolidated Financial Statements and notes are filed as part of this report.
Sealed Air Corporation
Page | ||
Reports of Independent Registered Public Accounting Firms | ||
Financial Statements: | ||
Financial Statement Schedule: | ||
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of Sealed Air Corporation
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheet of Sealed Air Corporation and its subsidiaries (the “Company”) as of December 31, 2019, and the related consolidated statements of operations, comprehensive income, stockholders’ equity (deficit) and cash flows for the year then ended, including the related notes and financial statement schedule for the year then ended listed in the accompanying index (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2019, and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Annual Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audit of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinions.
As described in Management’s Annual Report on Internal Control over Financial Reporting, management has excluded Automated Packaging Systems, LLC and MGM, Inc. from its assessment of internal control over financial reporting as of December 31, 2019, because they were acquired by the Company in purchase business combinations during 2019. We have also excluded Automated Packaging Systems, LLC and MGM, Inc. from our audit of internal control over financial reporting. Automated Packaging Systems, LLC and MGM, Inc. are wholly-owned subsidiaries whose total assets and total revenues excluded from management’s assessment and our audit of internal control over financial reporting collectively represent approximately 4% and 3%, respectively, of the related consolidated financial statement amounts as of and for the year ended December 31, 2019.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Unrecognized Tax Benefits from Uncertain Tax Positions
As described in Notes 2 and 19 to the consolidated financial statements, the Company has recorded unrecognized tax benefits from uncertain tax positions of $390.3 million as of December 31, 2019. The Company is subject to income taxes in the U.S. and in various foreign jurisdictions. Judgment is required by management in calculating the Company’s worldwide provision for income taxes. As disclosed by management, the Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. If the payment of additional taxes and interest ultimately proves unnecessary or less than the amount of the reserve, the reversal of the reserves would result in tax benefits being recognized in the period when management determines the reserves are no longer necessary. If an estimate of tax reserves proves to be less than the ultimate assessment, a further charge to the income tax provision would result.
The principal considerations for our determination that performing procedures relating to unrecognized tax benefits from uncertain tax positions is a critical audit matter are there was significant judgment by management in identifying and recognizing the tax benefits from uncertain tax positions, including determining whether it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. This in turn led to a high degree of auditor judgment, effort and subjectivity in performing procedures and evaluating the timely identification and accurate measurement of unrecognized tax benefits from uncertain tax positions. Also, the evaluation of audit evidence available to support unrecognized tax benefits from uncertain tax positions is complex and required significant auditor judgment as the nature of the evidence is often highly subjective. In addition, the audit effort involved the use of professionals with specialized skill and knowledge to assist in performing these procedures and evaluating the audit evidence obtained.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the identification and recognition of unrecognized tax benefits from uncertain tax positions, controls addressing completeness of the unrecognized tax benefits from uncertain tax positions, as well as controls over measurement of the unrecognized tax benefit from uncertain tax positions. These procedures also included, among others (i) testing the information used in the calculation of the unrecognized tax benefits from uncertain tax positions, including certain federal, foreign and state filing positions, and the related final tax returns; (ii) testing the calculation of the unrecognized tax benefits from uncertain tax positions by jurisdiction, including management’s assessment of the technical merits of tax positions and estimates of the amount of tax benefit expected to be sustained; (iii) testing the completeness of management’s assessment of both the identification of unrecognized tax benefits from uncertain tax positions and possible outcomes of each unrecognized tax benefit from an uncertain tax position; and (iv) evaluating the status and results of income tax audits with the relevant taxing authorities. Professionals with specialized skill and knowledge were used to assist in the evaluation of the completeness and measurement of the Company’s unrecognized tax benefits from uncertain tax positions, including evaluating the reasonableness of management’s assessment of whether tax positions are more likely than not of being sustained and the amount of potential benefit to be realized, the application of relevant tax laws, and estimated interest and penalties.
/s/ PricewaterhouseCoopers LLP
Charlotte, North Carolina
March 2, 2020
We have served as the Company's auditor since 2019.
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of Sealed Air Corporation
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheet of Sealed Air Corporation and subsidiaries (the Company) as of December 31, 2018, the related consolidated statements of operations, comprehensive income, stockholders' equity (deficit) and cash flows for each of the two years in the period ended December 31, 2018, and the related notes and financial statement schedule listed in the Index at Item 15(a)(2) for the two years in the period ended December 31, 2018 (collectively referred to as the “consolidated financial statements”). In our opinion, the 2018 and 2017 consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2018, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2018, in conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
/s/ Ernst & Young LLP
We served as the Company’s auditor from 2015 to 2019.
Charlotte, North Carolina
February 19, 2019,
except for Notes 3, 6, 17 and 18, as to which the date is
March 2, 2020
SEALED AIR CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
(In USD millions) | December 31, 2019 | December 31, 2018 | ||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | $ | ||||||
Trade receivables, net of allowance for doubtful accounts of $8.2 in 2019 and $9.1 in 2018 | ||||||||
Income tax receivables | ||||||||
Other receivables | ||||||||
Inventories, net of inventory reserves of $19.6 in 2019 and $18.1 in 2018 | ||||||||
Assets held for sale | ||||||||
Prepaid expenses and other current assets | ||||||||
Total current assets | ||||||||
Property and equipment, net | ||||||||
Goodwill | ||||||||
Identifiable intangible assets, net | ||||||||
Deferred taxes | ||||||||
Operating lease right-of-use-assets | — | |||||||
Other non-current assets | ||||||||
Total assets | $ | $ | ||||||
LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||
Current liabilities: | ||||||||
Short-term borrowings | $ | $ | ||||||
Current portion of long-term debt | ||||||||
Current portion of operating lease liabilities | — | |||||||
Accounts payable | ||||||||
Accrued restructuring costs | ||||||||
Income tax payable | ||||||||
Other current liabilities | ||||||||
Total current liabilities | ||||||||
Long-term debt, less current portion | ||||||||
Long-term operating lease liabilities, less current portion | — | |||||||
Deferred taxes | ||||||||
Other non-current liabilities | ||||||||
Total liabilities | ||||||||
Commitments and Contingencies - Note 20 | ||||||||
Stockholders’ deficit: | ||||||||
Preferred stock, $0.10 par value per share, 50,000,000 shares authorized; no shares issued in 2019 and 2018 | ||||||||
Common stock, $0.10 par value per share, 400,000,000 shares authorized; shares issued: 231,622,535 in 2019 and 231,619,037 in 2018; shares outstanding: 154,512,813 in 2019 and 155,654,370 in 2018 | ||||||||
Additional paid-in capital | ||||||||
Retained earnings | ||||||||
Common stock in treasury, 77,109,722 shares in 2019 and 75,964,667 shares in 2018 | ( | ) | ( | ) | ||||
Accumulated other comprehensive loss, net of taxes: | ||||||||
Unrecognized pension items | ( | ) | ( | ) | ||||
Cumulative translation adjustment | ( | ) | ( | ) | ||||
Unrealized net loss on net investment hedges | ( | ) | ( | ) | ||||
Unrealized net gain on cash flow hedges | ||||||||
Total accumulated other comprehensive loss, net of taxes | ( | ) | ( | ) | ||||
Total stockholders’ deficit | ( | ) | ( | ) | ||||
Total liabilities and stockholders’ deficit | $ | $ | ||||||
See accompanying Notes to Consolidated Financial Statements.
| 68 |
SEALED AIR CORPORATION AND SUBSIDIARIES
Consolidated Statements of Operations
Year Ended December 31, | ||||||||||||
(In USD millions, except per share data) | 2019 | 2018 | 2017 | |||||||||
Net sales | $ | $ | $ | |||||||||
Cost of sales | ||||||||||||
Gross profit | ||||||||||||
Selling, general and administrative expenses | ||||||||||||
Amortization expense of intangible assets acquired | ||||||||||||
Restructuring charges | ||||||||||||
Operating profit | ||||||||||||
Interest expense, net | ( | ) | ( | ) | ( | ) | ||||||
Foreign currency exchange loss due to highly inflationary economies | ( | ) | ( | ) | ||||||||
Other (expense) income, net | ( | ) | ( | ) | ||||||||
Earnings before income tax provision | ||||||||||||
Income tax provision | ||||||||||||
Net earnings from continuing operations | ||||||||||||
(Loss) Gain on sale of discontinued operations, net of tax | ( | ) | ||||||||||
Net earnings from discontinued operations, net of tax | ||||||||||||
Net earnings | $ | $ | $ | |||||||||
Basic: | ||||||||||||
Continuing operations | $ | $ | ||||||||||
Discontinued operations | ( | ) | ||||||||||
Net earnings per common share - basic | $ | $ | $ | |||||||||
Diluted: | ||||||||||||
Continuing operations | $ | $ | $ | |||||||||
Discontinued operations | ( | ) | ||||||||||
Net earnings per common share - diluted | $ | $ | $ | |||||||||
Weighted average number of common shares outstanding: | ||||||||||||
Basic | ||||||||||||
Diluted | ||||||||||||
See accompanying Notes to Consolidated Financial Statements.
| 69 |
SEALED AIR CORPORATION AND SUBSIDIARIES
Consolidated Statements of Comprehensive Income
Year Ended December 31, | ||||||||||||||||||||||||||||||||||||
(In USD millions) | 2019 | 2018 | 2017 | |||||||||||||||||||||||||||||||||
Gross | Taxes | Net | Gross | Taxes | Net | Gross | Taxes | Net | ||||||||||||||||||||||||||||
Net earnings | $ | $ | $ | |||||||||||||||||||||||||||||||||
Other comprehensive (loss) income: | ||||||||||||||||||||||||||||||||||||
Unrecognized pension items | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | ||||||||||||||||||||
Unrealized gains (losses) on derivative instruments for net investment hedge | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||||||
Unrealized (losses) gains on derivative instruments for cash flow hedge | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||||
Foreign currency translation adjustments | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||||||
Other comprehensive income (loss) | $ | $ | $ | ( | ) | $ | ( | ) | ( | ) | $ | $ | ||||||||||||||||||||||||
Comprehensive income, net of taxes | $ | $ | $ | |||||||||||||||||||||||||||||||||
See accompanying Notes to Consolidated Financial Statements.
| 70 |
SEALED AIR CORPORATION AND SUBSIDIARIES
Consolidated Statements of Stockholders’ Equity (Deficit)
(In USD millions) | Common Stock | Additional Paid-in Capital | Retained Earnings | Common Stock in Treasury | Accumulated Other Comprehensive Loss, Net of Taxes | Total Stockholders’ Equity (Deficit) | ||||||||||||||||||
Balance at December 31, 2016 | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | ||||||||||||||
Effect of share-based incentive compensation | — | ( | ) | — | ||||||||||||||||||||
Stock issued for profit sharing contribution paid in stock | — | — | — | |||||||||||||||||||||
Repurchases of common stock | — | ( | ) | — | ( | ) | — | ( | ) | |||||||||||||||
Unrecognized pension items, net of taxes | — | — | — | — | ||||||||||||||||||||
Foreign currency translation adjustments | — | — | — | — | ||||||||||||||||||||
Unrealized loss on derivative instruments, net of taxes | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||
Net earnings | — | — | — | — | ||||||||||||||||||||
Dividends on common stock ($0.64 per share) | — | — | ( | ) | — | — | ( | ) | ||||||||||||||||
Balance at December 31, 2017 | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | ||||||||||||||
Effect of share-based incentive compensation | — | ( | ) | — | ||||||||||||||||||||
Stock issued for profit sharing contribution paid in stock | — | — | — | |||||||||||||||||||||
Repurchases of common stock | — | — | ( | ) | — | ( | ) | |||||||||||||||||
Unrecognized pension items, net of taxes | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||
Foreign currency translation adjustments | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||
Unrealized gain on derivative instruments, net of taxes | — | — | — | — | ||||||||||||||||||||
Net earnings | — | — | — | — | ||||||||||||||||||||
Dividends on common stock ($0.64 per share) | — | — | ( | ) | — | — | ( | ) | ||||||||||||||||
Impact of recently adopted accounting standards(1) | — | — | — | ( | ) | ( | ) | |||||||||||||||||
Balance at December 31, 2018 | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||||||||
Effect of share-based incentive compensation | — | — | — | |||||||||||||||||||||
Stock issued for profit sharing contribution paid in stock | — | — | — | |||||||||||||||||||||
Repurchases of common stock | — | — | ( | ) | — | ( | ) | |||||||||||||||||
Unrecognized pension items, net of taxes | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||
Foreign currency translation adjustments | — | — | — | — | ||||||||||||||||||||
Unrealized gain on derivative instruments, net of taxes | — | — | — | — | ||||||||||||||||||||
Net earnings | — | — | — | — | ||||||||||||||||||||
Dividends on common stock ($0.64 per share) | — | — | ( | ) | — | — | ( | ) | ||||||||||||||||
Balance at December 31, 2019 | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||||||||
See accompanying Notes to Consolidated Financial Statements.
(1) | Due to the adoption of ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory and ASU 2014-09, Revenue from Contracts with Customers (Topic 606) as of January 1, 2018, the Company recorded decreases to retained earnings of $ |
| 71 |
SEALED AIR CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
Year Ended December 31, | ||||||||||||
(In USD millions) | 2019 | 2018 | 2017 | |||||||||
Net earnings | $ | $ | $ | |||||||||
Adjustments to reconcile net earnings to net cash provided by operating activities | ||||||||||||
Depreciation and amortization | ||||||||||||
Share-based incentive compensation | ||||||||||||
Profit sharing expense | ||||||||||||
Provisions for bad debt | ||||||||||||
Provisions for inventory obsolescence | ||||||||||||
Deferred taxes, net | ( | ) | ||||||||||
Net loss (gain) on sale of businesses | ( | ) | ( | ) | ||||||||
Other non-cash items | ||||||||||||
Changes in operating assets and liabilities: | ||||||||||||
Trade receivables, net | ( | ) | ( | ) | ||||||||
Inventories | ( | ) | ( | ) | ||||||||
Income tax receivable/payable | ( | ) | ( | ) | ||||||||
Accounts payable | ( | ) | ||||||||||
Other assets and liabilities | ( | ) | ||||||||||
Net cash provided by operating activities | $ | $ | $ | |||||||||
Cash flows from investing activities: | ||||||||||||
Capital expenditures | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||
Investment in equity investments | ( | ) | ||||||||||
Investment in marketable securities | ( | ) | ||||||||||
(Payments) Proceeds related to sale of business and property and equipment, net | ( | ) | ||||||||||
Businesses acquired in purchase transactions, net of cash acquired | ( | ) | ( | ) | ( | ) | ||||||
Loss from settlement of cross currency swaps | ( | ) | ||||||||||
Impact of sale of Diversey | ( | ) | ||||||||||
Settlement of foreign currency forward contracts | ( | ) | ( | ) | ( | ) | ||||||
Other investing activities | ( | ) | ||||||||||
Net cash (used in) provided by investing activities | $ | ( | ) | $ | ( | ) | $ | |||||
Cash flows from financing activities: | ||||||||||||
Net (payments) proceeds from short-term borrowings | $ | ( | ) | $ | $ | ( | ) | |||||
Proceeds from cross currency swap | ||||||||||||
Proceeds from long-term debt | ||||||||||||
Payments of long-term debt(1) | ( | ) | ( | ) | ||||||||
Dividends paid on common stock | ( | ) | ( | ) | ( | ) | ||||||
Repurchases of common stock(2) | ( | ) | ( | ) | ( | ) | ||||||
Payments for debt extinguishment/modification costs | ( | ) | ( | ) | ||||||||
Impact of tax withholding on share-based compensation | ( | ) | ( | ) | ( | ) | ||||||
Principal payments related to financing leases | ( | ) | ( | ) | ||||||||
Other financing activities | ( | ) | ||||||||||
Net cash provided by (used in) financing activities | $ | $ | ( | ) | $ | ( | ) | |||||
Effect of foreign currency exchange rate changes on cash and cash equivalents | $ | $ | ( | ) | $ | ( | ) | |||||
Cash Reconciliation: | ||||||||||||
Cash and cash equivalents | ||||||||||||
Restricted cash and cash equivalents | ||||||||||||
Balance, beginning of period | $ | $ | $ | |||||||||
Net change during the period | ( | ) | ( | ) | ||||||||
Cash and cash equivalents | ||||||||||||
Restricted cash and cash equivalents | ||||||||||||
Balance, end of period | $ | $ | $ | |||||||||
Supplemental Cash Flow Information: | ||||||||||||
Interest payments, net of amounts capitalized | $ | $ | $ | |||||||||
Income tax payments | $ | $ | $ | |||||||||
Payments related to sale of Diversey | $ | $ | $ | |||||||||
| 72 |
SEALED AIR CORPORATION AND SUBSIDIARIES
Year Ended December 31, | ||||||||||||
(In USD millions) | 2019 | 2018 | 2017 | |||||||||
Restructuring payments including associated costs | $ | $ | $ | |||||||||
Non-cash items: | ||||||||||||
Transfers of shares of common stock from treasury for profit-sharing plan contributions | $ | $ | $ | |||||||||
See accompanying Notes to Consolidated Financial Statements.
(1) | Payments of borrowings included in financing activities excludes amounts which were paid using cash proceeds from the sale of Diversey. As a result, $ |
(2) | The Company entered into an accelerated share repurchase agreement with a third-party financial institution to repurchase $ |
| 73 |
SEALED AIR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
Note 1 Organization and Nature of Operations
We are a leading global provider of packaging solutions for the food, e-Commerce, electronics and industrial markets. We serve an array of end markets including food and beverage processing, food service, retail, commercial and consumer applications, by providing food safety and security, product protection and equipment which allows our customers to increase automation. Our focus is on achieving quality profitable growth and increased earnings power through partnering with our customers to provide innovative, sustainable packaging solutions that solve their most complex packaging problems and create differential value for them. We do so through our iconic brands, differentiated technologies, leading market positions, global scale and market access and well-established customer relationships.
We conduct substantially all of our business through two wholly-owned subsidiaries, Cryovac, LLC and Sealed Air Corporation (US). Throughout this report, when we refer to “Sealed Air,” the “Company,” “we,” “our,” or “us,” we are referring to Sealed Air Corporation and all of our subsidiaries, except where the context indicates otherwise.
Note 2 Summary of Significant Accounting Policies and Recently Issued Accounting Standards
Summary of Significant Accounting Policies
Basis of Presentation
Our Consolidated Financial Statements include all of the accounts of the Company and our subsidiaries. We have eliminated all significant intercompany transactions and balances in consolidation. All amounts are in US Dollar denominated millions, except per share amounts and unless otherwise noted, and are approximate due to rounding.
Reclassification
As part of the Company's Reinvent SEE strategy, we have evaluated and made adjustments to our regional operating model. As of January 1, 2019, our Geographic regions are: North America, EMEA, South America and APAC. Our North American operations include Canada, the United States, Mexico and Central America. Mexico and Central America were previously included in Latin America. EMEA consists of Europe, Middle East, Africa and Turkey. APAC refers to our collective Asia Pacific region, including Greater China, India, Southeast Asia, Japan, Korea, Australia and New Zealand.
Use of Estimates
The preparation of our Consolidated Financial Statements and related disclosures in conformity with U.S. GAAP requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the period reported. These estimates include, among other items, assessing the collectability of receivables, asset retirement obligations, the use and recoverability of inventory, the estimation of fair value of financial instruments, assumptions used in the calculation of income taxes, useful lives and recoverability of tangible assets and goodwill and other intangible assets, assumptions used in our defined benefit pension plans and other post-employment benefit plans, estimates related to self-insurance such as the aggregate liability for uninsured claims using historical experience, insurance and actuarial estimates and estimated trends in claim values, fair value measurement of assets, costs for incentive compensation and accruals for commitments and contingencies. We review these estimates and assumptions periodically using historical experience and other factors and reflect the effects of any revisions in the Consolidated Financial Statements in the period we determine any revisions to be necessary. Actual results could differ from these estimates.
Financial Instruments
We may use financial instruments, such as cross-currency swaps, interest rate swaps, caps and collars, U.S. Treasury lock agreements and foreign currency exchange forward contracts and options related to our borrowing and trade activities. We may use these financial instruments from time to time to manage our exposure to fluctuations in interest rates and foreign currency exchange rates. We do not purchase, hold or sell derivative financial instruments for trading purposes. We face credit risk if the counterparties to these transactions are unable to perform their obligations. Our policy is to have counterparties to these contracts that have at least an investment grade rating.
| 74 |
We report derivative instruments at fair value and establish criteria for designation and effectiveness of transactions entered into for hedging purposes. Before entering into any derivative transaction, we identify our specific financial risk, the appropriate hedging instrument to use to reduce this risk, and the correlation between the financial risk and the hedging instrument. We use forecasts and historical data as the basis for determining the anticipated values of the transactions to be hedged. We do not enter into derivative transactions that do not have a high correlation with the underlying financial risk we are trying to reduce. We regularly review our hedge positions and the correlation between the transaction risks and the hedging instruments.
We account for derivative instruments as hedges of the related underlying risks if we designate these derivative instruments as hedges and the derivative instruments are effective as hedges of recognized assets or liabilities, forecasted transactions, unrecognized firm commitments or forecasted intercompany transactions.
We record gains and losses on derivatives qualifying as cash flow hedges in AOCL, to the extent that hedges are effective and until the underlying transactions are recognized on the Consolidated Statements of Operations, at which time we recognize the gains and losses on the Consolidated Statements of Operations. We recognize gains and losses on qualifying fair value hedges and the related loss or gain on the hedged item attributable to the hedged risk on the Consolidated Statements of Operations.
Generally, our practice is to terminate derivative transactions if the underlying asset or liability matures or is sold or terminated, or if we determine the underlying forecasted transaction is no longer probable of occurring. Any deferred gains or losses associated with derivative instruments are recognized on the Consolidated Statements of Operations over the period in which the income or expense on the underlying hedged transaction is recognized.
See Note 15, “Derivatives and Hedging Activities,” of the Notes to Consolidated Financial Statements for further details.
Foreign Currency Translation
In non-U.S. locations that are not considered highly inflationary, we translate the balance sheets at the end of period exchange rates with translation adjustments accumulated in stockholders’ deficit on our Consolidated Balance Sheets. We translate the statements of operations at the average exchange rates during the applicable period.
We translate assets and liabilities of our operations in countries with highly inflationary economies at the end of period exchange rates, except that nonmonetary asset and liability amounts are translated at historical exchange rates. In countries with highly inflationary economies, we translate items reflected in the statements of operations at average rates of exchange prevailing during the period, except that nonmonetary amounts are translated at historical exchange rates.
Impact of Inflation and Currency Fluctuation
Argentina - Economic and political events in Argentina have continued to expose us to heightened levels of foreign currency exchange risk. As of July 1, 2018, Argentina was designated as a highly inflationary economy under U.S. GAAP, and the US Dollar replaced the Argentine peso as the functional currency for our subsidiaries in Argentina. All Argentine peso-denominated monetary assets and liabilities were remeasured into US Dollars using the current exchange rate available to us, and any changes in the exchange rate are reflected in net foreign exchange transaction loss, within Foreign currency exchange loss due to highly inflationary economies on the Consolidated Statements of Operations. For the years ended December 31, 2019 and 2018, the Company recorded a $4.6 million and $2.4 million remeasurement loss, respectively. The exchange rate as of December 31, 2019 and 2018 was 59.8723 and 37.6679 , respectively.
We will continue to evaluate each reporting period the appropriate exchange rate to remeasure our financial statements based on the facts and circumstances as applicable.
Commitments and Contingencies — Litigation
On an ongoing basis, we assess the potential liabilities related to any lawsuits or claims brought against us. While it is typically very difficult to determine the timing and ultimate outcome of these actions, we use our best judgment to determine if it is probable that we will incur an expense related to the settlement or final adjudication of these matters and whether a reasonable estimation of the probable loss, if any, can be made. In assessing probable losses, we make estimates of the amount of insurance recoveries, if any. We accrue a liability when we believe a loss is probable and the amount of loss can be reasonably estimated. Due to the inherent uncertainties related to the eventual outcome of litigation and potential insurance recovery, it is possible that disputed matters may be resolved for amounts materially different from any provisions or
| 75 |
disclosures that we have previously made. We expense legal costs, including those legal costs expected to be incurred in connection with a loss contingency, as incurred.
Revenue Recognition
Revenue from contracts with customers is recognized using a five-step model consisting of the following: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the Company satisfies a performance obligation. Performance obligations are satisfied when the Company transfers control of a good or service to a customer, which can occur over time or at a point in time. The amount of revenue recognized is based on the consideration to which the Company expects to be entitled in exchange for those goods or services, including the expected value of variable consideration. The customer’s ability and intent to pay the transaction price is assessed in determining whether a contract exists with the customer. If collectability of substantially all of the consideration in a contract is not probable, consideration received is not recognized as revenue unless the consideration is nonrefundable and the Company no longer has an obligation to transfer additional goods or services to the customer or collectability becomes probable.
Sales taxes collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales on the Consolidated Statements of Operations.
Charges for rebates and other allowances are recognized as a deduction from revenue on an accrual basis in the period in which the associated revenue is recorded. When we estimate our rebate accruals, we consider customer-specific contractual commitments including stated rebate rates and history of actual rebates paid. Our rebate accruals are reviewed at each reporting period and adjusted to reflect data available at that time. We adjust the accruals to reflect any differences between estimated and actual amounts. These adjustments impact the amount of net sales recognized by us in the period of adjustment. Charges for rebates and other allowances were approximately 4 % of sales in 2019, and 5 % of sales in 2018 and 2017. Refer to Note 3, "Revenue Recognition, Contracts with Customers," of the Notes to Consolidated Financial Statements for further discussion of revenue.
Costs to obtain or fulfill a Contract and Shipping and Handling Costs
The Company recognizes incremental costs to obtain a contract as an expense when incurred if the amortization period of the asset that otherwise would have been recognized is one year or less. For example, the Company generally expenses sales commissions when incurred because the contract term is less than 1 year. These costs are recorded within sales and marketing expenses.
Costs for shipping and handling activities performed after a customer obtains control of a good are accounted for as costs to fulfill a contract and are included in cost of goods sold.
Research and Development
Share-Based Incentive Compensation
At the 2014 Annual Meeting, the 2014 Omnibus Incentive Plan (the “Omnibus Plan”) was approved by our stockholders. Subsequently, the Board of Directors adopted, and at the 2018 Annual Stockholders' Meeting, our stockholders approved, an amendment and restatement to the 2014 Omnibus Incentive Plan. See Note 21, “Stockholders’ Deficit,” of the Notes to the Consolidated Financial Statements for further information on this plan.
We record share-based compensation awards exchanged for employee services at fair value on the date of grant and record the expense for these awards in cost of sales and in selling, general and administrative expense, as applicable, on our Consolidated Statements of Operations over the requisite employee service period. Share-based incentive compensation expense includes an estimate for forfeitures and anticipated achievement levels and is generally recognized over the expected term of the award on a straight-line basis. The Company accelerates expense on performance-based awards using a graded vesting schedule for employees who meet retirement eligibility requirements prior to the end of the award’s service period. For performance-based awards, the Company reassesses at each reporting date whether achievement of the performance condition is probable and accrues compensation expense if and when achievement of the performance condition is probable. For
| 76 |
performance awards with market-based conditions, the fair value of the award is determined at the grant date and is recognized at 100 % over the performance period regardless of actual market condition performance.
Income Taxes
We file a consolidated U.S. federal income tax return and our non-U.S. subsidiaries file income tax returns in their respective local jurisdictions. We provide for income taxes on those portions of our foreign subsidiaries’ accumulated earnings that we believe are not reinvested indefinitely in our businesses.
We account for income taxes under the asset and liability method to provide for income taxes on all transactions recorded in the Consolidated Financial Statements. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax benefit carryforwards. We determine deferred tax assets and liabilities at the end of each period using enacted tax rates.
In assessing the need for a valuation allowance, we estimate future reversals of existing temporary differences, future taxable earnings, with consideration for the feasibility of ongoing planning strategies, taxable income in carryback periods and past operating results to determine which deferred tax assets are more likely than not to be realized in the future. Changes to tax laws, statutory tax rates and future taxable earnings can have an impact on valuation allowances related to deferred tax assets.
We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are measured based on the largest amount of benefit that has a greater than fifty percent likelihood of being realized upon settlement with tax authorities. We recognize interest and penalties related to unrecognized tax benefits in income tax expense on our Consolidated Statements of Operations. See Note 19, “Income Taxes,” of the Notes to Consolidated Financial Statements for further discussion.
Cash and Cash Equivalents
We consider highly liquid investments with original maturities of three months or less to be cash equivalents. Our policy is to invest cash in excess of short-term operating and debt service requirements in cash equivalents. Cash equivalents are stated at cost, which approximates fair value because of the short-term maturity of the instruments. Our policy is to transact with counterparties that are rated at least A- by Standard & Poor’s and A3 by Moody’s. Some of our operations are located in countries that are rated below A- or A3. In this case, we try to minimize our risk by holding cash and cash equivalents at financial institutions with which we have existing global relationships whenever possible, diversifying counterparty exposures and minimizing the amount held by each counterparty and within the country in total.
Accounts Receivable Securitization Programs
We and a group of our U.S. operating subsidiaries maintain an accounts receivable securitization program under which they sell eligible U.S. accounts receivable to an indirectly wholly-owned subsidiary that was formed for the sole purpose of entering into this program. The wholly-owned subsidiary in turn may sell an undivided fractional ownership interest in these receivables with two banks and an issuer of commercial paper administered by these banks. The wholly-owned subsidiary retains the receivables it purchases from the operating subsidiaries. Any transfers of undivided fractional ownership interests of receivables under the U.S. receivables securitization program to the two banks and an issuer of commercial paper administered by these banks are considered secured borrowings with pledge of collateral and will be classified as short-term borrowings on our Consolidated Balance Sheets. The net trade receivables that served as collateral for these borrowings are reclassified from trade receivables, net to prepaid expenses and other current assets on the Consolidated Balance Sheets.
We have a European accounts receivable securitization and purchase program with a special purpose vehicle, or SPV, two banks and a group of our European subsidiaries. The European program is structured to be a securitization of certain trade receivables that are originated by certain of our European subsidiaries. The SPV borrows funds from the banks to fund its acquisition of the receivables and provides the banks with a first priority perfected security interest in the accounts receivable. We do not have an equity interest in the SPV. We concluded the SPV is a variable interest entity because its total equity investment at risk is not sufficient to permit the SPV to finance its activities without additional subordinated financial support
| 77 |
Accounts Receivable Factoring Agreements
Trade Receivables, Net
In the normal course of business, we extend credit to customers that satisfy pre-defined credit criteria. Trade receivables, which are included on the Consolidated Balance Sheets, are stated at amounts due from our customers net of allowances for doubtful accounts.
Inventories, Net
Our inventories are determined using the FIFO method or a weighted average for some raw materials. We state inventories at the lower of cost or net realizable value. Costs related to inventories include raw materials, direct labor and manufacturing overhead which are included in cost of sales on the Consolidated Statements of Operations.
Property and Equipment, Net
We state property and equipment at cost, except for property and equipment that have been impaired, for which we reduce the carrying amount to the estimated fair value at the impairment date. We capitalize significant improvements and charge repairs and maintenance costs that do not extend the lives of the assets to expense as incurred. We remove the cost and accumulated depreciation of assets sold or otherwise disposed of from the accounts and recognize any resulting gain or loss upon the disposition of the assets.
We depreciate the cost of property and equipment over their estimated useful lives on a straight-line basis as follows: buildings, including leasehold improvements — 20 to 40 years; machinery and equipment — 5 to 10 years; and other property and equipment — 2 to 10 years.
Goodwill and Identifiable Intangible Assets, Net
Goodwill represents the excess of the purchase price over the estimated fair value of the net assets acquired, including the amount assigned to identifiable intangible assets.
Identifiable intangible assets consist primarily of patents, licenses, trademarks, trade names, customer lists and relationships, non-compete agreements and technology-based intangibles and other contractual agreements. We amortize finite lived identifiable intangible assets over the shorter of their stated or statutory duration or their estimated useful lives, currently ranging from 1 to 28 years, on a straight-line basis to their estimated residual values and periodically review them for impairment.
We use the acquisition method of accounting for all business combinations and do not amortize goodwill or intangible assets with indefinite useful lives. Goodwill and intangible assets with indefinite useful lives are tested for possible impairment
| 78 |
Impairment and Disposal of Long-Lived Assets
For finite-lived intangible assets, such as customer relationships, contracts, intellectual property, and for other long-lived assets, such as property, plant and equipment, whenever impairment indicators are present, we perform a review for impairment. We calculate the undiscounted value of the projected cash flows associated with the asset, or asset group, and compare this estimated amount to the carrying amount. If the carrying amount is found to be greater, we record an impairment loss for the excess of book value over the fair value. In addition, in all cases of an impairment review, we re-evaluate the remaining useful lives of the assets and modify them, as appropriate.
We retain the obligation for specified claims and losses related to property, casualty, workers’ compensation and employee benefit claims. We accrue for outstanding reported claims and claims that have been incurred but not reported based upon management’s estimates of the aggregate liability for retained losses using historical experience, insurance company estimates and the estimated trends in claim values. Our estimates include management’s and independent insurance companies’ assumptions regarding economic conditions, the frequency and severity of claims and claim development patterns and settlement practices. These estimates and assumptions are monitored and evaluated on a periodic basis by management and are adjusted when warranted by changing circumstances. Although management believes it has the ability to adequately project and record estimated claim payments, actual results could differ significantly from the recorded liabilities.
Pensions
For a number of our U.S. and international employees, we maintain defined benefit pension plans. We are required to make assumptions regarding the valuation of projected benefit obligations and the performance of plan assets for our defined benefit pension plans.
We review and approve the assumptions made by our third-party actuaries regarding the valuation of benefit obligations and performance of plan assets. The most significant assumptions used to determine the benefit obligation and expense of the pension plans are the discount rate used to measure future obligations and the expected future rate of return on plan assets. The measurement date used to determine benefit obligations and plan assets is December 31. In general, significant changes to these assumptions could have a material impact on the costs and liabilities recorded in our Consolidated Financial Statements.
See Note 17, “Profit Sharing, Retirement Savings Plans and Defined Benefit Pension Plans,” of the Notes to Consolidated Financial Statements for information about the Company’s benefit plans.
Net Earnings per Common Share
Basic earnings per common share is calculated by dividing net earnings available to common stockholders by the weighted average number of common shares outstanding for the period. Non-vested share-based payment awards that contain non-forfeitable rights to dividends are treated as participating securities and therefore included in computing earnings per common share using the “two-class method.” The two-class method is an earnings allocation formula that calculates basic and diluted net earnings per common share for each class of common stock separately based on dividends declared and participation rights in undistributed earnings. Non-vested restricted stock issued under our Omnibus Plan prior to January 1, 2018 are considered participating securities since these securities have non-forfeitable rights to dividends when we declare a dividend during the contractual vesting period of the share-based payment award and are therefore included in our earnings allocation formula using the two-class method.
When calculating diluted net earnings per common share, the more dilutive effect of applying either of the following is presented: (a) the two-class method (described above) assuming that the participating security is not exercised or converted, or, (b) the treasury stock method for the participating security. Our diluted net earnings per common share for all periods presented was calculated using the two-class method since such method was more dilutive.
See Note 24, “Net Earnings Per Common Share,” of the Notes to Consolidated Financial Statements for further discussion.
| 79 |
Recently Adopted Accounting Standards
In February 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, Leases (Topic 842), and issued subsequent amendments to the initial guidance thereafter. This ASU requires an entity to recognize a right-of-use asset (ROU) and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification of the underlying lease as either finance or operating. Similar modifications have been made to lessor accounting in-line with revenue recognition guidance. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The new standard was effective for us on January 1, 2019.
Entities are required to adopt ASC 842 using a modified retrospective transition method. Full retrospective transition is prohibited. The guidance permits an entity to apply the standard’s transition provisions at either the beginning of the earliest comparative period presented in the financial statements or the beginning of the period of adoption (i.e., on the effective date). We adopted the new standard on its effective date.
The new standard provides several optional practical expedients in transition. We elected the ‘package of practical expedients’, which permits us not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. We did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter not being applicable to us.
The new standard also provides practical expedients for an entity’s ongoing accounting. We elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets in transition. We also elected the practical expedient not to separate lease and non-lease components for all of our leases, which means all consideration that is fixed, or in-substance fixed, relating to the non-lease components will be captured as part of our lease components for balance sheet purposes.
As of December 31, 2019, we recognized additional operating lease liabilities of $91.9 million based on the present value of the remaining minimum rental payments for existing operating leases and corresponding ROU assets of $90.1 million on our Consolidated Balance Sheets. See Note 4, "Leases," of the Notes to the Consolidated Financial Statements for additional lease disclosures.
In October 2018, the FASB issued ASU 2018-16, Derivatives and Hedging (Topic 815), Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes. ASU 2018-16 adds the overnight index swap rate based on the Secured Overnight Financing Rate to the list of U.S. benchmark interest rates eligible to be hedged within ASC 815. This ASU names the Secured Overnight Financing Rate as the preferred reference rate alternative to the London Interbank Offered Rate (LIBOR). The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company adopted ASU 2018-16 on January 1, 2019. The adoption did not have an impact on the Company's Consolidated Financial Results.
Recently Issued Accounting Standards
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes. ASU 2109-12 eliminates certain exceptions to the guidance in Topic 740 related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes, enacted change in tax laws or rates and clarifies the accounting transactions that result in a step-up in the tax basis of goodwill. The guidance is effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. We are currently in the process of evaluating the effect that ASU 2019-12 will have on the Company's Consolidated Financial Results.
In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging and Topic 825, Financial Instruments. ASU 2019-04 provides updates and amendments to previously issued ASUs. The amendments clarify the scope of the credit losses standard and address issues related to accrued interest receivable balances, recoveries, variable interest rates and prepayments. Codification Improvements to Topic 326, Financial Instruments - Credit Losses is effective upon our adoption of ASU 2016-13 (discussed below), which we will adopt as of January 1, 2020. The amendment will be included in our overall adoption of ASU 2016-13. The amendments related to Derivatives and Hedging address partial-term fair value hedges and fair value hedge basis adjustments. Codification Improvements to Topic 815, Derivatives and Hedging are effective for us beginning the first annual reporting
| 80 |
period beginning after April 25, 2019. Amendments on Topic 825, Financial Instruments mainly address the scope of the guidance, the requirement for remeasurement under ASC 820 when using the measurement alternative, certain disclosure requirements and which equity securities have to be remeasured at historical exchange rates. For amendments related to ASU 2016-01 (Topic 825, Financial Instruments), the effective date is fiscal years and interim period beginning after December 15, 2019, with early adoption permitted. We do not believe that the adoption of ASU 2019-04 will have a material impact on the Company's Consolidated Financial Statements.
In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40), Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract ("ASU 2018-15"). ASU 2018-15 amends ASC 350-40 and aligns the accounting for costs incurred to implement a cloud computing arrangement that is a service contract with the guidance on capitalizing costs associated with developing or obtaining internal-use software. The guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt ASU 2018-15 effective January 1, 2020. We do not believe that the adoption of ASU 2018-15 will have a material impact on the Company's Consolidated Financial Statements.
In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20), Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans ("ASU 2018-14"). ASU 2018-14 eliminates, adds and clarifies certain disclosure requirements related to defined benefit plans and other postretirement plans. The guidance is effective for fiscal years ending after December 15, 2020, with early adoption permitted for reporting periods for which financial statements have yet to be issued or made available for issuance. We will adopt ASU 2018-14 for our fiscal year ending December 31, 2020. We do not believe that the adoption of ASU 2018-14 will have an impact on the Company's Consolidated Financial Statements with the exception of new and expanded disclosures.
In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820), Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement ("ASU 2018-13"). ASU 2018-13 amends the fair value measurement disclosure requirements of ASC 820, including new, eliminated and modified disclosure requirements. The guidance is effective for fiscal years beginning after December 15, 2019, including interim periods therein. The Company will adopt ASU 2018-13 effective January 1, 2020. We do not believe that the adoption of ASU 2018-13 will have an impact on the Company's Consolidated Financial Statements with the exception of new and expanded disclosures.
Note 3 Revenue Recognition, Contracts with Customers
Description of Revenue Generating Activities
We employ sales, marketing and customer service personnel throughout the world who sell and market our products and services to and/or through a large number of distributors, fabricators, converters, e-commerce and mail order fulfillment firms, and contract packaging firms as well as directly to end-users such as food processors, foodservice businesses, supermarket retailers, pharmaceutical companies, healthcare facilities, medical device manufacturers, and other manufacturers.
As discussed in Note 6, "Segments," of the Notes to Consolidated Financial Statements, our reporting segments are Food Care and Product Care. Our Food Care applications are largely sold directly to end customers, while our Product Care products are sold through business supply distributors and direct to the end customer.
| 81 |
Food Care:
Food Care largely serves perishable food processors, predominantly in chilled, smoked and processed meat, poultry and dairy-solid markets worldwide, and maintains positions in target applications. Food Care provides integrated packaging materials, equipment, and automation solutions and services to increase operational efficiency, extend shelf life and reduce resource use throughout the supply chain with innovative, sustainable packaging that enables customers to reduce costs and enhance their brands in the marketplace.
Product Care:
Product Care packaging solutions are utilized across many global markets and are especially valuable to e-Commerce, electronics and industrial manufacturing. Product Care solutions are designed to protect valuable goods in shipping, and drive operational excellence for our customers, increasing their order fulfillment velocity while minimizing material usage, dimensional weight and packaging labor requirements. Recent acquisitions in Product Care include Fagerdala Singapore Pte Ltd. ("Fagerdala") in 2017, AFP in 2018 and Automated Packaging Systems, LLC (“Automated”) in 2019.
Product Care benefits from the continued expansion of e-Commerce, increasing freight costs, scarcity of labor, and increasing demand for more sustainable packaging. Product Care solutions are largely sold through supply distributors that sell to business/industrial end-users. Product Care solutions are additionally sold directly to fabricators, original equipment manufacturers, contract manufacturers, third-party logistics partners, e-commerce/fulfillment operations, and at various retail centers. Product Care solutions are marketed under brands including Bubble Wrap® brand inflatable packaging, Sealed Air® brand performance shrink films and Autobag® brand bagging systems. Product Care product families include additional tradenames including Instapak® polyurethane foam packaging solutions and Korrvu® suspension and retention packaging.
Adoption of ASU 2014-09, Revenue from Contracts with Customers (Topic 606)
On January 1, 2018, the Company adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606) and subsequent amendments to the initial guidance, collectively, Topic 606. The Company adopted the new revenue recognition standard using the modified retrospective approach with a cumulative effect adjustment to retained earnings as of the adoption date. The adoption of Topic 606 did not have a significant impact on our consolidated financial statements with the exception of new and expanded disclosures. However, reporting periods prior to Topic 606 adoption may not be comparable due to differences between Topic 606 and the previous accounting guidance. For the year ending December 31, 2017, the Company recognized revenue under ASC 605, under which the following criteria were used for revenue recognition: persuasive evidence that an arrangement exists, shipment has occurred, selling price is fixed or determinable, and collection is reasonably assured.
Identify Contract with Customer:
For Sealed Air, the determination of whether an arrangement meets the definition of a contract under Topic 606 depends on whether it creates enforceable rights and obligations. While enforceability is a matter of law, we believe that enforceable rights and obligations in a contract must be substantive in order for the contract to be in scope of Topic 606. That is, the penalty for noncompliance must be significant relative to the minimum obligation. Fixed or minimum purchase obligations with penalties for noncompliance are the most common examples of substantive enforceable rights present in our contracts. We determined that the contract term is the period of enforceability outlined by the terms of the contract. This means that in many cases, the term stated in the contract is different than the period of enforceability. After the minimum purchase obligation is met, subsequent sales are treated as separate contracts on a purchase order by purchase order basis. If no minimum purchase obligation exists, the next level of enforceability is determined, which often represents the individual purchase orders and the agreed upon terms.
Performance Obligations:
The most common goods and services determined to be distinct performance obligations are consumables/materials, equipment sales, and maintenance. Free on loan and leased equipment is typically identified as a separate lease component in scope of Topic 842. The other goods or services promised in the contract with the customer in most cases do not represent performance obligations because they are neither separate nor distinct, or they are not material in the context of the contract.
Transaction Price and Variable Consideration:
Sealed Air has many forms of variable consideration present in its contracts with customers, including rebates and other discounts. Sealed Air estimates variable consideration using either the expected value method or the most likely amount method as described in the standard. We include in the transaction price some or all of an amount of variable consideration
| 82 |
estimated to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.
For all contracts that contain a form of variable consideration, Sealed Air estimates at contract inception, and periodically throughout the term of the contract, what volume of goods and/or services the customer will purchase in a given period and determines how much consideration is payable to the customer or how much consideration Sealed Air would be able to recover from the customer based on the structure of the type of variable consideration. In most cases the variable consideration in contracts with customers results in amounts payable to the customer by Sealed Air. Sealed Air adjusts the contract transaction price based on any changes in estimates each reporting period and performs an inception to date cumulative adjustment to the amount of revenue previously recognized. When the contract with a customer contains a minimum purchase obligation, Sealed Air only has enforceable rights to the amount of consideration promised in the minimum purchase obligation through the enforceable term of the contract. This amount of consideration, plus any variable consideration, makes up the transaction price for the contract.
The Company does not adjust consideration in contracts with customers for the effects of a significant financing component if the Company expects that the period between transfer of a good or service and payment for that good or service will be one year or less. This is expected to be the case for the majority of contracts.
Sales taxes collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales on the Consolidated Statements of Operations.
Allocation of Transaction Price:
Sealed Air determines the standalone selling price for a performance obligation by first looking for observable selling prices of that performance obligation sold on a standalone basis. If an observable price is not available, we estimate the standalone selling price of the performance obligation using one of the three suggested methods in the following order of preference: adjusted market assessment approach, expected cost plus a margin approach, and residual approach.
Sealed Air often offers rebates to customers in their contracts that are related to the amount of consumables purchased. We believe that this form of variable consideration should only be allocated to consumables because the entire amount of variable consideration relates to the customer’s purchase of and Sealed Air’s efforts to provide consumables. Additionally, Sealed Air has many contracts that have pricing tied to third-party indices. We believe that variability from index-based pricing should be allocated specifically to consumables because the pricing formulas in these contracts are related to the cost to produce consumables.
Transfer of Control:
Revenue is recognized upon transfer of control to the customer. Revenue for consumables and equipment sales is recognized based on shipping terms, which is the point in time the customer obtains control of the promised goods. Maintenance revenue is recognized straight-line on the basis that the level of effort is consistent over the term of the contract. Lease components within contracts with customers are recognized in accordance with Topic 842.
Disaggregated Revenue
For the years ended December 31, 2019 and 2018, revenues from contracts with customers summarized by Segment Geography were as follows:
| 83 |
Year Ended December 31, 2019 | ||||||||||||
(In millions)(1) | Food Care | Product Care | Total | |||||||||
North America | $ | $ | $ | |||||||||
EMEA | ||||||||||||
South America | ||||||||||||
APAC | ||||||||||||
Topic 606 Segment Revenue | ||||||||||||
Non-Topic 606 Revenue (Leasing: Sales-type and Operating) | ||||||||||||
Total | $ | $ | $ | |||||||||
Year Ended December 31, 2018 | ||||||||||||
(In millions)(1) | Food Care | Product Care | Total | |||||||||
North America | $ | $ | $ | |||||||||
EMEA | ||||||||||||
South America | ||||||||||||
APAC | ||||||||||||
Topic 606 Segment Revenue | ||||||||||||
Non-Topic 606 Revenue (Leasing: Sales-type and Operating) | ||||||||||||
Total | $ | $ | $ | |||||||||
(1) | Amounts by geography has been reclassified from prior year disclosure to reflect adjustments to our regional operating model. As of January 1, 2019, our geographic regions are: North America, EMEA, South America and APAC. Our North American operations include Canada, the United States, Mexico and Central America. Mexico and Central America were previously included in Latin America. Refer to Note 2, "Summary of Significant Accounting Policies and Recently Issued Accounting Standards," of the Notes to Consolidated Financial Statements. |
Contract Balances
The time between when a performance obligation is satisfied and when billing and payment occur is closely aligned, with the exception of equipment accruals. An equipment accrual is a contract offering, whereby a customer is incentivized to use a portion of the consumables transaction price for future equipment purchases. Long-term contracts that include an equipment accrual create a timing difference between when cash is collected and the performance obligation is satisfied, resulting in a contract liability (unearned revenue). The opening and closing balances of contract liabilities arising from contracts with customers as of December 31, 2019 were as follows:
(In millions) | December 31, 2019 | December 31, 2018 | ||||||
Contract liabilities | $ | $ | ||||||
There were no contract asset balances recorded on the Consolidated Balance Sheets as of December 31, 2019 and 2018.
Revenue recognized in the years ended December 31, 2019 and 2018, that was included in the contract liability balance at the beginning of the period was $5.6 million and $4.9 million, respectively. This revenue was driven primarily by equipment performance obligations being satisfied.
The contract liability balance represents deferred revenue, primarily related to equipment accruals. The increase in 2019 to deferred revenue was driven by new agreements and volume on existing agreements. The Automated acquisition did not have a material impact on the Company's contract asset or contract liability balances during the year.
| 84 |
Remaining Performance Obligations
The following table summarizes the estimated transaction price from contracts with customers allocated to performance obligations or portions of performance obligations that have not yet been satisfied as of December 31, 2019, as well as the expected timing of recognition of that transaction price.
(In millions) | Short-Term(1) (12 months or less) | Long-Term | Total | |||||||||
Total transaction price | $ | $ | $ | |||||||||
(1) Our enforceable contractual obligations tend to be short term in nature. The table above does not include the transaction price of any remaining performance obligations that are part of the contracts with expected durations of less than one year.
The Company recognizes incremental costs to fulfill a contract as an asset if such incremental costs are expected to be recovered, relate directly to a contract or anticipated contract, and generate or enhance resources that will be used to satisfy performance obligations in the future.
The Company recognizes incremental costs to obtain a contract as an expense when incurred if the amortization period of the asset that otherwise would have been recognized is one year or less. For example, the Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within sales and marketing expenses.
Costs for shipping and handling activities performed after a customer obtains control of a good are accounted for as costs to fulfill a contract and are included in cost of goods sold.
Note 4 Leases
Lessor
Sealed Air has contractual obligations as a lessor with respect to free on loan equipment and leased equipment, both sales-type and operating. The consideration in a contract that contains both lease and non-lease components is allocated based on the standalone selling price.
Our contractual obligations for operating leases can include termination and renewal options. Our contractual obligations for sales-type leases tend to have fixed terms and can include purchase options. We utilize the reasonably certain threshold criteria in determining which options our customers will exercise.
All lease payments are primarily fixed in nature and therefore captured in the lease receivable. Our lease receivable balance at December 31, 2019 was:
(in millions) | Short-Term (12 months or less) | Long-Term | Total | |||||||||
Total lease receivable (Sales-type and Operating) | $ | $ | $ | |||||||||
Lessee
Sealed Air has contractual obligations as a lessee with respect to warehouses, offices, and manufacturing facilities, IT equipment, automobiles, and material production equipment.
Under the leasing standard, ASC 842, leases that are more than one year in duration are capitalized and recorded on the balance sheet. Some of our leases, namely for automobiles and real estate, offer an option to extend the term of such leases. We utilize the reasonably certain threshold criteria in determining which options we will exercise. Furthermore, some of our lease payments are based on index rates with minimum annual increases. These represent fixed payments and are captured in the future minimum lease payments calculation.
| 85 |
In determining the discount rate to use in calculating the present value of lease payments, we estimate the rate of interest we would pay on a collateralized loan with the same payment terms as the lease by utilizing our bond yields traded in the secondary market to determine the estimated cost of funds for the particular tenor. We update our assumptions and discount rates on a quarterly basis.
The accounting standard update, ASU 2016-02, provides practical expedients for an entity’s transition and ongoing accounting. In terms of transition accounting, we elected the ‘package of practical expedients’, which permits us to not reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. We did not elect the use-of hindsight or the practical expedient pertaining to land easements; the latter not being applicable to us.
In terms of ongoing accounting, we have elected to use the short-term lease recognition exemption for all asset classes. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets. We have also elected the practical expedient to not separate lease and non-lease components for all asset classes, meaning all consideration that is fixed, or in-substance fixed, will be captured as part of our lease components for balance sheet purposes. Furthermore, all variable payments included in lease agreements will be disclosed as variable lease expense when incurred. Generally, variable lease payments are based on usage and common area maintenance. These payments will be included as variable lease expense when recognized.
The following table details our lease obligations included in our Consolidated Balance Sheets.
(in millions) | December 31, 2019 | |||
Other non-current assets: | ||||
Finance leases - ROU assets | $ | |||
Finance leases - Accumulated depreciation | ( | ) | ||
Operating lease right-of-use-assets: | ||||
Operating leases - ROU assets | ||||
Operating leases - Accumulated depreciation | ( | ) | ||
Total lease assets | $ | |||
Current portion of long-term debt: | ||||
Finance leases | $ | ( | ) | |
Current portion of operating lease liabilities: | ||||
Operating leases | ( | ) | ||
Long-term debt, less current portion: | ||||
Finance leases | ( | ) | ||
Long-term operating lease liabilities, less current portion: | ||||
Operating leases | ( | ) | ||
Total lease liabilities | $ | ( | ) | |
At December 31, 2019, estimated future minimum annual rental commitments under non-cancelable real and personal property leases were as follows:
(in millions) | Finance leases | Operating leases | ||||||
2020 | $ | $ | ||||||
2021 | ||||||||
2022 | ||||||||
2023 | ||||||||
2024 | ||||||||
Thereafter | ||||||||
Total lease payments | ||||||||
Less: Interest | ( | ) | ( | ) | ||||
Present value of lease liabilities | $ | $ | ||||||
| 86 |
At December 31, 2018, operating leases estimated future minimum annual rental commitments under non-cancelable real and personal property leases, prior to the adoption of ASC 842, were as follows:
(in millions) | Operating leases(1) | |||
2019 | $ | |||
2020 | ||||
2021 | ||||
2022 | ||||
2023 | ||||
Thereafter | ||||
Total lease payments | $ | |||
(1) | Amounts as of December 31, 2018 are based on ASC 840, and were superseded with our adoption of ASC 842, Leases on January 1, 2019. Refer to Note 2, "Recently Adopted and Issued Accounting Standards," of the Notes to Consolidated Financial Statements for additional information on our adoption of new accounting standards. |
The following lease cost is included in our Consolidated Statements of Operations:
(in millions) | December 31, 2019 | |||
Lease cost(1) | ||||
Finance leases | ||||
Amortization of ROU assets | $ | |||
Interest on lease liabilities | ||||
Operating leases | ||||
Short-term lease cost | ||||
Variable lease cost | ||||
Total lease cost | $ | |||
(1) | With the exception of Interest on lease liabilities, we record lease costs to Cost of Sales or Selling, general and administrative expenses on the Consolidated Statements of Operations, depending on the use of the leased asset. Interest on lease liabilities are recorded to Interest expense, net on the Consolidated Statement of Operations. |
(in millions) | December 31, 2019 | |||
Other information: | ||||
Cash paid for amounts included in the measurement of lease liabilities: | ||||
Operating cash flows - finance leases | $ | |||
Operating cash flows - operating leases | $ | |||
Financing cash flows - finance leases | $ | |||
ROU assets obtained in exchange for new finance lease liabilities | $ | |||
ROU assets obtained in exchange for new operating lease liabilities | $ | |||
| 87 |
Weighted average information: | |||
Finance leases | |||
Remaining lease term (in years) | |||
Discount rate | % | ||
Operating leases | |||
Remaining lease term (in years) | |||
Discount rate | % | ||
Note 5 Discontinued Operations, Divestitures and Acquisitions
Discontinued Operations
On March 25, 2017, we entered into a definitive agreement to sell our Diversey Care division and the food hygiene and cleaning business within our Food Care division (collectively, "Diversey") for gross proceeds of USD equivalent of $3.2 billion, subject to customary closing conditions. The transaction was completed on September 6, 2017. We recorded a net gain on the sale of Diversey of $640.7 million, net of taxes of $197.5 million. During 2019 and 2018, we recorded an additional net loss and net gain on the sale of Diversey of $30.7 million and $42.8 million, net of taxes, respectively. The net loss recorded in 2019 on the sale of Diversey relates primarily to changes in balance sheet positions associated with the sale including tax-related indemnification reserves and other receivable or payable positions arising from the sale. The net gain recorded in 2018 was related to the final net working capital settlement as well as the release of tax indemnity reserves upon expiration of the statutes of limitations.
We have classified the operating results of Diversey, together with certain costs related to the divestiture transaction, as discontinued operations, net of tax, in the Consolidated Statements of Operations for the year ended December 31, 2017.
Summary operating results of Diversey were as follows:
(In millions) | Year Ended December 31, 2017 | |||
Net sales | $ | |||
Cost of sales | ||||
Gross profit | ||||
Selling, general and administrative expenses | ||||
Amortization expense of intangible assets acquired | ||||
Operating profit | ||||
Other expense, net | ( | ) | ||
Earnings from discontinued operations before income tax provision | ||||
Income tax provision from discontinued operations(1) | ||||
Net earnings from discontinued operations | $ | |||
(1) | For the year ended December 31, 2017, net earnings from discontinued operations included tax expense of $ |
| 88 |
The following table presents selected financial information regarding cash flows of Diversey in the Consolidated Statements of Cash Flows but are within discontinued operations in the Consolidated Statements of Operations:
(In millions) | Year Ended December 31, 2017 | |||
Non-cash items included in net earnings from discontinued operations: | ||||
Depreciation and amortization | $ | |||
Share-based incentive compensation | ||||
Profit sharing expense | ||||
Provision for bad debt | ||||
Capital expenditures | ||||
Divestitures
Divestiture of Embalagens Ltda.
On August 1, 2017, we entered into an agreement to sell our polystyrene food tray business in Guarulhos, Brazil for a gross purchase price of R$26.9 million (or $8.2 million as of closing date of March 19, 2018). The purchase price was subject to working capital, cash and debt adjustments, which were finalized in the fourth quarter of 2018 for R$1.6 million (or $0.4 million). For the year ended December 31, 2018, the Company recognized a net gain on the sale of $1.4 million, on the Consolidated Statements of Operations.
Acquisitions
Automated Packaging Systems, LLC
On August 1, 2019 the Company acquired 100 % of the limited liability company interest in Automated Packaging Systems, LLC, formerly Automated Packaging Systems, Inc., a manufacturer of automated bagging systems. The acquisition is included in our Product Care reporting segment. Automated offers opportunities to expand the Company's automated solutions as well as expand into adjacent markets.
Consideration exchanged for Automated was $445.7 million in cash. The preliminary opening balance sheet includes $58.2 million of assumed liabilities in connection with a deferred incentive compensation plan for Automated's European employees. Of this amount $19.7 million was paid as of December 31, 2019. Sealed Air will make the remaining payments to deferred incentive compensation plan participants in approximately equal installments over the next two years .
The purchase price was primarily funded with proceeds from the incremental term facility provided for under an amendment to our Credit Agreement, as described in Note 14, "Debt and Credit Facilities," of the Notes to Consolidated Financial Statements. For the year ended December 31, 2019, transaction expenses recognized for the Automated acquisition was $3.3 million. These expenses are included within selling, general and administrative expenses in the Consolidated Statements of Operations.
The following table summarizes the consideration transferred to acquire Automated and the preliminary allocation of the purchase price among the assets acquired and liabilities assumed. The allocation of purchase price is still preliminary as the Company finalizes the final purchase price adjustment with the seller and finalizes other aspects of the valuation including deferred taxes and intangible valuations. Preliminary estimates will be finalized within one year of the date of acquisition.
| 89 |
Revised Preliminary Allocation | Measurement Period | Revised Preliminary Allocation | ||||||||||
(In millions) | As of August 1, 2019 | Adjustments | As of December 31, 2019 | |||||||||
Total consideration transferred | $ | $ | — | $ | ||||||||
Assets: | ||||||||||||
Cash and cash equivalents(1) | ( | ) | ||||||||||
Trade receivables, net | — | |||||||||||
Other receivables(1) | — | |||||||||||
Inventories, net | ( | ) | ||||||||||
Prepaid expenses and other current assets | — | |||||||||||
Property and equipment, net | ||||||||||||
Identifiable intangible assets, net | ( | ) | ||||||||||
Goodwill | ( | ) | ||||||||||
Operating lease right-of-use-assets | — | |||||||||||
Other non-current assets | ||||||||||||
Total assets | $ | $ | $ | |||||||||
Liabilities: | ||||||||||||
Accounts Payable | — | |||||||||||
Current portion of long-term debt | — | |||||||||||
Current portion of operating lease liabilities | — | |||||||||||
Other current liabilities(2) | ( | ) | ||||||||||
Long-term debt, less current portion | — | |||||||||||
Long-term operating lease liabilities, less current portion | — | |||||||||||
Deferred taxes | — | |||||||||||
Other non-current liabilities(2) | ||||||||||||
Total liabilities | $ | $ | $ | |||||||||
(1) | On August 1, 2019, $ |
(2) | On August 1, 2019, $ |
The following table summarizes the identifiable intangible assets, net and their useful lives.
Amount | Useful life | |||||
(in millions) | (in years) | |||||
Customer relationships | $ | |||||
Trademarks and tradenames | ||||||
Technology | ||||||
Backlog | ||||||
Total intangible assets with definite lives | $ | |||||
| 90 |
Goodwill is a result of the expected synergies and cross-selling opportunities this acquisition is expected to bring as well as the expected growth potential in Automated Packaging Systems' automated and sustainable solutions. Goodwill allocated to U.S. entities is deductible for tax purposes. Goodwill allocated to foreign entities is not deductible for tax purposes. The allocation between U.S. and non-U.S. entities is being finalized. The goodwill balance has been recorded to the Product Care reportable segment.
Other non-current assets includes the net overfunded position of a closed defined benefit pension plan in the United Kingdom. The plan does not have any material impact on the Company's overall defined benefit pension plans. Refer to Note 17, "Profit Sharing, Retirement Savings Plans and Defined Benefit Pension Plans," of the Notes to Consolidated Financial Statements for more detail on the Company's other defined benefit pension plans.
In conjunction with the acquisition and subsequent integration, the Company expects to incur restructuring charges. No restructuring accrual is included in our opening balance sheet as the liability did not exist at the time of acquisition. Refer to Note 12, "Restructuring Activities," of the Notes to Consolidated Financial Statements for more detail on the Company's Restructuring activity.
The inclusion of Automated in our consolidated financial statements is not deemed material with respect to the requirement to provide pro forma results of operations in ASC 805. As such, pro forma information is not presented.
Other 2019 Acquisition Activity
During the second quarter of 2019, Food Care had acquisition activity resulting in a total purchase price paid of $23.4 million. The Company allocated the consideration transferred to the fair value of assets acquired and liabilities assumed, resulting in an allocation to goodwill of $6.0 million. The final purchase price adjustments resulting in an increase to goodwill of $0.3 million were recorded in the third quarter of 2019. Identifiable intangible assets acquired were not material.
Acquisition of AFP
On August 1, 2018, the Company acquired AFP, Inc., a privately held fabricator of foam, corrugated, molded pulp and wood packaging solutions, to join its Product Care division. This acquisition expands our protective packaging offerings in the electronic, transportation and industrial markets with custom engineered applications. We acquired 100 % of AFP shares for an estimated consideration of $74.1 million, excluding $3.3 million of cash acquired.
The following table summarizes the consideration transferred to acquire AFP and the final allocation of the purchase price among the assets acquired and liabilities assumed.
Preliminary Allocation | Measurement Period | Final Allocation | ||||||||||
(In millions) | As of August 1, 2018 | Adjustments | As of September 30, 2019 | |||||||||
Total consideration transferred | $ | $ | $ | |||||||||
Assets: | ||||||||||||
Cash and cash equivalents | ||||||||||||
Trade receivables, net | — | |||||||||||
Inventories, net | — | |||||||||||
Prepaid expenses and other current assets | — | |||||||||||
Property and equipment, net | ( | ) | ||||||||||
Identifiable intangible assets, net | ||||||||||||
Goodwill | ||||||||||||
Other non-current assets | ( | ) | ||||||||||
Total assets | $ | $ | $ | |||||||||
Liabilities: | ||||||||||||
Current portion of long-term debt | ||||||||||||
Accounts payable | ( | ) | ||||||||||
Other current liabilities | ( | ) | ||||||||||
Long-term debt, less current portion | ||||||||||||
Total liabilities | $ | $ | ( | ) | $ | |||||||
| 91 |
The following table summarizes the identifiable intangible assets, net and their useful lives.
Amount | Useful life | |||||
(in millions) | (in years) | |||||
Customer relationships | $ | |||||
Trademarks and tradenames | ||||||
Total intangible assets with definite lives | $ | |||||
Acquisition of Fagerdala
On October 2, 2017, the Company acquired Fagerdala Singapore Pte Ltd., a manufacturer and fabricator of polyethylene foam based in Singapore, to join its Product Care division. We acquired 100 % of Fagerdala shares for estimated consideration of S$144.7 million, or $106.2 million, net of cash acquired of $13.3 million, inclusive of purchase price adjustments which were finalized in the third quarter of 2018. We acquired Fagerdala to leverage its manufacturing footprint in Asia, experience in foam manufacturing and fabrication and commercial organization to expand our presence across multiple industries utilizing fulfillment to distribute goods.
The following table summarizes the consideration transferred to acquire Fagerdala and the final allocation of the purchase price among the assets acquired and liabilities assumed.
Preliminary Allocation | Measurement Period | Final Allocation | ||||||||||
(In millions) | As of October 2, 2017 | Adjustments | As of December 31, 2018 | |||||||||
Total consideration transferred | $ | $ | ( | ) | $ | |||||||
Assets: | ||||||||||||
Cash and cash equivalents | — | |||||||||||
Trade receivables, net | — | |||||||||||
Inventories, net | ||||||||||||
Prepaid expenses and other current assets | — | |||||||||||
Property and equipment, net | — | |||||||||||
Identifiable intangible assets, net | ||||||||||||
Goodwill | ( | ) | ||||||||||
Total assets | $ | $ | ( | ) | $ | |||||||
Liabilities: | ||||||||||||
Short-term borrowings | — | |||||||||||
Accounts payable | — | |||||||||||
Other current liabilities | ( | ) | ||||||||||
Long-term debt, less current portion | — | |||||||||||
Non-current deferred taxes | ( | ) | ||||||||||
Total liabilities | $ | $ | ( | ) | $ | |||||||
The following table summarizes the identifiable intangible assets, net and their useful lives.
Amount | Useful life | |||||
(in millions) | (in years) | |||||
Customer relationships | $ | |||||
Trademarks and tradenames | ||||||
Technology | ||||||
Total intangible assets with definite lives | $ | |||||
Acquisition of Deltaplam
On August 1, 2017, the Company acquired Deltaplam Embalagens Indústria e Comércio Ltda ("Deltaplam"), a family owned and operated Brazilian flexible packaging manufacturer, to join its Food Care division. The preliminary fair value of consideration transferred was approximately $25.8 million. We recorded the fair value of the assets acquired and liabilities
| 92 |
assumed on the acquisition date, which included a preliminary allocation of $8.1 million of goodwill and $7.4 million of intangible assets. The final fair value of consideration transferred was $25.3 million, which included $9.7 million of goodwill and $5.9 million of intangible assets.
Note 6 Segments
The Company’s segment reporting structure consists of two reportable segments and a Corporate category as follows:
• | Food Care; and |
• | Product Care. |
The Company’s Food Care and Product Care segments are considered reportable segments under FASB ASC Topic 280. Our reportable segments are aligned with similar groups of products. Corporate includes certain costs that are not allocated to or monitored by the reportable segments' management. The Company evaluates performance of the reportable segments based on the results of each segment. The performance metric used by the Company's chief operating decision maker to evaluate performance of our reportable segments is Adjusted EBITDA. The Company allocates expense to each segment based on various factors including direct usage of resources, allocation of headcount, allocation of software licenses or, in cases where costs are not clearly delineated, costs may be allocated on portion of either net trade sales or an expense factor such as cost of goods sold.
We allocate and disclose depreciation and amortization expense to our segments, although depreciation and amortization are not included in the segment performance metric Adjusted EBITDA. We also allocate and disclose restructuring charges and impairment of goodwill and other intangible assets by segment. However, restructuring charges and goodwill are not included in the segment performance metric Adjusted EBITDA since they are categorized as certain specified items (“Special Items”), in addition to certain transaction and other charges and gains related to acquisitions and divestitures and certain other specific items excluded from the calculation of Adjusted EBITDA. The accounting policies of the reportable segments and Corporate are the same as those applied to the Consolidated Financial Statements.
The following tables show Net Sales and Adjusted EBITDA by reportable segment:
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Net Sales | ||||||||||||
Food Care | $ | $ | $ | |||||||||
As a % of Total Company net sales | % | % | % | |||||||||
Product Care | ||||||||||||
As a % of Total Company net sales | % | % | % | |||||||||
Total Company Net Sales | $ | $ | $ | |||||||||
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Adjusted EBITDA from continuing operations | ||||||||||||
Food Care | $ | $ | $ | |||||||||
Adjusted EBITDA Margin | % | % | % | |||||||||
Product Care | ||||||||||||
Adjusted EBITDA Margin | % | % | % | |||||||||
Corporate | ( | ) | ( | ) | ||||||||
Total Company Adjusted EBITDA from continuing operations | $ | $ | $ | |||||||||
Adjusted EBITDA Margin | % | % | % | |||||||||
| 93 |
The following table shows a reconciliation of net earnings before income tax provision to Total Company Adjusted EBITDA from continuing operations:
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Earnings before income tax provision | $ | $ | $ | |||||||||
Interest expense, net | ||||||||||||
Depreciation and amortization, net of adjustments(1) | ||||||||||||
Special Items: | ||||||||||||
Restructuring charges(2) | ||||||||||||
Other restructuring associated costs(3) | ||||||||||||
Foreign currency exchange loss due to highly inflationary economies | ||||||||||||
Loss on debt redemption and refinancing activities | ||||||||||||
Charges related to acquisition and divestiture activity | ||||||||||||
Charges related to the Novipax settlement agreement | ||||||||||||
Gain from class-action litigation settlement | ( | ) | ||||||||||
Curtailment related to retained Diversey retirement plans | ( | ) | ||||||||||
Other Special Items(4) | ||||||||||||
Pre-tax impact of Special Items | ||||||||||||
Total Company Adjusted EBITDA from continuing operations | $ | $ | $ | |||||||||
(1) | Depreciation and amortization by segment were as follows: |
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Food Care | $ | $ | $ | |||||||||
Product Care | ||||||||||||
Total Company depreciation and amortization(i) | ||||||||||||
Depreciation and amortization adjustments(ii) | ( | ) | ( | ) | ||||||||
Depreciation and amortization, net of adjustments | $ | $ | $ | |||||||||
(i) | Includes share-based incentive compensation of $ |
(ii) | Represents depreciation and amortization which is considered to be related to a Special Item and are also included in the Special Items presented in the above table. |
(2) | Restructuring and other charges by segment were as follows: |
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Food Care | $ | $ | $ | |||||||||
Product Care | ||||||||||||
Total Company restructuring charges | $ | $ | $ | |||||||||
(3) | Other restructuring associated costs for the year ended December 31, 2019, primarily relate to fees paid to third-party consultants in support of Reinvent SEE and costs related to property consolidations resulting from Reinvent SEE. |
(4) | Other Special Items for the years ended December 31, 2019 and 2018, primarily included fees related to professional services, mainly legal fees, directly associated with Special Items or events that are considered one-time or infrequent |
| 94 |
in nature. Other Special Items for the year ended December 31, 2017, primarily included transaction costs related to reorganizations.
Assets by Reportable Segments
The following table shows assets allocated by reportable segment. Assets allocated by reportable segment include: trade receivables, net; inventory, net; property and equipment, net; goodwill; intangible assets, net and leased systems, net.
December 31, | ||||||||
(In millions) | 2019 | 2018 | ||||||
Assets allocated to segments:(1) | ||||||||
Food Care | $ | $ | ||||||
Product Care | ||||||||
Total segments | $ | $ | ||||||
Assets not allocated: | ||||||||
Cash and cash equivalents | ||||||||
Assets held for sale | ||||||||
Income tax receivables | ||||||||
Other receivables | ||||||||
Deferred taxes | ||||||||
Other | ||||||||
Total | $ | $ | ||||||
(1) | The assets allocated to segments as of December 31, 2018 have been revised to correct an error in the previous allocation of property and equipment. Assets allocated to Food Care were understated by $ |
| 95 |
Geographic Information
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Net sales(1)(2): | ||||||||||||
North America(3) | $ | $ | $ | |||||||||
EMEA | ||||||||||||
South America | ||||||||||||
APAC | ||||||||||||
Total | $ | $ | $ | |||||||||
Total long-lived assets(1)(2)(4): | ||||||||||||
North America | $ | $ | ||||||||||
EMEA | ||||||||||||
South America | ||||||||||||
APAC | ||||||||||||
Total | $ | $ | ||||||||||
(1) | Amounts by geography have been reclassified from prior year disclosure to reflect adjustments to our regional operating model. As of January 1, 2019, our geographic regions are: North America, EMEA, South America and APAC. Our North American operations include Canada, the United States, Mexico and Central America. Mexico and Central America were previously included in Latin America. Refer to Note 2, "Summary of Significant Accounting Policies and Recently Issued Accounting Standards," of the Notes to Consolidated Financial Statements. |
(2) | No non-U.S. country accounted for net sales in excess of 10% of consolidated net sales for the years ended December 31, 2019, 2018 or 2017 or long-lived assets in excess of 10% of consolidated long-lived assets at December 31, 2019 and 2018. |
(3) | Net sales to external customers within the U.S. were $ |
(4) | Total long-lived assets represent total assets excluding total current assets, deferred tax assets, goodwill, intangible assets and non-current assets held for sale. |
Note 7 Inventories, net
The following table details our inventories, net:
December 31, | ||||||||
(In millions) | 2019 | 2018 | ||||||
Raw materials | $ | $ | ||||||
Work in process | ||||||||
Finished goods | ||||||||
Total | $ | $ | ||||||
| 96 |
Note 8 Property and Equipment, net
The following table details our property and equipment, net.
December 31, | ||||||||
(In millions) | 2019 | 2018(1) | ||||||
Land and improvements | $ | $ | ||||||
Buildings | ||||||||
Machinery and equipment | ||||||||
Other property and equipment | ||||||||
Construction-in-progress | ||||||||
Property and equipment, gross | ||||||||
Accumulated depreciation and amortization | ( | ) | ( | ) | ||||
Property and equipment, net | $ | $ | ||||||
(1) | Upon adoption of ASU 2016-02, $ |
The following table details our interest cost capitalized and depreciation and amortization expense for property and equipment.
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Interest cost capitalized | $ | $ | $ | |||||||||
Depreciation and amortization expense for property and equipment | $ | $ | $ | |||||||||
Note 9 Goodwill and Identifiable Intangible Assets, net
Goodwill
We review goodwill for impairment on a reporting unit basis annually during the fourth quarter of each year, using a measurement date of October 1st, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. For our 2019 annual review, the Company elected to bypass the optional qualitative assessment and performed a quantitative assessment by reporting unit as of October 1, 2019. Based on the results of the quantitative assessment, which indicated a fair value in excess of carrying amount for each of the Company's designated reporting units, we concluded there was no impairment of goodwill. There have been no significant events or circumstances affecting the valuation of goodwill subsequent to the quantitative assessment performed as of October 1, 2019.
| 97 |
Allocation of Goodwill to Reporting Segment
The following table shows our goodwill balances by reportable segment:
(In millions) | Food Care | Product Care | Total | |||||||||
Gross Carrying Value at December 31, 2017 | $ | $ | $ | |||||||||
Accumulated impairment | ( | ) | ( | ) | ( | ) | ||||||
Carrying Value at December 31, 2017 | $ | $ | $ | |||||||||
Acquisition, purchase price and other adjustments | ( | ) | ||||||||||
Currency translation | ( | ) | ( | ) | ( | ) | ||||||
Gross Carrying Value at December 31, 2018 | $ | $ | $ | |||||||||
Accumulated impairment | ( | ) | ( | ) | ( | ) | ||||||
Carrying Value at December 31, 2018 | $ | $ | $ | |||||||||
Acquisition, purchase price and other adjustments | ||||||||||||
Currency translation | ||||||||||||
Gross Carrying Value at December 31, 2019 | $ | $ | $ | |||||||||
Accumulated impairment | ( | ) | ( | ) | ( | ) | ||||||
Carrying Value at December 31, 2019 | $ | $ | $ | |||||||||
As noted above, it was determined under a quantitative assessment that there was no impairment of goodwill. However, if we become aware of indicators of impairment in future periods, we may be required to perform an interim assessment for some or all of our reporting units before the next annual assessment. Examples of such indicators may include a decrease in expected net earnings, adverse equity market conditions, a decline in current market multiples, a decline in our common stock price, a significant adverse change in legal factors or business climates, an adverse action or assessment by a regulator, unanticipated competition, strategic decisions made in response to economic or competitive conditions, or a more likely than not expectation that a reporting unit or a significant portion of a reporting unit will be sold or disposed of. In the event of significant adverse changes of the nature described above, we may have to recognize a non-cash impairment of goodwill, which could have a material adverse effect on our consolidated financial condition and results of operations.
Identifiable Intangible Assets, net
The following tables summarize our identifiable intangible assets, net with definite and indefinite useful lives:
December 31, 2019 | December 31, 2018 | |||||||||||||||||||||||
(In millions) | Gross Carrying Value | Accumulated Amortization | Net (1) | Gross Carrying Value | Accumulated Amortization | Net | ||||||||||||||||||
Customer relationships | $ | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||||||
Trademarks and tradenames | ( | ) | ( | ) | ||||||||||||||||||||
Software | ( | ) | ( | ) | ||||||||||||||||||||
Technology | ( | ) | ( | ) | ||||||||||||||||||||
Contracts | ( | ) | ( | ) | ||||||||||||||||||||
Total intangible assets with definite lives | ( | ) | ( | ) | ||||||||||||||||||||
Trademarks and tradenames with indefinite lives | — | — | ||||||||||||||||||||||
Total identifiable intangible assets, net | $ | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||||||
(1) | As of December 31, 2019, intangible assets increased due to the Automated acquisition. See Note 5, "Discontinued Operations, Divestitures and Acquisitions," to the Notes to Consolidated Financial Statements for additional information related to the Automated acquisition. |
| 98 |
The following table shows the estimated future amortization expense at December 31, 2019.
Year | Amount (in millions) | |||
2020 | $ | |||
2021 | ||||
2022 | ||||
2023 | ||||
2024 | ||||
Thereafter | ||||
Total | $ | |||
Amortization expense was $28.9 million in 2019, $15.7 million in 2018 and $13.1 million in 2017.
The following table shows the remaining weighted average useful life of our definite lived intangible assets as of December 31, 2019.
Remaining weighted average useful lives | |
Customer relationships | |
Trademarks and trade names | |
Technology | |
Contracts | |
Total identifiable intangible assets, net with definite lives | |
Note 10 Accounts Receivable Securitization Programs
U.S. Accounts Receivable Securitization Program
We and a group of our U.S. operating subsidiaries maintain an accounts receivable securitization program under which they sell eligible U.S. accounts receivable to an indirectly wholly-owned subsidiary that was formed for the sole purpose of entering into this program. The wholly-owned subsidiary in turn may sell an undivided fractional ownership interest in these receivables with two banks and issuers of commercial paper administered by these banks. The wholly-owned subsidiary retains the receivables it purchases from the operating subsidiaries. Any transfers of fractional ownership interests of receivables under the U.S. receivables securitization program to the two banks and issuers of commercial paper administered by these banks are considered secured borrowings with pledge of collateral and will be classified as short-term borrowings on our Consolidated Balance Sheets. These banks do not have any recourse against the general credit of the Company. The net trade receivables that served as collateral for these borrowings are reclassified from trade receivables, net to prepaid expenses and other current assets on the Consolidated Balance Sheets.
As of December 31, 2019, the maximum purchase limit for receivable interests was $50.0 million, subject to the availability limits described below.
The amounts available from time to time under this program may be less than $50.0 million due to a number of factors, including but not limited to our credit ratings, trade receivable balances, the creditworthiness of our customers and our receivables collection experience. As of December 31, 2019, the amount available to us under the program was $39.6 million. Although we do not believe restrictions under this program presently materially restrict our operations, if an additional event occurs that triggers one of these restrictive provisions, we could experience a further decline in the amounts available to us under the program or termination of the program.
The program expires annually in the fourth quarter and is renewable.
| 99 |
European Accounts Receivable Securitization Program
We and a group of our European subsidiaries maintain an accounts receivable securitization program with a special purpose vehicle, or SPV, two banks and issuers of commercial paper administered by these banks. The European program is structured to be a securitization of certain trade receivables that are originated by certain of our European subsidiaries. The SPV borrows funds from the banks to fund its acquisition of the receivables and provides the banks with a first priority perfected security interest in the accounts receivable. We do not have an equity interest in the SPV. We concluded the SPV is a variable interest entity because its total equity investment at risk is not sufficient to permit the SPV to finance its activities without additional subordinated financial support from the bank via loans or via the collections from accounts receivable already purchased. Additionally, we are considered the primary beneficiary of the SPV since we control the activities of the SPV, and are exposed to the risk of uncollectable receivables held by the SPV. Therefore, the SPV is consolidated in our Consolidated Financial Statements. Any activity between the participating subsidiaries and the SPV is eliminated in consolidation. Loans from the banks to the SPV will be classified as short-term borrowings on our Consolidated Balance Sheets. The net trade receivables that served as collateral for these borrowings are reclassified from trade receivables, net to prepaid expenses and other current assets on the Consolidated Balance Sheets.
As of December 31, 2019, the maximum purchase limit for receivable interests was €80.0 million, ($89.6 million equivalent) subject to availability limits. The terms and provisions of this program are similar to our U.S. program discussed above. As of December 31, 2019, the amount available under this program before utilization was €78.0 million ($87.4 million equivalent).
This program expires annually in August and is renewable.
Utilization of Our Accounts Receivable Securitization Programs
As of December 31, 2019, there were no amounts borrowed under our U.S. or European programs. As of December 31, 2018, there were no amounts borrowed under our U.S. program and €73.3 million, ($83.9 million equivalent) borrowed under our European program. We continue to service the trade receivables supporting the programs, and the banks are permitted to re-pledge this collateral. The total interest paid for these programs was $0.8 million, $0.6 million and $1.0 million for the years ended December 31, 2019, 2018 and 2017, respectively.
Under limited circumstances, the banks and the issuers of commercial paper can end purchases of receivables interests before the above expiration dates. A failure to comply with debt leverage or various other ratios related to our receivables collection experience could result in termination of the receivables programs. We were in compliance with these ratios at December 31, 2019.
Note 11 Accounts Receivable Factoring Agreements
The Company has entered into factoring agreements and customers' supply chain financing arrangements, to sell certain trade receivables to unrelated third-party financial institutions. These programs are entered into in the normal course of business. We account for these transactions in accordance with ASC 860, "Transfers and Servicing" ("ASC 860"). ASC 860 allows for the ownership transfer of accounts receivable to qualify for true-sale treatment when the appropriate criteria is met, which permits the Company to present the balances sold under the program to be excluded from Accounts receivable, net on the Consolidated Balance Sheets. Receivables are considered sold when (i) they are transferred beyond the reach of the Company and its creditors, (ii) the purchaser has the right to pledge or exchange the receivables, and (iii) the Company has no continuing involvement in the transferred receivables. In addition, the Company provides no other forms of continued financial support to the purchaser of the receivables once the receivables are sold.
Gross amounts factored under this program for the year ended December 31, 2019 and 2018 were $351.3 million and $249.8 million, respectively. The fees associated with transfer of receivables for all programs were approximately $3.5 million for the year ended December 31, 2019 and $2.0 million for the years ended December 31, 2018 and 2017.
| 100 |
Note 12 Restructuring Activities
For the year ended December 31, 2019, the Company incurred $41.9 million of restructuring charges and $60.3 million of other related costs for our restructuring program. These charges were primarily a result of restructuring and associated costs in connection with the Company’s Reinvent SEE strategy.
Our restructuring program (“Program”) is defined as the initiatives associated with our Reinvent SEE strategy in addition to the conclusion of our previously existing restructuring programs at the time of Reinvent SEE's approval. Reinvent SEE is a three-year program approved by the Board of Directors in December 2018. The expected spend in the previously existing program at the time of Reinvent SEE's approval was primarily related to elimination of stranded costs following the sale of Diversey. The Company expects restructuring activities to be completed by the end of 2021.
The Board of Directors has approved cumulative restructuring spend of $840 to $885 million for the Program. Restructuring spend is estimated to be incurred as follows:
(in millions) | Total Restructuring Program Range | Less Cumulative Spend to Date | Remaining Restructuring Spend(2) | |||||||||||||||||
Low | High | Low | High | |||||||||||||||||
Costs of reduction in headcount as a result of reorganization | $ | $ | $ | ( | ) | $ | $ | |||||||||||||
Other expenses associated with the Program | ( | ) | ||||||||||||||||||
Total expense | ( | ) | ||||||||||||||||||
Capital expenditures | ( | ) | ||||||||||||||||||
Total estimated cash cost(1) | $ | $ | $ | ( | ) | $ | $ | |||||||||||||
(1) | Total estimated cash cost excludes the impact of proceeds expected from the sale of property and equipment and foreign currency impact. |
(2) | Remaining restructuring spend primarily consists of restructuring costs associated with the Company’s Reinvent SEE strategy. |
Additionally, the Company anticipates approximately $6.0 million restructuring spend related to recent acquisitions, of which $2.3 million was incurred as of December 31, 2019. The Company expects the remainder of the anticipated spend to be incurred in 2020. See Note 5, "Discontinued Operations, Divestitures and Acquisitions," to the Notes to Consolidated Financial Statements for additional information related to our acquisitions.
The following table details our restructuring activities as reflected in the Consolidated Statements of Operations for the years ended December 31, 2019, 2018 and 2017:
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Continuing operations: | ||||||||||||
Other associated costs(1) | $ | $ | $ | |||||||||
Restructuring charges | ||||||||||||
Total charges from continuing operations | ||||||||||||
Charges included in discontinued operations | ||||||||||||
Total charges | $ | $ | $ | |||||||||
Capital expenditures | $ | $ | $ | |||||||||
(1) | Other associated costs excludes non-cash cost of $ |
| 101 |
The restructuring accrual, spending and other activity for the years ended December 31, 2019, 2018 and 2017 and the accrual balance remaining at those year-ends were as follows:
(In millions) | |||
Restructuring accrual at December 31, 2016 | $ | ||
Accrual and accrual adjustments | |||
Cash payments during 2017 | ( | ) | |
Transfers as part of the Diversey sale | ( | ) | |
Effects of changes in foreign currency exchange rates | ( | ) | |
Restructuring accrual at December 31, 2017 | $ | ||
Accrual and accrual adjustments | |||
Cash payments during 2018 | ( | ) | |
Effects of changes in foreign currency exchange rates | ( | ) | |
Restructuring accrual at December 31, 2018 | $ | ||
Accrual and accrual adjustments | |||
Cash payments during 2019 | ( | ) | |
Effect of changes in foreign currency exchange rates | ( | ) | |
Restructuring accrual at December 31, 2019 | $ | ||
We expect to pay $29.5 million of the accrual balance remaining at December 31, 2019 within the next twelve months. This amount is included in accrued restructuring costs on the Consolidated Balance Sheets at December 31, 2019. The remaining accrual of $2.0 million is included in other non-current liabilities on our Consolidated Balance Sheets at December 31, 2019. Of this amount, $1.6 million is expected to be paid in 2021.
One of the components of Reinvent SEE was to enhance the operational efficiency of the Company by acting as 'One SEE'. The program was approved by our Board of Directors as a consolidated program benefiting both Food Care and Product Care, as such expected program spend by reporting segment is not available. However, of the restructuring accrual of $31.5 million as of December 31, 2019, $18.8 million was attributable to Food Care and $12.7 million was attributable to Product Care.
Note 13 Other Current and Non-Current Liabilities
The following tables detail our other current liabilities and other non-current liabilities at December 31, 2019 and 2018:
December 31, | ||||||||
(In millions) | 2019 | 2018 | ||||||
Other current liabilities: | ||||||||
Accrued salaries, wages and related costs | $ | $ | ||||||
Accrued operating expenses | ||||||||
Accrued customer volume rebates | ||||||||
Accrued interest | ||||||||
Accrued employee benefit liability | ||||||||
Total | $ | $ | ||||||
| 102 |
December 31, | ||||||||
(In millions) | 2019 | 2018 | ||||||
Other non-current liabilities: | ||||||||
Accrued employee benefit liability | $ | $ | ||||||
Other postretirement liability | ||||||||
Uncertain tax position liability | ||||||||
Other various liabilities | ||||||||
Total | $ | $ | ||||||
Note 14 Debt and Credit Facilities
Our total debt outstanding consisted of the amounts set forth on the following table:
December 31, | ||||||||
(In millions) | 2019 | 2018 | ||||||
Short-term borrowings (1) | $ | $ | ||||||
Current portion of long-term debt(2) | ||||||||
Total current debt | ||||||||
Term Loan A due July 2022 | ||||||||
Term Loan A due July 2023 | ||||||||
6.50% Senior Notes due December 2020 | ||||||||
4.875% Senior Notes due December 2022 | ||||||||
5.25% Senior Notes due April 2023 | ||||||||
4.50% Senior Notes due September 2023 | ||||||||
5.125% Senior Notes due December 2024 | ||||||||
5.50% Senior Notes due September 2025 | ||||||||
4.00% Senior Notes due December 2027 | ||||||||
6.875% Senior Notes due July 2033 | ||||||||
Other(2) | ||||||||
Total long-term debt, less current portion(3) | ||||||||
Total debt(4) | $ | $ | ||||||
(1) | Short-term borrowings of $ |
(2) | The Current portion of long-term debt includes finance lease liabilities of $ |
(3) | Amounts are net of unamortized discounts and issuance costs of $ |
(4) | As of December 31, 2019, our weighted average interest rate on our short-term borrowings outstanding was |
| 103 |
Debt Maturities
The following table summarizes the scheduled annual maturities for the next five years and thereafter of our long-term debt, including the current portion of long-term debt and finance leases. This schedule represents the principal portion amount outstanding of our debt, and therefore excludes debt discounts, effect of present value discounting for capital lease obligations, interest rate swaps and lender and finance fees.
Year | Amount (in millions) | |||
2020 | $ | |||
2021 | ||||
2022 | ||||
2023 | ||||
2024 | ||||
Thereafter | ||||
Total | $ | |||
Senior Notes
2019 Activity
On November 26, 2019, Sealed Air issued $425 million aggregate principal amount of 4.00 % Senior Notes due December 1, 2027. The proceeds were used to repurchase and discharge the Company's $425 million 6.50 % Senior Notes due 2020. The aggregate repurchase price was $452.0 million, which included the principal amount of $425 million, a premium of $15.5 million and accrued interest of $11.5 million. We recognized a pre-tax loss of $16.1 million on the extinguishment, including the premium mentioned above and $1.2 million of accelerated amortization of non-lender fees partially offset by a $0.6 million gain on the settlement of interest rate swaps. We also capitalized $3.5 million of non-lender fees incurred in connection with the 4.00 % Senior Notes which are included in long-term debt, less current portion on our Consolidated Balance Sheets.
Amended and Restated Senior Secured Credit Facility
On August 1, 2019, Sealed Air Corporation, on behalf of itself and certain of its subsidiaries, and Sealed Air Corporation (US) entered into an amendment and incremental assumption agreement (the Amendment) further amending the Third Amended and Restated Credit Agreement, described below. The Amendment provides for a new incremental term facility in an aggregate principal amount of $475 million, to be used, in part, to finance the acquisition of Automated. In addition, we incurred $0.4 million of lender and third-party fees included in carrying amounts of outstanding debt. See Note 5, "Discontinued Operations, Divestitures and Acquisitions," of the Notes to Consolidated Financial Statements for additional information related to the Automated acquisition.
2018 Activity
On July 12, 2018, the Company and certain of its subsidiaries entered into a third amended and restated credit agreement and an amendment No. 1 thereto (the "Third Amended and Restated Agreement") whereby its senior secured credit facility was amended and restated with Bank of America, N.A., as agent and the other financial institutions party thereto. The changes include: (i) the refinancing of the term loan A facilities and revolving credit facilities with a new US Dollar term loan A facility in an aggregate principal amount of approximately $186.5 million, a new pounds sterling term loan A facility in an aggregate principal amount of approximately £29.4 million, and increased our revolving credit facilities from $700.0 million to $1.0 billion (including revolving facilities available in US Dollars, euros, pounds sterling, Canadian dollars, Australian dollars, Japanese yen, New Zealand dollars and Mexican pesos), (ii) increased flexibility to lower the interest rate margin for the term loan A facilities and revolving credit facilities, which will range from 125 to 200 basis points (bps) in the case of LIBOR loans, subject to the achievement of certain leverage tests, (iii) the extension of the final maturity of the term loan A facilities and revolving credit commitment to July 11, 2023, (iv) the removal of the requirement to prepay the loans with respect to excess cash flow, (v) adjustments to the financial maintenance covenant of Consolidated Net Debt to Consolidated EBITDA (in each case, as defined in the Third Amended and Restated Credit Agreement) and other covenants to provide additional flexibility to the Company, (vi) the release of certain non-U.S. asset collateral previously pledged by certain of the Company's subsidiaries and (vii) other amendments.
| 104 |
As a result of the Third Amended and Restated Credit Agreement, we recognized $1.9 million of loss on debt redemption in our Consolidated Statements of Operations in the year ended December 31, 2018. This amount includes $1.5 million of accelerated amortization of original issuance discount related to the term loan A and lender and non-lender fees related to the entire credit facility. Also included in the loss on debt redemption was $0.4 million of non-lender fees incurred in connection with the Third Amended and Restated Credit Agreement. In addition, we incurred $0.7 million of lender and third-party fees that are included in the carrying amounts of the outstanding debt under the credit facility. We also capitalized $4.9 million of fees that are included in other assets on our Consolidated Balance Sheets. The amortization expense related to original issuance discount and lender and non-lender fees is calculated using the effective interest rate method over the lives of the respective debt instruments.
Total amortization expense related to the senior secured credit facility was $1.8 million and $3.2 million for the years ended December 31, 2019 and 2018, respectively, and is included in interest expense in our Consolidated Statements of Operations.
2017 Activity
On July 1, 2017, we executed an amendment to the senior secured credit facility in order to permit the sale of Diversey. The amendment primarily allowed us to take steps necessary for the legal separation of the Diversey business and release the loan security effective with the sale closing. Subsequent to the execution of the amendment, we prepaid the Brazilian tranche of our Term Loan A facility due in July 2019 in the amount of $96.3 million in connection with the anticipated Diversey transaction. An additional $755.2 million of this facility was prepaid in conjunction with the Diversey closing.
Lines of Credit
The following table summarizes our available lines of credit and committed and uncommitted lines of credit, including the revolving credit facility discussed above, and the amounts available under our accounts receivable securitization programs.
December 31, | ||||||||
(In millions) | 2019 | 2018 | ||||||
Used lines of credit (1) | $ | $ | ||||||
Unused lines of credit | ||||||||
Total available lines of credit(2) | $ | $ | ||||||
(1) | Includes total borrowings under the accounts receivable securitization programs, the revolving credit facility and borrowings under lines of credit available to several subsidiaries. |
(2) |
Covenants
Each issue of our outstanding senior notes imposes limitations on our operations and those of specified subsidiaries. The Third Amended and Restated Credit Agreement contains customary affirmative and negative covenants for credit facilities of this type, including limitations on our indebtedness, liens, investments, restricted payments, mergers and acquisitions, dispositions of assets, transactions with affiliates, amendment of documents and sale leasebacks, and a covenant specifying a maximum permitted ratio of Consolidated Net Debt to Consolidated EBITDA (as defined in the Third Amended and Restated Credit Agreement). We were in compliance with the above financial covenants and limitations at December 31, 2019 and 2018.
Note 15 Derivatives and Hedging Activities
We report all derivative instruments on our Consolidated Balance Sheets at fair value and establish criteria for designation and effectiveness of transactions entered into for hedging purposes.
As a large global organization, we face exposure to market risks, such as fluctuations in foreign currency exchange rates and interest rates. To manage the volatility relating to these exposures, we enter into various derivative instruments from time to time under our risk management policies. We designate derivative instruments as hedges on a transaction basis to support hedge accounting. The changes in fair value of these hedging instruments offset in part or in whole corresponding changes in
| 105 |
the fair value or cash flows of the underlying exposures being hedged. We assess the initial and ongoing effectiveness of our hedging relationships in accordance with our policy. We do not purchase, hold or sell derivative financial instruments for trading purposes. Our practice is to terminate derivative transactions if the underlying asset or liability matures or is sold or terminated, or if we determine the underlying forecasted transaction is no longer probable of occurring.
We record the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized.
Foreign Currency Forward Contracts Designated as Cash Flow Hedges
The primary purpose of our cash flow hedging activities is to manage the potential changes in value associated with the amounts receivable or payable on equipment and raw material purchases that are denominated in foreign currencies in order to minimize the impact of the changes in foreign currencies. We record gains and losses on foreign currency forward contracts qualifying as cash flow hedges in AOCL to the extent that these hedges are effective and until we recognize the underlying transactions in net earnings, at which time we recognize these gains and losses in cost of sales on our Consolidated Statements of Operations. Cash flows from derivative financial instruments are classified as cash flows from operating activities on the Consolidated Statements of Cash Flows. These contracts generally have original maturities of less than 12 months.
Net unrealized after-tax gains/losses related to cash flow hedging activities included in AOCL were a $2.8 million loss, a $2.9 million gain and a $5.0 million loss for the years ended December 31, 2019, 2018 and 2017, respectively. The unrealized amounts in AOCL will fluctuate based on changes in the fair value of open contracts during each reporting period.
We estimate that $1.4 million of net unrealized losses related to cash flow hedging activities included in AOCL will be reclassified into earnings within the next 12 months.
Foreign Currency Forward Contracts Not Designated as Hedges
Our subsidiaries have foreign currency exchange exposure from buying and selling in currencies other than their functional currencies. The primary purposes of our foreign currency hedging activities are to manage the potential changes in value associated with the amounts receivable or payable on transactions denominated in foreign currencies and to minimize the impact of the changes in foreign currencies related to foreign currency-denominated interest-bearing intercompany loans and receivables and payables. The changes in fair value of these derivative contracts are recognized in other income, net, on our Consolidated Statements of Operations and are largely offset by the remeasurement of the underlying foreign currency-denominated items indicated above. Cash flows from derivative financial instruments are classified as cash flows from investing activities in the Consolidated Statements of Cash Flows. These contracts generally have original maturities of less than 12 months.
Interest Rate Swaps
From time to time, we may use interest rate swaps to manage our fixed and floating interest rates on our outstanding indebtedness. At December 31, 2019 and 2018, we had no outstanding interest rate swaps.
Net Investment Hedge
The €400.0 million 4.50 % notes issued in June 2015 are designated as a net investment hedge, hedging a portion of our net investment in a certain European subsidiary against fluctuations in foreign exchange rates. The decrease in the translated value of the debt was $2.0 million ($1.5 million net of tax) as of December 31, 2019, and is reflected in AOCL on our Consolidated Balance Sheets.
In March 2015, we entered into a series of cross-currency swaps with a combined notional amount of $425.0 million, hedging a portion of the net investment in a certain European subsidiary against fluctuations in foreign exchange rates. As a result of the sale of Diversey, we terminated these cross-currency swaps in September 2017 and settled these swaps in October 2017. The fair value of the swaps on the date of termination was a liability of $61.9 million which was partially offset by semi-annual interest settlements of $17.7 million. This resulted in a net impact of $(44.2 ) million which is recorded in AOCL.
For derivative instruments that are designated and qualify as hedges of net investments in foreign operations, changes in fair values of the derivative instruments are recognized in unrealized net gains or loss on derivative instruments for net investment hedge, a component of AOCL, net of taxes, to offset the changes in the values of the net investments being hedged.
| 106 |
Any portion of the net investment hedge that is determined to be ineffective is recorded in other (expense) income, net on the Consolidated Statements of Operations.
Other Derivative Instruments
We may use other derivative instruments from time to time to manage exposure to foreign exchange rates and to access international financing transactions. These instruments can potentially limit foreign exchange exposure by swapping borrowings denominated in one currency for borrowings denominated in another currency.
Fair Value of Derivative Instruments
See Note 16, “Fair Value Measurements and Other Financial Instruments,” of the Notes to Consolidated Financial Statements for a discussion of the inputs and valuation techniques used to determine the fair value of our outstanding derivative instruments.
The following table details the fair value of our derivative instruments included on our Consolidated Balance Sheets.
Cash Flow Hedge | Non-Designated as Hedging Instruments | Total | ||||||||||||||||||||||
December 31, | December 31, | December 31, | ||||||||||||||||||||||
(In millions) | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | ||||||||||||||||||
Derivative Assets | ||||||||||||||||||||||||
Foreign currency forward contracts | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total Derivative Assets | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Derivative Liabilities | ||||||||||||||||||||||||
Foreign currency forward contracts | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||
Total Derivative Liabilities(1) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||
Net Derivatives (2) | $ | ( | ) | $ | $ | $ | ( | ) | $ | ( | ) | $ | ||||||||||||
(1) | Excludes € |
(2) | The following table reconciles gross positions without the impact of master netting agreements to the balance sheet classification: |
Other Current Assets | Other Current Liabilities | |||||||||||||||
December 31, | December 31, | |||||||||||||||
(In millions) | 2019 | 2018 | 2019 | 2018 | ||||||||||||
Gross position | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||
Impact of master netting agreements | ( | ) | ( | ) | ||||||||||||
Net amounts recognized on the Consolidated Balance Sheets | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||
The following table details the effect of our derivative instruments on our Consolidated Statements of Operations.
| 107 |
Location of Gain (Loss) Recognized on | Amount of Gain (Loss) Recognized in Earnings on Derivatives | |||||||||||||
Consolidated Statements of Operations | Year Ended December 31, | |||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||||
Derivatives designated as hedging instruments: | ||||||||||||||
Cash Flow Hedges: | ||||||||||||||
Foreign currency forward contracts | Cost of sales | $ | $ | $ | ( | ) | ||||||||
Treasury locks | Interest expense, net | |||||||||||||
Sub-total cash flow hedges | ( | ) | ||||||||||||
Fair Value Hedges: | ||||||||||||||
Interest rate swaps | Interest expense, net | |||||||||||||
Derivatives not designated as hedging instruments: | ||||||||||||||
Foreign currency forward contracts | Other (expense) income, net | ( | ) | ( | ) | ( | ) | |||||||
Total | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||||
Note 16 Fair Value Measurements and Other Financial Instruments
Fair Value Measurements
Fair value represents the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels to the fair value hierarchy as follows:
Level 1 - observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets
Level 2 - inputs other than quoted prices included in Level 1 that are observable for the asset or liability either directly or indirectly
Level 3 - unobservable inputs for which there is little or no market data, which may require the reporting entity to develop its own assumptions.
The fair value, measured on a recurring basis, of our financial instruments, using the fair value hierarchy under U.S. GAAP are included in the table below.
December 31, 2019 | ||||||||||||||||
(In millions) | Total Fair Value | Level 1 | Level 2 | Level 3 | ||||||||||||
Cash equivalents | $ | $ | $ | $ | ||||||||||||
Other current assets(1) | ||||||||||||||||
Derivative financial and hedging instruments net asset (liability): | ||||||||||||||||
Foreign currency forward and option contracts | $ | ( | ) | $ | $ | ( | ) | $ | ||||||||
December 31, 2018 | ||||||||||||||||
(In millions) | Total Fair Value | Level 1 | Level 2 | Level 3 | ||||||||||||
Cash equivalents | $ | $ | $ | $ | ||||||||||||
Derivative financial and hedging instruments net asset (liability): | ||||||||||||||||
Foreign currency forward contracts | $ | $ | $ | $ | ||||||||||||
(1) | Other current assets in the fair value table above as of December 31, 2019 primarily represents time deposits greater than 90 days to maturity at time of purchase at our insurance captive. |
| 108 |
Cash Equivalents
Our cash equivalents consist of bank time deposits. Since these are short-term highly liquid investments with remaining maturities of 3 months or less, they present negligible risk of changes in fair value due to changes in interest rates and are Level 1.
Derivative Financial Instruments
Our foreign currency forward contracts, foreign currency options, interest rate swaps and cross-currency swaps are recorded at fair value on our Consolidated Balance Sheets using a discounted cash flow analysis that incorporates observable market inputs. These market inputs include foreign currency spot and forward rates, and various interest rate curves, and are obtained from pricing data quoted by various banks, third-party sources and foreign currency dealers involving identical or comparable instruments and are Level 2.
Counterparties to these foreign currency forward contracts have at least an investment grade rating. Credit ratings on some of our counterparties may change during the term of our financial instruments. We closely monitor our counterparties’ credit ratings and, if necessary, will make any appropriate changes to our financial instruments. The fair value generally reflects the estimated amounts that we would receive or pay to terminate the contracts at the reporting date.
Foreign currency forward contracts and options are included in Prepaid expenses and other current assets and Other current liabilities on the Consolidated Balance Sheets as of December 31, 2019 and 2018.
Other Financial Instruments
The following financial instruments are recorded at fair value or at amounts that approximate fair value: (1) trade receivables, net, (2) certain other current assets, (3) accounts payable and (4) other current liabilities. The carrying amounts reported on our Consolidated Balance Sheets for the above financial instruments closely approximate their fair value due to the short-term nature of these assets and liabilities.
Other liabilities that are recorded at carrying value on our Consolidated Balance Sheets include our credit facilities and senior notes. We utilize a market approach to calculate the fair value of our senior notes. Due to their limited investor base and the face value of some of our senior notes, they may not be actively traded on the date we calculate their fair value. Therefore, we may utilize prices and other relevant information generated by market transactions involving similar securities, reflecting U.S. Treasury yields to calculate the yield to maturity and the price on some of our senior notes. These inputs are provided by an independent third party and are considered to be Level 2 inputs.
We derive our fair value estimates of our various other debt instruments by evaluating the nature and terms of each instrument, considering prevailing economic and market conditions, and examining the cost of similar debt offered at the balance sheet date. We also incorporated our credit default swap rates and currency specific swap rates in the valuation of each debt instrument, as applicable.
These estimates are subjective and involve uncertainties and matters of significant judgment, and therefore we cannot determine them with precision. Changes in assumptions could significantly affect our estimates.
The table below shows the carrying amounts and estimated fair values of our debt, excluding lease liabilities:
| 109 |
December 31, 2019 | December 31, 2018 | |||||||||||||||
(In millions) | Carrying Amount | Fair Value | Carrying Amount | Fair Value | ||||||||||||
Term Loan A Facility due July 2022 | $ | $ | $ | $ | ||||||||||||
Term Loan A Facility due July 2023(1) | ||||||||||||||||
6.50% Senior Notes due December 2020 | ||||||||||||||||
4.875% Senior Notes due December 2022 | ||||||||||||||||
5.25% Senior Notes due April 2023 | ||||||||||||||||
4.50% Senior Notes due September 2023(1) | ||||||||||||||||
5.125% Senior Notes due December 2024 | ||||||||||||||||
5.50% Senior Notes due September 2025 | ||||||||||||||||
4.00% Senior Notes due December 2027 | ||||||||||||||||
6.875% Senior Notes due July 2033 | ||||||||||||||||
Other foreign borrowings(1) | ||||||||||||||||
Other domestic borrowings | ||||||||||||||||
Total debt(2) | $ | $ | $ | $ | ||||||||||||
(1) | Includes borrowings denominated in currencies other than US Dollars. |
(2) | At December 31, 2019, the carrying amount and estimated fair value of debt exclude lease liabilities. |
In addition to the table above, the Company remeasures amounts related to certain equity compensation that are carried at fair value on a recurring basis in the Consolidated Financial Statements or for which a fair value measurement was required. Refer to Note 21, “Stockholders’ Deficit,” of the Notes to Consolidated Financial Statements for share-based compensation in the Notes to Consolidated Financial Statements. Included among our non-financial assets and liabilities that are not required to be measured at fair value on a recurring basis are inventories, net property and equipment, goodwill, intangible assets and asset retirement obligations.
Credit and Market Risk
Financial instruments, including derivatives, expose us to counterparty credit risk for nonperformance and to market risk related to changes in interest or currency exchange rates. We manage our exposure to counterparty credit risk through specific minimum credit standards, establishing credit limits, diversification of counterparties, and procedures to monitor concentrations of credit risk.
We do not expect any of our counterparties in derivative transactions to fail to perform as it is our policy to have counterparties to these contracts that have at least an investment grade rating. Nevertheless, there is a risk that our exposure to losses arising out of derivative contracts could be material if the counterparties to these agreements fail to perform their obligations. We will replace counterparties if a credit downgrade is deemed to increase our risk to unacceptable levels.
We regularly monitor the impact of market risk on the fair value and cash flows of our derivative and other financial instruments considering reasonably possible changes in interest and currency exchange rates and restrict the use of derivative financial instruments to hedging activities. We do not use derivative financial instruments for trading or other speculative purposes and do not use leveraged derivative financial instruments.
We continually monitor the creditworthiness of our diverse base of customers to which we grant credit terms in the normal course of business and generally do not require collateral. We consider the concentrations of credit risk associated with our trade accounts receivable to be commercially reasonable and believe that such concentrations do not leave us vulnerable to significant risks of near-term severe adverse impacts. The terms and conditions of our credit sales are designed to mitigate concentrations of credit risk with any single customer. Our sales are not materially dependent on a single customer or a small group of customers.
| 110 |
Note 17 Profit Sharing, Retirement Savings Plans and Defined Benefit Pension Plans
Profit Sharing and Retirement Savings Plans
We have a qualified non-contributory profit sharing plan covering most of our U.S. employees. Contributions to this plan, which are made at the discretion of our Board of Directors, may be made in cash, shares of our common stock, or in a combination of cash and shares of our common stock. We also maintain a qualified contributory retirement savings plan in which most of our U.S. employees are eligible to participate. The qualified contributory retirement savings plans generally provide for our contributions in cash based upon the amount contributed to the plans by the participants.
Our contributions to our profit sharing plan accrual and retirement savings plans are charged to operations and amounted to $39.3 million in 2019, $36.3 million in 2018 and $39.9 million in 2017. In 2019, 487,108 shares were contributed as part of our contribution to the profit sharing plan related to 2018; in 2018, 538,524 shares were contributed as part of our contribution to the profit sharing plan related to 2017, and in 2017, 502,519 shares were contributed as part of our contribution to the profit sharing plan related to 2016. These shares were issued out of treasury stock.
We have various international defined contribution benefit plans which cover certain employees. We have expanded use of these plans in select countries where they have been used to supplement or replace defined benefit plans.
Defined Benefit Pension Plans
We recognize the funded status of each defined pension benefit plan as the difference between the fair value of plan assets and the projected benefit obligation of the employee benefit plans in the Consolidated Balance Sheets, with a corresponding adjustment to accumulated other comprehensive loss, net of taxes. Each overfunded plan is recognized as an asset and each underfunded plan is recognized as a liability on our Consolidated Balance Sheets. Subsequent changes in the funded status are reflected on the Consolidated Balance Sheets in unrecognized pension items, a component of AOCL, which are included in total stockholders’ deficit. The amount of unamortized pension items is recorded net of tax.
We have amortized actuarial gains or losses over the average future working lifetime (or remaining lifetime of inactive participants if there are no active participants). We have used the corridor method, where the corridor is the greater of ten percent of the projected benefit obligation or fair value of assets at year end. If actuarial gains or losses do not exceed the corridor, then there is no amortization of gain or loss.
During the year ended December 31, 2017, several of our pension plans transferred in the sale of Diversey. Two international plans were split between Diversey and Sealed Air at the close of the sale. Unless noted, the tables in this disclosure show only activity related to plans retained by Sealed Air.
The following table shows the components of our net periodic benefit cost for the three years ended December 31, for our pension plans charged to operations:
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Net periodic benefit (income) cost: | ||||||||||||
U.S. and international net periodic benefit cost included in cost of sales(1) | $ | $ | $ | |||||||||
U.S. and international net periodic benefit cost included in selling, general and administrative expenses | ||||||||||||
U.S. and international net periodic benefit (income) included in other (income) expense | ( | ) | ( | ) | ( | ) | ||||||
Total benefit (income) cost | $ | ( | ) | $ | ( | ) | $ | |||||
(1) | The amount recorded in inventory for the years ended December 31, 2019, 2018 and 2017 was not material. |
A number of our U.S. employees, including some employees who are covered by collective bargaining agreements, participate in defined benefit pension plans. Some of our international employees participate in defined benefit pension plans in their respective countries. The following table presents our funded status for 2019 and 2018 for our U.S. and
| 111 |
international pension plans. The measurement date used to determine benefit obligations and plan assets is December 31 for all material plans.
December 31, 2019 | December 31, 2018 | |||||||||||||||||||||||
(In millions) | U.S. | International | Total | U.S. | International | Total | ||||||||||||||||||
Change in benefit obligation: | ||||||||||||||||||||||||
Projected benefit obligation at beginning of period | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Service cost | ||||||||||||||||||||||||
Interest cost | ||||||||||||||||||||||||
Actuarial loss (gain) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
Settlement | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||
Benefits paid | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||
Employee contributions | ||||||||||||||||||||||||
Business acquisition | ||||||||||||||||||||||||
Other | ( | ) | ( | ) | ||||||||||||||||||||
Foreign exchange impact | ( | ) | ( | ) | ||||||||||||||||||||
Projected benefit obligation at end of period | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Change in plan assets: | ||||||||||||||||||||||||
Fair value of plan assets at beginning of period | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Actual return on plan assets | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
Employer contributions | ||||||||||||||||||||||||
Employee contributions | ||||||||||||||||||||||||
Benefits paid | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||
Settlement | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||
Business acquisition | ||||||||||||||||||||||||
Other | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
Foreign exchange impact | ( | ) | ( | ) | ||||||||||||||||||||
Fair value of plan assets at end of period | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Underfunded status at end of year | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||
Accumulated benefit obligation at end of year | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Amounts included in the Consolidated Balance Sheets, including plans which were deemed immaterial and not included above, consisted of:
December 31, 2019 | December 31, 2018 | |||||||||||||||||||||||
(In millions) | U.S. | International | Total | U.S. | International | Total | ||||||||||||||||||
Other non-current assets | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Other current liabilities | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||
Other non-current liabilities | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||
Net amount recognized | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||
The following table shows the components of our net periodic benefit cost (income) for the years ended December 31, for our pension plans charged to operations:
| 112 |
December 31, 2019 | December 31, 2018 | December 31, 2017 | ||||||||||||||||||||||||||||||||||
(In millions) | U.S. | International | Total | U.S. | International | Total | U.S. | International | Total | |||||||||||||||||||||||||||
Components of net periodic benefit (income) cost: | ||||||||||||||||||||||||||||||||||||
Service cost | $ | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Interest cost | ||||||||||||||||||||||||||||||||||||
Expected return on plan assets | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
Other adjustments | ||||||||||||||||||||||||||||||||||||
Amortization of net prior service cost | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||
Amortization of net actuarial loss | ||||||||||||||||||||||||||||||||||||
Net periodic benefit (income) cost | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||
Cost of settlement | ||||||||||||||||||||||||||||||||||||
Total benefit (income) cost | $ | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | $ | $ | $ | |||||||||||||||||||
As part of our acquisition of Automated, the Company acquired a frozen defined benefit pension plan in the United Kingdom. As of the date of acquisition, the plan was in a net asset position and recorded to other non-current assets on our Consolidated Balance Sheets. The plan does not have a material impact on the Company's overall defined benefit pension plans, including the weighted average of the key assumptions.
The amounts in AOCL that have not yet been recognized as components of net periodic benefit cost at December 31, 2019 and 2018 are:
December 31, 2019 | December 31, 2018 | |||||||||||||||||||||||
(In millions) | U.S. | International | Total | U.S. | International | Total | ||||||||||||||||||
Unrecognized net prior service costs | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Unrecognized net actuarial loss | ||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Changes in plan assets and benefit obligations recognized in AOCL at December 31, 2019 and 2018 were as follows:
December 31, 2019 | December 31, 2018 | |||||||||||||||||||||||
(In millions) | U.S. | International | Total | U.S. | International | Total | ||||||||||||||||||
Current year actuarial loss | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Prior year service cost occurring during the year(1) | ||||||||||||||||||||||||
Amortization of actuarial loss | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||
Amortization of prior service cost | ( | ) | ( | ) | ||||||||||||||||||||
Other adjustments | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
Settlement | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
(1) | On October 26, 2018, the UK High Court ruled that formulas used to determine guaranteed minimum pension (GMP) benefits violated gender-pay equality laws due to differences in the way benefits were calculated for men and women. This will result in the Company amending plan benefit formulas for our UK defined benefit plans to account for the higher pension payments. While the specifics of the calculation are not yet known, the Company has recorded our current best estimate of the GMP equalization as a prior service cost deferred in AOCL. The court ruling did not have a material impact on our Consolidated Statement of Operations for the year ended December 31, 2019. |
| 113 |
The amounts in AOCL that are expected to be recognized as components of net periodic benefit cost during the year ending December 31, 2020 are as follows:
Year Ended 2020 | ||||||||||||
(In millions) | U.S. | International | Total | |||||||||
Unrecognized prior service costs | $ | $ | $ | |||||||||
Unrecognized net actuarial loss | ||||||||||||
Total | $ | $ | $ | |||||||||
Information for plans with accumulated benefit obligations in excess of plan assets as of December 31, 2019 and 2018 are as follows:
December 31, 2019 | December 31, 2018 | |||||||||||||||||||||||
(In millions) | U.S. | International | Total | U.S. | International | Total | ||||||||||||||||||
Accumulated benefit obligation | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Fair value of plan assets | ||||||||||||||||||||||||
Actuarial Assumptions
Weighted average assumptions used to determine benefit obligations at December 31, 2019 and 2018 were as follows:
December 31, 2019 | December 31, 2018 | |||||||||||
(In millions) | U.S. | International | U.S. | International | ||||||||
Benefit obligations | ||||||||||||
Discount rate | % | % | % | % | ||||||||
Rate of compensation increase | N/A | % | N/A | % | ||||||||
Weighted average assumptions used to determine net periodic benefit cost for the years ended December 31, were as follows:
December 31, 2019 | December 31, 2018 | December 31, 2017 | ||||||||||||||||
(In millions) | U.S. | International | U.S. | International | U.S. | International | ||||||||||||
Net periodic benefit cost | ||||||||||||||||||
Discount rate | % | % | % | % | % | % | ||||||||||||
Expected long-term rate of return | % | % | % | % | % | % | ||||||||||||
Rate of compensation increase | N/A | % | N/A | % | N/A | % | ||||||||||||
| 114 |
Estimated Future Benefit Payments
We expect the following estimated future benefit payments, which reflect expected future service as appropriate, to be paid in the years indicated:
Amount (in millions) | ||||||||||||
Year | U.S. | International | Total | |||||||||
2020 | $ | $ | $ | |||||||||
2021 | ||||||||||||
2022 | ||||||||||||
2023 | ||||||||||||
2024 | ||||||||||||
2025 to 2029 (combined) | ||||||||||||
Total | $ | $ | $ | |||||||||
Plan Assets
We review the expected long-term rate of return on plan assets annually, taking into consideration our asset allocation, historical returns, and the current economic environment. The expected return on plan assets is calculated based on the fair value of plan assets at year end. To determine the expected return on plan assets, expected cash flows have been taken into account.
Our long-term objectives for plan investments are to ensure that (a) there is an adequate level of assets to support benefit obligations to participants over the life of the plans, (b) there is sufficient liquidity in plan assets to cover current benefit obligations, and (c) there is a high level of investment return consistent with a prudent level of investment risk. The investment strategy is focused on a long-term total return in excess of a pure fixed income strategy with short-term volatility less than that of a pure equity strategy. To accomplish these objectives, in many instances the plan assets are invested on a glide-path which reduce the exposure to return-seeking assets as the plan's funded status increases. Overall, we invest assets primarily in a diversified mix of equity and fixed income investments. For our U.S. plan, the target asset allocation includes 65 %-75 % in return seeking assets, which are primarily comprised of global equities. The remainder of the assets in the U.S. plan are comprised of liability hedging assets which are primarily fixed income investments.
In some of our international pension plans, we have purchased bulk annuity contracts (buy-ins). These annuity contracts provide cash flows that match the future benefit payments for a specific group of pensioners. These contacts are issued by third party insurance companies with no affiliation to Sealed Air. Insurance companies from which we purchase the annuity contracts are assessed as credit worthy. As of December 31, 2019, buy-ins represented $119.5 million of total plan assets.
We currently expect our contributions to the pension plans to be approximately $20.0 million in 2020. Additionally, we expect benefits paid directly by the Company related to our defined benefit pension plans to be $3.6 million in 2020.
The fair values of our U.S. and international pension plan assets, by asset category and by the level of fair values are as follows:
December 31, 2019 | December 31, 2018 | |||||||||||||||||||||||||||||||||||||||
Total | Total | |||||||||||||||||||||||||||||||||||||||
(In millions) | Fair Value | Level 1 | Level 2 | Level 3 | NAV(5) | Fair Value | Level 1 | Level 2 | Level 3 | NAV(5) | ||||||||||||||||||||||||||||||
Cash and cash equivalents(1) | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Fixed income funds(2) | ||||||||||||||||||||||||||||||||||||||||
Equity funds(3) | ||||||||||||||||||||||||||||||||||||||||
Other(4) | ||||||||||||||||||||||||||||||||||||||||
Total(6) | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
| 115 |
(1) | Short-term investment fund that invests in a collective trust that holds short-term highly liquid investments with principal preservation and daily liquidity as its primary objectives. Investments are primarily comprised of certificates of deposit, government securities, commercial paper, and time deposits. |
(2) | Fixed income funds that invest in a diversified portfolio primarily consisting of publicly traded government bonds and corporate bonds. There are no restrictions on these investments, and they are valued at the net asset value of shares held at year end. |
(3) | Equity funds that invest in a diversified portfolio of publicly traded domestic and international common stock, with an emphasis in European equities. There are no restrictions on these investments, and they are valued at the net asset value of units held at year end. |
(4) | The majority of these assets are guaranteed insurance contracts, which consist of Company and employee contributions and accumulated interest income at guaranteed stated interest rates and provides for benefit payments and plan expenses. Also includes real estate and other alternative investments. |
(5) | These assets are measured at Net Asset Value (NAV) as a practical expedient under ASC 820. |
(6) | Balances as of December 31, 2018 have been revised from our 2018 Form 10-K filing to reflect changes in leveling classification of specific funds. These reclassifications did not impact the fair value of any of our pension plan assets. |
The following table shows the activity of our U.S. and international plan assets, which are measured at fair value using Level 3 inputs.
December 31, | ||||||||
(In millions) | 2019 | 2018 | ||||||
Balance at beginning of period(1) | $ | $ | ||||||
Gains (losses) on assets still held at end of year | ( | ) | ||||||
Purchases, sales, issuance, and settlements(2) | ||||||||
Transfers in and/or out of Level 3 | ||||||||
Foreign exchange gain (loss) | ( | ) | ||||||
Balance at end of period(1) | $ | $ | ||||||
(1) | Balances as of December 31, 2018 have been revised from our 2018 Form 10-K filing to reflect changes in leveling classification of specific funds. These reclassifications did not impact the fair value of any of our pension plan assets. |
(2) |
Note 18 Other Post-Employment Benefits and Other Employee Benefit Plans
In addition to providing pension benefits, we maintain two Other Post-Employment Benefit Plans which provide a portion of healthcare, dental, vision and life insurance benefits for certain retired legacy employees. These plans are in the U.S. and Canada. Covered employees who retired on or after attaining age 55 and who had rendered at least 10 years of service were entitled to post-retirement healthcare, dental and life insurance benefits. These benefits are subject to deductibles, co-payment provisions and other limitations. The information below relates to these two plans.
Contributions made by us, net of Medicare Part D subsidies received in the U.S., are reported below as benefits paid. We may change the benefits at any time. The status of these plans, including a reconciliation of benefit obligations, a reconciliation of plan assets and the funded status of the plans, follows:
| 116 |
December 31, | ||||||||
(In millions) | 2019 | 2018 | ||||||
Change in benefit obligations: | ||||||||
Benefit obligation at beginning of period | $ | $ | ||||||
Service cost | ||||||||
Interest cost | ||||||||
Actuarial (gain) loss | ( | ) | ( | ) | ||||
Benefits paid, net | ( | ) | ( | ) | ||||
Plan amendments | ( | ) | ||||||
Benefit obligation at end of period | $ | $ | ||||||
Change in plan assets: | ||||||||
Fair value of plan assets at beginning of period | $ | $ | ||||||
Employer contribution | ||||||||
Benefits paid, net | ( | ) | ( | ) | ||||
Fair value of plan assets at end of period | $ | $ | ||||||
Net amount recognized: | ||||||||
Underfunded status | $ | ( | ) | $ | ( | ) | ||
Accumulated benefit obligation at end of year | $ | $ | ||||||
Net amount recognized in consolidated balance sheets consists of: | ||||||||
Current liability | $ | ( | ) | $ | ( | ) | ||
Non-current liability | ( | ) | ( | ) | ||||
Net amount recognized | $ | ( | ) | $ | ( | ) | ||
Amounts recognized in accumulated other comprehensive loss consist of: | ||||||||
Net actuarial (gain) loss | $ | ( | ) | $ | ||||
Prior service credit | ( | ) | ( | ) | ||||
Total | $ | ( | ) | $ | ( | ) | ||
The accumulated post-retirement benefit obligations were determined using a weighted-average discount rate of 3.1 % at December 31, 2019 and 4.1 % at December 31, 2018. The components of net periodic benefit cost were as follows:
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Components of net periodic benefit cost: | ||||||||||||
Service cost | $ | $ | $ | |||||||||
Interest cost | ||||||||||||
Amortization of net gain | ( | ) | ( | ) | ( | ) | ||||||
Amortization of prior service credit | ( | ) | ( | ) | ( | ) | ||||||
Net periodic benefit cost | $ | $ | $ | |||||||||
Income of settlement/curtailment | ( | ) | ||||||||||
Total benefit (income) cost for fiscal year | $ | $ | $ | ( | ) | |||||||
Changes in benefit obligations that were recognized in AOCL at December 31, 2019 and December 31, 2018 were as follows:
| 117 |
December 31, 2019 | December 31, 2018 | |||||||||||||||||||||||
(In millions) | U.S. | International | Total | U.S. | International | Total | ||||||||||||||||||
Current year actuarial gain | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | ||||||||
Prior year service credit occurring during the year | ( | ) | ( | ) | ||||||||||||||||||||
Amortization of actuarial gain | ||||||||||||||||||||||||
Amortization of prior service credit | ||||||||||||||||||||||||
Total | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | ||||||||||
The amounts in AOCL at December 31, 2019 that are expected to be recognized as components of net periodic benefit cost during the next fiscal year are as follows:
(In millions) | December 31, 2019 | |||
Unrecognized net prior service credits | $ | ( | ) | |
Unrecognized net actuarial gain | ( | ) | ||
Total | $ | ( | ) | |
Healthcare Cost Trend Rates
For the year ended December 31, 2019, healthcare cost trend rates were assumed to be 6.2 % for the U.S. plan in 2019 and decreasing to 5.0 % by 2025, and 5.0 % for the Canada plan in 2019, and unchanged in future years. The assumed healthcare cost trend rate has an effect on the amounts reported for the healthcare plans. A one percentage point change on assumed healthcare cost trend rates would have the following effect for the year ended December 31, 2019:
(In millions) | 1% Increase | 1% Decrease | ||||||
Effect on total of service and interest cost components | $ | $ | ||||||
Effect on post-retirement benefit obligation | ( | ) | ||||||
The amortization of any prior service cost is determined using a straight-line amortization of the cost over the average remaining service period of employees expected to receive benefits under the plan.
Expected post-retirement benefits (net of Medicare Part D subsidies) for each of the next five years and succeeding five years are as follows:
Year | Amount (in millions) | |||
2020 | $ | |||
2021 | ||||
2022 | ||||
2023 | ||||
2024 | ||||
2025 to 2029 (combined) | ||||
Total | $ | |||
| 118 |
Note 19 Income Taxes
In 2019, 2018 and 2017, we recorded tax provisions of $76.6 million, $307.5 million and $330.5 million, respectively. Cash tax payments, net of refunds were $94.7 million, $155.0 million and $161.7 million for 2019, 2018 and 2017, respectively.
Tax Cuts and Jobs Act
On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (“TCJA”). The legislation significantly changed U.S. tax law by, among other things, lowering the corporate income tax rate, implementing a territorial tax system and imposing a repatriation tax on deemed repatriated earnings of foreign subsidiaries. (“Transition Tax”). The TCJA permanently reduced the U.S. corporate income tax rate from a maximum of 35% to 21%, effective January 1, 2018.
While the TCJA provides for a territorial tax system, beginning in 2018, it includes the global intangible low-taxed income (“GILTI”) provision. The Company has elected to account for GILTI tax in the period in which it is incurred. The GILTI provisions require the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets.
Provisional Tax Impacts
On December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Reform Act. SAB 118 provided that where reasonable estimates can be made, the provisional accounting should be based on such estimates and when no reasonable estimate can be made, the provisional accounting may be based on the tax law in effect before the TCJA.
We applied the guidance in SAB 118 when accounting for the enactment-date effects of TCJA. Accordingly, we remeasured U.S. deferred tax assets and liabilities in 2017 based on the income tax rates at which the deferred tax assets and liabilities were expected to reverse in the future and recorded a provisional amount of $41.1 million of tax expense for the year ended December 31, 2017. Upon further analysis and refinement of our calculations, during the year ended December 31, 2018, we recorded an incremental expense of $1.6 million related to the remeasurement of the U.S. deferred tax assets.
At December 31, 2017, we were not able to reasonably estimate the impact of Transition Tax and therefore our estimate of Transition Tax expense was recorded in the first quarter of 2018. Accordingly, we recognized a provisional tax expense of $290 million related to the tax on the deemed repatriated earnings in our consolidated financial statements for the quarter ended March 31, 2018. The one-time Transition Tax is based on our total post-1986 earnings and profits ("E&P"), which had been deferred from U.S. taxes under prior law. A final adjustment was made to the provisional amounts allowed under SAB 118 in the fourth quarter of 2018 based on additional guidance from the IRS and state taxing authorities, and the filing of the 2017 tax returns. After the adjustment, total Transition Tax recorded in 2018 was $222 million. The impact of the Transition Tax comprised 48.5 % of the 2018 effective tax rate. As of December 31, 2018, we completed our accounting for the tax effects of enactment of the TCJA.
In the fourth quarter of 2019, as part of our Reinvent SEE strategy and in order to align our structure with our evolving global operations, we transferred certain intangible assets between wholly-owned subsidiaries. The transfer resulted in the establishment of a deferred tax asset and the corresponding recognition of deferred tax benefit of $49 million.
The components of earnings before income tax provision were as follows:
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Domestic | $ | $ | $ | |||||||||
Foreign | ||||||||||||
Total | $ | $ | $ | |||||||||
| 119 |
The components of our income tax provision (benefit) were as follows:
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Current tax expense: | ||||||||||||
Federal | $ | $ | $ | |||||||||
State and local | ||||||||||||
Foreign | ||||||||||||
Total current expense | $ | $ | $ | |||||||||
Deferred tax (benefit) expense: | ||||||||||||
Federal | $ | ( | ) | $ | $ | |||||||
State and local | ( | ) | ||||||||||
Foreign | ( | ) | ( | ) | ( | ) | ||||||
Total deferred tax (benefit) expense | ( | ) | ||||||||||
Total income tax provision | $ | $ | $ | |||||||||
Deferred tax assets (liabilities) consist of the following:
December 31, | ||||||||
(In millions) | 2019 | 2018 | ||||||
Accruals not yet deductible for tax purposes | $ | $ | ||||||
Net operating loss carryforwards | ||||||||
Foreign, federal and state credits | ||||||||
Employee benefit items | ||||||||
Capitalized expenses | ||||||||
Intangibles | ||||||||
Derivatives and other | ||||||||
Sub-total deferred tax assets | ||||||||
Valuation allowance | ( | ) | ( | ) | ||||
Total deferred tax assets | $ | $ | ||||||
Depreciation and amortization | $ | ( | ) | $ | ( | ) | ||
Unremitted foreign earnings | ( | ) | ||||||
Intangible assets | ( | ) | ||||||
Other | ( | ) | ( | ) | ||||
Total deferred tax liabilities | ( | ) | ( | ) | ||||
Net deferred tax assets | $ | $ | ||||||
A valuation allowance has been provided based on the uncertainty of utilizing the tax benefits, mainly related to the following deferred tax assets:
• | $ |
• | $ |
For the year ended December 31, 2019, the valuation allowance decreased by $20.8 million. This is primarily driven by our Reinvent SEE initiatives and decreases in foreign tax rates.
As of December 31, 2019, we have foreign net operating loss carryforwards of $899.4 million expiring in years beginning in 2020 with the majority of losses having an unlimited carryover. The state net operating loss carryforwards totaling $569.3 million expire in various amounts over 1 to 19 years.
| 120 |
As of December 31, 2019, we have $0.6 million of foreign and federal tax credit carryforwards and we have $9.8 million of state credit carryovers expiring in 2020 – 2028. Most of the state credit carryovers have a valuation allowance.
Although a deferred tax liability of $10.0 million was recorded in 2019 for planned repatriation of foreign earnings, the Company has indefinitely reinvested the large majority of its foreign earnings, which are the principal component of U.S and foreign outside basis differences. The total amount of unremitted foreign earnings is $4.7 billion upon which the U.S. federal income tax effect has largely been recorded as a result of Transition Tax. Remitting these foreign earnings would result in additional foreign and U.S. income tax consequences, the net tax costs of which are not practicable to determine.
A reconciliation of the provision for income taxes, with the amount computed by applying the statutory federal income tax rate (21% in 2019-2018 and 35% in 2017) to income before provision for income taxes, is as follows (dollars in millions):
Year Ended December 31, | |||||||||||||||||||||
2019 | 2018 | 2017 | |||||||||||||||||||
Computed expected tax | $ | % | $ | % | $ | % | |||||||||||||||
State income taxes, net of federal tax benefit | % | % | % | ||||||||||||||||||
Foreign earnings taxed at different rates | % | % | ( | ) | ( | )% | |||||||||||||||
U.S. tax on foreign earnings | % | % | % | ||||||||||||||||||
Tax credits | ( | ) | ( | )% | ( | ) | ( | )% | ( | ) | ( | )% | |||||||||
Unremitted foreign earnings | % | % | % | ||||||||||||||||||
Reorganization and divestitures | ( | ) | ( | )% | % | % | |||||||||||||||
Withholding tax | % | % | % | ||||||||||||||||||
Net change in valuation allowance | ( | ) | ( | )% | ( | ) | ( | )% | ( | ) | ( | )% | |||||||||
Net change in unrecognized tax benefits | % | % | % | ||||||||||||||||||
Tax Cuts and Jobs Act | % | % | % | ||||||||||||||||||
Deferred tax adjustments | % | % | % | ||||||||||||||||||
Other | % | % | ( | ) | ( | )% | |||||||||||||||
Income tax expense and rate | $ | % | $ | % | $ | % | |||||||||||||||
The primary adjustments to the statutory rate in 2019 were the following items:
• | increase for unrecognized tax benefits; |
• | increase for minimum tax on certain non-U.S. earnings; |
• | increase for tax on unremitted foreign earnings; |
• | decrease related to Reinvent SEE and other restructuring initiatives; |
• | decrease as a result of larger U.S. tax credits including benefits associated with prior year research & development credits; and |
• | decrease for release of valuation allowance attributable to Reinvent SEE initiatives. |
Unrecognized Tax Benefits
We are providing the following disclosures related to our unrecognized tax benefits and the effect on our effective income tax rate if recognized:
| 121 |
Year Ended December 31, | ||||||||||||
(in millions) | 2019 | 2018 | 2017 | |||||||||
Beginning balance of unrecognized tax benefits | $ | $ | $ | |||||||||
Additions for tax positions of current year | ||||||||||||
Additions for tax positions of prior years | ||||||||||||
Reductions for tax positions of prior years | ( | ) | ( | ) | ( | ) | ||||||
Reductions for lapses of statutes of limitation and settlements | ( | ) | ( | ) | ( | ) | ||||||
Ending balance of unrecognized tax benefits | $ | $ | $ | |||||||||
In 2019, our unrecognized tax benefit increased by $33.9 million, primarily related to increases in North America. In 2018, we increased our unrecognized tax benefit by $142.1 million, also primarily related to North America.
If the unrecognized tax benefits at December 31, 2019 were recognized, our income tax provision would decrease by $343.5 million, resulting in a substantially lower effective tax rate. Based on the potential outcome of the Company’s global tax examinations and the expiration of the statute of limitations for specific jurisdictions, it is possible that the unrecognized tax benefits could change significantly within the next 12 months. Absent resolution of significant tax controversy, the associated impact on the reserve balance is estimated to be a decrease in the range of $4.6 to $6.6 million during 2020.
We recognize interest and penalties associated with unrecognized tax benefits in our income tax provision in the Consolidated Statements of Operations. Interest and penalties recorded were $13.1 million, negligible and $4.0 million, respectively in 2019, 2018 and 2017. We had gross liabilities, for interest and penalties, of $56.2 million at December 31, 2019, $18.2 million at December 31, 2018 and $14.8 million at December 31, 2017. The increase in the gross liability related to interest and penalties from 2018 to 2019 was primarily due to a reclass within other non-current liabilities from unrecognized tax benefits to interest and penalties which had no impact on the overall Consolidated Balance Sheets or Consolidated Statement of Operations.
The majority of the unrecognized tax benefit amount of $390.3 million relates to North America.
Income Tax Returns
The Internal Revenue Service (the “IRS”) has concluded its examination of Sealed Air U.S. federal income tax returns for all years through 2008, except 2007 which remains open to the extent of a capital loss carryback. The IRS is currently auditing the years 2011-2014 and has proposed to disallow, as deductible expense, the entirety of the $1.49 billion payment made pursuant to the Settlement agreement (as defined in Note 20, Commitments and Contingencies). We believe that we have meritorious defenses to the proposed disallowance and are protesting it with the IRS. An unfavorable resolution of this matter could have a material adverse effect on our consolidated financial condition and results of operations, including cash flows.
State income tax returns are generally subject to examination for a period of 3 to 5 years after their filing date. We have various state income tax returns in the process of examination and are generally open to examination for periods after 2012.
Our foreign income tax returns are under examination in various jurisdictions in which we conduct business. Income tax returns in foreign jurisdictions have statutes of limitations generally ranging from 3 to 5 years after their filing date. We have various foreign returns in the process of examination but have largely concluded all other income tax matters for the years prior to 2010.
Management believes that an adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any of the issues addressed in the Company’s tax audits are resolved in a manner that is inconsistent with management’s expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs and could be required to make significant payments as a result.
| 122 |
Note 20 Commitments and Contingencies
Diversey Sale Clawback Agreement and Receivables
As part of our 2017 sale of Diversey to Diamond (BC) B.V. (the “Buyer”), Sealed Air and the Buyer entered into that certain Letter Agreement (the “Clawback Agreement”), under which Sealed Air could be required to return a portion of the proceeds we received in the sale, if, and to the extent, Diversey failed to achieve a specified minimum gross margin arising from sales of certain products during the one year period following a successful renewal of certain commercial contracts. In the third quarter of 2019, the Buyer submitted a claim to us under the Clawback Agreement seeking such a refund in the amount of $49.2 million. In the fourth quarter, we delivered a dispute notice to the Buyer in respect to its claim. We are in discussions with the Buyer, in accordance with the provisions of the Clawback Agreement, in a good faith attempt to resolve this dispute.
Additionally, Sealed Air has a net receivable balance of $11.6 million included within Other Receivables on our Consolidated Balance Sheets as of December 31, 2019, representing amounts owed to Sealed Air from Diversey and/or the Buyer relating to the sale of Diversey or transition services we provided to Diversey after the closing under that certain Transition Service Agreement ("TSA"). This receivable balance includes: income tax receivables related to taxable periods prior to the sale of Diversey; cash held by Diversey in certain non-U.S. jurisdictions as of the sale closing date, which amounts the Buyer must cooperate to deliver to Sealed Air when and as permitted, subject to certain limitations; and receivables due from Diversey for services performed under the TSA.
Novipax Complaint
On March 31, 2017, a complaint was filed in the Superior Court of the State of Delaware against Sealed Air Corporation, Cryovac Inc., Sealed Air Corporation (US) and Sealed Air (Canada) Co./Cie. (individually and collectively the “Company”) styled Novipax Holdings LLC ("Novipax") v. Sealed Air Corporation, Cryovac Inc., Sealed Air Corporation (US) and Sealed Air (Canada) Co. / Cie. (the “Complaint”). To cover the estimated costs of settlement, including a one-time cash payment as well as accrual of expenses relating to a proposed supply agreement under which the Company would continue to purchase materials from Novipax for a specified period for use in the manufacturing of the Company’s products, the Company recorded a charge of $59.0 million during the second quarter of 2019, which is included in Selling, general and administrative expenses in the Company’s Consolidated Statements of Operations for the year ended December 31, 2019. On July 10, 2019 the settlement agreement was finalized and executed, and the parties agreed to the release and dismissal of the litigation claims.
Settlement Agreement Tax Deduction
On March 31, 1998, we completed a multi-step transaction (the “Cryovac transaction”) involving W.R. Grace & Co. (“Grace”) which brought the Cryovac packaging business and the former Sealed Air’s business under the common ownership of the Company. As part of that transaction, Grace and its subsidiaries retained all liabilities arising out of their operations before the Cryovac transaction (including asbestos-related liabilities), other than liabilities relating to Cryovac’s operations, and agreed to indemnify the Company with respect to such retained liabilities. Beginning in 2000, we were served with a number of lawsuits alleging that the Cryovac transaction was a fraudulent transfer or gave rise to successor liability or both, and as a result we were responsible for alleged asbestos liabilities of Grace and its subsidiaries. On April 2, 2001, Grace and a number of its subsidiaries filed petitions for reorganization under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”). In connection with Grace’s Chapter 11 case, the Bankruptcy Court issued orders staying all asbestos actions against the Company (the “Preliminary Injunction”) but granted the official committees appointed to represent asbestos claimants in Grace’s Chapter 11 case (the “Committees”) permission to pursue fraudulent transfer, successor liability, and other claims against the Company and its subsidiary Cryovac, Inc. based upon the Cryovac transaction. In November 2002, we reached an agreement in principle with the Committees to resolve all current and future asbestos-related claims made against us and our affiliates, as well as indemnification claims by Fresenius Medical Care Holdings, Inc. and affiliated companies, in each case, in connection with the Cryovac transaction (as memorialized by the parties and approved by the Bankruptcy Court, the “Settlement agreement”). A definitive Settlement agreement was entered into as of November 10, 2003 consistent with the terms of the agreement in principle. On June 27, 2005, the Bankruptcy Court approved the Settlement agreement and the Settlement agreement was subsequently incorporated into the plan of reorganization for Grace filed in September 2008 (as filed and amended from time to time, the "Plan"). Subsequently, the Bankruptcy Court (in January and February 2011) and the United States District Court for the District of Delaware (in January and June 2012) entered orders confirming the Plan in its entirety.
On February 3, 2014 (the “Effective Date”), the Plan implementing the Settlement agreement became effective with W. R. Grace & Co., or Grace, emerging from bankruptcy and the injunctions and releases provided by the Plan becoming effective. On the Effective Date, the Company’s subsidiary, Cryovac, Inc. (which was converted to Cryovac, LLC on December 31,
| 123 |
2018), made the payments contemplated by the Settlement agreement, consisting of aggregate cash payments in the amount of $929.7 million to the WRG Asbestos PI Trust (the “PI Trust”) and the WRG Asbestos PD Trust (the “PD Trust”) and the transfer of 18 million shares of Sealed Air common stock (the “Settlement Shares”) to the PI Trust, in each case, reflecting adjustments made in accordance with the Settlement agreement. On June 13, 2014, we repurchased for $130 million from the PI Trust 3,932,244 Settlement Shares (a price of $33.06 per share).
We are currently under examination by the IRS with respect to the deduction of the approximately $1.49 billion for the 2014 taxable year for the payments made pursuant to the Settlement agreement and the reduction of our U.S. federal tax liability by approximately $525 million. The IRS has proposed to disallow, as deductible expense, the entirety of the $1.49 billion settlement payments. Although we believe that we have meritorious defenses to the proposed disallowance and are protesting it with the IRS, this matter could take several years to resolve and there can be no assurance that it will be resolved in the Company's favor. An unfavorable resolution of this matter could have a material adverse effect on our consolidated financial condition and results of operations, including cash flows.
Environmental Matters
We are subject to loss contingencies resulting from environmental laws and regulations, and we accrue for anticipated costs associated with investigatory and remediation efforts when an assessment has indicated that a loss is probable and can be reasonably estimated. These accruals are not reduced by potential insurance recoveries, if any. We do not believe that it is reasonably possible that our liability in excess of the amounts that we have accrued for environmental matters will be material to our Consolidated Balance Sheets or Statements of Operations. Environmental liabilities are reassessed whenever circumstances become better defined or remediation efforts and their costs can be better estimated.
We evaluate these liabilities periodically based on available information, including the progress of remedial investigations at each site, the current status of discussions with regulatory authorities regarding the methods and extent of remediation and the apportionment of costs among potentially responsible parties. As some of these issues are decided (the outcomes of which are subject to uncertainties) or new sites are assessed and costs can be reasonably estimated, we adjust the recorded accruals, as necessary. We believe that these exposures are not material to our Consolidated Balance Sheets or Statements of Operations. We believe that we have adequately reserved for all probable and estimable environmental exposures.
Guarantees and Indemnification Obligations
We are a party to many contracts containing guarantees and indemnification obligations. These contracts primarily consist of:
• | indemnities in connection with the sale of businesses, primarily related to the sale of Diversey. Our indemnity obligations under the relevant agreements may be limited in terms of time, amount or scope. As it relates to certain income tax related liabilities, the relevant agreements may not provide any cap for such liabilities, and the period in which we would be liable would lapse upon expiration of the statute of limitation for assessment of the underlying taxes. Because of the conditional nature of these obligations and the unique facts and circumstances involved in each particular agreement, we are unable to reasonably estimate the potential maximum exposure associated with these items; |
• | product warranties with respect to certain products sold to customers in the ordinary course of business. These warranties typically provide that products will conform to specifications. We generally do not establish a liability for product warranty based on a percentage of sales or other formula. We accrue a warranty liability on a transaction-specific basis depending on the individual facts and circumstances related to each sale. Both the liability and annual expense related to product warranties are immaterial to our consolidated financial position and results of operations; and |
• | licenses of intellectual property by us to third parties in which we have agreed to indemnify the licensee against third-party infringement claims. |
As of December 31, 2019, the Company has no reason to believe a loss exceeding amounts already recognized would be incurred.
Other Matters
We are also involved in various other legal actions incidental to our business. We believe, after consulting with counsel, that the disposition of these other legal proceedings and matters will not have a material effect on our consolidated financial condition or results of operations including potential impact to cash flows.
| 124 |
Other Principal Contractual Obligations
At December 31, 2019, we had other principal contractual obligations, which included agreements to purchase an estimated amount of goods, including raw materials, or services in the normal course of business, aggregating to approximately $86.2 million. The estimated future cash outlays are as follows:
Year | Amount (in millions) | ||
2020 | $ | ||
2021 | |||
2022 | |||
2023 | |||
2024 | |||
Total | $ | ||
Asset Retirement Obligations
The Company has recorded asset retirement obligations primarily associated with asbestos abatement, lease restitution and the removal of underground tanks. The Company's asset retirement obligation liabilities were $10.7 million and $10.5 million at December 31, 2019 and 2018, respectively. The Company also recorded assets within property and equipment, net which included $3.6 million and $3.6 million related to buildings and $6.4 million and $6.9 million related to leasehold improvements as of December 31, 2019 and 2018, respectively. For the years ended December 31, 2019, 2018 and 2017 accretion expense was $0.3 million.
Note 21 Stockholders’ Deficit
Repurchase of Common Stock
On May 2, 2018, the Board of Directors increased the total authorization to repurchase the Company's issued and outstanding stock to $1.0 billion. This current program has no expiration date and replaced the previous authorizations. Share purchases made prior to May 2, 2018 were under previous Board of Directors share repurchase authorizations, specifically the $1.5 billion authorization made in July 2015 plus the increase to that existing share repurchase program by up to an additional $1.5 billion made in March 2017.
During the year ended December 31, 2019, we repurchased 1,560,633 shares for a total of approximately $67.2 million with an average share price of $43.09 . These repurchases were made under open market transactions, including through plans complying with Rule 10b5-1 under the of the Securities Exchange Act of 1934, or the Exchange Act, as amended, and pursuant to the share repurchase program authorized by our Board of Directors.
During the year ended December 31, 2018, we repurchased 14,898,454 shares, for approximately $651.4 million with an average share price of $43.72 . These repurchases were made under privately negotiated, accelerated share repurchase programs or open market transactions pursuant to the share repurchase program previously approved by our Board of Directors.
During the year ended December 31, 2018, share purchases under open market transactions were 13,678,818 shares, for approximately $571.4 million with an average share price of $41.77 .
In November 2017, the Company entered into an accelerated share repurchase agreement with a third-party financial institution to repurchase $400.0 million of the Company’s common stock. At the conclusion of the program in February 2018, the Company received a total of 8,308,692 shares with an average price of $48.14 .
Dividends
The following table shows our total cash dividends paid in the years ended December 31:
| 125 |
(In millions, except per share amounts) | Total Cash Dividends Paid | Total Cash Dividends Paid Per Common Share | ||||||
2017 | $ | $ | ||||||
2018 | ||||||||
2019 | ||||||||
Total | $ | |||||||
On February 13, 2020, our Board of Directors declared a quarterly cash dividend of $0.16 per common share payable on March 20, 2020 to stockholders of record at the close of business on March 6, 2020. The estimated amount of this dividend payment is $24.8 million based on 154.7 million shares of our common stock issued and outstanding as of February 21, 2020.
The dividend payments discussed above are recorded as reductions to cash and cash equivalents and retained earnings on our Consolidated Balance Sheets. Our credit facility and our senior notes contain covenants that restrict our ability to declare or pay dividends and repurchase stock. However, we do not believe these covenants are likely to materially limit the future payment of quarterly cash dividends on our common stock. From time to time, we may consider other means of returning value to our stockholders based on our consolidated financial condition and results of operations. There is no guarantee that our Board of Directors will declare any further dividends.
Common Stock
The following is a summary of changes during the years ended December 31, in shares of our common stock and common stock in treasury:
2019 | 2018 | 2017 | |||||||
Changes in common stock: | |||||||||
Number of shares, beginning of year | |||||||||
Restricted stock shares issued for new awards(1) | |||||||||
Restricted stock shares, forfeited(1) | ( | ) | ( | ) | ( | ) | |||
Shares issued for vested restricted stock units | |||||||||
Shares issued as part of acquisition(2) | |||||||||
Shares issued for 2014 Special Performance Stock Units (PSU) Awards | |||||||||
Shares issued for 2015 Three-Year PSU Awards | |||||||||
Shares issued for 2014 Three-Year PSU Awards | |||||||||
Shares issued for Stock Leverage Opportunity Awards (SLO) | |||||||||
Shares granted and issued under the Omnibus Incentive Plan and Directors Stock Plan to Directors | |||||||||
Canceled shares for tax netting(3) | ( | ) | |||||||
Other activity(4) | ( | ) | |||||||
Number of shares issued, end of year(1) | |||||||||
Changes in common stock in treasury: | |||||||||
Number of shares held, beginning of year | |||||||||
Repurchase of common stock(5) | |||||||||
Profit sharing contribution paid in stock | ( | ) | ( | ) | ( | ) | |||
Shares withheld for taxes(3) | |||||||||
Number of shares held, end of year(5) | |||||||||
Number of common stock outstanding, end of year | |||||||||
(1) | Restricted stock shares issued for new awards under the Omnibus Incentive Plan and restricted stock shares, forfeited as shown above for the year ended December 31, 2019 includes |
| 126 |
restricted stock shares forfeited related to 2018 that were not yet reflected by our Recordkeeper as of December 31, 2018. The table above and our Consolidated Balance Sheets reflect the number of shares issued per our Recordkeeper.
(2) | In connection with the acquisition of B+ Equipment in the third quarter of 2015, the Company issued |
(3) | Effective January 1, 2019, new share issuances for vested awards are netted by the number of shares required to cover the recipients' portion of income tax. The portion withheld for taxes are canceled. Prior to January 1, 2019, the shares required to cover the recipients' portion of income tax were issued and recorded to treasury stock. Shares netted for taxes in 2019 primarily relates to vesting activity for restricted stock shares issued in prior years. |
(4) | Other activity in 2018 primarily relates to prior period adjustment related to years not contained within the table. |
(5) | Repurchase of common stock for the year ended December 31, 2019 as shown above includes |
Share-Based Compensation
In 2014, the Board of Directors adopted, and our stockholders approved, the 2014 Omnibus Incentive Plan (“Omnibus Incentive Plan”). Under the Omnibus Incentive Plan, the maximum number of shares of Common Stock authorized was 4,250,000 , plus total shares available to be issued as of May 22, 2014 under the 2002 Directors Stock Plan and the 2005 Contingent Stock Plan (collectively, the “Predecessor Plans”). The Omnibus Incentive Plan replaced the Predecessor Plans and no further awards were granted under the Predecessor Plans. The Omnibus Incentive Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, unrestricted stock, performance share units known as PSU awards, other stock awards and cash awards to officers, non-employee directors, key employees, consultants and advisors.
In 2018, the Board of Directors adopted, and stockholders approved an amendment and restatement to the Omnibus Incentive Plan. The amended plan adds 2,199,114 shares of common stock to the share pool previously available under the Omnibus Incentive Plan.
Prior to the Omnibus Incentive Plan, the 2005 Contingent Stock Plan represented our sole long-term equity compensation program for officers and employees. The 2005 Contingent Stock Plan provided for awards of equity-based compensation, including restricted stock, restricted stock units, PSU awards and cash awards measured by share price, to our executive officers and other key employees, as well as U.S.-based key consultants. Prior to the Omnibus Incentive Plan, the 2002 Directors Stock Plan provided for annual grants of shares to non-employee directors, and interim grants of shares to eligible directors elected at times other than at an annual meeting, as all or part of the annual or interim retainer fees for non-employee directors. During 2002, we adopted a plan that permitted non-employee directors to elect to defer all or part of their annual retainer until the non-employee director retires from the Board of Directors. The non-employee director could elect to defer the portion of the annual retainer payable in shares of stock, as well as the portion, if any, payable in cash. Cash dividends on deferred shares are reinvested into additional deferred units in each non-employee director’s account.
A summary of the changes in common shares available for awards under the Omnibus Incentive Plan and Predecessor Plans follows:
| 127 |
2019 | 2018 | 2017 | |||||||
Number of shares available, beginning of year | |||||||||
Newly Registered Shares under Omnibus Incentive Plan | |||||||||
Restricted stock shares issued for new awards(1) | ( | ) | ( | ) | |||||
Restricted stock shares forfeited(1) | |||||||||
Restricted stock units awarded | ( | ) | ( | ) | ( | ) | |||
Restricted stock units forfeited | |||||||||
Shares issued for 2014 Special PSU Awards | ( | ) | ( | ) | |||||
Shares issued for 2015 Three-Year PSU Awards | ( | ) | |||||||
Shares issued for 2014 Three-Year PSU Awards | ( | ) | |||||||
Restricted stock units awarded for SLO Awards | ( | ) | ( | ) | ( | ) | |||
SLO units forfeited | |||||||||
Director shares granted and issued | ( | ) | ( | ) | ( | ) | |||
Director units granted and deferred(2) | ( | ) | ( | ) | ( | ) | |||
Shares withheld for taxes(3) | |||||||||
Number of shares available, end of year(4) | |||||||||
(1) | As of December 31, 2018, there were |
(2) | Director units granted and deferred include the impact of share-settled dividends earned and deferred on deferred shares. |
(3) | The Omnibus Incentive Plan and 2005 Contingent Stock Plan permit withholding of taxes and other charges that may be required by law to be paid attributable to awards by withholding a portion of the shares attributable to such awards. |
(4) | The above table excludes approximately |
We record share-based incentive compensation expense in selling, general and administrative expenses and cost of sales on our Consolidated Statements of Operations for both equity-classified awards and liability-classified awards. We record a corresponding credit to additional paid-in capital within stockholders’ deficit for equity-classified awards, and to either a current or non-current liability for liability-classified awards based on the fair value of the share-based incentive compensation awards at the date of grant. Total expense for the liability-classified awards continues to be remeasured to fair value at the end of each reporting period. We recognize an expense or credit reflecting the straight-line recognition, net of estimated forfeitures, of the expected cost of the program. The number of PSUs earned may equal, exceed or be less than the targeted number of shares depending on whether the performance criteria are met, surpassed or not met.
The following table summarizes the Company’s pre-tax share-based incentive compensation expense and related income tax benefit for the years ended December 31, 2019, 2018 and 2017 related to the Company’s PSU awards, SLO awards and restricted stock awards.
| 128 |
(In millions) | 2019 | 2018 | 2017 | |||||||||
2019 Three-year PSU Awards | $ | $ | $ | |||||||||
2018 Three-year PSU Awards | ||||||||||||
2017 Three-year PSU Awards(1) | ||||||||||||
2017 COO and Chief Executive Officer-Designate 2017 New Hire Equity Awards | ||||||||||||
2016 Three-year PSU Awards(1) | ( | ) | ||||||||||
2016 President & CEO Inducement Award | ||||||||||||
2015 Three-year PSU Awards | ( | ) | ||||||||||
2014 Special PSU Awards(2) | ||||||||||||
SLO Awards | ||||||||||||
Other long-term share-based incentive compensation programs(3)(4) | ||||||||||||
Total share-based incentive compensation expense(5) | $ | $ | $ | |||||||||
Associated tax benefits recognized | $ | $ | $ | |||||||||
(1) | On May 18, 2017, The Organization and Compensation Committee of our Board of Directors (“O&C Committee”) approved a change in the vesting policy regarding the existing 2017 Three-year PSU Awards and 2016 Three-year PSU Awards for Ilham Kadri. The approved change resulted in a pro-rata share of vesting calculated on the close date of the sale of Diversey. Dr. Kadri’s awards were still subject to the performance metrics stipulated in the plan documents, and will be paid out in accordance with the original planned timing. |
(2) | The amount does not include expense related to the 2014 Special PSU awards that were settled in cash of $ |
(3) | The amount includes the expenses associated with the restricted stock awards consisting of restricted stock shares, restricted stock units and cash-settled restricted stock unit awards. |
(4) | On August 4, 2017, the Equity Award Committee approved a change in the vesting condition regarding the existing long-term share-based compensation programs transferring to Diversey as part of the sale of Diversey. The approved change resulted in a pro-rata share of vesting calculated on the close date of the sale of Diversey. In December 2018, the Equity Award Committee approved a change in the vesting condition for certain individuals who would be leaving the Company under a phase of our Reinvent SEE Restructuring program. For both modifications, we recorded the cumulative expense of the higher fair value of the impacted awards at modification approval. |
(5) | The amounts do not include the expense related to our U.S. profit sharing contributions made in the form of our common stock as these contributions are not considered share-based incentive compensation. |
Restricted Stock, Restricted Stock Units and Cash-Settled Restricted Stock Unit Awards
Restricted stock, restricted stock units and cash-settled restricted stock unit awards (cash payment in an amount equal to the value of the shares on the vesting date) provide for a vesting period. Awards vest earlier in the event of the participant’s death or disability. If a participant terminates employment prior to vesting, then the award of restricted stock, restricted stock units or cash-settled restricted stock unit awards is forfeited, except for certain circumstances following a change in control. The O&C Committee may waive the forfeiture of all or a portion of an award. During the vesting period, holders of unvested shares of restricted stock (but not holders of unvested shares of restricted stock units or cash-settled restricted stock unit awards) are entitled to receive dividends on the same basis as dividends are paid to other stockholders and are entitled to vote the unvested shares. Dividends are accrued and paid at vesting for all restricted stock units granted after January 1, 2019.
The following table summarizes activity for unvested restricted stock and restricted stock units for 2019:
| 129 |
Restricted stock shares | Restricted stock units | |||||||||||||||||||||
Shares | Weighted-Average per Share Fair Value on Grant Date | Aggregate Intrinsic Value (in millions) | Shares | Weighted-Average per Share Fair Value on Grant Date | Aggregate Intrinsic Value (in millions) | |||||||||||||||||
Non-vested at December 31, 2018 | $ | $ | ||||||||||||||||||||
Granted | ||||||||||||||||||||||
Vested | ( | ) | $ | ( | ) | $ | ||||||||||||||||
Forfeited or expired | ( | ) | ( | ) | ||||||||||||||||||
Non-vested at December 31, 2019 | $ | $ | ||||||||||||||||||||
A summary of the Company’s fair values of its vested restricted stock shares and restricted stock units are shown in the following table:
(In millions) | 2019 | 2018 | 2017 | |||||||||
Fair value of restricted stock shares vested | $ | $ | $ | |||||||||
Fair value of restricted stock units vested | $ | $ | $ | |||||||||
A summary of the Company’s unrecognized compensation cost and weighted average periods over which the compensation cost is expected to be recognized for its non-vested restricted stock shares and restricted stock units are shown in the following table:
(In millions) | Unrecognized Compensation Costs | Weighted Average to be recognized (in years) | ||||
Restricted Stock shares | $ | |||||
Restricted Stock units | $ | |||||
The non-vested cash awards excluded from table above had $1.3 million unrecognized compensation costs and weighted-average remaining contractual life of approximately 0.8 years. We have recognized liabilities of $0.6 million and $ $0.9 million in other current liabilities and other non-current liabilities on our Consolidated Balance Sheets, respectively. Cash paid for vested cash-settled restricted stock unit awards was $1.3 million and $1.0 million in 2019 and 2018, respectively.
PSU Awards
Three-year PSU awards for 2017, 2018 and 2019
During the first 90 days of each year, the O&C Committee of our Board of Directors approves PSU awards for our executive officers and other selected key executives, which include for each officer or executive a target number of shares of common stock and performance goals and measures that will determine the percentage of the target award that is earned following the end of the three-year performance period. Following the end of the performance period, in addition to shares, participants will also receive a cash payment in the amount of the dividends (without interest) that would have been paid during the performance period on the number of shares that they have earned. Each PSU is subject to forfeiture if the recipient terminates employment with the Company prior to the end of the three-year award performance period for any reason other than death, disability or retirement. In the event of death, disability or retirement, a participant will receive a prorated payment based on such participant’s number of full months of service during the award performance period, further adjusted based on the achievement of the performance goals during the award performance period. All of these PSUs are classified as equity in the Consolidated Balance Sheets.
The O&C Committee established principal performance goals, which are (i) total shareholder return for three-year performance period weighted at 34 % for the 2017, 2018 and 2019 awards; (ii) consolidated Adjusted EBITDA margin measured in the final year of the award weighted at 33 % for the 2017, 2018 and 2019 awards; and (iii) three-year compound annual growth rate of net trade sales weighted at 33 % for the 2017 and 2018 awards; or return on invested capital weighted at 33 %, in the case of the 2019 awards. The total number of shares to be issued for these awards can range from zero to 200 % of the target number of shares.
| 130 |
In the third quarter of 2019, the O&C Committee approved PSU awards for an additional pool of individuals in connection with Reinvent SEE. The established performance goals are identical to those approved for awards granted to our executive officers and other selected key executives during the first quarter.
PSUs – Adjusted EBITDA Margin
The PSUs granted based on Adjusted EBITDA margin are contingently awarded and will be payable in shares of the Company’s common stock based on the Company’s Adjusted EBITDA margin at the end of the performance period compared a target set at the time of the grant by the O&C Committee. The fair value of the PSUs based on Adjusted EBITDA margin is based on grant date fair value which is equivalent to the closing price of one share of the Company’s common stock on the date of grant. The number of PSUs based on Adjusted EBITDA margin varies based on the probable outcome of the performance condition. The Company reassesses at each reporting date whether achievement of the performance condition is probable and accrues compensation expense if and when achievement of the performance condition is probable.
The number of PSUs granted based on Adjusted EBITDA margin and the grant date fair value are shown in the following table:
2019 | 2018 | 2017 | ||||||||||
Number of units granted | ||||||||||||
Weighted average fair value on grant date(1) (2) | $ | $ | $ | |||||||||
(1) | For 2019, this represents the weighted average fair value for PSU awards approved during the first and third quarter. |
(2) | On May 18, 2017, the O&C Committee approved a change in the vesting policy regarding the 2017 Three-year PSU Awards for Ilham Kadri. The modified vesting terms resulted in award modification accounting treatment. The weighted average fair value on grant date reflects the impact of the fair value on date of modification for these awards. |
PSUs – Total Shareholder Return (TSR)
The PSUs granted based on TSR are contingently awarded and will be payable in shares of the Company’s common stock subject to the condition that the number of PSUs, if any, earned by the employees upon the expiration of a three-year award performance period is dependent on the Company’s TSR ranking relative to a peer group of companies. The fair value of the PSUs based on TSR was estimated on the grant date using a Monte Carlo Simulation. Other assumptions include the expected volatility of all companies included in the TSR, the historical share price returns analysis of all companies included in the TSR and assumes dividends are reinvested. The expected volatility was based on the historical volatility for a period of time that approximates the duration between the valuation date and the end of the performance period. The risk-free interest rate is based on the Zero-Coupon Treasury STRIP yield curve matching the term from the valuation date to the end of the performance period. Compensation expense for the PSUs based on TSR (which is considered a market condition) is a fixed amount determined at the grant date fair value and is recognized 100 % over the three-year award performance period regardless of whether PSUs are awarded at the end of the award performance period.
The number of PSUs granted based on TSR and the assumptions used to calculate the grant date fair value of the PSUs based on TSR are shown in the following table:
2019 | 2018 | 2017 | ||||||||||
Number of units granted | ||||||||||||
Weighted average fair value on grant date(1) (3) | $ | $ | $ | |||||||||
Expected Price volatility(2) | % | % | % | |||||||||
Risk-free interest rate(2) | % | % | % | |||||||||
(1) | For 2019, this represents the weighted average fair value for PSU awards approved during the first and third quarter. |
(2) | For 2019, values represent weighted average assumptions for PSU awards approved during the first and third quarter. |
| 131 |
(3) | On May 18, 2017, the O&C Committee approved a change in the vesting policy regarding the existing 2017 Three-year PSU Awards for Ilham Kadri. The modified vesting terms resulted in award modification accounting treatment. The weighted average fair value on grant date reflects the impact of the fair value on date of modification for these awards. |
PSUs - Net Trade Sales Compound Annual Growth Rate
The PSUs granted based on Net Trade Sales Compound Annual Growth Rate (CAGR) are contingently awarded and will be payable in shares of the Company’s common stock based on the Company’s Net Trade Sales growth over a three-year award performance period compared to a target set at the time of the grant by the O&C Committee. The fair value of the PSUs based on Net Trade Sales Growth is based on grant date fair value which is equivalent to the closing price of one share of the Company’s common stock on the date of grant. The number of PSUs based on Net Trade Sales Growth varies based on the probable outcome of the performance condition. The Company reassesses at each reporting date whether achievement of the performance condition is probable and accrues compensation expense if and when achievement of the performance condition is probable.
The number of PSUs granted based on Net Trade Sales Growth and the grant date fair value are shown in the following table:
2018 | 2017 | |||||||
Number of units granted | ||||||||
Weighted average fair value on grant date(1) | $ | $ | ||||||
(1) | On May 18, 2017, the O&C Committee approved a change in the vesting policy regarding the existing 2017 Three-year PSU Awards for Ilham Kadri. The modified vesting terms resulted in award modification accounting treatment. The weighted average fair value on grant date reflects the impact of the fair value on date of modification for these awards. |
PSUs - Return on Invested Capital
The PSUs granted based on Return on Invested Capital (ROIC) are contingently awarded and will be payable in shares of the Company’s common stock based on the Company’s return on invested capital over a three-year award performance period compared to a target set at the time of the grant by the O&C Committee. The fair value of the PSUs based on Return on Invested Capital is based on grant date fair value which is equivalent to the closing price of one share of the Company’s common stock on the date of grant. The number of PSUs based on Return on Invested Capital varies based on the probable outcome of the performance condition. The Company reassesses at each reporting date whether achievement of the performance condition is probable and accrues compensation expense if and when achievement of the performance condition is probable.
The number of PSUs granted based on Return on Invested Capital and the grant date fair value are shown in the following table:
2019 | ||||
Number of units granted | ||||
Weighted average fair value on grant date(1) | $ | |||
(1) | This represents the weighted average fair value for PSU awards approved during the first and third quarter. |
The following table includes additional information related to estimated earned payout based on the probable outcome of the performance condition and market condition as of December 31, 2019:
| 132 |
Estimated Payout % | |||||||||||||||
Return on Invested Capital | Net Trade Sales Growth | Adjusted EBITDA | TSR(1) | Combined | |||||||||||
2019 Three-year PSU Awards | % | N/A | % | % | % | ||||||||||
2018 Three-year PSU Awards | N/A | — | % | % | % | % | |||||||||
2017 Three-year PSU Awards | N/A | % | % | % | % | ||||||||||
(1) | Total shareholder return is a market-based condition. Accordingly, we make no assumptions related to future performance. The percentages above represent actual rankings as of December 31, 2019. Any portion of outstanding awards based on the achievement of market-based conditions are accrued at |
The following table summarizes activity for outstanding Three-year PSU awards for 2019:
Shares | Aggregate Intrinsic Value (in millions) | ||||||
Outstanding at December 31, 2018 | |||||||
Granted(1) | |||||||
Converted | $ | ||||||
Forfeited or expired | ( | ) | |||||
Outstanding at December 31, 2019 | |||||||
Fully vested at December 31, 2019 | $ | ||||||
(1) | This represents the target number of performance units granted. Actual number of PSUs earned, if any, is dependent upon performance and may range from |
The following table summarizes activity for non-vested Three-year PSU awards for 2019:
Shares | Weighted-Average per Share Fair Value on Grant Date | ||||||
Non-vested at December 31, 2018 | $ | ||||||
Granted | |||||||
Vested | ( | ) | |||||
Forfeited or expired | ( | ) | |||||
Non-vested at December 31, 2019 | $ | ||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Fair value of three-year PSU awards vested | $ | $ | $ | |||||||||
A summary of the Company’s unrecognized compensation cost for three-year PSU awards at the current estimated earned payout based on the probable outcome of the performance condition and weighted average periods over which the compensation cost is expected to be recognized as shown in the following table:
(In millions) | Unrecognized Compensation Costs | Weighted Average to be recognized (in years) | ||||
2019 Three-year PSU Awards | $ | |||||
2018 Three-year PSU Awards | ||||||
2017 Three-year PSU Awards | ||||||
| 133 |
Chief Operating Officer (COO) and Chief Executive Officer-Designate 2017 New Hire Equity Awards
On September 5, 2017, the Board elected Edward L. Doheny II, Chief Operating Officer and CEO-Designate and elected him as a Director of the Company effective September 18, 2017. Mr. Doheny worked on transitioning with Jerome Peribere until December 31, 2017 and then assumed the role and title of President and Chief Executive Officer effective as of January 1, 2018. Additionally, on September 5, 2017, the Company entered into an offer letter agreement, effective September 18, 2017, with Mr. Doheny. The Letter Agreement provides that Mr. Doheny will be granted on his start date two new-hire equity awards, one that is time-vesting and the other that is performance-vesting (the “New Hire Awards”).
The time-vesting New Hire Award, for 30,000 shares, requires Mr. Doheny to remain in service with the Company through December 31, 2020. The grant date fair value for this award was $42.89 per share.
The performance-vesting New Hire Award, for 70,000 shares, in addition to the time-vesting requirement noted above, requires that either (i) the Company’s cumulative total stockholder return for 2018-2020 be in the top 33 % of its peers (using the same peers and methodology under the Company’s performance stock unit (PSU) awards) and the Company’s stock price as of December 31, 2020 equals at least $60.00 per share, or (ii) the Company’s stock price as of December 31, 2020 equals at least $75.00 per share. The Letter Agreement provides that the stock price as of December 31, 2020 for this purpose will be determined using a 30-day arithmetic mean of closing prices. Since the award includes a market condition, compensation expense will be recognized regardless of whether the market condition is satisfied provided that the requisite service has been provided.
The grant date fair value for this award was determined using a Monte Carlo Simulation model that incorporates predictive modeling techniques using Geometric Brownian Motion and Crystal Ball’s random number generation. Other assumptions include the expected volatility of all companies included in the total shareholder return, valuation modeling of vesting payoff determination featuring both performance goals as noted above, the historical share price returns analysis of all companies included in the total shareholder return and assumes dividends are reinvested. The expected volatility was based on the historical volatility of peer companies for a period of time that approximates the duration between the beginning and the end of the performance period. The risk-free interest rate is based on the Zero-Coupon Treasury STRIP yield curve matching the term from the valuation date to the end of the performance period Compensation expense for the performance-vesting Inducement Award is a fixed amount determined at the grant date fair value and is recognized 100 % from the time of the award to the end of the performance period regardless of whether shares are awarded at the end of the award performance period. The assumptions used to calculate the grant date fair value of the performance-vesting New Hire Award are shown in the following table:
2017 Performance-vesting New Hire Award | ||||
Fair value on grant date | $ | |||
Expected price volatility | % | |||
Risk-free interest rate | % | |||
The awards are described in further detail in Mr. Doheny’s Offer Letter filed with the SEC as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on September 7, 2017.
2016 Three-year PSU Awards
In February 2019, the O&C Committee reviewed the performance results for the 2016-2018 PSUs. Performance goals for these PSUs were based on Adjusted EBITDA margin and relative TSR. Based on overall performance for 2016-2018 PSUs, these awards paid out at 0 % of target or zero units.
Stock Leverage Opportunity Awards
Before the start of each performance year, certain key executives are eligible to elect to receive all or a portion of their annual cash bonus for that year, in increments of 25 % of the annual bonus, as an award of restricted stock or restricted stock units under the Omnibus Incentive Plan in lieu of cash. The portion provided as an equity award may be given a premium to be determined by the O&C Committee each year and will be rounded up to the nearest whole share. The award will be granted following the end of the performance year and after determination by the O&C Committee of the amount of the annual bonus award for each executive officer and other selected key executives who has elected to take all or a portion of his or her annual bonus as an equity award, but no later than the March 15 following the end of the performance year.
| 134 |
The equity award will be made in the form of an award of restricted stock units that will vest on the second anniversary of the grant date or earlier in the event of death, disability or retirement from employment with the Company, and the shares subject to the award will not be transferable by the recipient until the later of vesting or the second anniversary of the grant date. For the “principal portion” of the award that would have otherwise been paid in cash, the award vests upon any termination of employment, other than for cause. For the “premium portion” of the award, the award may early vest only in case of death, disability or retirement from the Company. Except as described above, if the recipient ceases to be employed by the Company prior to vesting, then the award is forfeited, except for certain circumstances following a change in control. SLO awards in the form of restricted stock units have no voting rights until shares are issued to them but do receive a cash payment in the amount of the dividends (without interest) on the shares they have earned at about the same time that shares are issued to them following vesting.
The 2019 SLO awards comprise an estimated aggregate of 71,663 restricted stock units as of December 31, 2019. The final number of units issued will be determined based on Annual Incentive Plan payout. During 2019, 46,195 restricted units were issued for the 2018 annual incentive plan. We recorded $3.2 million, $1.6 million and $1.1 million in expense related to the SLO program in the years ended December 31, 2019, 2018 and 2017, respectively. We record compensation expense for these awards in selling, general and administrative expenses on the Consolidated Statements of Operations with a corresponding credit to additional paid-in capital within stockholders’ deficit, based on the fair value of the awards at the end of each reporting period, which reflects the effects of stock price changes. The expense is recognized over a fifteen-month period.
Other Common Stock Issuances
In connection with the acquisition of B+ Equipment in the third quarter of 2015, the Company issued 20,000 shares of restricted common stock on September 26, 2018 to certain former equity holders of B+ Equipment. These shares were issued in offshore transactions with no direct selling efforts in the United States and without registration under the Securities Act of 1933, as amended, in reliance upon the issuer safe harbor provided by Regulation S.
During 2017, we granted 30,506 performance share unit awards to key executives based on acquisition activity, of which 7,130 and 5,177 were forfeited during 2019 and 2018, respectively. The performance metrics require the acquired business to reach certain performance-based conditions over a set period of time. The fair value is determined on the grant date. The expense recognized on the awards reflects the probable achievement and corresponding payout on the metrics. The (income) expense incurred for the years ended December 31, 2019 and 2018 was $(0.4 ) million and $0.3 million, respectively.
| 135 |
Note 22 Accumulated Other Comprehensive Loss
The following table provides details of comprehensive loss:
(In millions) | Unrecognized Pension Items | Cumulative Translation Adjustment | Unrecognized (Losses) Gains on Derivative Instruments for net investment hedge | Unrecognized (Losses) Gains on Derivative Instruments for cash flow hedge | Accumulated Other Comprehensive Loss, Net of Taxes | |||||||||||||||
Balance at December 31, 2017(1) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||||
Other comprehensive (loss) income before reclassifications | ( | ) | ( | ) | ( | ) | ||||||||||||||
Less: amounts reclassified from accumulated other comprehensive loss | ( | ) | ||||||||||||||||||
Net current period other comprehensive (loss) income | ( | ) | ( | ) | ( | ) | ||||||||||||||
Impact of Accounting Standard Update(2) | ( | ) | ( | ) | ( | ) | ||||||||||||||
Balance at December 31, 2018(1) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | |||||||
Other comprehensive (loss) income before reclassifications | ( | ) | ( | ) | ||||||||||||||||
Less: amounts reclassified from accumulated other comprehensive loss | ( | ) | ||||||||||||||||||
Net current period other comprehensive (loss) income | ( | ) | ( | ) | ||||||||||||||||
Balance at December 31, 2019(1) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | |||||||
(1) | The ending balance in AOCL includes gains and losses on intra-entity foreign currency transactions. The intra-entity currency translation adjustments were $( |
(2) | In the fourth quarter of 2018, the Company Adopted ASU 2018-02. As part of the adoption, the Company has elected to reclassify the tax effects of the TCJA from AOCL to retained earnings. The adoption of the ASU 2018-02 resulted in a $ |
The following table provides detail of amounts reclassified from AOCL:
(In millions) | 2019 | 2018 | 2017 | Location of Amount Reclassified from AOCL | ||||||||||
Defined benefit pension plans and other post-employment benefits: | ||||||||||||||
Prior service credits | $ | $ | $ | |||||||||||
Actuarial losses | ( | ) | ( | ) | ( | ) | ||||||||
Total pre-tax amount | ( | ) | ( | ) | ( | ) | Other (expense) income, net | |||||||
Tax benefit | ||||||||||||||
Net of tax | ( | ) | ( | ) | ( | ) | ||||||||
Net gains (losses) on cash flow hedging derivatives:(1) | ||||||||||||||
Foreign currency forward contracts | Cost of sales | |||||||||||||
Interest rate and currency swaps | ( | ) | Interest expense, net and Other (expense) income, net | |||||||||||
Treasury locks | Interest expense, net | |||||||||||||
Total pre-tax amount | ( | ) | ||||||||||||
Tax (expense) benefit | ( | ) | ( | ) | ||||||||||
Net of tax | ( | ) | ||||||||||||
Total reclassifications for the period | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||||
(1) | These accumulated other comprehensive components are included in our derivative and hedging activities. See Note 15, “Derivatives and Hedging Activities,” of the Notes to Consolidated Financial Statements for additional details. |
| 136 |
Note 23 Other (Expense) Income, net
The following table provides details of other (expense) income, net:
Year Ended December 31, | ||||||||||||
(In millions) | 2019 | 2018 | 2017 | |||||||||
Net foreign exchange transaction loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||
Bank fee expense | ( | ) | ( | ) | ( | ) | ||||||
Pension income other than service costs | ||||||||||||
Loss on debt redemption and refinancing activities | ( | ) | ( | ) | ||||||||
Other, net(1) | ||||||||||||
Other (expense) income, net | $ | ( | ) | $ | ( | ) | $ | |||||
(1) | Cryovac Brasil Ltda., a Sealed Air subsidiary, received a final decision from the Brazilian court regarding a claim in which Sealed Air contended that certain indirect taxes paid were calculated on an incorrect amount. As a result, for the year ended December 31, 2019, we recorded income of $ |
| 137 |
Note 24 Net Earnings per Common Share
The following table sets forth the calculation of basic and diluted net earnings per common share under the two-class method for the years ended December 31:
Year Ended December 31, | ||||||||||||
(In millions, except per share amounts) | 2019 | 2018 | 2017 | |||||||||
Basic Net Earnings Per Common Share: | ||||||||||||
Numerator | ||||||||||||
Net earnings | $ | $ | $ | |||||||||
Distributed and allocated undistributed net earnings to unvested restricted stockholders | ( | ) | ( | ) | ( | ) | ||||||
Distributed and allocated undistributed net earnings | ||||||||||||
Distributed net earnings - dividends paid to common stockholders | ( | ) | ( | ) | ( | ) | ||||||
Allocation of undistributed net earnings to common stockholders | $ | $ | $ | |||||||||
Denominator | ||||||||||||
Weighted average number of common shares outstanding - basic | ||||||||||||
Basic net earnings per common share: | ||||||||||||
Distributed net earnings | $ | $ | $ | |||||||||
Allocated undistributed net earnings to common stockholders | ||||||||||||
Basic net earnings per common share | $ | $ | $ | |||||||||
Diluted Net Earnings Per Common Share: | ||||||||||||
Numerator | ||||||||||||
Distributed and allocated undistributed net earnings to common stockholders | $ | $ | $ | |||||||||
Add: Allocated undistributed net earnings to unvested restricted stockholders | ||||||||||||
Less: Undistributed net earnings reallocated to unvested restricted stockholders | ( | ) | ( | ) | ( | ) | ||||||
Net earnings available to common stockholders - diluted | $ | $ | $ | |||||||||
Denominator | ||||||||||||
Weighted average number of common shares outstanding - basic | ||||||||||||
Effect of contingently issuable shares | ||||||||||||
Effect of unvested restricted stock units | ||||||||||||
Weighted average number of common shares outstanding - diluted under two-class | ||||||||||||
Effect of unvested restricted stock - participating security | ||||||||||||
Weighted average number of common shares outstanding - diluted under treasury stock | ||||||||||||
Diluted net earnings per common share | $ | $ | $ | |||||||||
PSU Awards
We included contingently issuable shares using the treasury stock method for our PSU awards in the diluted weighted average number of common shares outstanding based on the number of contingently issuable shares that would be issued assuming the end of our reporting period was the end of the relevant PSU award contingency period. The calculation of diluted weighted average shares outstanding related to PSUs was nominal in 2019 and 2018 and approximately 1 million shares in 2017.
SLO Awards
The shares or units associated with the 2019 SLO awards are considered contingently issuable shares and therefore are not included in the basic or diluted weighted average number of common shares outstanding for the year ended December 31,
| 138 |
2019. These shares or units will not be included in the common shares outstanding until the final determination of the amount of annual incentive compensation is made in the first quarter of 2020. Once this determination is made, the shares or units will be included in diluted weighted average number of common shares outstanding if the impact to diluted net earnings per common share is dilutive. The numbers of shares or units associated with SLO awards for 2019, 2018 and 2017 were nominal.
Note 25 Summarized Quarterly Financial Information (Unaudited)
2019 | ||||||||||||||||
First | Second | Third | Fourth | |||||||||||||
(In millions, except per share amounts) | Quarter | Quarter | Quarter | Quarter | ||||||||||||
Net sales | $ | $ | $ | $ | ||||||||||||
Gross profit | ||||||||||||||||
Net earnings from continuing operations | ||||||||||||||||
(Loss) gain on sale of discontinued operations, net of tax | ( | ) | ( | ) | ( | ) | ||||||||||
Net earnings(1) | $ | $ | $ | $ | ||||||||||||
Basic: | ||||||||||||||||
Continuing operations | $ | $ | $ | $ | ||||||||||||
Discontinued operations | ( | ) | ( | ) | ( | ) | ||||||||||
Net earnings per common share - basic | $ | $ | $ | $ | ||||||||||||
Diluted: | ||||||||||||||||
Continuing operations | $ | $ | $ | $ | ||||||||||||
Discontinued operations | ( | ) | ( | ) | ( | ) | ||||||||||
Net earnings per common share - diluted | $ | $ | $ | $ | ||||||||||||
2018 | ||||||||||||||||
First | Second | Third | Fourth | |||||||||||||
(In millions, except per share amounts) | Quarter | Quarter | Quarter | Quarter | ||||||||||||
Net sales | $ | $ | $ | $ | ||||||||||||
Gross profit | ||||||||||||||||
Net (loss) earnings from continuing operations | ( | ) | ||||||||||||||
Gain on sale of discontinued operations, net of tax | ||||||||||||||||
Net (loss) earnings | $ | ( | ) | $ | $ | $ | ||||||||||
Basic: | ||||||||||||||||
Continuing operations | $ | ( | ) | $ | $ | $ | ||||||||||
Discontinued operations | ||||||||||||||||
Net (loss) earnings per common share - basic(1) | $ | ( | ) | $ | $ | $ | ||||||||||
Diluted: | ||||||||||||||||
Continuing operations | $ | ( | ) | $ | $ | $ | ||||||||||
Discontinued operations | ||||||||||||||||
Net (loss) earnings per common share - diluted(1) | $ | ( | ) | $ | $ | $ | ||||||||||
(1) | The sum of the quarterly per share amounts may not agree to the respective annual amounts due to differences in outstanding shares. |
| 139 |
Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |
None.
Item 9A. Controls and Procedures
Disclosure Controls and Procedures
We maintain disclosure controls and procedures, as defined in Rule 13a-15 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are designed to ensure that information required to be disclosed in our reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that our employees accumulate this information and communicate it to our management, including our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial officer), as appropriate, to allow timely decisions regarding the required disclosure. In designing and evaluating the disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only “reasonable assurance” of achieving the desired control objectives, and management necessarily must apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this report, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures under Rule 13a-15. Our management, including our Chief Executive Officer and Chief Financial Officer, supervised and participated in this evaluation. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the “reasonable assurance” level.
Changes in Internal Control over Financial Reporting
There have been no changes in our internal control over financial reporting during the quarter ended December 31, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Management’s Annual Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness, as of December 31, 2019, of our internal control over financial reporting. The suitable recognized control framework on which management’s evaluation of our internal control over financial reporting is based is the Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based upon that evaluation under the COSO framework, our management concluded that our internal control over financial reporting as of December 31, 2019 was effective.
Our management has excluded Automated Packaging Systems, LLC and MGM, Inc. from its assessment of the Company’s internal control over financial reporting as of December 31, 2019, because they were acquired by the Company in purchase business combinations during 2019. Automated Packaging Systems, LLC and MGM, Inc. are wholly-owned subsidiaries whose total assets and total revenues excluded from our management's assessment of internal control over financial reporting collectively represent approximately 4% and 3%, respectively, of the related consolidated financial statement amounts as of and for the year ended December 31, 2019.
Our internal control over financial reporting as of December 31, 2019 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, which also audited our Consolidated Financial Statements for the year ended December 31, 2019, as stated in their report included in this Annual Report on Form 10-K, which expresses an unqualified opinion on the effectiveness of our internal control over financial reporting as of December 31, 2019.
Item 9B. Other Information
None.
| 140 |
PART III
Item 10. | Directors, Executive Officers and Corporate Governance |
Part of the information required in response to this Item is set forth in Part I of this Annual Report on Form 10-K under the caption “Executive Officers of the Registrant,” and the balance will be included in our Proxy Statement for our 2020 Annual Meeting of Stockholders under the captions “Corporate Governance,” “Election of Directors — Information Concerning Nominees” and “Election of Directors -Nominees for Election as Director”, except as set forth below. All such information is incorporated herein by reference.
We have adopted a Code of Conduct applicable to all of our directors, officers and employees and those of our subsidiaries and a supplemental Code of Ethics for Senior Financial Executives applicable to our Chief Executive Officer, Chief Financial Officer, Controller, Treasurer, and all other employees performing similar functions for us. The Code of Conduct and the Code of Ethics for Senior Financial Executives are posted on our website at www.sealedair.com. We will post any amendments to the Code of Conduct and the Code of Ethics for Senior Financial Executives on our website. We will also post on our website any waivers applicable to any of our directors or officers, including the senior financial officers listed above, from provisions of the Code of Conduct or the Code of Ethics for Senior Financial Executives.
Item 11. | Executive Compensation |
The information required in response to this Item will be set forth in our Proxy Statement for our 2020 Annual Meeting of Stockholders under the captions “Director Compensation,” “Executive Compensation,” and “Corporate Governance -Compensation Committee Interlocks and Insider Participation. ” Such information is incorporated herein by reference.
Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
The information required in response to this Item will be set forth in our Proxy Statement for our 2020 Annual Meeting of Stockholders under the captions “Beneficial Ownership Table” and “Equity Compensation Plan Information.” Such information is incorporated herein by reference.
Item 13. | Certain Relationships and Related Transactions, and Director Independence |
The information required in response to this Item will be set forth in our Proxy Statement for our 2020 Annual Meeting of Stockholders under the captions “Corporate Governance - Independence of Directors” and “Certain Relationships and Related Person Transactions.” Such information is incorporated herein by reference.
Item 14. | Principal Accounting Fees and Services |
The information required in response to this Item will be included in our Proxy Statement for our 2020 Annual Meeting of Stockholders under the captions “Principal Independent Auditor Fees” and “Audit Committee Pre-Approval Policies and Procedures.” Such information is incorporated herein by reference.
| 141 |
PART IV
Item 15. | Exhibits and Financial Statement Schedules |
(a) Documents filed as a part of this Annual Report on Form 10-K:
(1) Financial Statements
See Index to Consolidated Financial Statements and Schedule of this Annual Report on Form 10-K in Part II Item 8.
(2) Financial Statement Schedule
See Schedule II — Valuation and Qualifying Accounts and Reserves — Years Ended December 31, 2019, 2018 and 2017 of this Annual Report on Form 10-K. The other schedules are omitted as they are not applicable or the amounts involved are not material.
| 142 |
(3) Exhibits
Exhibit Number | Description | |
2.1 | ||
2.2 | ||
3.1 | ||
3.2 | ||
4.1 | ||
4.2 | ||
4.3 | ||
4.4 | ||
4.5 | ||
4.6 | ||
4.7 | ||
4.8 | ||
4.9 | ||
4.10 | ||
4.11 | ||
4.12 | ||
4.13 | ||
4.14 | ||
| 143 |
Exhibit Number | Description | |
4.15 | ||
10.1 | ||
10.2 | ||
10.3 | ||
10.4 | ||
10.5 | ||
10.6 | ||
10.7 | ||
10.8 | ||
10.9 | ||
10.10 | ||
10.11 | ||
10.12 | ||
10.13 | ||
10.14 | ||
10.15 | ||
10.16 | ||
10.17 | ||
| 144 |
Exhibit Number | Description | |
10.18 | ||
10.19 | ||
10.20 | ||
10.21 | ||
10.22 | ||
10.23 | ||
10.24 | ||
10.25 | ||
10.26 | ||
10.27 | ||
10.28 | ||
10.29 | ||
10.30 | ||
10.31 | ||
10.32 | ||
10.33 | ||
| 145 |
Exhibit Number | Description | |
10.34 | ||
10.35 | ||
10.36 | ||
10.37 | ||
10.38 | ||
10.39 | ||
10.40 | ||
10.41 | ||
10.42 | ||
10.43 | ||
10.44 | ||
21 | ||
23.1 | ||
23.2 | ||
31.1 | ||
31.2 | ||
32 | ||
101.INS | Inline XBRL Instance Document - the Instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |
| 146 |
Exhibit Number | Description | |
101.SCH | Inline XBRL Taxonomy Extension Schema | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase | |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase | |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained within Exhibit 101). | |
* Compensatory plan or arrangement of management required to be filed as an exhibit to this report on Form 10-K.
In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be deemed to be “filed” or part of any registration statement or other document filed for purposes of Sections 11 or 12 of the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
In lieu of filing certain instruments with respect to long-term debt of the kind described in Item 601(b)(4)(iii) of Regulation S-K, the Company agrees to furnish a copy of such instruments to the SEC upon request.
| 147 |
(2) Financial Statement Schedule
SEALED AIR CORPORATION AND SUBSIDIARIES
SCHEDULE II
Valuation and Qualifying Accounts and Reserves
Years Ended December 31, 2019, 2018 and 2017
Description | Balance at Beginning of Year | Charged to Costs and Expenses | Deductions | Foreign Currency Translation and Other | Balance at End of Year | |||||||||||||||||
(in millions) | ||||||||||||||||||||||
Year Ended December 31, 2019 | ||||||||||||||||||||||
Allowance for doubtful accounts | $ | $ | $ | ( | ) | (1) | $ | $ | ||||||||||||||
Inventory obsolescence reserve | $ | $ | $ | ( | ) | (2) | $ | ( | ) | $ | ||||||||||||
Valuation allowance on deferred tax assets | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | |||||||||||
Year Ended December 31, 2018 | ||||||||||||||||||||||
Allowance for doubtful accounts | $ | $ | $ | ( | ) | (1) | $ | $ | ||||||||||||||
Inventory obsolescence reserve | $ | $ | $ | ( | ) | (2) | $ | ( | ) | $ | ||||||||||||
Valuation allowance on deferred tax assets | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||
Year Ended December 31, 2017 | ||||||||||||||||||||||
Allowance for doubtful accounts | $ | $ | $ | ( | ) | (1) | $ | $ | ||||||||||||||
Inventory obsolescence reserve | $ | $ | $ | ( | ) | (2) | $ | $ | ||||||||||||||
Valuation allowance on deferred tax assets | $ | $ | $ | $ | $ | |||||||||||||||||
(1) | Primarily accounts receivable balances written off, net of recoveries. |
(2) | Primarily items removed from inventory. |
| 148 |
Item 16. | Form 10-K Summary |
Not applicable.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SEALED AIR CORPORATION (Registrant) | ||
By: | /S/ EDWARD L. DOHENY II | |
Edward L. Doheny II | ||
President and Chief Executive Officer | ||
Date: March 2, 2020
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
Signature | Title | Date | |||
By: | /S/ EDWARD L. DOHENY II | President, Chief Executive Officer and Director (Principal Executive Officer) | March 2, 2020 | ||
Edward L. Doheny II | |||||
By: | /S/ JAMES M. SULLIVAN | Senior Vice President and Chief Financial Officer (Principal Financial Officer) | March 2, 2020 | ||
James M. Sullivan | |||||
By: | /S/ MICHAEL A. LEON | Chief Accounting Officer and Controller (Principal Accounting Officer) | March 2, 2020 | ||
Michael A. Leon | |||||
By: | /S/ MICHAEL CHU | Director | March 2, 2020 | ||
Michael Chu | |||||
By: | /S/ FRANÇOISE COLPRON | Director | March 2, 2020 | ||
Françoise Colpron | |||||
By: | /S/ PATRICK DUFF | Director | March 2, 2020 | ||
Patrick Duff | |||||
By: | /S/ HENRY R. KEIZER | Director | March 2, 2020 | ||
Henry R. Keizer | |||||
By: | /S/ JACQUELINE B. KOSECOFF | Director | March 2, 2020 | ||
Jacqueline B. Kosecoff | |||||
By: | /S/ HARRY A. LAWTON III | Director | March 2, 2020 | ||
Harry A. Lawton III | |||||
By: | /S/ NEIL LUSTIG | Director | March 2, 2020 | ||
Neil Lustig | |||||
By: | /S/ JERRY R. WHITAKER | Director | March 2, 2020 | ||
Jerry R. Whitaker | |||||
| 149 |
Exhibit 4.15
DESCRIPTION OF SEALED AIR CORPORATION COMMON STOCK
The following description of our common stock, which is registered under Section 12(b) of the Securities Exchange Act of 1934, as amended, is a summary and is qualified in its entirety by reference to our amended and restated certificate of incorporation (the “Certificate of Incorporation”) and our amended and restated by-laws (the “By-laws”), which are incorporated by reference as exhibits to the Annual Report on Form 10-K of which this exhibit is a part. We encourage you to read the Certificate of Incorporation and By-laws, as well as applicable provisions of the General Corporation Law of the State of Delaware, as amended (the “DGCL”), for more information.
References herein to “we,” “our,” “us,” the “Company” or “Sealed Air” refers to Sealed Air Corporation, a Delaware corporation.
Authorized Shares
We are authorized to issue up to 400,000,000 shares of common stock, par value $0.10 per share. There were 154,670,740 shares of our common stock issued and outstanding as of February 21, 2020. We are authorized to issue up to 50,000,000 shares of preferred stock, par value $0.10 per share. No shares of our preferred stock were issued and outstanding as of February 21, 2020.
Listing
Our outstanding shares of common stock are listed on the New York Stock Exchange under the symbol “SEE.” Any additional common stock we issue will also be listed on the New York Stock Exchange.
Dividends
Dividends on shares of common stock may be declared by our Board of Directors (the “Board”) from the surplus or net profits of the Company to the extent such funds are legally available for the payment of dividends. We are incorporated in Delaware and are governed by Delaware law. Delaware law allows a corporation to pay dividends only out of surplus, as determined under Delaware law, or, if no such surplus exists, out of the corporation’s net profits for the fiscal year in which the dividend is declared and/or the preceding fiscal year (provided that such payment will not reduce capital below the amount of capital represented by all classes of shares having a preference upon the distribution of assets).
Voting Rights
Each share of common stock is entitled to one vote on all matters submitted to a vote of stockholders. The holders of shares of our common stock do not have cumulative voting rights. In other words, a holder of a single share of common stock cannot cast more than one vote for each position to be filled on our Board. A consequence of not having cumulative voting rights is that the holders of a majority of the shares of common stock entitled to vote in the election of directors can elect all directors standing for election, which means that the holders of the remaining shares will not be able to elect any directors.
Liquidation and Other Rights
In the event of any liquidation, holders of common stock will be entitled to share on a pro rata basis in all of the remaining assets and funds available for distribution under such liquidation, subject to the payment in full of all claims of creditors and prior rights of any class or series of preferred stock then outstanding. The rights of holders of common stock may only be modified by a vote of a majority of the shares outstanding or through the issuance of preferred stock as authorized in the Certificate of Incorporation.
The shares of common stock have no preemptive, conversion or similar rights. The shares of common stock also have no redemption rights. The issued and outstanding shares of our common stock are fully paid and non-assessable. This means the full purchase price for the outstanding shares of our common stock has been paid and the holders of such shares will not be assessed any additional amounts for such shares. Any additional shares of common stock that we may issue in the future will also be fully paid and non-assessable. Our common stock is not subject to any provision discriminating against any existing or prospective holder of the Company’s common stock as a result of such holder owning a substantial amount of common stock.
Transfer Agent and Registrar
The transfer agent and registrar for our common stock is Broadridge.
Anti-takeover Effects of Our Certificate of Incorporation and By-laws and Delaware Law
Some provisions of our Certificate of Incorporation and By-laws and of Delaware law may be deemed to have an anti-takeover effect and may delay or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.
Size of Board and Vacancies. The number of directors on our Board will be fixed exclusively by our Board. Newly created directorships resulting from any increase in our authorized number of directors and vacancies will be filled by a majority of our directors then in office, though less than a quorum, or by a sole remaining director. A vacancy shall be deemed to exist in the case of death, removal or resignation of any director, or if stockholders fail at any meeting of stockholders at which directors are to be elected to elect the number of directors then constituting the whole Board.
Requirements for Advance Notification of Stockholder Nominations and Proposals. Our By-laws establish advance notice procedures with respect to stockholder proposals and nomination of candidates for election as directors other than nominations made by or at the direction of our Board.
No Cumulative Voting. Our Certificate of Incorporation and By-laws do not provide for cumulative voting in the election of directors.
Undesignated Preferred Stock. The authorization in our Certificate of Incorporation of undesignated preferred stock makes it possible for our Board to issue our preferred stock with voting or other rights or preferences that could impede the success of any attempt to change control of us. The provision in our Certificate of Incorporation authorizing such preferred stock may have the effect of deferring hostile takeovers or delaying changes of control of our management.
Delaware Anti-takeover Law. We are subject to Section 203 of the DGCL an anti-takeover law. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a business combination with an interested stockholder for a period of three years following the date such person becomes an interested stockholder, unless the business combination or the transaction in which such person becomes an interested stockholder is approved in a prescribed manner. Generally, a “business combination” includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. Generally, an “interested stockholder” is a person that, together with affiliates and associates, owns, or within three years prior to the determination of interested stockholder status did own, 15% or more of a corporation’s voting stock. The existence of this provision may have an anti-takeover effect with respect to transactions not approved in advance by our Board and the anti-takeover effect includes discouraging attempts that might result in a premium over the market price for the shares of our common stock.
Limitation on Liability of Directors and Indemnification of Directors and Officers
Section 145 of the DGCL provides that: (1) under certain circumstances a corporation may indemnify a director or officer made party to, or threatened to be made party to, any civil, criminal, administrative or investigative action, suit or proceeding (other than an action by or in the right of the corporation) because such person is or was a director, officer, employee or agent of the corporation, or because such person is or was so serving another enterprise at the request of the corporation, against expenses, judgments, fines and amounts paid in settlement reasonably incurred by such person in connection with such action, suit or proceeding, if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to criminal cases, had no reasonable cause to believe such person’s conduct was unlawful; (2) under certain circumstances a corporation may indemnify a director or officer made party to, or threatened to be made party to, any action or suit by or in the right of the corporation for judgment in favor of the corporation because such person is or was a director, officer, employee or agent of the corporation, or because such person is or was so serving another enterprise at the request of the corporation, against expenses reasonably incurred by such person in connection with the defense or settlement of such action or suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation; and (3) a present or former director or officer shall be indemnified by the corporation against expenses reasonably incurred by such person in connection with and to the extent that such person has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in the preceding clauses, or in defense of any claim, issue or matter therein.
Our Certificate of Incorporation and By-laws provide that, to the fullest extent legally permitted by the DGCL, we will indemnify and hold harmless any person who was or is a party or is threatened to be made a party to or is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or a person of whom he is the legal representative, is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the Company or for its benefit as a director, officer employee or agent of another corporation, or as its representative in a partnership, joint venture, trust or other enterprise, from and against any and all expenses, liabilities and losses (including without limitation attorney’s fees, judgments, fines and amounts paid or to be paid in settlement) actually and reasonably incurred or suffered by such person in connection therewith.
Our Certificate of Incorporation eliminates the liability of directors for monetary damages for breach of fiduciary duty as directors, except for liability (1) for any breach of the director’s duty of loyalty to the Company or its stockholders, (2) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (3) under Section 174 of the DGCL, or (4) for any transaction from which the director derived an improper personal benefit. The DGCL and our By-Laws permit the purchase by the Company of insurance for indemnification of directors and officers. We currently maintain directors and officers liability insurance.
Other Features of Our Certificate of Incorporation and By-Laws
Proxy Access. Our By-laws permit a stockholder, or a group of up to 20 stockholders, owning 3% or more of our outstanding common stock continuously for at least three years, to nominate and include in our annual meeting proxy materials director candidates to occupy up to two or 20% of our board seats (whichever is greater), provided that such stockholders or group of stockholders satisfies the requirements set forth in the By-laws.
Special Meetings. Special meetings of the stockholders may be called by the chair of the Board, by the chief executive officer or by resolution of the Board and, subject to the procedures set forth in our By-laws, shall be called by the chief executive officer or the secretary at the request in writing of stockholders owning a majority of the voting power of the then outstanding voting stock of the Company.
Exhibit 10.10
Fees to be Paid to the Non-Employee Directors
of
Sealed Air Corporation (the “Corporation”)
2020
Members of the Board of Directors who are not officers or employees of the Corporation or any subsidiary of the Corporation (“non-employee directors”) shall be paid the following directors’ fees in cash, payable quarterly in arrears on or about the first day of the succeeding calendar quarter, which fees shall be in addition to retainers payable to non-employee directors under the 2014 Omnibus Incentive Plan:
(i) | for each non-employee director who is designated as chair of the Audit Committee, a fee of Six Thousand Two Hundred Fifty Dollars ($6,250) per calendar quarter for serving as chair, and for each other member of the Audit Committee, a fee of Two Thousand Five Hundred Dollars ($2,500) per calendar quarter for serving as a member; |
(ii) | for each non-employee director who is designated as chair of the Nominating and Corporate Governance Committee, a fee of Three Thousand Seven Hundred Fifty Dollars ($3,750) per calendar quarter for serving as chair, and for each other member of the Nominating and Corporate Governance Committee, a fee of One Thousand Eight Hundred Seventy Five Dollars ($1,875) per calendar quarter for serving as a member; |
(iii) | for each non-employee director who is designated as chair of the Organization and Compensation Committee, a fee of Five Thousand Dollars ($5,000) per calendar quarter for serving as chair, and for each other member of the Organization and Compensation Committee, a fee of Two Thousand Five Hundred Dollars ($2,500) per calendar quarter for serving as a member; |
(iv) | a fee of Two Thousand Dollars ($2,000) per day for special assignments undertaken by a non-employee director at the request of the Board or any committee of the Board or for attending a director education program; and |
(v) | meeting fees as approved by the Board of Directors for non-employee directors who serve on any special committee or for attendance at special meetings of the Board of Directors or a committee of the Board of Directors in the event of a major transaction, etc. |
The amount of the Annual Retainer (as defined in the 2014 Omnibus Incentive Plan) to be paid to the non-employee directors of the Corporation who are elected at the 2020 Annual Meeting of Stockholders is $125,000 payable in shares of Common Stock plus $95,000 payable in cash unless the non-employee director elects payment of the cash portion in shares of Common Stock.
The amount of the Annual Retainer to be paid to the independent Chairman of the Board is $200,000 payable in shares of Common Stock plus $152,000 payable in cash unless the Chairman elects payment of the cash portion in shares of Common Stock.
Under the Sealed Air Corporation Deferred Compensation Plan for Directors, a non-employee director may elect to defer all or part of his or her Annual Retainer until the director retires from the Board. None of the other fees mentioned above are eligible to be deferred.
Exhibit 21
SUBSIDIARIES OF THE COMPANY
AFP (Shanghai) Limited | China |
AFPTOH, LTD | Texas |
Air Ride Pallets Hong Kong Limited | Hong Kong |
A.P.S. (Holdings) Limited | United Kingdom |
APS Verwaltungs-GmbH | Germany |
Austin Foam Plastics, Inc. (dba AFP, Inc.) | Texas |
Automated Packaging Systems Asia Holding Company Limited | Hong Kong |
Automated Packaging Systems Comerciale Importacao do Brasil Ltda. | Brazil |
Automated Packaging Systems Europe | Belgium |
Automated Packaging Systems GmbH & Co. KG | Germany |
Automated Packaging Systems Limited | United Kingdom |
Automated Packaging Systems Southeast Asia Co., Ltd. | Thailand |
Automated Packaging Systems, LLC | Ohio |
B+ Equipment SAS | France |
Beacon Holdings, LLC | Delaware |
Blue Dot Packaging Pty Ltd. | Australia |
BluPack (New Zealand) | New Zealand |
Cactus (Shanghai) Trading Co., Ltd. | China |
Ciras C.V. | Netherlands |
Cryovac (Malaysia) SDN. BHD | Malaysia |
Cryovac Brasil Ltda. | Brazil |
Cryovac Holdings II, LLC | Delaware |
Cryovac International Holdings Inc. | Delaware |
Cryovac Leasing Corporation | Delaware |
Cryovac Londrina Ltda. | Brazil |
Cryovac Packaging Portugal - Embalagens, Ltda. | Portugal |
Cryovac, LLC* | Delaware |
Cryovac-Sealed Air de Costa Rica S.R.L. | Costa Rica |
Diversey J Trustee Limited | United Kingdom |
Diversey Trustee Limited | United Kingdom |
Entapack Pty. Ltd. | Australia |
Fagerdala (Chengdu) Packaging Co., Ltd | China |
Fagerdala (Shanghai) Foams Co. Ltd. | China |
Fagerdala (Shanghai) Polymer Co. Ltd. | China |
Fagerdala (Suzhou) Packaging Co. Ltd. | China |
Fagerdala (Thailand) Limited | Thailand |
Fagerdala (Xiamen) Packaging Co. Ltd. | China |
Fagerdala Leamchabung Limited | Thailand |
Fagerdala Malaysia Sdn Bhd | Malaysia |
Fagerdala Mexico S.A. De C.V. | Mexico |
Fagerdala Mexico Supply Chain S.A. De C.V. | Mexico |
Fagerdala Packaging Inc. (Indiana) | Indiana |
Fagerdala Singapore Pte Ltd | Singapore |
Getpacking.com, GmbH | Switzerland |
Invertol S. de R.L. de C.V. | Mexico |
JSC Sealed Air Kaustik | Russia |
Kevothermal Limited | United Kingdom |
Kevothermal LLC | Delaware |
KRIS Automated Packaging Systems Holding Company | Mauritius |
KRIS Automated Packaging Systems Private Limited | India |
Packaging C.V. | Netherlands |
Pack-Tiger GmbH | Switzerland |
Polyrol Limited | United Kingdom |
Polyrol Packaging Systems, LLC | Ohio |
Producembal- Producao de Embalagens, LTDA | Portugal |
Reflectix, Inc. | Delaware |
Saddle Brook Insurance Company | Vermont |
Sealed Air (Asia) Holdings BV | Netherlands |
Sealed Air (Barbados) S.R.L. | Barbados |
Sealed Air (Canada) Co./CIE | Canada |
Sealed Air (Canada) Holdings B.V. | Netherlands |
Sealed Air (China) Limited | Delaware |
Sealed Air (China) Co. Ltd. | China |
Sealed Air (India) Limited | Delaware |
Sealed Air (Israel) Ltd. | Israel |
Sealed Air (Latin America) Holdings II, LLC | Delaware |
Sealed Air (Malaysia) SDN. BHD. | Malaysia |
Sealed Air (New Zealand) | New Zealand |
Sealed Air (Philippines) Inc. | Philippines |
Sealed Air (Singapore) Pte. Limited | Singapore |
Sealed Air (Ukraine) Limited | Ukraine |
Sealed Air Africa (Pty.) Limited | South Africa |
Sealed Air Americas Manufacturing S. de R.L. de C.V. | Mexico |
Sealed Air Argentina S.A. | Argentina |
Sealed Air Australia (Holdings) Pty. Limited | Australia |
Sealed Air Australia Pty. Limited | Australia |
Sealed Air Australia Real Estate Pty Ltd | Australia |
Sealed Air B.V. | Netherlands |
Sealed Air Belgium N.V. | Belgium |
Sealed Air Central America, S.A. | Guatemala |
Sealed Air Chile SpA | Chile |
Sealed Air Colombia Ltda. | Colombia |
Sealed Air Corporation (US) | Delaware |
Sealed Air Cyprus Ltd. | Cyprus |
Sealed Air de Mexico Operations, S. de RL. de C.V. | Mexico |
Sealed Air de Venezuela, S.A. | Venezuela |
Sealed Air Denmark A/S | Demnark |
Sealed Air Europe Holdings C.V. | Netherlands |
Sealed Air Europe Holdings LP | Delaware |
Sealed Air Finance B.V. | Netherlands |
Sealed Air Finance II, LLC | Delaware |
Sealed Air Finance Luxembourg S.a.r.l. | Luxembourg |
Sealed Air Funding LLC | Delaware |
Sealed Air General Trading LLC | United Arab Emirates |
Sealed Air Global Holdings C.V. | Netherlands |
Sealed Air Global Holdings I, C.V. | Netherlands |
Sealed Air GmbH | Germany |
Sealed Air GmbH | Switzerland |
Sealed Air Hellas SA | Greece |
Sealed Air Holding France SAS | France |
Sealed Air Holdings (New Zealand) Pty. Ltd. | New Zealand |
Sealed Air Holdings I, LLC | Delaware |
Sealed Air Holdings South Africa Proprietary Limited | South Africa |
Sealed Air Holdings, LLC | Delaware |
Sealed Air Hong Kong Limited | Hong Kong |
Sealed Air Hungary Ltd. | Hungary |
Sealed Air International Holdings LLC | Delaware |
Sealed Air Investment and Management (Shanghai) Co., Ltd. | China |
Sealed Air Japan G.K. | Japan |
Sealed Air Korea Limited | Korea |
Sealed Air Limited | Ireland |
Sealed Air Limited | United Kingdom |
Sealed Air LLC | Delaware |
Sealed Air Luxembourg S.a.r.l. | Luxembourg |
Sealed Air Luxembourg (I) S.a.r.l. | Luxembourg |
Sealed Air Luxembourg (II) S.a.r.l. | Luxembourg |
Sealed Air Management Holding Verwaltungs GmbH | Germany |
Sealed Air Multiflex GmbH | Germany |
Sealed Air Netherlands (Holdings) I B.V. | Netherlands |
Sealed Air Netherlands (Holdings) II B.V. | Germany |
Sealed Air Netherlands (Holdings) III, B.V. | Netherlands |
Sealed Air Netherlands Holdings V B.V. | Netherlands |
Sealed Air Nevada Holdings Limited | Nevada |
Sealed Air Norge AS | Norway |
Sealed Air OY | Finland |
Sealed Air Packaging (India) Private Limited | India |
Sealed Air Packaging (Shanghai) Co., Limited | China |
Sealed Air Packaging (Thailand) Co., Ltd. | Thailand |
Sealed Air Packaging LLC | Delaware |
Sealed Air Packaging Materials (India) LLP | India |
Sealed Air Packaging S.L.U. | Spain |
Sealed Air Peru S.A.C. | Peru |
Sealed Air Polska Sp. Zoo | Poland |
Sealed Air Pty Limited | Australia |
Sealed Air S.r.l. | Italy |
Sealed Air s.r.o. | Czech Republic |
Sealed Air S.A S. | France |
Sealed Air South Africa (Pty.) Ltd. | South Africa |
Sealed Air Svenska AB | Sweden |
Sealed Air Taiwan Limited | Taiwan |
Sealed Air Uruguay S.A. | Uruguay |
Sealed Air US Holdings (Thailand), LLC | Delaware |
Sealed Air Venezuela Corporation | Delaware |
Sealed Air Verpackungen GmbH | Germany |
Shanklin Corporation | Delaware |
SLD Air Packaging Paketleme Malzemeleri Ticaret Limited Sirketi | Turkey |
TempTrip LLC | Delaware |
TXAFP Asia Pacific, Ltd. | Texas |
TXAFP GP LLC | Texas |
* Cryovac, LLC does business in certain states under the name “Sealed Air Shrink Packaging Division.”
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑8 (Nos. 333-226619, 333-223460, 333-196508, 333-176267 and 333- 89090) of Sealed Air Corporation of our report dated March 2, 2020 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP |
Charlotte, North Carolina |
March 2, 2020 |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-8 No. 333-226619) of Sealed Air Corporation, |
(2) | Registration Statement (Form S-8 No. 333-223460) of Sealed Air Corporation, |
(3) | Registration Statement (Form S-8 No. 333-196508) of Sealed Air Corporation, |
(4) | Registration Statement (Form S-8 No. 333-176267) of Sealed Air Corporation, and |
(5) | Registration Statement (Form S-8 No. 333- 89090) of Sealed Air Corporation; |
of our report dated February 19, 2019, except for Notes 3, 6, 17 and 18, as to which the date is March 2, 2020, with respect to the consolidated financial statements of Sealed Air Corporation and subsidiaries included in this Annual Report (Form 10-K) of Sealed Air Corporation for the year ended December 31, 2019.
/s/ Ernst & Young LLP |
Charlotte, North Carolina |
March 2, 2020 |
Exhibit 31.1
CERTIFICATIONS
I, Edward L. Doheny II, certify that:
1. I have reviewed this Annual Report on Form 10-K of Sealed Air Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
/S/ EDWARD L. DOHENY II |
Edward L. Doheny II |
President and Chief Executive Officer |
Date: March 2, 2020
Exhibit 31.2
CERTIFICATIONS
I, James M. Sullivan, certify that:
1. I have reviewed this Annual Report on Form 10-K of Sealed Air Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
/S/ JAMES M. SULLIVAN |
James M. Sullivan |
Senior Vice President and Chief Financial Officer |
Date: March 2, 2020
Exhibit 32
Certification of CEO and CFO Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report on Form 10-K of Sealed Air Corporation (the “Company”) for the fiscal year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Edward L. Doheny II, as President and Chief Executive Officer of the Company, and James M. Sullivan, as Senior Vice President and Chief Financial Officer of the Company, each hereby certifies pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his/her knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
By: | /s/ EDWARD L. DOHENY II | ||
Name: Edward L. Doheny II | |||
Title: President and Chief Executive Officer | |||
Date: March 2, 2020 | |||
By: | /s/ JAMES M. SULLIVAN | ||
Name: James M. Sullivan | |||
Title: Senior Vice President and Chief Financial Officer | |||
Date: March 2, 2020 | |||